Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Commercialization & Economic De Commercialization & Economic Development $128,592.
$0.
$128,592.
$128,592.
$0.
$128,592.
$175,000.
$0.
$175,000.
$175,000.
$0.
$175,000.
$0.
$13,500.
$13,500.
$36,200. Naugle, Lottie Becky 3048110057 Louisville Metro Government Lousiville/Jefferson County Metro Government Funding for Lousiville SBDC
$0.
$36,200.
Naugle, Lottie Becky 3048110108 Small Business Administration Kentucky Small Business Development Center
$619,832.
$0.
$619,832.
Naugle, Lottie Becky 3048110108 Small Business Administration Kentucky Small Business Development Center
$0.
$721,647.
$721,647.
$656,032. $959,624.
$735,147. $735,147.
$1,391,179. $1,694,771.
$57,679.
$0.
$57,679.
$57,679.
$0.
$57,679.
$283,658.
$0.
$283,658.
$283,658. $341,337.
$0. $0.
$283,658. $341,337.
$24,282.
$0.
$24,282.
Harvey, Dean E 3048109671 Economic Development Administration Transforming Innovation into Jobs in the Bluegrass Commercialization & Economic Development Business Development
Totals:
Nash, Warren O 3048109541 KY Science and Technology Co Inc Lexington ICC Business Development Small Business Development Center
Totals:
Naugle, Lottie Becky 3048105989 Commerce Lexington Inc KY Small Business Development Center Lease
Small Business Development Center Totals: Commercialization & Economic Development Totals: Vice President Institutional Divers Vice President Institutional Diversity Jackson, Judy F. 3048110015 KY Council on Postsecondary Education Governors Minority Student College Preparation Program Vice President Institutional Diversity Student Support Services
Totals:
Wims, Lydia E 3048109866 Department of Education Univeristy of Kentucky Student Support Services Student Support Services Totals: Vice President Institutional Diversity Totals: Exec VP for Health Affairs Exec VP for Health Affairs Christmann, Jennifer A Sandia National Laboratories Global Threat Reduction Initiative
Page 1 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Exec VP for Health Affairs Exec VP for Health Affairs $35,000. Swartz, Colleen Hope 3048109564 Center for Creative Leadership Center for Creative Leadership RWJ Fellowship Grant - Colleen Swartz
$0.
$35,000.
$199,947. $0. $199,947. Swartz, Colleen Hope 3048109992 National Science Foundation Collaborative Research: Modeling and Analysis of Rapid Response Operations to Improve Patient Care and Safety: A Systems-Theoretic Approach" Exec VP for Health Affairs Totals: $259,229. $0. $259,229. Exec VP for Health Affairs Totals: $0. $259,229. $259,229. Campus Services UK Police $9,120. Brown, Charles Nathan 3048110148 KY Office of Homeland Security University of Kentucky Police Department, Mobile Data Computer Project
$0.
$9,120.
$0. $0.
$9,120. $9,120.
$0. Tracy, James W 3048103738 KY Department of Environmental Protection Supplemental Environmental Project Compliance Assistance Tools and Services
$6,793.
$6,793.
$0. Tracy, James W 3048103738 KY Department of Environmental Protection Supplemental Environmental Project Compliance Assistance Tools and Services
$208.
$208.
$0. Tracy, James W 3048103738 KY Department of Environmental Protection Supplemental Environmental Project Compliance Assistance Tools and Services
$195.
$195.
$7,196.
$7,196.
UK Police
Totals: Campus Services Totals:
$9,120. $9,120.
Research VP for Research
VP for Research KY Geological Survey
Totals:
$0.
$203,069. $0. Andrews, William M 3048109448 US Geological Survey Quaternary and Surficial Geologic Mapping for Geotechnical and Geohazards Applications in Kentucky
$203,069.
$11,328.
$0.
$11,328.
Curl, Douglas C 3048107211 Arizona Geological Survey ARRA: National Geothermal Data System Program
$0.
$167,888.
$167,888.
Curl, Douglas C 3048107211 Arizona Geological Survey ARRA: National Geothermal Data System Program
$0.
$24,102.
$24,102.
Andrews, William M 3048110384 University of Louisville RFP 3004 - Consultant for Soil Engineering Data Enhancement
Page 2 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research KY Geological Survey $39,300. Curl, Douglas C 3048109625 KY Energy and Environment Cabinet An Internet Map Application for Kentucky Coal Resource Information
$0.
$39,300.
$25,000. Curl, Douglas C 3048109751 US Geological Survey 2012 National Geological and Geophysical Data Preservation for Kentucky
$0.
$25,000.
$50,250. $0. $50,250. Davidson, Oscar B 3048110119 KY Energy and Environment Cabinet Enhancing the Capacity for Environmental and Public Health Surveillance of Unregulated Drinking Water in Kentucky $0. $43,952. $43,952. Hickman, John B 3048109677 West Virginia University Utica Shale Appalachian Basin Exploration Consortium $0.
$147,140.
$7,700. Lynch, Michael J 3048109672 KY Board of Registration for Professional Geologis Communications Liaison for Kentucky Board of Registration for Professional Geologists
$0.
$7,700.
$51,792. Parris, Thomas M 3048110553 Battelle Memorial Institute Development of Subsurface Brine Disposal Framework in the Northern Appalachian Basin
$0.
$51,792.
$535,579.
$235,942.
$771,521.
$0.
$1,300,000.
$1,300,000.
$345,996.
$0.
$345,996.
Adams, Chithra 3048107507 University of Tennessee Tennessee State Improvement Grant
$0.
$82,126.
$82,126.
Adams, Chithra 3048109847 KY Department of Education School Improvement Evaluation FY13
$70,177.
$0.
$70,177.
Adams, Chithra 3048110513 American Printing House for the Blind Incorporated National Instructional Materials Access Center Evaluation
$25,000.
$0.
$25,000.
Hickman, John B 3048109677 West Virginia University Utica Shale Appalachian Basin Exploration Consortium
KY Geological Survey Interdisc Human Development Institute
Totals:
Abell, Michael 3048106788 Department of Education Mid-South Regional Resource Center Abell, Michael 3048110195 KY Department of Education KY State Personnel Development Grant (KY SPDG)
Page 3 of 223
$147,140.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Interdisc Human Development Institute Compton, Jonathan F 3046846000 Pearson Educational Measurement ILSSA NJ
$0.
$179,302.
$179,302.
Compton, Jonathan F 3048107020 Keystone Alternate Assessment Design Assessment Design
$0.
$-35,000.
$-35,000.
Compton, Jonathan F 3048109583 KY Cabinet for Health and Family Services Supports for Community Living - FY 2013
$3,262,436.
$0.
$3,262,436.
$0. $2,504. Compton, Jonathan F 3048109841 KY Department of Education State Professinal Development Grant (SPDG): KY Post-School Outcome Study (KYPSO)
$2,504.
$408,553. Compton, Jonathan F 3048109841 KY Department of Education State Professinal Development Grant (SPDG): KY Post-School Outcome Study (KYPSO)
$0.
$408,553.
Compton, Jonathan F 3048109862 KY Department of Education Kentucky Alternate Assessment Program
$704,148.
$0.
$704,148.
Compton, Jonathan F Questar Assessment Incorporated ILSSA Questar New Jersey
3048110105
$203,429.
$0.
$203,429.
Compton, Jonathan F Questar Assessment Incorporated ILSSA Questar New Jersey
3048110105
$0.
$47,345.
$47,345.
Compton, Jonathan F Questar Assessment Incorporated ILSSA Questar New Jersey
3048110105
$0.
$26,246.
$26,246.
Espinosa, Christina KY Department for the Blind Client Satisfaction Survey FY13
3048109616
$28,988.
$0.
$28,988.
Espinosa, Christina 3048109669 KY Department of Vocational Rehabilitation Statewide Independent Living Council Coordinator
$36,091.
$0.
$36,091.
Hall, Meada G 3048109454 KY Department of Education Community Based Work Transition Program (CBWT)
$109,912.
$0.
$109,912.
Hall, Meada G 3048109668 KY Department of Vocational Rehabilitation Community Based Work Transition Program (OVR)
$151,187.
$0.
$151,187.
Page 4 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Interdisc Human Development Institute Harrison, Mary Elizabeth Mille 3048107720 Department of Education Supported Higher Education Project of Kentucky
$0.
$100.
$100.
Harrison, Mary Elizabeth Mille 3048107720 Department of Education Supported Higher Education Project of Kentucky
$0.
$381,751.
$381,751.
Howard, Mary S 3048109871 National Association of Child Care Resource and Referra Military Child Care Liaison
$0.
$2,650.
$2,650.
Howard, Mary S 3048109871 National Association of Child Care Resource and Referra Military Child Care Liaison
$16,250.
$0.
$16,250.
Howard, Mary S 3048110418 National Association of Child Care Resource and Referra Military Child Care Liaison Initiative
$48,352.
$0.
$48,352.
$2,380,520.
$2,380,520.
$0.
$36,324.
$36,324.
$554,000.
$0.
$554,000.
$90,000.
$0.
$90,000.
$0. Kearns, Jacqueline 3048107790 University of Minnesota National Center and State Collaborative General Supervision Enhancement Grant Kearns, Jacqueline KY Department of Education SPDG: Low Incidence Initiative
3048108608
Kleinert, Harold L 3048109471 Administration for Children and Families University Center for Excellence in Developmental Disabilities Norton, Lori 3048109580 KY Cabinet for Health and Family Services Dartmouth Supported Employment Project FY 13 Rous, Beth KY Department for Public Health UK KEDS First Steps
3048109472
$178,160.
$0.
$178,160.
Rous, Beth KY Department for Public Health UK KEDS First Steps
3048109472
$0.
$25,520.
$25,520.
$236,631.
$0.
$236,631.
$2,440,010.
$0.
$2,440,010.
Rous, Beth 3048109482 KY Department of Education UK Early Childhood KY Data Systems (KEDS) 12-13 Rous, Beth 3048109617 KY Cabinet for Health and Family Services Child Care Resource and Referral SFY13/ZEAA
Page 5 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Interdisc Human Development Institute $375,000.
$0.
$375,000.
$2,858,040. Rous, Beth 3048109798 KY Cabinet for Health and Family Services QEI FY13 Quality Coordinator (ZEBN) Quality Enhancement Initiative
$0.
$2,858,040.
Sheppard-Jones, Kathleen A 3048109526 KY Cabinet for Health and Family Services Home Modification Project
$1,053,744.
$0.
$1,053,744.
Sheppard-Jones, Kathleen A 3048109546 KY Department of Vocational Rehabilitation Customer Satisfaction Survey
$476,245.
$0.
$476,245.
Sheppard-Jones, Kathleen A 3048109546 KY Department of Vocational Rehabilitation Customer Satisfaction Survey
$0.
$43,200.
$43,200.
Sheppard-Jones, Kathleen A 3048109579 KY Cabinet for Health and Family Services Belonging in the Community FY 13
$251,723.
$0.
$251,723.
Tyree, Milton S 3048109659 KY Department of Vocational Rehabilitation Supported Employment Training Project
$228,374.
$0.
$228,374.
Wheeler, Carolyn Bardwell 3048109682 KY Department of Vocational Rehabilitation Migrant Program FY13
$124,061.
$0.
$124,061.
$14,276,507.
$4,472,588.
$18,749,095.
Rous, Beth 3048109792 KY Cabinet for Health and Family Services Training Into Practice Project (TIPP) FY13
Interdisc Human Development Institute Computational Sciences
Totals:
$298,999. Dozier, Alan 3048109884 National Science Foundation SI2-SSI Collaborative Research: A Computational Materials Data and Design Environment
$0.
$298,999.
$0.
$1,615.
$1,615.
$298,999.
$1,615.
$300,614.
Kucera, Barbara A 3048108832 Clemson University A National EPSCoR Cyberinfrastructure Student Engagement Program Computational Sciences KY Water Resources Institute
Totals:
$0. $1,006,450. $1,006,450. Ormsbee, Lindell E 3048108070 National Institute for Hometown Security Studying Distriburtion System Hydraulics and Flow Dynamics to Improve Water Utility Operational Decision Making $0. $55,525. $55,525. Ormsbee, Lindell E 3048108119 US Geological Survey State Water Institute Fiscal Year 2011-2012 Page 6 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research KY Water Resources Institute Ormsbee, Lindell E 3048109468 KY River Authority Watershed Management Services FY13
$98,670.
$0.
$98,670.
Ormsbee, Lindell E 3048109774 KY Department of Environmental Protection Center for Excellence For Watershed Management
$41,793.
$0.
$41,793.
Ormsbee, Lindell E 3048109778 KY Environmental and Public Protection Cabinet FY2013 Floyd's Fork Watershed
$144,155.
$0.
$144,155.
$90,000.
$0.
$90,000.
$374,618.
$1,061,975.
$1,436,593.
Andrews, Rodney 3048105615 Department of Energy Kentucky Research Consortium for Energy and Environment
$0.
$100,000.
$100,000.
Andrews, Rodney 3048105615 Department of Energy Kentucky Research Consortium for Energy and Environment
$0.
$324,998.
$324,998.
Andrews, Rodney 3048105615 Department of Energy Kentucky Research Consortium for Energy and Environment
$0.
$200,000.
$200,000.
Andrews, Rodney 3048108525 National Science Foundation NSF/EPSCoR: Transforming Kentucky's New Economy with EPSCoR
$0.
$2,531,000.
$2,531,000.
Andrews, Rodney 3048108526 KY Council on Postsecondary Education KY EPSCoR: Transforming Kentucky's New Economy with EPSCoR
$0.
$447,530.
$447,530.
Andrews, Rodney 3048108526 KY Council on Postsecondary Education KY EPSCoR: Transforming Kentucky's New Economy with EPSCoR
$0.
$486,267.
$486,267.
Ormsbee, Lindell E 3048109976 KY Natural Resources Environmental Protection Cabinet EPA Scholarship Program KY Water Resources Institute Ctr for Applied Energy Research
Totals:
$582,153. $0. $582,153. Andrews, Rodney 3048109889 Department of Energy AOI1:Small-scale pilot plant for the gasification of coal and coal/biomass blends and conversion of derived syngas to liquid fuels ... $531,408. $0. $531,408. Andrews, Rodney 3048110020 KY Energy and Environment Cabinet Demonstration of an Algae-based System for CO2 Mitigation from Coal-fired Power Plants
Page 7 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Ctr for Applied Energy Research $0. Andrews, Rodney 3048110020 KY Energy and Environment Cabinet Demonstration of an Algae-based System for CO2 Mitigation from Coal-fired Power Plants
$1.
$1.
$30,000.
$0.
$30,000.
$140,166. Anthony, John Edward 3048110003 Merck KGaA Functionalization approaches to high mobility organic semiconductors
$0.
$140,166.
Copley, Gregory C 3048108775 Morehead State University UK-CAER Support for Morehead Innovation Center
$0.
$22,500.
$22,500.
Copley, Gregory C 3048108775 Morehead State University UK-CAER Support for Morehead Innovation Center
$0.
$-1,500.
$-1,500.
$0.
$75,753.
$0. $-75,753. Craddock, John D 3048109588 Materials Sciences Corp Task 3-Integration of New Functionalities into Polymer Reinforced Composite Structures
$-75,753.
Andrews, Rodney 3048110423 KY Council on Postsecondary Education KY EPSCoR Collaborative Research Development Grant
$75,753. Craddock, John D 3048109588 Materials Sciences Corp Task 3-Integration of New Functionalities into Polymer Reinforced Composite Structures
$75,753. Craddock, John D 3048109611 Materials Sciences Corp Task 3-Integration of New Functionalities into Polymer Reinforced Composite Structures
$0.
$75,753.
$0. $76,251. Craddock, John D 3048109611 Materials Sciences Corp Task 3-Integration of New Functionalities into Polymer Reinforced Composite Structures
$76,251.
$0. $153,395. $153,395. Crocker, Mark 3048106749 University of Houston Development of Optimal Catalyst Designs and Operating Strategies for Lean NOx Reduction in Coupled LNT-SCR Systems $0. $50,000. $50,000. Crocker, Mark 3048106828 Sapphire Energy Inc Upgrading of algae oil to hydrocarbon fuels via catalytic decarboxylation Davis, Burtron H 3048108426 National Aeronautics and Space Administration Relating FTS Catalyst Properties to Performance
$0.
$130,000.
$130,000.
Davis, Burtron H 3048108426 National Aeronautics and Space Administration Relating FTS Catalyst Properties to Performance
$0.
$261,293.
$261,293.
Page 8 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Ctr for Applied Energy Research $0.
Davis, Burtron H 3048108426 National Aeronautics and Space Administration Relating FTS Catalyst Properties to Performance
$100,000.
$100,000.
$988,136. $0. $988,136. Davis, Burtron H 3048110112 University of Wyoming Fischer-Tropsch Conversion of Wyoming Derived Syngas Using a Small Channel Reactor for Improving Efficiency and Limiting Emissions $27,551. $0. $27,551. Groppo, John G 3048110414 Physical Sciences Inc STTR:Novel Flotation Techniques for REE Enrichment of Raw Materials Hampson, Steven K KY Department for Public Health FY13 DPH UK Maxey Flats
3048109539
$0.
$25,000.
$25,000.
Hampson, Steven K KY Department for Public Health FY13 DPH UK Maxey Flats
3048109539
$0.
$-12,000.
$-12,000.
Hampson, Steven K KY Department for Public Health FY13 DPH UK Maxey Flats
3048109539
$111,801.
$0.
$111,801.
Hampson, Steven K 3048109540 KY Department for Public Health UK Paducah Gaseous Diffusion - AIP
$0.
$-76,000.
$-76,000.
Hampson, Steven K 3048109540 KY Department for Public Health UK Paducah Gaseous Diffusion - AIP
$235,864.
$0.
$235,864.
Hiett, John K 3048109459 KY Department for Mines and Minerals Mine Mapping Program
$238,449.
$0.
$238,449.
$84,823. $0. $84,823. Hower, James C 3048109761 National Science Foundation Collaborative Research: Characterization of Contaminants and Isotopic Tracers Associated with Coal Combustion Products $20,000. $0. $20,000. Hower, James C 3048110483 Physical Sciences Inc A Low-Cost Rare Earth Elements Recovery Technology. $20,000. Jacobs, Gary 3048110187 Department of Energy Kokes Awards for the 23rd North American Catalysis Society Meeting
$0.
$20,000.
$25,000. Jacobs, Gary 3048110236 National Science Foundation Kokes Awards for the 23rd North American Catalysis Society Meeting
$0.
$25,000.
Page 9 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Ctr for Applied Energy Research Jewell, Robert 3048110330 Electric Power Research Institute The Utilization Potential of Dry FGD Material in OPC Concrete
$151,964.
$74,162. Lipka, Steve 3048110084 ITN Energy Systems Incorporated Demonstration of 2.5kW/10kWh Vanadium Redox Flow Battery (VRFB) through rationally
$0.
$151,964.
$0.
$74,162.
3048110417
$88,837.
$0.
$88,837.
Liu, Kunlei 3048105493 Multiple Industry Sponsors Carbon Management Research Group
$0.
$350,000.
$350,000.
Liu, Kunlei 3048105493 Multiple Industry Sponsors Carbon Management Research Group
$0.
$200,000.
$200,000.
Liu, Kunlei 3048105493 Multiple Industry Sponsors Carbon Management Research Group
$0.
$450,000.
$450,000.
Liu, Kunlei 3048105493 Multiple Industry Sponsors Carbon Management Research Group
$0.
$100,000.
$100,000.
$0. Liu, Kunlei 3048107931 West Virginia University US-China Clean Energy Research Center Advanced Coal Technology Consortium
$103,265.
$103,265.
$0. Liu, Kunlei 3048107931 West Virginia University US-China Clean Energy Research Center Advanced Coal Technology Consortium
$272,060.
$272,060.
Lipka, Steve General Electric Appliances Anode end of life detection system
Liu, Kunlei 3048108590 University of Wyoming Novel Carbon Capture Technology Development for Power Generation Using Wyoming Coal
$0.
$-422,273.
$-422,273.
Liu, Kunlei 3048108590 University of Wyoming Novel Carbon Capture Technology Development for Power Generation Using Wyoming Coal
$0.
$322,873.
$322,873.
$0. $-673,705. $-673,705. Liu, Kunlei 3048109307 Department of Energy Application of A Heat-Integrated Post-combustion CO2 Capture System with Hitachi Advanced Solvent into Existing Coal-Fired Power Plant $0. $986,820. $986,820. Liu, Kunlei 3048109307 Department of Energy Application of A Heat-Integrated Post-combustion CO2 Capture System with Hitachi Advanced Solvent into Existing Coal-Fired Power Plant Page 10 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Ctr for Applied Energy Research $2,000,000. $0. Liu, Kunlei 3048109400 KY Energy and Environment Cabinet Carbon Management Research Group and Support for DOE Cooperative Agreement DE-FE0007395
$2,000,000.
$598,560. $0. $598,560. Liu, Kunlei 3048109810 Department of Energy Solid-Fueled Pressurized Chemical Looping with Flue-Gas Turbine Combined Cycle for Improved Plant Efficiency and CO2 Capture $0. $1,127. $1,127. Liu, Kunlei 3048109810 Department of Energy Solid-Fueled Pressurized Chemical Looping with Flue-Gas Turbine Combined Cycle for Improved Plant Efficiency and CO2 Capture $422,273. $0. $422,273. Liu, Kunlei 3048110035 University of Wyoming Novel Carbon Capture Technology Development for Power Generation Using Wyoming Coal $149,852. $0. $149,852. Liu, Kunlei 3048110180 Green Technology Limited Company STTR: A Contaminant-Tolerant Solvent/Stripping Chemical Hybrid Process for Carbon Capture in Existing Coal-Fired Power Plants $39,000. $0. $39,000. McCarney, Bree Anna 3048110056 KY Energy and Environment Cabinet Kentucky Energy Club - Year 3 Medina, Shiela 3048109687 KY Energy and Environment Cabinet Regional Energy Partnership
$56,811.
$0.
$56,811.
Rantell, Terry D 3048110436 KY Energy and Environment Cabinet Anode Coke from Coal - A Low Cost Approach
$163,565.
$0.
$163,565.
$0. $32,000. Remias, Joseph E 3048108897 Novozymes North America Incorporated Low-Energy Solvents for Carbon Dioxide Capture Enabled by a Combination of Enzymes and Ultrasonics
$32,000.
$300,000. $0. $300,000. Remias, Joseph E 3048110275 University of Wyoming Advanced Solvents for CO2 Capture and Separation Technology for CO2 Sequestration to Enhance Utilization and Reduce Emissions from Wyoming Coal $203,344. $0. $203,344. Remias, Joseph E 3048110437 KY Energy and Environment Cabinet Efficiency improvement in CO2 capture solvent regeneration using a load leveling electricity to thermal energy absorption strategy Ctr for Applied Energy Research Totals: $7,435,225. $6,465,149. $13,900,374. Magnetic Resonance Imaging System Cntr $0. $2,625. $2,625. Smith, Charles D 3048107157 University of California San Diego ARRA: Alzheimer's Disease Neuroimaging Initiative Page 11 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Research Magnetic Resonance Imaging System Cntr Smith, Charles D 3048108031 University of California San Diego Alzheimer's Disease Neuroimaging Initiative 2
$0.
$19,062.
$19,062.
Smith, Charles D 3048108031 University of California San Diego Alzheimer's Disease Neuroimaging Initiative 2
$0.
$-2,625.
$-2,625.
Smith, Charles D 3048108031 University of California San Diego Alzheimer's Disease Neuroimaging Initiative 2
$0.
$31,575.
$31,575.
Smith, Charles D 3048108031 University of California San Diego Alzheimer's Disease Neuroimaging Initiative 2
$0.
$44,046.
$44,046.
Smith, Charles D 3048108031 University of California San Diego Alzheimer's Disease Neuroimaging Initiative 2
$0.
$47,275.
$47,275.
$0. $22,920,928.
$141,958. $12,386,423.
$141,958. $35,307,351.
Turner, Sharon P 3048108800 Morehead State University Appalachian Rural Dental Education Program
$0.
$36,233.
$36,233.
Turner, Sharon P 3048108800 Morehead State University Appalachian Rural Dental Education Program
$0.
$68,000.
$68,000.
$0.
$104,233.
$104,233.
$2,152,938. Ebersole, Jeffrey L 3048109713 National Institute of General Medical Sciences Center for the Biologic Basis of Oral/Systemic Diseases (CBBOSD)
$0.
$2,152,938.
$2.
$0.
$2.
$2,152,940.
$0.
$2,152,940.
$10,000.
$0.
$10,000.
$5,000. Hancock Jones, Laura B. 3048109626 Raymond B Preston Family Foundation Patient Care Reimbursement for Un-insured Children in Henderson County
$0.
$5,000.
Magnetic Resonance Imaging System Cntr Totals: Research Totals: Dentistry Dentistry
Dentistry Dentistry Research & Graduate Studies
Totals:
Ebersole, Jeffrey L 3048110175 Biomedical Development Corporation KSEF SBIR: Ability of Frio Oral Rinse to Lower CV Risk - Lab Analysis Dentistry Research & Graduate Studies Oral Health Science Bimstein, Enrique 3048109642 National Childrens Oral Health Foundation Tooth Fairy Services
Page 12 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Dentistry Oral Health Science $25,000. Huja, Sarandeep S 3048109288 American Association of Orthodontics Foundation Rigidity and Osseointegration of Implants Intended for Orthodontic Applications
$0.
$25,000.
$77,027.
$0.
$77,027.
$2,000.
$0.
$2,000.
$119,027.
$0.
$119,027.
$0.
$2.
$2.
$0.
$2.
Kovarik, Robert E 3048109776 Trover Clinic Foundation Innovation: Delta States Rural Development Grant
$100,000.
$0.
$100,000.
Kovarik, Robert E 3048109939 KY Cabinet for Health and Family Services FY 13 CHFS/DPH UK Oral Health: Outreach HSSJB4
$276,692.
$0.
$276,692.
Kovarik, Robert E 3048109939 KY Cabinet for Health and Family Services FY 13 CHFS/DPH UK Oral Health: Outreach HSSJB4
$0.
$39,532.
$39,532.
Kovarik, Robert E 3048109939 KY Cabinet for Health and Family Services FY 13 CHFS/DPH UK Oral Health: Outreach HSSJB4
$0.
$190,756.
$190,756.
Raybould, Ted P 3048109762 Health Resources and Services Administration Ryan White Dental Reimbursement Grant 2012 Stein, Pamela Ann 3048110122 New York University Oral Health Nursing Education and Practice Program Oral Health Science Oral Health Practice
Totals:
$2. Al-Sabbagh, Mohanad 3048109972 Luitpold Pharmaceuticals, Inc. Xenogenic Collagen Matrix to Increase the Zone of Attached Mucosa Around Implant Dawson, Dolph R 3048110176 Biomedical Development Corporation NIH SBIR: Ability of Frio Oral Rinse to Lowe3r CV Risk - Clinical Part
$498,075. Kovarik, Robert E 3048109947 Health Resources and Services Administration Faculty Development in General, Pediatric, and Public Health Dentistry and Dental Hygiene
$0.
$498,075.
$0. $7,750. $7,750. Miller, Craig S 3048108177 Beech Tree Labs Incorporated A Randomized, Double-Blind, Parallel, Placebo-Controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection $0. $5,250. $5,250. Miller, Craig S 3048108177 Beech Tree Labs Incorporated A Randomized, Double-Blind, Parallel, Placebo-Controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection
Page 13 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Dentistry Oral Health Practice Miller, Craig S 3048110249 Four Tigers LLC STTR: Delivery of Polyphenols for Treatment of Gingivitis - Phase II
$15,194.
$0.
$15,194.
Miller, Craig S HDV Enterprises LLC Antiviral Studies of Calcitonin
3048110258
$20,000.
$0.
$20,000.
Miller, Craig S 3048110566 Carma Laboratories Incorporated Antiviral Studies of Active Ingredients in CARMEX
$50,000.
$0.
$50,000.
$0. Morford, Lorri A 3048108749 National Institute of Dental Research Genetic Markers Associated with Epithelial Ovarian Cancer and Hypodontia
$111,375.
$111,375.
$959,965. $3,231,932.
$354,663. $458,896.
$1,314,628. $3,690,828.
Ashford, Kristin Beth 3048109551 KY Cabinet for Health and Family Services Prenatal and Postpartum Training
$0.
$1,498.
$1,498.
Ashford, Kristin Beth 3048109551 KY Cabinet for Health and Family Services Prenatal and Postpartum Training
$2.
$0.
$2.
$175,571. Ashford, Kristin Beth 3048110271 Centers for Medicare and Medicaid Services EMPOWR: Efforts to maximize perinatal outcomes in women at risk
$0.
$175,571.
$0.
$411,467.
$411,467.
$199,082.
$0.
$199,082.
$0. $118,529. Dekker, Rebecca L 3048109238 National Institute of Nursing Research Cognitive Therapy for Depressive Symptoms in Hospitalized Patients with Heart Failure.
$118,529.
Oral Health Practice
Totals: Dentistry Totals:
Nursing Nursing
Ashford, Kristin Beth 3048110271 Centers for Medicare and Medicaid Services EMPOWR: Efforts to maximize perinatal outcomes in women at risk Darville, Audrey 3048110134 Pfizer Inc Managing Nicotine Withdrawal in Medical and Surgical Patients
Hahn, Ellen J 3048107631 Flight Attendant Medical Research Institute COPD and Strength of Smoke-free Laws Hahn, Ellen J 3048109506 KY Department for Public Health Community Partnerships for Tobacco Use Prevention (KDPH)
Page 14 of 223
$0.
$108,500.
$108,500.
$114,263.
$0.
$114,263.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Nursing Nursing Hahn, Ellen J 3048109811 National Institute of Environmental Health Sciences FRESH: Dual Home Screening for Lung Cancer Prevention
$450,790.
$0.
$450,790.
Hahn, Ellen J 3048109811 National Institute of Environmental Health Sciences FRESH: Dual Home Screening for Lung Cancer Prevention
$0.
$429,606.
$429,606.
Hahn, Ellen J 3048109811 National Institute of Environmental Health Sciences FRESH: Dual Home Screening for Lung Cancer Prevention
$0.
$-8,591.
$-8,591.
$0.
$50,000.
$426,313.
$426,313.
$0.
$10,000.
$2,092,473. $0. Moser, Debra K 3048110484 Patient Centered Outcomes Research Institute Reducing Health Disparities in Appalachians with Multiple Cardiovascular Disease Risk Factors
$2,092,473.
$50,000. Hahn, Ellen J 3048110485 Foundation for a Healthy KY Promoting Responsive Smoke-and Tobacco-free Policy Adoption and Implementation $0. Lennie, Terry A 3048108646 National Institute of Nursing Research Nutrition Intervention to Reduce Symptoms in Patients with Advanced Heart Failure $10,000.
Lennie, Terry A 3048109328 Jonas Center for Nursing Excellence The Jonas Nurse Leaders Scholar Program
$0.
$4,104.
$4,104.
$105,476. Prevost, Suzanne 3048109638 Vanderbilt University Bridging the Gap to Quality Cared: The ISAT Initiative for Nursing Faculty
$0.
$105,476.
$0.
$100,000.
$100,000.
$3,197,657. $3,197,657.
$1,591,426. $1,591,426.
$4,789,083. $4,789,083.
$361,100.
$0.
$361,100.
$0.
$274,284.
$0.
$635,384.
Prevost, Suzanne 3048108069 Vanderbilt University Crafting the Ultimate Faculty Simulation Experience
Salt, Elizabeth Garrison 3048107254 American College of Rheumatology A Model of Decision-Making in Rheumatoid Arthritis Nursing
Totals: Nursing Totals:
Medicine Area Health Educ Ctr Norton, James C 3048109554 KY Department for Public Health FY13-14 SAAA UK Area Health Education Centers
$274,284. Norton, James C 3048110065 University of Louisville Area Health Educaton Centers (AHEC) Point of Service Maintenance and Enhancement Area Health Educ Ctr Page 15 of 223
Totals:
$635,384.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Kentucky Telecare Sprang, Robert R 3048109488 University of Virginia Regional Telehealth Resource Center
$17,250.
$0.
$17,250.
Sprang, Robert R 3048110076 University of Virginia Regional Telehealth Resource Center
$11,920.
$0.
$11,920.
Sprang, Robert R 3048110265 Cumberland Family Medical Center Incorporated Rural Health Network Development Planning
$5,000.
$0.
$5,000.
$34,170.
$0.
$34,170.
Geddes, James W 3048104350 KY Spinal Cord and Head Injury Research Trust Implications of High Neuronal Cyclophilin D Levels for Spinal Cord Injury
$0.
$1,063.
$1,063.
Geddes, James W 3048106042 National Institute of Neurological Disorders & Stroke Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury
$0.
$307,205.
$307,205.
Geddes, James W 3048106042 National Institute of Neurological Disorders & Stroke Cyclophilin D as a Therapeutic Target following Traumatic Brain Injury
$0.
$977.
$977.
$27,989. $0. Geddes, James W 3048109407 National Institute of Neurological Disorders & Stroke Fellowship for Dexter Reneer: Contribution of blast wave components to mild traumatic brain injury
$27,989.
Kentucky Telecare Spinal Cord & Brain Injury Res Ctr
Totals:
$86,004.
$0.
$86,004.
$11,377. Gensel, John Carib 3048109944 Craig H Neilsen Foundation Altering Macrophages to Improve Neuroprotection after Spinal Cord Injury
$0.
$11,377.
$4,300. Gensel, John Carib 3048110582 American Physiological Society Predictive Value of Macrophage Cell lines on Phenotype and Function
$0.
$4,300.
Hall, Edward D 3048107935 National Institute of Neurological Disorders & Stroke UK Spinal Cord and Brain Injury Research Center Core Grant
$0.
$42,806.
$42,806.
Hall, Edward D 3048107935 National Institute of Neurological Disorders & Stroke UK Spinal Cord and Brain Injury Research Center Core Grant
$0.
$592,707.
$592,707.
Hall, Edward D 3048108637 National Institute of Neurological Disorders & Stroke Inhibition of Lipid Peroxidation in SCI
$0.
$185,625.
$185,625.
Geddes, James W 3048110493 KY Spinal Cord and Head Injury Research Trust SCoBIRC Support
Page 16 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Spinal Cord & Brain Injury Res Ctr $0. $100,000. Hall, Edward D 3048108954 KY Spinal Cord and Head Injury Research Trust Diffuse traumatic brain injury induces synaptogenesis and consequent adverse incidents
$100,000.
$153,882.
$0.
$153,882.
$0. Lifshitz, Jonathan 3048106935 National Institute of Neurological Disorders & Stroke Neural Circuit disruption by diffuse brain injury: basis for morbidity & therapy
$-655,298.
$-655,298.
$0. O'Hara, Bruce 3048107973 KY Spinal Cord and Head Injury Research Trust Post-Traumatic Sleep: An Individualized Indicator of Severity and Recovery
$100,000.
$100,000.
Hall, Edward D 3048109146 National Institute of Neurological Disorders & Stroke Neurobiology of CNS Injury and Repair
$0. $-63. $-63. Rabchevsky, Alexander G 3048105500 KY Spinal Cord and Head Injury Research Trust Effects of acety-l-carnitine treatment on mitochondrial function, tissue sparing and hind limb locomotor recovery following contusion spinal cord injury $0. $48,958. $48,958. Rabchevsky, Alexander G 3048108012 University of Louisville Pathophysiology of sensory and sympathetic neurons in SCI-induced autonomic dysreflexia Rabchevsky, Alexander G 3048108635 Craig H Neilsen Foundation Mitochondrial-targeted neuroprotection following spinal cord injury
$0.
$149,982.
$149,982.
Saatman, Kathryn 3048108377 National Institute of Neurological Disorders & Stroke Preclinical evaluation of IGF1 therapy for traumatic brain injury
$0.
$55,950.
$55,950.
Saatman, Kathryn 3048108377 National Institute of Neurological Disorders & Stroke Preclinical evaluation of IGF1 therapy for traumatic brain injury
$0.
$313,476.
$313,476.
$0.
$16,387.
$16,387. Saatman, Kathryn 3048110128 National Institute of Neurological Disorders & Stroke Calpastatin overexpression as a therapeutic approach to traumatic brain injury--Year 3
$49,214. $0. Saatman, Kathryn 3048110310 National Institute of Neurological Disorders & Stroke Fellowship: Sama: Role of Beta Catenin Mediated Neural Stem Cell and Astrocyte Poliferation in TBI
$49,214.
Sullivan, Patrick G 3048108293 National Institute of Neurological Disorders & Stroke Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury
$0.
$21,115.
$21,115.
Sullivan, Patrick G 3048108293 National Institute of Neurological Disorders & Stroke Mitochondrial-Targeted Therapeutics for Treatment of Spinal Cord Injury
$0.
$292,359.
$292,359.
Page 17 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Spinal Cord & Brain Injury Res Ctr $12,000.
$0.
$12,000.
$0.
$99,875.
$99,875.
$361,153.
$1,656,737.
$2,017,890.
Izumi, Tadahide 3048109346 National Cancer Institute Repair of oxidative DNA damage in mammalian cells
$0.
$228,945.
$228,945.
Izumi, Tadahide 3048109346 National Cancer Institute Repair of oxidative DNA damage in mammalian cells
$0.
$230,806.
$230,806.
Li, Guo-Min 3048107290 National Institute of General Medical Sciences DNA Repair Mechanisms in Trinucleotide Repeat Instability
$0.
$253,145.
$253,145.
Li, Guo-Min 3048109397 KY Lung Cancer Research Fund Molecular basis underlying cigarette smoking-induced lung cancer
$0.
$50,000.
$50,000.
Li, Guo-Min 3048109397 KY Lung Cancer Research Fund Molecular basis underlying cigarette smoking-induced lung cancer
$50,000.
$0.
$50,000.
$43,667. Li, Guo-Min 3048109863 University of South Florida Role of HDAC6 in Platinum Resistance of Non-Small Cell Lung Cancer
$0.
$43,667.
$231,103.
$0.
$231,103.
$75,000. Mellon, Isabel 3048110255 KY Lung Cancer Research Fund Nucleotide excision repair and lung cancer in Appalachian Kentucky
$0.
$75,000.
$0. Orren, David K 3048109403 KY Lung Cancer Research Fund Measuring DNA and protein oxidation in populations at risk for lung cancer
$50,000.
$50,000.
$50,000. Orren, David K 3048109403 KY Lung Cancer Research Fund Measuring DNA and protein oxidation in populations at risk for lung cancer
$0.
$50,000.
$0.
$300,713.
$300,713.
Sullivan, Patrick G Environmental Protection Agency Mitochondrial Bioenergetics
3048109733
Yu, Chen-Guang 3048108955 KY Spinal Cord and Head Injury Research Trust Calpain knockdown to minimize damage and deficits following SCI Spinal Cord & Brain Injury Res Ctr Graduate Center for Toxicology
Totals:
Li, Guo-Min 3048110225 National Cancer Institute Novel Mechanism of Genome Instability in Colorectal Cancer
Shi, Xianglin 3048108202 National Institute of Environmental Health Sciences Prevention of UV-Induced Carcinogenesis by Cyanidin-3-glucoside Page 18 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Graduate Center for Toxicology $0.
$300,713.
$300,713.
$100,238.
$0.
$100,238.
St Clair, Daret K 3048105006 National Cancer Institute Redox Regulation of Tumor Suppression by MnSOD
$0.
$361,194.
$361,194.
St Clair, Daret K 3048105194 National Cancer Institute MbSOD in Chemotherapeutic-Induced Cardiac Injury
$0.
$261,900.
$261,900.
St Clair, Daret K 3048107872 National Cancer Institute Mechanisms of MnSOD Expression in Normal and Tumor Cells
$0.
$56,201.
$56,201.
St Clair, Daret K 3048107920 National Cancer Institute Rel B Mediated-Redox Regulation of Radiation Therapy
$0.
$192,709.
$192,709.
St Clair, Daret K 3048107920 National Cancer Institute Rel B Mediated-Redox Regulation of Radiation Therapy
$0.
$169,581.
$169,581.
3048109368
$73,344.
$0.
$73,344.
VORE, MARY 3048105232 National Cancer Institute The Role of MRP1 in Protection of Cardiac Injury
$0.
$261,901.
$261,901.
$50,000. VORE, MARY 3048109411 KY Lung Cancer Research Fund MRP2 expression: Regulation by arsenic and effects on treatment outcomes in lung
$0.
$50,000.
$0. VORE, MARY 3048109411 KY Lung Cancer Research Fund MRP2 expression: Regulation by arsenic and effects on treatment outcomes in lung
$50,000.
$50,000.
$227,299.
$0.
$227,299.
$0.
$109,685.
$109,685.
Shi, Xianglin 3048108905 National Institute of Environmental Health Sciences Cell survival and arsenic carcinogenesis Shi, Xianglin 3048109971 Wayne State University MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis
St Clair, Daret K KY Lung Cancer Research Fund Mechanism of redox injury
VORE, MARY 3048109483 National Institute of Environmental Health Sciences NRSA: Training Grant in Molecular Mechanisms of Toxicology Wei, Qiou 3048109240 National Cancer Institute The Role of Sulfiredoxin in Tumorigenesis and Cancer Progression
Page 19 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Graduate Center for Toxicology Yang, Hsin-Sheng 3048105499 National Cancer Institute The Role of Pdcd4 in Colorectal Tumor Progression
$0.
$129,741.
$129,741.
Yang, Hsin-Sheng 3048105499 National Cancer Institute The Role of Pdcd4 in Colorectal Tumor Progression
$0.
$147,435.
$147,435.
Zhang, Zhuo 3048108654 National Institute of Environmental Health Sciences HIF-alpha in Cr (VI) Carcinogenesis
$0.
$297,705.
$297,705.
$74,250.
$0.
$74,250.
$974,901.
$3,452,374.
$4,427,275.
Zhang, Zhuo 3048109786 National Cancer Institute Apple peel extract inhibits Cr(VI)-induced lung cancer Graduate Center for Toxicology McDowell Cancer Network
Totals:
$0. $13,943. $13,943. Anthony, Lowell 3048110120 Lexicon Pharmaceuticals Incorporated 12-GI-85-LP (LX1606) Evaluate LX1606 in Patients with Carcinoid Syndrome Refractory to Somatostatin Analog (SSA) Therapy $2. $0. $2. Anthony, Lowell 3048110120 Lexicon Pharmaceuticals Incorporated 12-GI-85-LP (LX1606) Evaluate LX1606 in Patients with Carcinoid Syndrome Refractory to Somatostatin Analog (SSA) Therapy $18,000. $0. $18,000. Armstrong, Debra K 3048110474 KY Department for Public Health KCCSP KCP East - Kentucky Cancer Program (KCP) Colon Cancer Screening Project $0. $-452. $-452. Arnold, Susanne M 3048107014 AMGen Phase 2, Single Arm, Open-Label, Multi-Center Trial of Second-Line Panitumumab Monotherapy in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck $0. $3,550. $3,550. Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$400.
$400.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$6,550.
$6,550.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$4,000.
$4,000.
Page 20 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$-4,050.
$-4,050.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$2,500.
$2,500.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$4,050.
$4,050.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$6,450.
$6,450.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$6,100.
$6,100.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$8,044.
$8,044.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$4,000.
$4,000.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$-2,500.
$-2,500.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$2,500.
$2,500.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$27,850.
$27,850.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$7,850.
$7,850.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$5,904.
$5,904.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$650.
$650.
Page 21 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$2,888.
$2,888.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$5,704.
$5,704.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$500.
$500.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$4,050.
$4,050.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$16,050.
$16,050.
Arnold, Susanne M 3048107028 Southwest Oncology Group SOUTHWEST ONCOLOGY GROUP STUDIES
$0.
$30,450.
$30,450.
$0. $75. $75. Arnold, Susanne M 3048107793 Arno Therapeutics Inc A Phase 2 Study of AR-67 (7-t-butyldimrthydiltyl-10-hydroxycamptothecin) in Adult Patients with Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma $0. $12,998. $12,998. Arnold, Susanne M 3048110021 Bristol Myers Squibb Company 11-LUN-87-BMS: (CA184156) Study comparing Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum $0. $10,484. $10,484. Arnold, Susanne M 3048110021 Bristol Myers Squibb Company 11-LUN-87-BMS: (CA184156) Study comparing Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum $2. $0. Arnold, Susanne M 3048110021 Bristol Myers Squibb Company 11-LUN-87-BMS: (CA184156) Study comparing Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum
$2.
$0. $8,000. $8,000. Crispen, Paul 3048109239 Medical Diagnostic Laboratories LLC A Multi-Center, Double-Blind Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects with Bladder Cancer $0. $-2. $-2. Crispen, Paul 3048109239 Medical Diagnostic Laboratories LLC A Multi-Center, Double-Blind Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects with Bladder Cancer $0. $1,469. $1,469. Crispen, Paul 3048109239 Medical Diagnostic Laboratories LLC A Multi-Center, Double-Blind Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects with Bladder Cancer Page 22 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. D'Orazio, John A 3048107428 National Cancer Institute The Role of Mc1r in Melanocytic UV-Induced DNA Damage and Repair Responses
$82,668.
$82,668.
$374,206. Durbin, Eric B 3048109674 National Center for Chronic Disease Prevention & Healt Enhancing Regional Infrastructures for Early Case Capture of Pediatric and Young
$0.
$374,206.
$0.
$1,593,724.
$1,593,724.
$262,814.
$0.
$262,814.
$25,000.
$0.
$25,000.
Evers, Bernard Mark 3048107413 KY Lung Cancer Research Fund Kentucky Lung Cancer Program, Prime Account Evers, Bernard Mark 3048109658 National Cancer Institute Oncology Research Training for Surgeon-Scientists Evers, Bernard Mark 3048109961 Lexington Cancer Foundation Incorporated Integrative Medicine and Cancer Using Jin Shin Jyutsu
$0. $1,260. Fleischman, Roger A 3048107011 Eli Lilly and Company A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
$1,260.
$0. $378. Fleischman, Roger A 3048107011 Eli Lilly and Company A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
$378.
Gao, Tianyan 3048105914 National Cancer Institute The Role of PHLPP in Colon Cancer
$0.
$75,510.
$75,510.
Gao, Tianyan 3048105914 National Cancer Institute The Role of PHLPP in Colon Cancer
$0.
$117,511.
$117,511.
$0. $498. Hayslip, John 3048106938 Cephalon Inc An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Predmisone (R-CVP) $0. $10,096. Hayslip, John 3048106938
$10,096.
Cephalon Inc An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Predmisone (R-CVP) $0. $1,970. Hayslip, John 3048106938
$1,970.
Cephalon Inc An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Predmisone (R-CVP) $0. $150. Hayslip, John 3048106938
$150.
$498.
Cephalon Inc An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Predmisone (R-CVP) Page 23 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $2,516. Hayslip, John 3048108538 Celgene A Phase I, Open-Label, Multi-Center, Parallel Group Study to Assess the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients with and without Impaired Renal Function $0. $4,602. Hayslip, John 3048108929
$2,516.
$4,602.
Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409 Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$22,913.
$22,913.
Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$18,733.
$18,733.
Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$47,616.
$47,616.
Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$37,970.
$37,970.
Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$15,563.
$15,563.
Hayslip, John 3048108929 Sanofi Aventis US Inc HEM02 (ARD130) A Phase 2 Study of SAR245409
$0.
$3,745.
$3,745.
$0. $2,888. Hayslip, John 3048109215 Pfizer Inc An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed or Refractory $0. $2,812. Hayslip, John 3048109215
$2,888.
$2,812.
Pfizer Inc An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed or Refractory $0. $14,445. $14,445. Hayslip, John 3048109215 Pfizer Inc An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed or Refractory $0. $14,234. $14,234. Hayslip, John 3048109215 Pfizer Inc An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed or Refractory
Page 24 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $13,943. $13,943. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $7,111. $7,111. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $756. $756. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $7,756. $7,756. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $1,140. $1,140. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $3,528. $3,528. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $6,938. $6,938. Hayslip, John 3048109302 Celgene A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of rituximab Plus lenalidomide (CC-5013) versus rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma $0. $10,445. $10,445. Hayslip, John 3048109842 Janssen Research and Development LLC 12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib $0. $24,285. $24,285. Hayslip, John 3048109842 Janssen Research and Development LLC 12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib $2. $0. Hayslip, John 3048109842 Janssen Research and Development LLC 12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib
$2.
$0. $1,998. Hayslip, John 3048109842 Janssen Research and Development LLC 12NHL14JJ BTK Inhibitor+Ibrutinib in Patients with Mantle Cell Lymphoma who Progress After Bortezomib
$1,998.
$2. $0. Hayslip, John 3048110412 Janssen Research and Development LLC 12-NHL-18-JJ (PCI-32765MCL3002) Bendamustine-Rituximab +/- Ibrutinib for newly diagnosed Mantle Cell Lymphoma (SHINE) Page 25 of 223
generated on 7/1/2013 15:07:29
$2.
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $13,943. $13,943. Hayslip, John 3048110412 Janssen Research and Development LLC 12-NHL-18-JJ (PCI-32765MCL3002) Bendamustine-Rituximab +/- Ibrutinib for newly diagnosed Mantle Cell Lymphoma (SHINE) $2. $0. $2. Hayslip, John 3048110492 Janssen Research and Development LLC 12-NHL-15-JJ (PCI-32765MCL2002): Ibrutinib for refractory follicular lymphoma $0. $10,158. $10,158. Howard, Dianna S 3048108919 National Marrow Donor Program A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia $0. $5,079. $5,079. Howard, Dianna S 3048108919 National Marrow Donor Program A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia $0. $15,235. $15,235. Howard, Dianna S 3048108919 National Marrow Donor Program A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia $0. $5,079. Howard, Dianna S 3048108919
$5,079.
National Marrow Donor Program A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia $0. $5,079. Howard, Dianna S 3048108919
$5,079.
National Marrow Donor Program A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia $2. $0. Howard, Dianna S 3048110345
$2.
ICON Clinical Research 12-HEM-04-BB (RT12-US-AML-a) PD-616+Cytarabine in Patients with Untreated or Replased/Refractory AML or MDS $0. $6,992. $6,992. Jones, Dennie V 3048109344 Medpace Inc A Randomized Phase 2 Study of Ruxolitinib Efficacy and Safety in Combination with CApecitabine for Subjects with Recurrent or Treatment Refractory Metastatic Pancreatic Cancer (the RECAP trial) $0. $10,399. $10,399. Jones, Dennie V 3048109389 Alpha Oncology Incorporated An Open-Label, Randomized, Phase IIIB Trial Evaluating the Efficacy and Safety of Standard of Care +/Continuous Bevacizumab Treatment beyond Progression of Disease (PD) in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) $0. $988. Jones, Dennie V 3048109389
$988.
Alpha Oncology Incorporated An Open-Label, Randomized, Phase IIIB Trial Evaluating the Efficacy and Safety of Standard of Care +/Continuous Bevacizumab Treatment beyond Progression of Disease (PD) in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Page 26 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Jones, Dennie V 3048109698 Oncothyreon Incorporated A Phase 1/2 study of PX-866 and Cetuximab
$2.
$0.
$2.
Jones, Dennie V 3048109698 Oncothyreon Incorporated A Phase 1/2 study of PX-866 and Cetuximab
$0.
$8,598.
$8,598.
$4,200. $0. $4,200. Jones, Dennie V 3048110226 PPD Development Inc LUN-89(OAM4971g) MetMAb+Tarceva in Patients with NSCLC who Have Received Chemotherapy for Metastatic Disease (Start-Up Only) $0. $31,410. $31,410. Liu, Chunming 3048105898 National Institute Diabetes & Digestive & Kidney GKLF/Beta-Catenin Crosstalk in the Intestine $0. Liu, Chunming 3048108540 National Cancer Institute Mechanisms of Wnt/beta-catenin inhibition by resveratrol and its derivatives
$193,793.
$193,793.
$0. $33,145. $33,145. Massarweh, Suleiman A. 3048107104 Novartis A Phase II Study of Combined Fulvestrant (Fulvestrant) and RAD001 (Everolimus) in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure $0. $19,887. $19,887. Massarweh, Suleiman A. 3048107104 Novartis A Phase II Study of Combined Fulvestrant (Fulvestrant) and RAD001 (Everolimus) in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure $50,820. $0. $50,820. Massarweh, Suleiman A. 3048110529 Bayer Pharmaceuticals BRE-41 Supplemental Budget: Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Advanced Breast Ca $0. $189. $189. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma $0. $2,020. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma
$2,020.
$0. $9,912. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma
$9,912.
$0. $2,965. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma
$2,965.
$0. $3,344. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma
$3,344.
Page 27 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $-3,344. McDonagh, Kevin T 3048107101 Proteolix Inc An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed Multiple Myeloma $0. $3,868. McDonagh, Kevin T 3048107102 Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $127. McDonagh, Kevin T 3048107102
$-3,344.
$3,868.
$127.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $1,368. McDonagh, Kevin T 3048107102
$1,368.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $6,448. McDonagh, Kevin T 3048107102
$6,448.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $3,156. McDonagh, Kevin T 3048107102
$3,156.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $6,448. McDonagh, Kevin T 3048107102
$6,448.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $3,344. McDonagh, Kevin T 3048107102
$3,344.
Millennium Pharmaceuticals Inc An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies $0. $16,324. McDonagh, Kevin T 3048109363
$16,324.
Millennium Pharmaceuticals Inc A Multicenter, Phase 1-2 study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lympohma Treated with Rituximab and Vincristine $0. $5,927. McDonagh, Kevin T 3048109363
$5,927.
Millennium Pharmaceuticals Inc A Multicenter, Phase 1-2 study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lympohma Treated with Rituximab and Vincristine $0. $7,691. McDonagh, Kevin T 3048109363
$7,691.
Millennium Pharmaceuticals Inc A Multicenter, Phase 1-2 study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lympohma Treated with Rituximab and Vincristine
Page 28 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $11,371. $11,371. McDonagh, Kevin T 3048109363 Millennium Pharmaceuticals Inc A Multicenter, Phase 1-2 study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lympohma Treated with Rituximab and Vincristine $0. $21,787. $21,787. McDonagh, Kevin T 3048109363 Millennium Pharmaceuticals Inc A Multicenter, Phase 1-2 study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients with Relapsed or Refractory Aggressive B-Cell Lympohma Treated with Rituximab and Vincristine $0. $1,890. Monohan, Gregory Patrick 3048108521
$1,890.
Cephalon Inc An Open-Label Study to Determine the Maximum Tolerated Dose and Evaluate the Safety and Efficacy of CEP-18770 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma $0. $-2. Monohan, Gregory Patrick 3048108521
$-2.
Cephalon Inc An Open-Label Study to Determine the Maximum Tolerated Dose and Evaluate the Safety and Efficacy of CEP-18770 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma $8,600. $0. Monohan, Gregory Patrick 3048109675
$8,600.
Parexel International Co Phase 2 study of Bortezomib/dexamethasone w or w/o Elotuzumab in pts. with relapsed/refractory MM Moscow, Jeffrey National Cancer Institute Intergovernmental Personnel Act
3048109897
$126,947.
$0.
$126,947.
$0. $-2. $-2. Mullett, Timothy 3048106967 AMGen A Randomized, Double-blind, Placebo-controlled study to evaluate the long-term safety and efficacy of Darbepoetin alfa administered at 500 ug once every 3 weeks in anemic subjects with advanced NSCLC receiving multi-cy $0. $4,498. $4,498. Mullett, Timothy 3048108947 Pfizer Inc A Randomized, Double-Blind, Phase III Efficacy and Safety Study of PF-00299804 vs. Erlotinib for the treatment of Advanced Non-Small Cell Lung Cancer following Progression after, or intolerance to, at least One Prior Chemotherapy $0. $62,432. $62,432. Mullett, Timothy 3048108947 Pfizer Inc A Randomized, Double-Blind, Phase III Efficacy and Safety Study of PF-00299804 vs. Erlotinib for the treatment of Advanced Non-Small Cell Lung Cancer following Progression after, or intolerance to, at least One Prior Chemotherapy $268,166. $0. $268,166. O'Connor, Kathleen L 3048110002 National Cancer Institute Novel Mechanisms of Carcinoma Cell Migration O'Connor, Kathleen L 3048110002 National Cancer Institute Novel Mechanisms of Carcinoma Cell Migration
Page 29 of 223
$0.
$115,760.
$115,760.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $20,000.
$0.
$20,000.
$196,267.
$0.
$196,267.
Romond, Edward H 3048107111 NSABP Foundation STAR Trial Breast Cancer Prevention Trial (P-2)
$0.
$2,100.
$2,100.
Romond, Edward H 3048107111 NSABP Foundation STAR Trial Breast Cancer Prevention Trial (P-2)
$0.
$300.
$300.
Romond, Edward H 3048107111 NSABP Foundation STAR Trial Breast Cancer Prevention Trial (P-2)
$0.
$3,298.
$3,298.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$-600.
$-600.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$9,450.
$9,450.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$13,400.
$13,400.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$400.
$400.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$5,600.
$5,600.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$8,435.
$8,435.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$13,900.
$13,900.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$11,050.
$11,050.
Pauley, Tonya A 3048109530 KY Breast Cancer Trust and Research Fund Horses and Hope Rangnekar, Vivek M 3048110362 National Cancer Institute NRSA T32: Interdisciplinary Research Training in Cancer Biology
Page 30 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$350.
$350.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$100.
$100.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$1,000.
$1,000.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$550.
$550.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$2,050.
$2,050.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$2,750.
$2,750.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$700.
$700.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$100.
$100.
Romond, Edward H NSABP Foundation NSABP Master Agreement
3048107113
$0.
$300.
$300.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$2,250.
$2,250.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$5,200.
$5,200.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$100.
$100.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$5,700.
$5,700.
Page 31 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$-150.
$-150.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,050.
$1,050.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,900.
$1,900.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$-150.
$-150.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$150.
$150.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$50.
$50.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,000.
$1,000.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$2,200.
$2,200.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$150.
$150.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,850.
$1,850.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,300.
$1,300.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$500.
$500.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$200.
$200.
Page 32 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$800.
$800.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$800.
$800.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$50.
$50.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$6,350.
$6,350.
Romond, Edward H NSABP Foundation NSABP Master Agreement (TIND)
3048107126
$0.
$1,700.
$1,700.
Rowland, Randall 3048107131 Southwest Oncology Group SWOG UCOP Urologic Cancer Outreach Program
$0.
$15,050.
$15,050.
Rowland, Randall 3048107131 Southwest Oncology Group SWOG UCOP Urologic Cancer Outreach Program
$0.
$-50.
$-50.
$232,854. She, Qing-Bai 3048110303 National Cancer Institute Targeting Translation Dependence in Colorectal Cancer Progression
$0.
$232,854.
$270,000.
$0.
$270,000.
$36,440. Tucker, Thomas C United Biosource Corp Novo Nordisk, Inc. - NNI Project # MTC - 22341/RSA/Registry Agreement
$0.
$36,440.
Spear, Brett T American Cancer Society Institutional Research Grant
3048110030
$0. $48,947. $48,947. Tucker, Thomas C 3048107899 Macro International Co ARRA: Enhancing Cancer Registry Data for Comparative Effectiveness Research Increased Electronic Reporting Through Electronic Health Records at Non-Hospital Provider Settings $0. $36,217. $36,217. Tucker, Thomas C 3048107899 Macro International Co ARRA: Enhancing Cancer Registry Data for Comparative Effectiveness Research Increased Electronic Reporting Through Electronic Health Records at Non-Hospital Provider Settings $1,297,400. $0. $1,297,400. Tucker, Thomas C 3048109524 National Center for Chronic Disease Prevention & Healt Policy & Environmental Approaches & Community-Clinical Linkages in Cancer Program (NPCR Component) Page 33 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0.
$1,254,381.
$106,858. $0. Tucker, Thomas C 3048109812 National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Patterns of Care/Quality of Care Diagnosis
$106,858.
Tucker, Thomas C 3048109718 National Cancer Institute Surveillance, Epidemiology and End Results (SEER)
$1,254,381.
$1,226,615. Tucker, Thomas C 3048110586 National Center for Chronic Disease Prevention & Healt Policy & Environmental Approaches & Community - Clinical Linkages in Cancer Program
$0.
$1,226,615.
$75,000. $0. $75,000. Valentino, Joseph 3048110274 KY Lung Cancer Research Fund Optimization of Smoking Cessation Strategies in Community Cancer Programs for Newly Diagnosed Lung and Head and Neck Cancer Patients $0. $1,000,000. $1,000,000. Van Zant, Gary 3048109311 Edward P Evans Foundation Molecular Mechanisms and Therapies for Radiation-Induced Myelodysplastic Syndrome (MDS) $2. $0. Villano, John 3048109566 Novocure Ltd A Prospective, Multi-CenterTrial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM $0. $-2. Villano, John 3048109566
$2.
$-2.
Novocure Ltd A Prospective, Multi-CenterTrial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM $0. $1,756. $1,756. Villano, John 3048109566 Novocure Ltd A Prospective, Multi-CenterTrial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM $0. $13,000. $13,000. Villano, John 3048109566 Novocure Ltd A Prospective, Multi-CenterTrial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM $2. $0. Villano, John 3048109655
$2.
Inc Research Inc An Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) with Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy $0. $7,890. $7,890. Villano, John 3048109655 Inc Research Inc An Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) with Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy
Page 34 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine McDowell Cancer Network $0. $756. $756. Villano, John 3048109655 Inc Research Inc An Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) with Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy $0. $6,000. $6,000. Villano, John 3048109655 Inc Research Inc An Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) with Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy $0. $3,443. $3,443. Villano, John 3048109655 Inc Research Inc An Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) with Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy $0. $756. $756. Villano, John 3048109803 Celldex Therapeutics Incorporated 12-GBM-05-CT(CDX 110-04) Rindopepimut+Temozolomide in Newly Diagnosed, Surgically Resected, EGFRVIII-positive Glioblastoma $2. $0. Villano, John 3048109803
$2.
Celldex Therapeutics Incorporated 12-GBM-05-CT(CDX 110-04) Rindopepimut+Temozolomide in Newly Diagnosed, Surgically Resected, EGFRVIII-positive Glioblastoma $0. $13,943. Villano, John 3048109803
$13,943.
Celldex Therapeutics Incorporated 12-GBM-05-CT(CDX 110-04) Rindopepimut+Temozolomide in Newly Diagnosed, Surgically Resected, EGFRVIII-positive Glioblastoma $175,000. $0. Wyatt, Stephen W 3048109734
$175,000.
National Center for Chronic Disease Prevention & Healt Demonstrating the Capacity of the Kentucky Cancer Consortium to Implement Policy $77,000. Xu, Ren 3048109986 American Heart Association Activation of ROR alpha-SEMA3F pathway in epithelial cells inhibits angiogenesis
$0.
$77,000.
$6,106,588.
$4,242,952.
$10,349,540.
Ansari, Mubeen Ahmad 3048108823 Alzheimers Association The complex role of nadph-oxidase in alzheimer's disease
$0.
$50,000.
$50,000.
Bix, Gregory Jaye 3048110086 National Institute of Neurological Disorders & Stroke Perlecan Domain V is a Novel Promoter of Brain Repair after Stroke
$0.
$286,513.
$286,513.
Bix, Gregory Jaye 3048110086 National Institute of Neurological Disorders & Stroke Perlecan Domain V is a Novel Promoter of Brain Repair after Stroke
$0.
$20,692.
$20,692.
McDowell Cancer Network Sanders-Brown Center on Aging
Page 35 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Sanders-Brown Center on Aging $243,300. Bix, Gregory Jaye 3048110086 National Institute of Neurological Disorders & Stroke Perlecan Domain V is a Novel Promoter of Brain Repair after Stroke
$0.
$243,300.
$224,416.
$0.
$224,416.
Head, Elizabeth 3048105504 National Institute on Aging Beta-Amyloid Immunization in a Canine Model of Aging
$0.
$13,481.
$13,481.
Head, Elizabeth 3048105504 National Institute on Aging Beta-Amyloid Immunization in a Canine Model of Aging
$0.
$269,627.
$269,627.
$0. Head, Elizabeth 3048106593 National Institute on Aging Aging of Frontal Structure and Function in Down Syndrome and Dementia
$455,943.
$455,943.
$0. $232,187. Head, Elizabeth 3048107661 PhotoThera Incorporated Transcranial Laser Therapy (TLT) In a Canine Model of Human Aging and Alzheimer's Disease
$232,187.
Bix, Gregory Jaye 3048110312 National Institute of Neurological Disorders & Stroke Neuronal Regeneration of Stroked Brain with Perlecan Domain V
$0. $4,937. $4,937. Jicha, Gregory A 3048103788 University of California San Diego MultiCenter Trial to Evaluate Home-Based Assessment Methods for Alzheimer's Disease Prevention Research in People over 75 Years Old $0. $531. $531. Jicha, Gregory A 3048103788 University of California San Diego MultiCenter Trial to Evaluate Home-Based Assessment Methods for Alzheimer's Disease Prevention Research in People over 75 Years Old $0. $1,094. $1,094. Jicha, Gregory A 3048103788 University of California San Diego MultiCenter Trial to Evaluate Home-Based Assessment Methods for Alzheimer's Disease Prevention Research in People over 75 Years Old $0. $1,413. $1,413. Jicha, Gregory A 3048103788 University of California San Diego MultiCenter Trial to Evaluate Home-Based Assessment Methods for Alzheimer's Disease Prevention Research in People over 75 Years Old $0. $6,650. $6,650. Jicha, Gregory A 3048105559 University of California San Diego Study of the Safety and Effectiveness of Immune Globulin Intravenous (IGIV) for the Treatment of Mild to Moderate Alzheimer Disease $0. $18,031. $18,031. Jicha, Gregory A 3048105559 University of California San Diego Study of the Safety and Effectiveness of Immune Globulin Intravenous (IGIV) for the Treatment of Mild to Moderate Alzheimer Disease
Page 36 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Sanders-Brown Center on Aging $0. $-2. $-2. Jicha, Gregory A 3048105559 University of California San Diego Study of the Safety and Effectiveness of Immune Globulin Intravenous (IGIV) for the Treatment of Mild to Moderate Alzheimer Disease $0. $4,214. $4,214. Jicha, Gregory A 3048107207 Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $7,735. Jicha, Gregory A 3048107207
$7,735.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $10,349. Jicha, Gregory A 3048107207
$10,349.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $23,692. Jicha, Gregory A 3048107207
$23,692.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $34. Jicha, Gregory A 3048107207
$34.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $7,521. Jicha, Gregory A 3048107207
$7,521.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $9,775. Jicha, Gregory A 3048107207
$9,775.
Janssen Alzheimer Immunotherapy Research and Develo ELAN 351 Extension - A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with AD who Participated in Study ELN115727-301 or ELN115727-302 $0. $3,222. Jicha, Gregory A 3048107781
$3,222.
Medivation Inc An Open Label Extension of the CONCERT Protocol (DIM18) Evaluating Dimebon in Patients with AD $0. $2,773. Jicha, Gregory A 3048107783 Janssen Alzheimer Immunotherapy Research and Develo 301 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 NON-Carriers
Page 37 of 223
$2,773.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Sanders-Brown Center on Aging $0. $28,350. Jicha, Gregory A 3048107783 Janssen Alzheimer Immunotherapy Research and Develo 301 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 NON-Carriers $0. $284. Jicha, Gregory A 3048107784
$28,350.
$284.
Janssen Alzheimer Immunotherapy Research and Develo 302 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 CARRIERS $0. $19,660. $19,660. Jicha, Gregory A 3048107784 Janssen Alzheimer Immunotherapy Research and Develo 302 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 CARRIERS $0. $107,894. $107,894. Jicha, Gregory A 3048109141 Alltech Biotechnology Inc Multiple-Ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress $0. $968. $968. Jicha, Gregory A 3048109141 Alltech Biotechnology Inc Multiple-Ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress $0. $58,141. Jicha, Gregory A 3048109141
$58,141.
Alltech Biotechnology Inc Multiple-Ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress $0. $74,417. Jicha, Gregory A 3048109141
$74,417.
Alltech Biotechnology Inc Multiple-Ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress $0. $68,539. Jicha, Gregory A 3048109141
$68,539.
Alltech Biotechnology Inc Multiple-Ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress $2. $0. Jicha, Gregory A 3048109870
$2.
University of California San Diego Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients with Mild to Moderate Alzheimer's Disease $0. $360,985. $360,985. Jicha, Gregory A 3048109945 National Institute of Nursing Research Early detection and prevention of mild cognitive impairment due to cerebrovascular disease $336,640. Jicha, Gregory A 3048109945 National Institute of Nursing Research Early detection and prevention of mild cognitive impairment due to cerebrovascular disease
$0.
$336,640.
$2. $0. Jicha, Gregory A 3048110091 Quintiles Inc Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer#s Disease or Mild Alzheimer's Disease Page 38 of 223
generated on 7/1/2013 15:07:29
$2.
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Sanders-Brown Center on Aging $2. $0. Jicha, Gregory A 3048110561 Eisai Medical Research Inc A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer#s Disease $0. $580,631. Kryscio, Richard J 3048108539
$2.
$580,631.
National Institute on Aging Role of Impaired Cognitive States and Risk Factors in Conversion to Mixed Dementias Lovell, Mark 3048110036 CoPlex Therapeutics LLC STTR: Development of a Novel Therapeutic for Alzheimer's disease
$57,245.
$0.
$57,245.
Lovell, Mark 3048110038 Scout Diagnostics LLC Development of a Plamsa Biomarker of Alzheimer's Disease
$34,685.
$0.
$34,685.
$0. $25,637. Nelson, Peter 3048105195 National Institute of Neurological Disorders & Stroke A Specific microRNA (MIR-107) is a Potential Therapeutic Target in Alzheimer's Disease
$25,637.
$371,250. Nelson, Peter 3048109946 National Institute on Aging MiR-15/107 microRNAs are important genetic regulators in Alzheimer disease
$0.
$371,250.
$0. $-15,000. Norris, Christopher M 3048107937 PhRMA Foundation Fellowship: Jennifer Furman Astrocytic NFAT Activity: A Promising Target for Alzheimer's Therapy
$-15,000.
$0. Norris, Christopher M 3048109207 National Institute on Aging Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
$13,499.
$13,499.
$0. Norris, Christopher M 3048109207 National Institute on Aging Calcineurin and inflammatory signaling processes in aging and Alzheimer's Disease
$269,973.
$269,973.
$99,999.
$0.
$99,999.
$126,181.
$0.
$126,181.
$99,999.
$0.
$99,999.
$307,244.
$0.
$307,244.
Norris, Christopher M 3048110188 KY Spinal Cord and Head Injury Research Trust Role of calcineurin/NFAT signaling in traumatic brain injury Scheff, Stephen W 3048109670 University of Pittsburgh Neurobiology and Cognitive Impairment of the Elderly Scheff, Stephen W 3048110185 KY Spinal Cord and Head Injury Research Trust Pycnogenol and traumatic brain injury Scheff, Stephen W 3048110477 National Institute on Aging Cellular Changes Altering Synaptic Connectivity in PreClinical AD Page 39 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Sanders-Brown Center on Aging Van Eldik, Linda J. 3048106962 National Institute of Neurological Disorders & Stroke Modulation of CNS Proinflammatory Cytokine Production
$0.
$276,485.
$276,485.
Van Eldik, Linda J. 3048106962 National Institute of Neurological Disorders & Stroke Modulation of CNS Proinflammatory Cytokine Production
$0.
$286,513.
$286,513.
Van Eldik, Linda J. 3048107901 Medical Foundation Refinement of p38alpha MAPK Inhibitors for Alzheimer's Disease
$0.
$250,000.
$250,000.
$1,360,603.
$0.
$1,360,603.
$25,000.
$0.
$25,000.
$0.
$16,372.
Van Eldik, Linda J. 3048109481 National Institute on Aging ALZHEIMERS DISEASE CENTER CORE - ADMIN CORE Van Eldik, Linda J. 3048109690 University of Washington National Alzheimer's Coordinating Center (NACC) - Year 14
$16,372. Van Eldik, Linda J. 3048109691 University of Washington Organization of Neuropathologic Assessment of Alzheimer's Disease NACC2012-COLLAB Van Eldik, Linda J. 3048109955 Lilly Endowment Inc 2012 WR Markesbery Symposium on Aging and Dementia
$10,000.
$0.
$10,000.
Van Eldik, Linda J. 3048109958 Baxter Healthcare Co 2nd Annual Markesbery Symposium on Aging and Dementia
$10,000.
$0.
$10,000.
$100,000. Van Eldik, Linda J. 3048110184 KY Spinal Cord and Head Injury Research Trust Novel Therapies for Traumatic Brain Injury: Targeting the Acute Cytokine Surge
$0.
$100,000.
$314,554. Wilcock, Donna M. 3048109487 National Institute of Neurological Disorders & Stroke Vascular breakdown in Alzheimers disease with cerebrovascular disease
$0.
$314,554.
Wilcock, Donna M. 3048109487 National Institute of Neurological Disorders & Stroke Vascular breakdown in Alzheimers disease with cerebrovascular disease
$0.
$20,634.
$20,634.
Wilcock, Donna M. 3048109487 National Institute of Neurological Disorders & Stroke Vascular breakdown in Alzheimers disease with cerebrovascular disease
$0.
$285,697.
$285,697.
$3,737,494.
$4,143,719.
$7,881,213.
$0.
$-8,625.
$-8,625.
Sanders-Brown Center on Aging Cardiovascular Research Center
Totals:
Bruemmer, Dennis C 3048110146 American Diabetes Association Inc Telomere Attrition in Adipose Tissue Senescence and Insulin Resistance Page 40 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Cardiovascular Research Center $163,875. Bruemmer, Dennis C 3048110146 American Diabetes Association Inc Telomere Attrition in Adipose Tissue Senescence and Insulin Resistance
$0.
$163,875.
$104,789. Daugherty, Alan 3048109460 Lexington Biomedical Research Institute MIF: A Pro-Inflammatory Cytokine as a Novel Target to Reduce Bladder Inflammation
$0.
$104,789.
Daugherty, Alan 3048110316 National Heart Lung and Blood Institute Mechanisms of thoracic aortic aneurysms
$536,861.
$0.
$536,861.
Daugherty, Alan 3048110316 National Heart Lung and Blood Institute Mechanisms of thoracic aortic aneurysms
$0.
$-53,685.
$-53,685.
$100,000.
$0.
$100,000.
Lu, Hong 3048110305 Charles River Laboratories Incorporated Enface Analysis
$0.
$5,748.
$5,748.
Lu, Hong 3048110305 Charles River Laboratories Incorporated Enface Analysis
$2.
$0.
$2.
Randall, David C 3048110450 National Heart Lung and Blood Institute Interdisciplinary Cardiovascular Training Program
$115,808.
$0.
$115,808.
$0.
$66,000.
$1,087,335.
$-56,562.
$1,030,773.
Allen, Larry 3048109553 Health Resources and Services Administration State Office of Rural Health Grant Program (SORH)
$180,000.
$0.
$180,000.
Allen, Larry 3048109802 Health Resources and Services Administration Small Rural Hospital Improvement Grant Program (SHIP)
$357,503.
$0.
$357,503.
Allen, Larry 3048109819 Health Resources and Services Administration Kentucky State Loan Repayment Program (SLRP)
$200,000.
$0.
$200,000.
Allen, Larry 3048109837 Health Resources and Services Administration Rural Hospital Flexibility Program
$516,132.
$0.
$516,132.
Li, Zhenyu 3048110366 American Society of Hematology Bridge Grant: cGMP regulates platelet function and thrombosis
$66,000. Subramanian, Venkateswaran 3048110099 American Heart Association Great Rivers Affiliate Role of macrophage-specific calpain in hypercholesterolemia-induced atherosclerosis Cardiovascular Research Center Rural Ky Healthcare
Page 41 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Rural Ky Healthcare Feltner, Frances J KY Department for Public Health Kentucky Homeplace
3048109490
$0.
$-128,600.
$-128,600.
Feltner, Frances J KY Department for Public Health Kentucky Homeplace
3048109490
$1,463,000.
$0.
$1,463,000.
$0.
$30,000.
$0.
$127,105.
$127,105.
$2,746,635.
$-1,495.
$2,745,140.
$565,845. Havens, Jennifer Rochussen 3048110007 National Institute on Drug Abuse Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
$0.
$565,845.
$30,000. Feltner, Frances J 3048109913 Lotts Creek Community School Incorporated Rural Health Care Services Outreach Grant Program (Lotts Creek Community School Project) Knox, Tamara L 3048105140 National Institute of General Medical Sciences Appalachian Kentucky Bridges to Success Rural Ky Healthcare Center on Drug and Alcohol Research
Totals:
Leukefeld, Carl G Purdue Pharma LP Prescription Drug Study - PSO #4
3048109444
$0.
$43,342.
$43,342.
Leukefeld, Carl G Purdue Pharma LP Prescription Drug Study - PSO #3
3048109445
$0.
$2,930.
$2,930.
$5,442,042. Leukefeld, Carl G 3048109568 KY Cabinet for Health and Family Services TAP and Substance Abuse and Domestic Violence Project (Targeted Assessment Program)
$0.
$5,442,042.
Logan, Tk 3048107638 KY Housing Corp Kentucky Housing Corporation - KTOS
$0.
$11,725.
$11,725.
Logan, Tk 3048107638 KY Housing Corp Kentucky Housing Corporation - KTOS
$0.
$875.
$875.
$1,053,540. $0. $1,053,540. Logan, Tk 3048109548 KY Department for Behavioral Health, Developmental and KTOS/Needs Assess (TAA6) and KTOS Research (TAA7) - Kentucky Treatment Outcome Study (KTOS) $0. $49,352. Logan, Tk 3048109548 KY Department for Behavioral Health, Developmental and KTOS/Needs Assess (TAA6) and KTOS Research (TAA7) - Kentucky Treatment Outcome Study (KTOS)
$49,352.
$60,000. Stevenson, Jennifer Erin 3048109705 Mountain Comprehensive Care Center Family-based Offender Substance Abuse Treatment Project - Johnson County
$60,000.
Page 42 of 223
$0.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Center on Drug and Alcohol Research $0. Stevenson, Jennifer Erin 3048109705 Mountain Comprehensive Care Center Family-based Offender Substance Abuse Treatment Project - Johnson County
$-21,000.
$-21,000.
Stevenson, Jennifer Erin 3048109706 Mountain Comprehensive Care Center Co-Occurring Treatment Program - Johnson County
$60,000.
$0.
$60,000.
Stevenson, Jennifer Erin 3048110123 Mountain Comprehensive Care Center Assertive Adolescent and Family Treatment Grant (AAFT)
$60,000.
$0.
$60,000.
Stevenson, Jennifer Erin 3048110130 KY Administrative Office of the Courts Pike County Drug Court: Expansion and Enhancement Project
$65,000.
$0.
$65,000.
$0.
$100,000.
$100,000.
Studts, Christina R 3048107119 Pennyroyal Regional Mental Health Mental Retardation B Pennyroyal Comprehensive Health Care
$208,486. Tindall, Michele Staton 3048109527 KY Department of Corrections Treatment Outcome Study for Prison-Based Substance Abuse Treatment Program - CJKTOS
$0.
$208,486.
Tindall, Michele Staton 3048109956 KY Department of Corrections Evaluation for Family Based Treatment Grant
$40,000.
$0.
$40,000.
Tindall, Michele Staton KY Department of Corrections Co-Occurring Treatment Program
$60,000.
$0.
$60,000.
Walker, James R 3048109719 KY Department of Public Advocacy Alternative Sentencing Social Work Program Outcome Study
$0.
$47,300.
$47,300.
Walker, James R 3048109719 KY Department of Public Advocacy Alternative Sentencing Social Work Program Outcome Study
$47,300.
$0.
$47,300.
Walsh, Sharon L 3048107199 National Institute on Drug Abuse Licit & Illicit Opioids: Comparative Studies in Humans
$0.
$32,664.
$32,664.
Walsh, Sharon L 3048107199 National Institute on Drug Abuse Licit & Illicit Opioids: Comparative Studies in Humans
$0.
$489,972.
$489,972.
Walsh, Sharon L 3048109129 University of Cincinnati Clinical Trial Network, Ohio Valley Node
$0.
$81,228.
$81,228.
Page 43 of 223
3048109957
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Medicine Center on Drug and Alcohol Research Walsh, Sharon L 3048110182 University of Cincinnati Clinical Trials Network, Ohio Valley Node
$15,362.
$0.
$15,362.
Walsh, Sharon L 3048110182 University of Cincinnati Clinical Trials Network, Ohio Valley Node
$0.
$293,940.
$293,940.
$0.
$501,384.
$0. Webster, John Matthew 3048106673 HOPE Center of Lexington Evaluation for the Center on Substance Abuse Treatment Men (CSAT-Men)
$44,200.
$44,200.
$18,460.
$0.
$18,460.
$8,197,419.
$1,176,528.
$9,373,947.
$501,384. Walsh, Sharon L 3048110515 National Institute on Drug Abuse Evaluation of Novel Pharmacotherapies for the Treatment of Opioid Dependence
Webster, John Matthew 3048110066 Eastern KY University DUI Education Delivery Evaluation Study Center on Drug and Alcohol Research Anatomy & Neurobiology
Totals:
$0. $99,997. $99,997. Bing, Guoying 3048108957 KY Spinal Cord and Head Injury Research Trust Neuroinflammation mediates delayed nigrostriatal dopaminergic neurodegeneration after diffuse brain injury $0. $-15. $-15. Bueler, Hans Rudolf 3048108144 Parkinson Schweiz Combining PINK1 gene deletion and mutant LRRK2 overexpression to generate a mouse model with progressive dopamine neuron loss $0. $-20. $-20. Bueler, Hans Rudolf 3048109106 Parkinson Schweiz Impact of defective IGF-1/Akt signaling on a-synuclein and calcium-induced neuronal death in Parkinson's disease Gerhardt, Greg A 3048106768 Wake Forest University Restorative Encoding Memory Integration Neural Device-In Vivo Testing
$0.
$292,363.
$0. $-3,207. Gerhardt, Greg A 3048108232 National Institute of Neurological Disorders & Stroke Fellowship for Jason Hinzman: Alterations in Glutamate Neurotransmission after experimental brain injury
$292,363.
$-3,207.
Gerhardt, Greg A 3048109304 National Institute on Drug Abuse Tonic and Phasic Glutamate Release from Psychomotor Stimulants
$0.
$11,137.
$11,137.
Gerhardt, Greg A 3048109304 National Institute on Drug Abuse Tonic and Phasic Glutamate Release from Psychomotor Stimulants
$0.
$167,063.
$167,063.
Page 44 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Medicine Anatomy & Neurobiology $0. $51,117. $51,117. Gerhardt, Greg A 3048109465 Eli Lilly and Company Intracarnial Delivery of a Newly Diagnosed GDNF formulation (GDNFv) in the Adult Non-Human Primate Brian: MPTP Efficacy Study $26,384. $0. $26,384. Gerhardt, Greg A 3048110443 National Institute on Aging The Cellular and Molecular Basis of Brain Aging $0. Gold, Brian T 3048106564 National Institute on Aging The effects of bilingualism on age-related cognitive and neurobiological declines $0. Grondin, Richard C 3048108563 Alnylam Pharmaceuticals Incorporated Pilot study to select flow rate for siRNA infusion into the Rhesus monkey substantia nigra
$289,688.
$289,688.
$-1.
$-1.
$0. $162,668. $162,668. Grondin, Richard C 3048108917 Alnylam Pharmaceuticals Incorporated siRNA distribution and alpha-synuclein suppression following 7-day siRNA infusion in the Rhesus substantia nigra $0. $36,028. $36,028. Zhang, Zhiming 3048108207 University of Pittsburgh CDNF (Cerebral Dopamine Neurotropic Factor) for Therapy of Parkinson's Disease Program - Supplement 2011 Anatomy & Neurobiology Anesthesiology
Totals:
$1,106,818.
$1,133,202.
$4,000. $0. Rebel, Annette 3048109903 Southern Group for Educational Affairs Use of the Human Patient Simulator to Assess Transfer of Care Using a Rapid Response Model
$4,000.
Anesthesiology Emergency Medicine
Totals:
$26,384.
$4,000.
$0.
$4,000.
Bowers, Rebecca Catherine 3048109975 BTG International Incorporated Observational Study of Recovery from Copperhead Snake Envenomation
$2.
$0.
$2.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$112,500.
$112,500.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$29,700.
$29,700.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$2,115.
$2,115.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$111,687.
$111,687.
Page 45 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Emergency Medicine Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$51,675.
$51,675.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$97,574.
$97,574.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$3,250.
$3,250.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$125,250.
$125,250.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$2,115.
$2,115.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$77,475.
$77,475.
Humphries, Roger L University of Michigan UK NETT Clinical Hub Site
3048104000
$0.
$4,465.
$4,465.
Humphries, Roger L University of Michigan ARRA: POINT
3048108050
$0.
$7,800.
$7,800.
Humphries, Roger L University of Michigan ARRA: POINT
3048108050
$0.
$9,850.
$9,850.
Humphries, Roger L University of Michigan ARRA: POINT
3048108050
$0.
$44,850.
$44,850.
Humphries, Roger L University of Michigan ARRA: POINT
3048108050
$0.
$3,900.
$3,900.
$279,584.
$0.
$279,584.
$0.
$13,648.
$13,648.
Humphries, Roger L 3048109966 National Institute of Neurological Disorders & Stroke UK NETT Clinical Site Hub Humphries, Roger L University of Michigan POINT
Page 46 of 223
3048110215
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Emergency Medicine $2.
$0.
$2.
$85,874.
$0.
$85,874.
$365,462.
$697,854.
$1,063,316.
$565,845. Havens, Jennifer Rochussen 3048109850 National Institute on Drug Abuse Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
$0.
$565,845.
$0. Havens, Jennifer Rochussen 3048109850 National Institute on Drug Abuse Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
$-565,845.
$-565,845.
$0.
$24,996.
$24,996.
Humphries, Roger L University of Michigan POINT
3048110215
Humphries, Roger L 3048110524 University of Michigan UK NETT Clinical Hub Site: Cost Reimb. funds remaining Emergency Medicine Behavioral Science
Totals:
Knudsen, Hannah K 3048105325 University of Georgia Use of Evidence-Based Practices in Alcoholism Treatment
$0. $17,073. $17,073. Knudsen, Hannah K 3048108129 University of Georgia Smoking Cessation Interventions and Program Availability for Drug and Alcohol Addicted Low Income Populations in Substance Abuse Treatment $0. $20,190. $20,190. Knudsen, Hannah K 3048108131 University of Georgia Adoption of Innovations in Private A&D Treatment Centers $214,188. Knudsen, Hannah K 3048110389 National Institute on Drug Abuse Buprenorphine Treatment and Health Reform: Availability, Utilization, and Quality Leukefeld, Carl G 3048109604 New York University School of Medicine Longitudinal Pathways to the Use of Health Services Leukefeld, Carl G 3048109715 National Institute on Drug Abuse Central States Criminal Justice Drug Abuse Center
$0.
$214,188.
$34,005.
$0.
$34,005.
$654,672.
$0.
$654,672.
$125,000. $0. $125,000. Leukefeld, Carl G 3048109851 National Institute on Drug Abuse Implementation of Evidenced-Based Practices for Criminal Justice Agencies or Community Treatment Providers to Research Sites Participating in CJ-DATS $34,131. $0. $34,131. Leukefeld, Carl G 3048110170 New York University School of Medicine Longitudinal Pathways to the Use of Health Services
Page 47 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Behavioral Science Lile, Joshua 3048108286 National Institute on Drug Abuse Medications Development for Cannabis-Use Disorders:Clinical Studies
$0.
$97,468.
$97,468.
Lile, Joshua 3048108286 National Institute on Drug Abuse Medications Development for Cannabis-Use Disorders:Clinical Studies
$0.
$97,468.
$97,468.
$0.
$284,640.
$0.
$23,508.
$23,508.
$191,554. Reynolds, Brady Allen 3048110391 National Institute on Drug Abuse Impulsive Behavior and Treatment Outcomes for Adolescent Smoking
$0.
$191,554.
$634,060. Reynolds, Brady Allen 3048110441 National Institute on Drug Abuse Web-Based Contingency Management for Smoking Abstinence with Adolescents
$0.
$634,060.
$0. Reynolds, Brady Allen 3048110441 National Institute on Drug Abuse Web-Based Contingency Management for Smoking Abstinence with Adolescents
$21,448.
$21,448.
$0. Rush, Craig R 3048105510 National Institute on Drug Abuse Agonist Replacement Therapy for Methamphetamine Dependence: Human Lab Studies
$21,102.
$21,102.
$0. $316,540. Rush, Craig R 3048105510 National Institute on Drug Abuse Agonist Replacement Therapy for Methamphetamine Dependence: Human Lab Studies
$316,540.
$284,640. Lile, Joshua 3048110192 National Institute on Drug Abuse Medications Development for Cocaine: A Translational Approach in Monkey and Human Logan, Tk 3048107981 University of Louisville Victimization and Women in the Criminal Justice System
$0.
$313,371.
$629,694. Rush, Craig R 3048109809 National Institute on Drug Abuse A Novel Anti Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
$0.
$629,694.
$207,130. Rush, Craig R 3048110387 National Institute on Drug Abuse Buspirone as a Candidate Medication for Methamphetamine Abuse
$0.
$207,130.
$581,368.
$581,368.
Rush, Craig R 3048109396 National Institute on Drug Abuse NRSA T32: Research Training in Drug Abuse Behavior
$313,371.
$0. Schoenberg, Nancy E 3048105145 National Institute Diabetes & Digestive & Kidney An Intergenerational CBPR Intervention to Reduce Appalachian Health Disparities
Page 48 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Behavioral Science $167,561. Stoops, William W 3048109663 National Institute on Drug Abuse A Human Laboratory Study to Investigate Buspirone for Cocaine Use Disorders
$0.
$167,561.
$106,366. $0. Studts, Jamie Lawrence 3048110075 Health Decision Technologies LLC STTR: QuitAdvisorOB: A Tool for Delivering Smoking Cessation Guidance to Pregnant Women
$106,366.
Behavioral Science Graduate Center for Nutritional Sciences
Totals:
$4,162,217.
$655,316.
$4,817,533.
$0. $25,000. $25,000. Cassis, Lisa A 3048109428 American Heart Association Great Rivers Affiliate Fellowship for Shoemaker: The Role of the Pancreatic Renin-Angiotensin System in the Development of Type 2 Diabetes $25,000. $0. $25,000. Cassis, Lisa A 3048109428 American Heart Association Great Rivers Affiliate Fellowship for Shoemaker: The Role of the Pancreatic Renin-Angiotensin System in the Development of Type 2 Diabetes $128,004. $0. $128,004. Cassis, Lisa A 3048109571 National Institute Diabetes & Digestive & Kidney NRSA T32: Training Program in Oxidative Stress and Nutrition $0. Pearson, Kevin J. 3048107917 National Institute Diabetes & Digestive & Kidney Maternal Exercise Protects Offspring from Obesity and Insulin Resistance
$290,689.
$290,689.
$0. Pearson, Kevin J. 3048107917 National Institute Diabetes & Digestive & Kidney Maternal Exercise Protects Offspring from Obesity and Insulin Resistance
$20,995.
$20,995.
$74,250.
$0.
$74,250.
$0. Wang, Shuxia 3048105920 National Institute Diabetes & Digestive & Kidney Upstream Stimulatory Factor 2 Regulation of Renin in Diabetic Nephropathy
$249,837.
$249,837.
$77,000.
$0.
$77,000.
$304,254.
$586,521.
$890,775.
$0.
$361,162.
$361,162.
$0. $1,000. Andres, Douglas A 3048110186 KY Spinal Cord and Head Injury Research Trust Role for RitGTPAses Signaling in Forebrain Neurogenesis Following Traumatic Brain Injury
$1,000.
Pearson, Kevin J. 3048109557 National Cancer Institute Maternal Exercise Enhances Cancer Protection in Offspring
Zhou, Changcheng 3048109461 American Heart Association Endocrine Disrupting Chemicals, PXR and Atherosclerosis Graduate Center for Nutritional Sciences Molecular & Cellular Biochemistry
Totals:
Andres, Douglas A 3048107419 National Heart Lung and Blood Institute Regulation of Calcium Channel Function by the Rem GTPase
Page 49 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Cellular Biochemistry $98,867. Andres, Douglas A 3048110186 KY Spinal Cord and Head Injury Research Trust Role for RitGTPAses Signaling in Forebrain Neurogenesis Following Traumatic Brain Injury
$0.
$98,867.
Creamer, Trevor P 3048107140 National Science Foundation REU Site: Summer Program in the Biochemical Sciences
$0.
$30,000.
$30,000.
Dickson, Robert C 3048105541 National Institute on Aging Characterization of the Sch9 Longevity Pathway in Yeast
$0.
$12,861.
$12,861.
Dickson, Robert C 3048105541 National Institute on Aging Characterization of the Sch9 Longevity Pathway in Yeast
$0.
$257,207.
$257,207.
Dutch, Rebecca 3048105529 National Institute of Allergy and Infectious Diseases Paramyxovirus F protein mediated membrane fusion
$0.
$12,345.
$12,345.
Dutch, Rebecca 3048105529 National Institute of Allergy and Infectious Diseases Paramyxovirus F protein mediated membrane fusion
$0.
$277,747.
$277,747.
Dutch, Rebecca 3048105529 National Institute of Allergy and Infectious Diseases Paramyxovirus F protein mediated membrane fusion
$0.
$26,918.
$26,918.
Dutch, Rebecca 3048110293 University of North Carolina Transmembrane domain interactions in pathogenic viruses
$0.
$8,387.
$8,387.
Dutch, Rebecca 3048110293 University of North Carolina Transmembrane domain interactions in pathogenic viruses
$152,486.
$0.
$152,486.
$49,999.
$0.
$49,999.
Galperin, Emilia 3048107578 National Cancer Institute Regulation of MAPK Activity by EGFR Endocytosis
$0.
$241,114.
$241,114.
Gentry, Matthew Shawn 3048107237 National Institute of Neurological Disorders & Stroke Regulation, signaling, and dynamics of glucan phosphatases
$0.
$8,100.
$8,100.
Gentry, Matthew Shawn 3048107237 National Institute of Neurological Disorders & Stroke Regulation, signaling, and dynamics of glucan phosphatases
$0.
$259,019.
$259,019.
Fondufe-Mittendorf, Yvonne N 3048110201 International Rett Syndrome Foundation The epigenetic role of MeCP2 in gene regualtion
Page 50 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Cellular Biochemistry Gentry, Matthew Shawn 3048107237 National Institute of Neurological Disorders & Stroke Regulation, signaling, and dynamics of glucan phosphatases
$0.
$287,799.
$287,799.
Gentry, Matthew Shawn 3048107237 National Institute of Neurological Disorders & Stroke Regulation, signaling, and dynamics of glucan phosphatases
$0.
$18,706.
$18,706.
$46,000. $0. $46,000. Gentry, Matthew Shawn 3048109453 American Heart Association Great Rivers Affiliate Fellowship for Dukhande: Regulation of glycogen phosphorylase by the malin-laforin complex: Implications for cardiac and brain glycogenoses. $40,570. $0. $40,570. Gentry, Matthew Shawn 3048109745 KY Science and Technology Co Inc KSEF RDE: Defining Starch Dephosphorylation in Algal Energy Storage $600,217. Gentry, Matthew Shawn 3048110247 National Science Foundation CAREER: Glucan phosphatases: a key to designer starches and plant energy storage
$0.
$600,217.
$60,919. Gentry, Matthew Shawn 3048110370 Mizutani Foundation for Glycoscience Glucan phosphatases in neurodegeneration and plant starch metabolism
$0.
$60,919.
$0.
$20,708.
$20,708.
$0.
$2,149,009.
$334,125.
$334,125.
Hersh, Louis B 3048104925 Alzheimers Association A Modified Neprilysin for Gene Therapy
$2,149,009. Hersh, Louis B 3048109479 National Institute of General Medical Sciences Center of Biomedical Research Excellence in the Molecular Basis of Human Disease $0. Moncman, Carole 3048108534 National Eye Institute Functional role of sarcomeric nonmuscle myosin IIB in extraocular muscle
$0. $45,000. $45,000. Morris, Andrew 3048108938 American Heart Association Great Rivers Affiliate Fellowship for Fredrick Onono: Physiological role of isoprenols in sterol synthesis and protein isoprenylation Murphy, Michael Paul 3048107472 Alzheimers Association Leptin Resistance and Alzheimer's Disease Murphy, Michael Paul American Heart Association Diabetes, Amyloid and Stroke
3048110251
Rodgers, David W 3048109424 National Institute of Neurological Disorders & Stroke Cavities in Choline Acetyltransferase and Neuromuscular Disorders
Page 51 of 223
$0.
$79,000.
$79,000.
$75,000.
$0.
$75,000.
$0.
$74,250.
$74,250.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Cellular Biochemistry $74,250.
$0.
$74,250.
Stamm, Stefan 3048105877 National Institute of General Medical Sciences Regulation of alternative pre-mRNA processing by small nucleolar RNA's
$0.
$261,981.
$261,981.
Stamm, Stefan 3048108187 US-Israel Binational Science Foundation Alternative splicing regulation by small RNAs
$0.
$39,445.
$39,445.
Stamm, Stefan 3048108187 US-Israel Binational Science Foundation Alternative splicing regulation by small RNAs
$0.
$-2,000.
$-2,000.
Rodgers, David W 3048109424 National Institute of Neurological Disorders & Stroke Cavities in Choline Acetyltransferase and Neuromuscular Disorders
$0. $37,125. Stamm, Stefan 3048108349 National Institute on Drug Abuse Identification of Substances That Change Alternative Pre-mRNA Splicing of the Serotonin 2C Receptor
$37,125.
Turco, Salvatore J 3048105277 Washington University Glycosylation Mutants of Leishmania
$0.
$-133,318.
$-133,318.
Turco, Salvatore J 3048105277 Washington University Glycosylation Mutants of Leishmania
$0.
$291,750.
$291,750.
Vander Kooi, Craig William 3048107603 National Institute of General Medical Sciences Mechanism of Neuropilin Dependent Angiogenesis
$0.
$258,012.
$258,012.
Waechter, Charles J 3048109825 National Institute of General Medical Sciences In Search of Mannolipid Intermediate Flippases
$0.
$-100,168.
$-100,168.
Waechter, Charles J 3048109825 National Institute of General Medical Sciences In Search of Mannolipid Intermediate Flippases
$371,250.
$0.
$371,250.
Waechter, Charles J 3048109825 National Institute of General Medical Sciences In Search of Mannolipid Intermediate Flippases
$0.
$11,068.
$11,068.
$100,000. $0. $100,000. Wang, Qingjun 3048109529 Ellison Medical Foundation Elucidating the Molecular Mechanism of Macroautophagy in Aging Dietary Restriction Utilizing an Integrated Mouse Genetic-proteomic Approach $0. $18,559. $18,559. Whiteheart, Sidney W 3048109245 National Heart Lung and Blood Institute Molecular Mechanisms of Platelet Exocytosis
Page 52 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Cellular Biochemistry Whiteheart, Sidney W 3048109245 National Heart Lung and Blood Institute Molecular Mechanisms of Platelet Exocytosis
$0.
$321,205.
$321,205.
Zhu, Haining 3048108441 ALS Association Studying FUS-mediated Familial ALS using a Drosophilia Model
$0.
$79,260.
$79,260.
Zhu, Haining 3048108541 National Institute of Neurological Disorders & Stroke Role of FUS in ALS
$0.
$21,116.
$21,116.
Zhu, Haining 3048108541 National Institute of Neurological Disorders & Stroke Role of FUS in ALS
$0.
$292,359.
$292,359.
$3,818,567.
$3,751,842.
$7,570,409.
Molecular & Cellular Biochemistry Internal Medicine
Totals:
Abdel-Latif, Ahmed Amorcyte LLC PreSERVE AMI
3048110209
$0.
$1,260.
$1,260.
Abdel-Latif, Ahmed Amorcyte LLC PreSERVE AMI
3048110209
$0.
$6,928.
$6,928.
Abdel-Latif, Ahmed Amorcyte LLC PreSERVE AMI
3048110209
$2.
$0.
$2.
$0. $442. $442. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $630. $630. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $30,000. $30,000. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $1,730. $1,730. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer
Page 53 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $-30,000. $-30,000. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $878. $878. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $7,804. $7,804. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $653. $653. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $-25,000. $-25,000. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $25,500. $25,500. Ain, Kenneth B 3048093400 AstraZeneca Pharmaceuticals An international Phase II randomized double-blinded, placebo-controlled, mulit-center study to assess the efficacy of ZD6474(Zactima TM) versus placebo in patients wiht unresectable locally advanced or metastatic medullary thyroid cancer $0. $2,268. $2,268. Ain, Kenneth B 3048108926 Eisai Medical Research Inc 11-THY-02-EI: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III $0. Ain, Kenneth B 3048108926 Eisai Medical Research Inc 11-THY-02-EI: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III
$11,925.
$11,925.
$0. $1,330. $1,330. Anaya, Paul 3048106728 Duke University Solstice, a Study of Losmapimod Treatment on Inflammation and Infarct Size: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 $0. $1,260. $1,260. Angulo, Paul 3048107740 Medpace Inc A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients with NASH $0. $2,517. Angulo, Paul 3048107740 Medpace Inc A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients with NASH Page 54 of 223
$2,517.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $1,354. Angulo, Paul 3048107740 Medpace Inc A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients with NASH
$1,354.
$0. $7,270. Angulo, Paul 3048107740 Medpace Inc A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients with NASH
$7,270.
$0. $4,970. $4,970. Angulo, Paul 3048108334 Ikaria Incorporated A Multi-Center, Randomized, Placebo-Controlled, Double Blind, Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Lucassin (Terlipressin) $0. $1,260. $1,260. Angulo, Paul 3048108334 Ikaria Incorporated A Multi-Center, Randomized, Placebo-Controlled, Double Blind, Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Lucassin (Terlipressin) $2. $0. Angulo, Paul 3048110218 Premier Research International LLC A Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH) $0. $1,829. Bailey, Alison L 3048109223
$2.
$1,829.
Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $725. $725. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $626. $626. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $24,335. $24,335. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $1,829. $1,829. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease
Page 55 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $24,961. $24,961. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $2,225. $2,225. Bailey, Alison L 3048109223 Duke University Medical Center A Phase 2a, Multi-center, Randomized, Double-blind, Placebocontrolled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics ofa Single Intravenous Infusion of CSLl12 in Patients with Stable Atherotbrombotic Disease $0. $945. $945. Booth, David C 3048106500 Actelion Pharmaceuticals Ltd COMPASS 2: Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Pts. with Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, RAndomized, Placebo-Controlled,.....Phase IV Study $0. $945. $945. Booth, David C 3048106500 Actelion Pharmaceuticals Ltd COMPASS 2: Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Pts. with Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, RAndomized, Placebo-Controlled,.....Phase IV Study $0. $945. $945. Booth, David C 3048106500 Actelion Pharmaceuticals Ltd COMPASS 2: Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Pts. with Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, RAndomized, Placebo-Controlled,.....Phase IV Study $0. $2,079. $2,079. Booth, David C 3048106500 Actelion Pharmaceuticals Ltd COMPASS 2: Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Pts. with Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, RAndomized, Placebo-Controlled,.....Phase IV Study $0. $2,032. $2,032. Booth, David C 3048109392 New York University School of Medicine International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) $0. $3,148. $3,148. Booth, David C 3048109392 New York University School of Medicine International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) $2.
$0.
$2.
$0.
$353,430.
$353,430.
$371,250. Bruemmer, Dennis C 3048109886 National Heart Lung and Blood Institute Epigenetic Regulation of Inflammatory Gene Expression by Telomerase
$0.
$371,250.
Booth, David C INO Therapeutics LLC IK-7001-PAH-201
3048110395
Bruemmer, Dennis C 3048109886 National Heart Lung and Blood Institute Epigenetic Regulation of Inflammatory Gene Expression by Telomerase
Page 56 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine Callahan, Leigh Ann 3048110234 National Heart Lung and Blood Institute Effects of Sleep Deprivation on Infection Induced Organ Failure
$371,250.
$0.
$371,250.
$0. $1,962. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$1,962.
$0. $3,225. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$3,225.
$0. $3,762. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$3,762.
$0. $1,787. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$1,787.
$0. $175. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$175.
$0. $3,025. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$3,025.
$0. $1,962. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$1,962.
$0. $5,987. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$5,987.
$0. $175. Campbell, Charles L. 3048106943 GlaxoSmithKline SOLID TIMI-52 The Stabilization of pLaques Using Darapladib-Thrombolysis in Myocardial Infarction 52
$175.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$2,000.
$2,000.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$5,050.
$5,050.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$8,450.
$8,450.
Page 57 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$1,750.
$1,750.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$2,000.
$2,000.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$948.
$948.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$2,250.
$2,250.
$0. Campbell, Charles L. 3048109214 Schering Plough Co IMPROVE-IT: Improved Reduction of Outcomes: Vytorin Efficacy International Trail
$2,750.
$2,750.
$0.
$259,875.
Chen, Gang 3048109848 National Institute on Alcohol Abuse and Alcoholism RAX, PKR and ethanol neurotoxicity
$259,875.
$0. $4,750. $4,750. Crofford, Leslie J 3046930900 Duke University Medical Center A Randomized, Opel-Label Phase II/III Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with AutoCD34+HPC Versus Intravenous Pulse Cyclophosphamide for the $0. $1. $1. Crofford, Leslie J 3048106859 National Institute Arthritis Musculoskeletal & Skin Microsomal Prostaglandin E Synthase in Rheumatoid Arthritis Crofford, Leslie J 3048106859 National Institute Arthritis Musculoskeletal & Skin Microsomal Prostaglandin E Synthase in Rheumatoid Arthritis
$0.
$288,684.
$0. $2,364. Crofford, Leslie J 3048108488 Bioenergy Incorporated A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects with Fibromyalgia $0. $630. Crofford, Leslie J 3048108488 Bioenergy Incorporated A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects with Fibromyalgia $0. $1,200. Crofford, Leslie J 3048108488
$288,684.
$2,364.
$630.
$1,200.
Bioenergy Incorporated A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects with Fibromyalgia
Page 58 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $5,353. $5,353. Crofford, Leslie J 3048109316 Celgene A Phase 2, Proof-of-Concept, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects with Diffuse Cutaneous Systemic Sclero $2. $0. $2. Crofford, Leslie J 3048110211 Duke University Medical Center A Randomized, Open-Label Phase II/III Multicenter Study of High Dose Immunosuppressive therapy $0. $748. Crofford, Leslie J 3048110211 Duke University Medical Center A Randomized, Open-Label Phase II/III Multicenter Study of High Dose Immunosuppressive therapy
$748.
$0. $750. Crofford, Leslie J 3048110211 Duke University Medical Center A Randomized, Open-Label Phase II/III Multicenter Study of High Dose Immunosuppressive therapy
$750.
$0. $-750. Crofford, Leslie J 3048110211 Duke University Medical Center A Randomized, Open-Label Phase II/III Multicenter Study of High Dose Immunosuppressive therapy
$-750.
$25,000. Daugherty, Alan 3048109431 American Heart Association Great Rivers Affiliate FELLOWSHIP for Wu: The role of angiotensinogen oxidation in atherosclerosis
$0.
$25,000.
$0. Daugherty, Alan 3048109431 American Heart Association Great Rivers Affiliate FELLOWSHIP for Wu: The role of angiotensinogen oxidation in atherosclerosis
$25,000.
$25,000.
$46,000. $0. Daugherty, Alan 3048109432 American Heart Association Great Rivers Affiliate FELLOWSHIP for Poduri: Role of fibroblast cell-specific AT1aR activation in AngII-induced aortic medial hyperplasia in ascending aorta. $0. $3,922. De Villiers, Willem 3048104255
$46,000.
$3,922.
Quintiles Inc A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety & Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis $0. $7,497. $7,497. De Villiers, Willem 3048105468 Quintiles Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter, Multiple Dose Study for the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Ulcerative Colitis $0. $1,260. $1,260. De Villiers, Willem 3048105468 Quintiles Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter, Multiple Dose Study for the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Ulcerative Colitis
Page 59 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $3,780. $3,780. De Villiers, Willem 3048105468 Quintiles Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter, Multiple Dose Study for the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Ulcerative Colitis $0. $3,780. $3,780. De Villiers, Willem 3048105469 Quintiles Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Crohn's Disease $0. $1,260. $1,260. De Villiers, Willem 3048105469 Quintiles Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission with MLN0002 in Patients with Moderate to Severe Crohn's Disease $0. $21,008. $21,008. De Villiers, Willem 3048105470 Quintiles Inc A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease $0. $19,733. $19,733. De Villiers, Willem 3048105470 Quintiles Inc A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease $0. $13,759. $13,759. De Villiers, Willem 3048105470 Quintiles Inc A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease $0. $10,557. $10,557. De Villiers, Willem 3048105470 Quintiles Inc A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease $0. $5,040. $5,040. De Villiers, Willem 3048105470 Quintiles Inc A Phase 3, Open-Label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease $0. $630. De Villiers, Willem 3048106676
$630.
Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring $0. $3,410. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$3,410.
$0. $630. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$630.
$0. $730. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$730.
Page 60 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $730. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$730.
$0. $780. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$780.
$0. $680. De Villiers, Willem 3048106676 Elan Pharmaceuticals PLC INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
$680.
$0. $1,512. $1,512. De Villiers, Willem 3048106989 Schwarz BioSciences Inc A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075 $0. $2,106. $2,106. De Villiers, Willem 3048106989 Schwarz BioSciences Inc A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075 $0. $-90. $-90. De Villiers, Willem 3048106989 Schwarz BioSciences Inc A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075 $0. $1,260. $1,260. De Villiers, Willem 3048106989 Schwarz BioSciences Inc A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075 $0. $504. $504. De Villiers, Willem 3048106989 Schwarz BioSciences Inc A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia) for Crohn's Disease - C87075 $0. $1,600. $1,600. De Villiers, Willem 3048108017 Centocor Inc Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Remicade (Infliximab) and Placebo in the Previention of Recurrence in Crohn's Disease Patients $0. $1,120. $1,120. De Villiers, Willem 3048108017 Centocor Inc Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Remicade (Infliximab) and Placebo in the Previention of Recurrence in Crohn's Disease Patients $0. $630. $630. De Villiers, Willem 3048108017 Centocor Inc Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Remicade (Infliximab) and Placebo in the Previention of Recurrence in Crohn's Disease Patients $0. $1,260. $1,260. De Villiers, Willem 3048108083 Millennium Pharmaceuticals Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients with Moderate to Severe Crohn's Disease Page 61 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $630. $630. De Villiers, Willem 3048108083 Millennium Pharmaceuticals Inc A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients with Moderate to Severe Crohn's Disease $0. $-540. $-540. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $16,806. $16,806. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $748. $748. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $3,880. $3,880. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $1,830. $1,830. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $7,465. $7,465. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $630. $630. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $398. $398. De Villiers, Willem 3048108511 Bristol Myers Squibb Company A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC) $0. $546. $546. De Villiers, Willem 3048108537 Pfizer Inc A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Sfaety of PF-04236921 in subjects with Crohn's Disease Who are Anti-TNF Inadequate Responders $0. $892. $892. De Villiers, Willem 3048108537 Pfizer Inc A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Sfaety of PF-04236921 in subjects with Crohn's Disease Who are Anti-TNF Inadequate Responders
Page 62 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $1,890. $1,890. De Villiers, Willem 3048108537 Pfizer Inc A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Sfaety of PF-04236921 in subjects with Crohn's Disease Who are Anti-TNF Inadequate Responders $0. $6,161. $6,161. De Villiers, Willem 3048108935 Parexel International Co UNITI1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who have Failed $0. $17,134. $17,134. De Villiers, Willem 3048108935 Parexel International Co UNITI1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who have Failed $0. $5,798. $5,798. De Villiers, Willem 3048108935 Parexel International Co UNITI1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who have Failed $0. $728. $728. De Villiers, Willem 3048108935 Parexel International Co UNITI1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who have Failed $0. $5,355. $5,355. De Villiers, Willem 3048108935 Parexel International Co UNITI1 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who have Failed $0. $4,410. $4,410. De Villiers, Willem 3048108936 Parexel International Co UNITI2 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's $0. $5,353. $5,353. De Villiers, Willem 3048108936 Parexel International Co UNITI2 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's $0. $6,161. $6,161. De Villiers, Willem 3048108936 Parexel International Co UNITI2 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's $0. $4,410. $4,410. De Villiers, Willem 3048108937 Parexel International Co IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas
Page 63 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $945. $945. De Villiers, Willem 3048108937 Parexel International Co IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas $0. $943. $943. De Villiers, Willem 3048108937 Parexel International Co IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas $0. $6,791. $6,791. De Villiers, Willem 3048108937 Parexel International Co IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas $0. $-2. $-2. De Villiers, Willem 3048108963 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of CP-690,550 for Maintenance Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $1,890. $1,890. De Villiers, Willem 3048108963 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of CP-690,550 for Maintenance Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $326. $326. De Villiers, Willem 3048109104 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety and Efficacy of CP-690,550 for Induction Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $5,983. $5,983. De Villiers, Willem 3048109104 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety and Efficacy of CP-690,550 for Induction Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $2,520. $2,520. De Villiers, Willem 3048109104 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety and Efficacy of CP-690,550 for Induction Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $6,193. $6,193. De Villiers, Willem 3048109104 Pfizer Inc A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety and Efficacy of CP-690,550 for Induction Therapy in Subjects with Moderate to Severe Crohn's Disease $0. $5,125. $5,125. De Villiers, Willem 3048109130 Pfizer Inc A Multicenter Open-Label Extension Study for Subjects who Participated in Study B0151003. ANDANTE II $0. $7,014. De Villiers, Willem 3048109130 Pfizer Inc A Multicenter Open-Label Extension Study for Subjects who Participated in Study B0151003. ANDANTE II
Page 64 of 223
$7,014.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $786. De Villiers, Willem 3048109130 Pfizer Inc A Multicenter Open-Label Extension Study for Subjects who Participated in Study B0151003. ANDANTE II
$786.
$0. $2,780. De Villiers, Willem 3048109130 Pfizer Inc A Multicenter Open-Label Extension Study for Subjects who Participated in Study B0151003. ANDANTE II
$2,780.
$0. De Villiers, Willem 3048109222 Centocor Inc Remicade Safety Under Long Term Study in Ulcerative Colitis (RESULTS-UC)
$200.
$200.
$0. $965. $965. De Villiers, Willem 3048109228 University of North Carolina MERIT - Randomized, Double-Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis. $0. $1,953. $1,953. De Villiers, Willem 3048109262 GlaxoSmithKline GSK Induction Phase - A Randomized, Double-Blind, Placebo-Controlled Study to Envestigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease. GSK1605786. CCX114151 Induction Phase. $0. $5,983. $5,983. De Villiers, Willem 3048109262 GlaxoSmithKline GSK Induction Phase - A Randomized, Double-Blind, Placebo-Controlled Study to Envestigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease. GSK1605786. CCX114151 Induction Phase. $0. $6,722. $6,722. De Villiers, Willem 3048109262 GlaxoSmithKline GSK Induction Phase - A Randomized, Double-Blind, Placebo-Controlled Study to Envestigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease. GSK1605786. CCX114151 Induction Phase. $2. $0. De Villiers, Willem 3048109555
$2.
Pfizer Inc A3921086 - An Open-Label Extension Study of CP-690,550 as Maintenance Therapy in Patients with Crohn's Disease $0. $630. $630. De Villiers, Willem 3048109555 Pfizer Inc A3921086 - An Open-Label Extension Study of CP-690,550 as Maintenance Therapy in Patients with Crohn's Disease $0. $5,983. $5,983. De Villiers, Willem 3048109555 Pfizer Inc A3921086 - An Open-Label Extension Study of CP-690,550 as Maintenance Therapy in Patients with Crohn's Disease $0. $5,353. $5,353. De Villiers, Willem 3048109648 GlaxoSmithKline CCX114157 - A 52 Week Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease
Page 65 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $2. $0. $2. De Villiers, Willem 3048109648 GlaxoSmithKline CCX114157 - A 52 Week Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease $0. $2,075. $2,075. De Villiers, Willem 3048109648 GlaxoSmithKline CCX114157 - A 52 Week Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease $0. $1,323. $1,323. De Villiers, Willem 3048109648 GlaxoSmithKline CCX114157 - A 52 Week Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease $0. $1,323. $1,323. De Villiers, Willem 3048109650 GlaxoSmithKline CCX114644 - An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn's Disease. $0. $5,353. $5,353. De Villiers, Willem 3048109650 GlaxoSmithKline CCX114644 - An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn's Disease. $2. $0. De Villiers, Willem 3048109650
$2.
GlaxoSmithKline CCX114644 - An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn's Disease. $2. $0. De Villiers, Willem 3048109962
$2.
Altheus Therapeutics Incorporated ZA-201 A Phase II Double-Blind, Randomized, Comparator-Controlled Study of the Safety and Efficacy of Zoenasa Rectal Gel in subjects with Left-Sided Ulcerative Colitis $0. $5,983. De Villiers, Willem 3048109962
$5,983.
Altheus Therapeutics Incorporated ZA-201 A Phase II Double-Blind, Randomized, Comparator-Controlled Study of the Safety and Efficacy of Zoenasa Rectal Gel in subjects with Left-Sided Ulcerative Colitis $1,196,990. $0. $1,196,990. Dignan, Mark B 3048109840 National Cancer Institute Appalachia Community Cancer Network II - U54 $13,712. $0. $13,712. Dignan, Mark B 3048109980 Meharry Medical College Administrative Supplement for a Transdisciplinary Geographic Management Program (GMaP) Pilot Project Dignan, Mark B 3048110181 KY Cabinet for Health and Family Services Kentucky Tobacco Program Evaluation
$5,000.
$0.
$5,000.
Dignan, Mark B George Washington University GMAP Focus Groups
$5,904.
$0.
$5,904.
Page 66 of 223
3048110376
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $4,741. Elayi, Samy Claude 3048105763 University of California San Francisco Evaluating the Effectiveness of the LifeVest Defibrillator and Imporving Methods for Determining the Use of Implantable Cardioverter Defibrillators (The VEST/PREDICTS Study) $0. $7,248. Elayi, Samy Claude 3048109906
$4,741.
$7,248.
Otsuka America Pharmaceutical Inc A Multi-center... Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects with Paroxysmal and Persistent Atrial Fibrillation $2. $0. $2. Elayi, Samy Claude 3048109906 Otsuka America Pharmaceutical Inc A Multi-center... Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects with Paroxysmal and Persistent Atrial Fibrillation $0. $24,697. $24,697. Elayi, Samy Claude 3048109906 Otsuka America Pharmaceutical Inc A Multi-center... Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects with Paroxysmal and Persistent Atrial Fibrillation $0. $621. $621. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $1,890. $1,890. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $3,396. $3,396. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $2,088. $2,088. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $536. $536. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $2,129. $2,129. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $3,803. $3,803. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease.
Page 67 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $2,258. $2,258. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $2,482. $2,482. Flomenhoft, Deborah Ruth 3048108920 Alba Therapeutics Corp A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease. $0. $-1,489. $-1,489. Greenberg, Richard N 3046860900 Covalent Group Phase 1 Open Label Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenity of the Recombinant Plague Vaccine rF1V in Healthy Volunteers $0. $-3,144. Greenberg, Richard N 3046901100
$-3,144.
Acambis Inc A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult volunteers (18-55 years) $0. $5,777. $5,777. Greenberg, Richard N 3046918500 Virxsys Corporation A Phase II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Repeated doses of Autologous T Cells Transduced with VRX496 in HIV-Positive Subjects $0. $3,000. $3,000. Greenberg, Richard N 3046918500 Virxsys Corporation A Phase II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Repeated doses of Autologous T Cells Transduced with VRX496 in HIV-Positive Subjects $0. $-63,227. $-63,227. Greenberg, Richard N 3046978600 Origin Pharmaceutical Services Ltd Randomized, Double-Blind, Placebo-Controlled Phase II Trail of the Safety, Tolerability and Immunology of Lyophilized Chimerivax TM-WN02 West Nile Vaccine in Healthy Adults; Safety and Effectiveness of West Nile Vaccine in Healthy Adults $0. $2. Greenberg, Richard N 3048060300 DP Clinical Inc Immunogenicity Study of a Three-Dose Subcutaneous BioThrax Regimen for Post-Exposure Prophylaxis in Healthy Adults $0. $500. Greenberg, Richard N 3048104349
$2.
$500.
Wyeth Pharmaceuticals Inc A Phase 3, Randomized, Active-Controlled, Modified, Double-Blind Trial to Evaluate the Safety, Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine When Administered Over 12 Months $0. $3,213. $3,213. Greenberg, Richard N 3048104861 Pfizer Inc An International, Multi-Center, Prospective, Observational Study of the Safety of Maraviroc Used With Optimized Background Therapy in Treatment Experienced HIV 1 Infected Patients $0. $1,512. $1,512. Greenberg, Richard N 3048104861 Pfizer Inc An International, Multi-Center, Prospective, Observational Study of the Safety of Maraviroc Used With Optimized Background Therapy in Treatment Experienced HIV 1 Infected Patients
Page 68 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $1,323. $1,323. Greenberg, Richard N 3048104861 Pfizer Inc An International, Multi-Center, Prospective, Observational Study of the Safety of Maraviroc Used With Optimized Background Therapy in Treatment Experienced HIV 1 Infected Patients $0. $3,591. $3,591. Greenberg, Richard N 3048104861 Pfizer Inc An International, Multi-Center, Prospective, Observational Study of the Safety of Maraviroc Used With Optimized Background Therapy in Treatment Experienced HIV 1 Infected Patients $0. $234. $234. Greenberg, Richard N 3048105117 Tibotec Pharmaceuticals Ltd A Phase III, Randomized, Double-Blind Trial of TMC278 25 mg q.d. versus efavirenz 600 mg q.d. in Combination with a Background Regimen Containing 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-naive HIV-1 Infected Subjects $0. $37,367. $37,367. Greenberg, Richard N 3048106600 PaxVax Incorporated A Phase 1 Evaluation of the Safety and Immunogenicity of a Replication-Competent Adenovirus Serotype 4-Vectored H5N1 $0. $2,331. Greenberg, Richard N 3048106922
$2,331.
Wyeth Pharmaceuticals Inc A Phase 3, Open-Label Single Arm Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Doses of 13-Valent Pneumococcal Conjugate Vaccine in Human Immunodeficiency Virus Subjects 18 Years of Age or Older $0. $3,225. $3,225. Greenberg, Richard N 3048106922 Wyeth Pharmaceuticals Inc A Phase 3, Open-Label Single Arm Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Doses of 13-Valent Pneumococcal Conjugate Vaccine in Human Immunodeficiency Virus Subjects 18 Years of Age or Older $0. $3,130. $3,130. Greenberg, Richard N 3048108753 ViroPharma Inc A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI $0. $10,898. $10,898. Greenberg, Richard N 3048108753 ViroPharma Inc A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI $0. $3,459. $3,459. Greenberg, Richard N 3048108753 ViroPharma Inc A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI $0. $-3,459. $-3,459. Greenberg, Richard N 3048108753 ViroPharma Inc A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI
Page 69 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $3,459. $3,459. Greenberg, Richard N 3048108753 ViroPharma Inc A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI $0. $5,479. $5,479. Greenberg, Richard N 3048108784 Pfizer Inc B1851022 - A Phase 3, Open-Label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine $0. $15,733. $15,733. Greenberg, Richard N 3048109126 T2 Biosystems Incorporated Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT Study) - Part 1 Prospective Collection and Freezing of Whole Blood Specimens (PRO-00030 / Site # 11-ID-191) $0. $6,699. $6,699. Greenberg, Richard N 3048109126 T2 Biosystems Incorporated Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT Study) - Part 1 Prospective Collection and Freezing of Whole Blood Specimens (PRO-00030 / Site # 11-ID-191) $0. $63,227. $63,227. Greenberg, Richard N 3048109212 Origin Pharmaceutical Services Ltd Randomized, Double-Blind, Placebo-Controlled Phase II Trail of the Safety, Tolerability and Immunology of Lyophilized Chimerivax TM-WN02 West Nile Vaccine in Healthy Adults; Safety and Effectiveness of West Nile Vaccine in Healthy Adults $0. $-3,000. $-3,000. Greenberg, Richard N 3048109213 Virxsys Corporation A Phase II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Repeated doses of Autologous T Cells Transduced with VRX496 in HIV-Positive Subjects $0. $52,472. $52,472. Greenberg, Richard N 3048109213 Virxsys Corporation A Phase II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Repeated doses of Autologous T Cells Transduced with VRX496 in HIV-Positive Subjects $0. $3,144. $3,144. Greenberg, Richard N 3048109216 Acambis Inc A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult volunteers (18-55 years) $0. $1,489. $1,489. Greenberg, Richard N 3048109219 Covalent Group Phase 1 Open Label Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenity of the Recombinant Plague Vaccine rF1V in Healthy Volunteers $0. $-2,000. Greenberg, Richard N 3048109293
$-2,000.
PaxVax Incorporated 12-ID-192: A Phase 1 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD103-HgR $0. $53,851. $53,851. Greenberg, Richard N 3048109293 PaxVax Incorporated 12-ID-192: A Phase 1 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD103-HgR Page 70 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $454,725. $454,725. Greenberg, Richard N 3048109293 PaxVax Incorporated 12-ID-192: A Phase 1 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD103-HgR $0. $3,498. $3,498. Greenberg, Richard N 3048110206 GlaxoSmithKline 12-ID-193: A phase III, randomised, observer-blind, placebo controlled, multicentre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals# herpes zoster gE/AS01B candidate vaccine when administered intramuscul $2. $0. $2. Greenberg, Richard N 3048110206 GlaxoSmithKline 12-ID-193: A phase III, randomised, observer-blind, placebo controlled, multicentre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals# herpes zoster gE/AS01B candidate vaccine when administered intramuscul $2. $0. $2. Greenberg, Richard N 3048110283 Bavarian Nordic 12-ID-195: A randomized, double-blind, multicenter Phase II trial to compare the immunogenicity and safety of a liquid frozen and a freeze-dried formulation of IMVAMUNE# (MVABN #) smallpox vaccine in vaccinia-na#ve healthy subjects (POX-MVA-027) $0. $-370. $-370. Gurley, John C 3046857600 Atritech Inc WATCHMEN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrilation (Protect AF) $0. $749. $749. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $29,377. $29,377. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $10,036. $10,036. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $8,405. $8,405. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $1,558. $1,558. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $1,521. $1,521. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management Page 71 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $6,448. $6,448. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $3,270. $3,270. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $6,010. $6,010. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $20,521. $20,521. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $35,345. $35,345. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $12,569. $12,569. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $26,986. $26,986. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $3,298. $3,298. Gurley, John C 3048034600 AGA Medical Co Prospective Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder Compared to Medical Management $0. $1,000. $1,000. Gurley, John C 3048105525 AGA Medical Co Closure of Atrial Septal Defects with the Amplatzer Septal Occluder - Post Market Study II (ASD PMS II) $0. $900. Gurley, John C 3048105525 AGA Medical Co Closure of Atrial Septal Defects with the Amplatzer Septal Occluder - Post Market Study II (ASD PMS II)
$900.
$0. $850. Gurley, John C 3048105525 AGA Medical Co Closure of Atrial Septal Defects with the Amplatzer Septal Occluder - Post Market Study II (ASD PMS II)
$850.
Gurley, John C 3048107152 AGA Medical Co AMPLATZER Cardiac Plug (ACP) Clinical Study - Feasibility Study
Page 72 of 223
$0.
$5,973.
$5,973.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine Gurley, John C 3048107152 AGA Medical Co AMPLATZER Cardiac Plug (ACP) Clinical Study - Feasibility Study
$0.
$50.
$50.
Gurley, John C 3048107152 AGA Medical Co AMPLATZER Cardiac Plug (ACP) Clinical Study - Feasibility Study
$0.
$50.
$50.
Gurley, John C 3048107152 AGA Medical Co AMPLATZER Cardiac Plug (ACP) Clinical Study - Feasibility Study
$0.
$125.
$125.
Gurley, John C 3048107152 AGA Medical Co AMPLATZER Cardiac Plug (ACP) Clinical Study - Feasibility Study
$0.
$2,211.
$2,211.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$51.
$51.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$19,410.
$19,410.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$332.
$332.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$16,144.
$16,144.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$405.
$405.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$4,000.
$4,000.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$23,144.
$23,144.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$42,501.
$42,501.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$7,039.
$7,039.
Page 73 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$448.
$448.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$803.
$803.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$82.
$82.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$121.
$121.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$1,410.
$1,410.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$283.
$283.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$541.
$541.
$0. Gurley, John C 3048107818 St Jude Medical Incorporated LAPTOP-HF "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study
$680.
$680.
$0. $315. $315. Gurley, John C 3048109221 Atritech Inc WATCHMEN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrilation (Protect AF) $0. Gurley, John C 3048109340 EKOS Corporation SEATTLE II: Submassive and Massive PE Treatment with Ultrasound Accelerated..
$9,000.
$9,000.
$0. Gurley, John C 3048109340 EKOS Corporation SEATTLE II: Submassive and Massive PE Treatment with Ultrasound Accelerated..
$21,000.
$21,000.
$0. Gurley, John C 3048109340 EKOS Corporation SEATTLE II: Submassive and Massive PE Treatment with Ultrasound Accelerated..
$1,000.
$1,000.
$0. Gurley, John C 3048109340 EKOS Corporation SEATTLE II: Submassive and Massive PE Treatment with Ultrasound Accelerated..
$3,498.
$3,498.
Page 74 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $2. $0. $2. Gurley, John C 3048110351 W L Gore Association Inc GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study) $60,000. $0. $60,000. Hanaoka, Beatriz 3048109417 Arthritis Foundation Muscle Architecture in Chronic DM and PM $0. Hirschowitz, Edward A 3048108592 National Cancer Institute Bionanoconjugates for Detection of Circulating Tumor Cells in Lung Cancer
$74,250.
$74,250.
$0. $1,322. $1,322. Karounos, Dennis G 3048105225 TKL Research Inc A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mellitus $0. $6,775. $6,775. Karounos, Dennis G 3048105238 Osiris Therapeutics Inc A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Prochymal (ex vivo cultured adult human mesenchymal stem cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) $0. $14,356. $14,356. Karounos, Dennis G 3048107731 Novo Nordisk Pharmaceuticals Inc An Extension to Trial NN1250-3583 Comparing Safety and Efficacy of NN1250 With InsulinGlargine, Both With Insulin Aspart as Meal-Time Insulin, in Type 1 Diabetes $0. $10,236. $10,236. Kern, Philip A. 3048106977 GlaxoSmithKline Effects of Fish Oils on Inflammation and Insulin Resistance $0.
$21,546.
$21,546.
$112,732.
$0.
$112,732.
$0. Li, Zhenyu 3048108409 American Heart Association Great Rivers Affiliate Post-Doc Fellowship Binggang Xiang: cGMP regulates platelets activation
$45,000.
$45,000.
Kern, Philip A. 3048106977 GlaxoSmithKline Effects of Fish Oils on Inflammation and Insulin Resistance Kern, Philip A. 3048110338 Washington University in St. Louis University of Kentucky Pilot and Feasibility Research Program
$0. $1,103. $1,103. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities $0. $1,144. $1,144. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities
Page 75 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $2,938. $2,938. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities $0. $2,540. $2,540. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities $0. $4,070. $4,070. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities $0. $4,343. $4,343. Lohr, Kristine 3048107695 Takeda Pharmaceuticals North America Inc A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities $25,000. $0. $25,000. Lohr, Kristine 3048108902 American College of Rheumatology FELLOWSHIP FOR Alikhan: ACR REF Amgen/Pfizer Rheumatology Fellowship Training Award $0. $29,998. $29,998. Malluche, Hartmut H 3048108907 Novartis Effects of Zortress® + Tacrolimus (everolimua) versus Standard Immunosuppression therapy on Progression of Coronary Artery Calcifications in Patients with Renal Transplantation $2. $0. $2. Malluche, Hartmut H 3048108907 Novartis Effects of Zortress® + Tacrolimus (everolimua) versus Standard Immunosuppression therapy on Progression of Coronary Artery Calcifications in Patients with Renal Transplantation $0. $307,559. $307,559. Malluche, Hartmut H 3048109467 National Institute Arthritis Musculoskeletal & Skin Bisphosphonate Use and Bone Quality $0.
$325,573.
$2. Mawad, Hanna W 3048109861 Celgene A Phase 2A, Multi-Center, Randomized, Single-Dose, Double-Blind, Placebo-Controlled
$0.
$2.
$0. Mawad, Hanna W 3048109861 Celgene A Phase 2A, Multi-Center, Randomized, Single-Dose, Double-Blind, Placebo-Controlled
$7,398.
$7,398.
Malluche, Hartmut H 3048109467 National Institute Arthritis Musculoskeletal & Skin Bisphosphonate Use and Bone Quality
$325,573.
$0. $630. $630. McDonagh, Kevin T 3046952500 Bristol Myers Squibb Company A Randomized Two Arm, Multicenter, Open-Label Phase II Study of BMS-354825 Administered Orally at a Dose of 70 mg Twice Daily or 140 mg Once Daily in Subjects with Chronic Myeloid Leukemia in Accelerated Phae or in Myeloid or Lymphoid Page 76 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $630. $630. McDonagh, Kevin T 3046959100 Bristol Myers Squibb Company A Randomized Two-by-Two, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 50 mg or 70 mg Twice Daily or 100 mg or 140 mg Once Daily in Subjects with Chronic Phase Philadelphia Chromosome or BCR-ABL Positive Chronic $0. $9,482. $9,482. Miller, Beth A 3048106757 GlaxoSmithKline A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects with Severe Uncontrolled Refractory Asthma. $0. $152. $152. Miller, Beth A 3048108225 Cephalon Inc A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 years of age) $0. $7,710. Miller, Beth A 3048108225
$7,710.
Cephalon Inc A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 years of age) $0. $2,471. Miller, Beth A 3048108225
$2,471.
Cephalon Inc A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 years of age) $0. $14,670. $14,670. Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET) Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET)
$0.
$2,858.
$2,858.
Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET)
$0.
$5,343.
$5,343.
Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET)
$0.
$500.
$500.
Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET)
$2.
$0.
$2.
Miller, Beth A 3048109712 PPD Development Inc A 12-Week Dose-ranging Study (TRUMPET)
$0.
$1,890.
$1,890.
Page 77 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $3,368. $3,368. Miller, Beth A 3048109916 Cephalon Inc An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma Who Completed a Prior Cephalon-Sponsored Study in Eosinophilic Asthma $0. $5,998. $5,998. Miller, Beth A 3048109916 Cephalon Inc An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma Who Completed a Prior Cephalon-Sponsored Study in Eosinophilic Asthma $2. $0. Miller, Beth A 3048109916
$2.
Cephalon Inc An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma Who Completed a Prior Cephalon-Sponsored Study in Eosinophilic Asthma $0. $1,390. $1,390. Miller, Beth A 3048110018 GlaxoSmithKline GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial. $2. $0. Miller, Beth A 3048110018
$2.
GlaxoSmithKline GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial. $0. $4,289. Miller, Beth A 3048110018
$4,289.
GlaxoSmithKline GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial. $0. $1,390. Miller, Beth A 3048110018
$1,390.
GlaxoSmithKline GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial. $0. $4,469. Miller, Beth A 3048110171
$4,469.
Parexel International Co A 6-month safety and benefit study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6200 Pediatric Subjects 4-11 years old with Persistent Asthma $2. $0. Miller, Beth A 3048110171
$2.
Parexel International Co A 6-month safety and benefit study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6200 Pediatric Subjects 4-11 years old with Persistent Asthma $0. $2,700. $2,700. Moliterno, David Jon 3048108117 Mount Sinai The PARIS Registry: Patterns of Non-Adherence to Anti-platelet Regimens In Stented Patients - An Observational Single Arm Study $0. $5,450. $5,450. Moliterno, David Jon 3048108117 Mount Sinai The PARIS Registry: Patterns of Non-Adherence to Anti-platelet Regimens In Stented Patients - An Observational Single Arm Study Page 78 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $675. $675. Moliterno, David Jon 3048108117 Mount Sinai The PARIS Registry: Patterns of Non-Adherence to Anti-platelet Regimens In Stented Patients - An Observational Single Arm Study $0. $878. $878. Nickl, Nicholas J 3048109496 PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $0. $4,807. $4,807. Nickl, Nicholas J 3048109496 PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $0. $2,299. $2,299. Nickl, Nicholas J 3048109496 PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $2. $0. Nickl, Nicholas J 3048109496
$2.
PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $0. $75. $75. Nickl, Nicholas J 3048109496 PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $0. $75. $75. Nickl, Nicholas J 3048109496 PPD Development Inc 27018966IBS3001: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome $77,000. $0. $77,000. Panchatcharam, Manikandan 3048109434 American Heart Association Scientist Development Grant: Manikandan Panchatcharam Regulation of Vascular Cells and the Arterial Response to Injury by Lipid Phosphate Phosphatase 3 $0. $630. Pena, Luis R 3048104481
$630.
GlaxoSmithKline Randomized, placebo-controlled, multi-center study to assess the efficacy and safety of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligible to initiate antiviral therapy ENABLE 2 $0. $1,000. $1,000. Pena, Luis R 3048106944 Schering Plough Co Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Use Versus Ribavirin Dose Reduction for the Management of Anemia
Page 79 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. Rajagopalan, Navin 3048107340 University of Pittsburgh ARRA: Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
$1,000.
$1,000.
$0. Rajagopalan, Navin 3048107340 University of Pittsburgh ARRA: Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
$920.
$920.
$0. Rajagopalan, Navin 3048107340 University of Pittsburgh ARRA: Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
$1,600.
$1,600.
$0.
$77,000.
$0.
$25,000.
$0.
$53,274.
$53,274.
$200,000.
$0.
$200,000.
$50,000.
$0.
$50,000.
$0. Selby, Lisbeth Ann 3048107723 University of California San Francisco PIANO: Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes
$150.
$150.
$0.
$344,365.
$344,365.
$0. $25,000. Smyth, Susan 3048108174 AstraZeneca Pharmaceuticals Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
$25,000.
$0. $4,999. Sorrell, Vincent 3048109274 Duke Clinical Research Institute ARRA: PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$4,999.
Ren, Hongmei 3048109430 American Heart Association Regulation of Mitochondrial Oxidative Metabolism by Lipin 1
$77,000.
$25,000. Rose, Stephanie A. 3048109969 Obesity Society Improvement in Provider and Patient Self-Efficacy in Weight Loss in Primary Care Rudy, David W 3048106758 University of Massachusetts RCT for Smoking Cessation in 10 Medical Schools Schaninger, Takako 3048109610 Health Resources and Services Administration Southern Central AIDS Education Telehealth Training Center Schaninger, Takako Emory University Telehealth TTCP
3048109878
Smyth, Susan 3048107439 National Heart Lung and Blood Institute Lysolipid Signaling in Cardiovasuclar Disease
$0. Sorrell, Vincent 3048109274 Duke Clinical Research Institute ARRA: PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
Page 80 of 223
$200.
$200.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $1,200. Sorrell, Vincent 3048109274 Duke Clinical Research Institute ARRA: PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$1,200.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$1,600.
$1,600.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$3,400.
$3,400.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$600.
$600.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$6,100.
$6,100.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$200.
$200.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$1,000.
$1,000.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$800.
$800.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$2,800.
$2,800.
$0. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$398.
$398.
$2. Sorrell, Vincent 3048109892 Duke Clinical Research Institute PROMISE: Prospective Multicenter Imaging study for the Evaluation of Chest Pain
$0.
$2.
Tannock, Lisa R 3048109437 American Heart Association Great Rivers Affiliate FELLOWSHIP for Thompson: Serum Amyloid A is proatherogenic
$0.
$25,000.
$25,000.
Tannock, Lisa R 3048109437 American Heart Association Great Rivers Affiliate FELLOWSHIP for Thompson: Serum Amyloid A is proatherogenic
$25,000.
$0.
$25,000.
Page 81 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $157,989. Thornton, Alice C 3048109466 KY Cabinet for Health and Family Services Kentucky HIV/AIDS Care Coordinator Program - Ryan White Part B
$0.
$157,989.
Thornton, Alice C 3048109603 Emory University KY Aids Education Training Center (KYAETC)
$0.
$-496.
$-496.
Thornton, Alice C 3048109603 Emory University KY Aids Education Training Center (KYAETC)
$160,496.
$0.
$160,496.
Thornton, Alice C 3048109605 Emory University KY Aids Education Training Center (KYAETC)
$20,000.
$0.
$20,000.
$400,000. $0. $400,000. Thornton, Alice C 3048109653 Health Resources and Services Administration Ryan White Part D - Coordinated HIV Services and Access to Research for Women, Infants, Children , and Youth (WICY) $0. $320,407. $320,407. Thornton, Alice C 3048109796 KY Cabinet for Health and Family Services Kentucky HIV/AIDS Care Coordinator Program - Lexington Region $0.
$-320,407.
$-320,407.
$1,165,933. Thornton, Alice C 3048109796 KY Cabinet for Health and Family Services Kentucky HIV/AIDS Care Coordinator Program - Lexington Region
$0.
$1,165,933.
Thornton, Alice C 3048110299 Health Resources and Services Administration Ryan White Part C Early Intervention Services
$0.
$537,367.
$537,367.
Thornton, Alice C 3048110299 Health Resources and Services Administration Ryan White Part C Early Intervention Services
$0.
$-571,814.
$-571,814.
Thornton, Alice C 3048110299 Health Resources and Services Administration Ryan White Part C Early Intervention Services
$688,932.
$0.
$688,932.
Thornton, Alice C 3048109796 KY Cabinet for Health and Family Services Kentucky HIV/AIDS Care Coordinator Program - Lexington Region
$0. $630. Waid, Thomas 3048107990 Clinical Trial Services Long-Term Follow-Up of Sirolimus-Based Therapy Versus Continued Calcineurin Based Therapy in Renal Allograft Recipients $0. $1,197. Waid, Thomas 3048107990
$630.
$1,197.
Clinical Trial Services Long-Term Follow-Up of Sirolimus-Based Therapy Versus Continued Calcineurin Based Therapy in Renal Allograft Recipients Page 82 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. $5,109. $5,109. Waid, Thomas 3048107990 Clinical Trial Services Long-Term Follow-Up of Sirolimus-Based Therapy Versus Continued Calcineurin Based Therapy in Renal Allograft Recipients $0. $311,928. $311,928. Webb, Nancy R 3048106063 National Institute Diabetes & Digestive & Kidney Group X sPLA2: Regulator of Lipolysis and Glucose Homeostasis $0. $900. $900. Ziada, Khaled M 3048104460 Schering Plough Co A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease $0. $1,330. $1,330. Ziada, Khaled M 3048104460 Schering Plough Co A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease $0. $-365. $-365. Ziada, Khaled M 3048104460 Schering Plough Co A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease $0. $365. $365. Ziada, Khaled M 3048104460 Schering Plough Co A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease $0. $-1,330. $-1,330. Ziada, Khaled M 3048104460 Schering Plough Co A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease $0. $1,000. $1,000. Ziada, Khaled M 3048106689 Abbott Vascular Carotid Stenting for High Surgical Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence (CHOICE) $0. $5,970. $5,970. Ziada, Khaled M 3048106689 Abbott Vascular Carotid Stenting for High Surgical Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence (CHOICE) $0. $387. $387. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial $0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$71.
$71.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$354.
$354.
Page 83 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Internal Medicine $0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$84,593.
$84,593.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$864.
$864.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$22,938.
$22,938.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$4,351.
$4,351.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$4,385.
$4,385.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$4,998.
$4,998.
$0. Ziada, Khaled M 3048109364 Medtronics Inc Renal Denervation in Patients with Uncontrolled Hypertension - Symplicity HTN-3 Trial
$1,000.
$1,000.
Ziada, Khaled M Genentech Inc Dal-Outcomes 2
3048109977
$0.
$3,498.
$3,498.
Ziada, Khaled M Genentech Inc Dal-Outcomes 2
3048109977
$2.
$0.
$2.
$0. $3,998. $3,998. Ziada, Khaled M 3048110227 Covance ACCELERATE "Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes " $2. $0. $2. Ziada, Khaled M 3048110227 Covance ACCELERATE "Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes " Internal Medicine Totals: $5,865,680. $3,706,172. $9,571,852. Microbiology, Immunology & Molecular Gen $297,793. $0. $297,793. Bondada, Subbarao 3048110212 National Cancer Institute Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
Page 84 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Microbiology, Immunology & Molecular Gen $0.
$115,830.
$343,276.
$343,276.
$0.
$318,087.
$318,087.
$115,830. Kaetzel, Charlotte S 3048110254 Crohns and Colitis Foundation of America Cross-talk between gutbacteria and intestinal epithelial cells in IBD
$0.
$115,830.
Luo, Guangxiang 3048108300 National Institute of Allergy and Infectious Diseases Viral and Cellular Determinants of HCV Assembly
$0.
$-311,727.
$-311,727.
Luo, Guangxiang 3048109124 National Institute of Allergy and Infectious Diseases Underlying mechanisms of AoE in HCV Infection and Assembly
$0.
$-323,434.
$-323,434.
McGillis, Joseph P 3048109775 National Institute of Allergy and Infectious Diseases Genetic Regulation of Macrophage Polarization
$216,497.
$0.
$216,497.
Perry, Robert D 3048105494 National Institute of Allergy and Infectious Diseases Yersiniabactin and plague pathogenesis
$0.
$14,359.
$14,359.
Perry, Robert D 3048105494 National Institute of Allergy and Infectious Diseases Yersiniabactin and plague pathogenesis
$0.
$323,066.
$323,066.
Perry, Robert D 3048105790 National Institute of Allergy and Infectious Diseases Plague biofilm formation--regulation and function
$0.
$11,902.
$11,902.
Perry, Robert D 3048105790 National Institute of Allergy and Infectious Diseases Plague biofilm formation--regulation and function
$0.
$267,815.
$267,815.
Sinai, Anthony P 3048109113 National Institute of Allergy and Infectious Diseases Contribution of N-glycosylation to the Toxoplasma glycoproteome
$0.
$180,193.
$180,193.
$50,000. Sinai, Anthony P 3048109508 KY Science and Technology Co Inc KSEF RDE: Autophagy in the parasitic protozoan Toxoplasma gondii
$0.
$50,000.
Cohen, Donald A 3048109924 Crohns and Colitis Foundation of America Resident intestinal dendritic cells - negative regulators of colitis
$115,830.
$0. D'Orazio, Sarah 3048109423 National Institute of Allergy and Infectious Diseases Role of Rapid IFNg Secretion by CD8+ T cells in Clearance of Foodborne Listeria Garvy, Beth A 3048106123 National Heart Lung and Blood Institute Host Response to P. carinii in Neonatal Mice
Page 85 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Microbiology, Immunology & Molecular Gen $185,625. Sinai, Anthony P 3048110153 National Institute of Allergy and Infectious Diseases Host glycosyltransferases in the glycosylation of Toxoplasma proteins
$0.
$185,625.
$230,799. Spear, Brett T 3048109749 National Institute of General Medical Sciences Kentucky Bridge to a Biomedical Doctorate for Appalachian Students
$0.
$230,799.
$315,073.
$0.
$315,073.
$60,000.
$0.
$60,000.
$0. Suzuki, Yasuhiro 3048109125 National Institute of Allergy and Infectious Diseases Cooperation of CD8+ T cells and phagocytes to eliminate Toxoplasma cysts
$14,850.
$14,850.
$0. Suzuki, Yasuhiro 3048109125 National Institute of Allergy and Infectious Diseases Cooperation of CD8+ T cells and phagocytes to eliminate Toxoplasma cysts
$334,125.
$334,125.
Suzuki, Yasuhiro 3048109613 University of Chicago Toward a vaccine to prevent toxoplasmosis
$0.
$2,220.
$2,220.
Suzuki, Yasuhiro 3048109613 University of Chicago Toward a vaccine to prevent toxoplasmosis
$89,100.
$0.
$89,100.
Spear, Brett T 3048109964 National Institute Diabetes & Digestive & Kidney Albumin AFP Gene Family Regulation in Fetal and Adult Liver Stevenson, Brian 3048110210 National Research Fund for Tick Borne Diseases Inc Impacts of B. burgdorferi EbfC on Pathogenesis
$0. $70,420. $70,420. Woodward, Jerold G 3048107296 PDS Biotechnology Tumor Regression Studies of Versamune Formulations of HPV E7 Lipidated Peptides in Transgenic Humanized Mice $0. $100,828. $100,828. Woodward, Jerold G 3048107296 PDS Biotechnology Tumor Regression Studies of Versamune Formulations of HPV E7 Lipidated Peptides in Transgenic Humanized Mice $0. $35,210. $35,210. Woodward, Jerold G 3048107296 PDS Biotechnology Tumor Regression Studies of Versamune Formulations of HPV E7 Lipidated Peptides in Transgenic Humanized Mice $0. $35,210. $35,210. Woodward, Jerold G 3048107296 PDS Biotechnology Tumor Regression Studies of Versamune Formulations of HPV E7 Lipidated Peptides in Transgenic Humanized Mice Microbiology, Immunology & Molecular Gen Totals: $1,676,547. $1,416,400. $3,092,947.
Page 86 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Family Practice & Community Medicine $0. $69,967. Birdwhistell, Mark D 3048108208 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator - UK Administration
$69,967.
$0. $14,246. Birdwhistell, Mark D 3048108208 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator - UK Administration
$14,246.
$0. $56,542. Birdwhistell, Mark D 3048108208 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator - UK Administration
$56,542.
Birdwhistell, Mark D 3048109510 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator
$0.
$91,134.
$91,134.
Birdwhistell, Mark D 3048109510 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator
$0.
$27,873.
$27,873.
Birdwhistell, Mark D 3048109510 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator
$2.
$0.
$2.
Birdwhistell, Mark D 3048109510 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator
$0.
$71,078.
$71,078.
Birdwhistell, Mark D 3048109510 KY Department of Corrections Department of Corrections Health Care Network Monitor & Coordinator
$0.
$1,218.
$1,218.
$173,301. $0. Elder, William G 3048109928 Health Resources and Services Administration Program to Foster Competencies and Attitudes for Care of the Underserved in Western Kentucky
$173,301.
$140,009. $0. $140,009. King, Michael Rhea 3048109937 Health Resources and Services Administration Residency Training in Primary Care- Preparing Primary Care Physicians for Quality Health Care through Practice Based Learning and Improvement $589,701. $0. $589,701. Kingery, Joe 3048110155 Health Resources and Services Administration Health Center Cluster Kingery, Joe 3048110155 Health Resources and Services Administration Health Center Cluster Family Practice & Community Medicine
Page 87 of 223
Totals:
$0.
$825,581.
$825,581.
$903,013.
$1,157,639.
$2,060,652.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Obstetrics & Gynecology $0. $279,830. $279,830. Coker, Ann L 3048106644 National Institute on Minority Health and Health Disparitie Does Violence Against Women Result in Disparities in Cancer Care for Women with Breast, Colorectal, or Cervical Cancer? $0. $165,392. $165,392. Coker, Ann L 3048106644 National Institute on Minority Health and Health Disparitie Does Violence Against Women Result in Disparities in Cancer Care for Women with Breast, Colorectal, or Cervical Cancer? $400,000. $0. $400,000. Coker, Ann L 3048109832 Center for Disease Control and Prevention Green Dot Across the Bluegrass: Evaluation of Primary Prevention Intervention $0. Curry, Thomas E 3048106578 National Institute of Child Health and Human Develop The MMP system in human ovulation: localization, regulation, and function
$276,881.
$276,881.
$450,180. Curry, Thomas E 3048109692 National Institute on Drug Abuse Kentucky BIRCWH Program: Training theNext Generation of Women's Health Scholars
$0.
$450,180.
$74,250. Curry, Thomas E 3048110197 National Institute of Child Health and Human Develop The Role Of CCL20 In Ovulation: A Novel Mediator Of Ovarian Leukocyte Recruitment
$0.
$74,250.
$0.
$229,992.
$229,992.
$15,000.
$0.
$15,000.
Jo, Misung 3048107659 National Institute of Child Health and Human Develop Function of RUNX transcription factors in COC's Miller, Rachel Ware 3048110393 Lexington Cancer Foundation Incorporated Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
$0. $4,180. $4,180. Muse, Kenneth N 3048104550 Biosante Pharmaceuticals Inc A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Libigel for the Treatment of Hypoactive Sexual Disorder in Surgically Menopausal Women(testW008) $5,000. $0. $5,000. O'Brien, John Michael 3048109887 March of Dimes Birth Defects Foundation HBWW Kentucky $0. $1,248. $1,248. Ueland, Frederick R 3048103872 Genentech Inc A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gencitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Promary Peritoneal, or Fallopian Tube Carcinoma $0. $4,768. $4,768. Ueland, Frederick R 3048109233 Gynecologic Oncology Group Gynecologic Oncology Group
Page 88 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Obstetrics & Gynecology Ueland, Frederick R Gynecologic Oncology Group Gynecologic Oncology Group
3048109233
$0.
$7,516.
$7,516.
Ueland, Frederick R Gynecologic Oncology Group Gynecologic Oncology Group
3048109233
$0.
$11,348.
$11,348.
Ueland, Frederick R Gynecologic Oncology Group Gynecologic Oncology Group
3048109233
$0.
$12,600.
$12,600.
Ueland, Frederick R Gynecologic Oncology Group Gynecologic Oncology Group
3048109233
$0.
$-100,016.
$-100,016.
$2. $0. Ueland, Frederick R 3048110183 AMGen GOG 3001 - AMG 386 (TRINOVA-3): AMG 386 With Taxol and Carbo as First-line for Stage III-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancers $0. $-6,994. VanNagell, John R 3048107480
$2.
$-6,994.
KY Council on Postsecondary Education Ovarian Cancer Screening in Kentucky $775,000.
$0.
$775,000.
$180,193. Williams, Corrine Marie 3048109839 National Institute of Child Health and Human Develop Consortium to Evaluate a Novel Violence Prevention Program on College Campuses
$0.
$180,193.
$0. Williams, Corrine Marie 3048109839 National Institute of Child Health and Human Develop Consortium to Evaluate a Novel Violence Prevention Program on College Campuses
$205,820.
$205,820.
$142,281.
$0.
$142,281.
$2,041,906.
$1,092,565.
$3,134,471.
$7,870.
$0.
$7,870.
$0.
$171,644.
$171,644.
VanNagell, John R 3048109894 KY Council on Postsecondary Education Ovarian Cancer Screening in Kentucky
Williams, Corrine Marie KY Department for Public Health UK HANDS Evaluation
3048110374
Obstetrics & Gynecology Pathology & Lab Medicine Cibull, Michael L Gynecologic Oncology Group Ovarian Tissue Bank
Totals: 3048109846
Horbinski, Craig 3048108489 National Cancer Institute The Significance of Isocitrate Dehydrogenase Mutations in Gliomas
Page 89 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pathology & Lab Medicine Lutz, Charles 3048108493 National Institute of Allergy and Infectious Diseases Molecular Mechanisms Controlling NK Cells Receptor Expression Lutz, Charles 3048109628 National Institute on Aging Muscle, Fat and NK Lymphocytes in Aging Pathology & Lab Medicine Pediatrics
Totals:
$0.
$367,874.
$367,874.
$222,750.
$0.
$222,750.
$230,620.
$539,518.
$770,138.
$0. $2,599. $2,599. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $1,000. $1,000. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $15,654. $15,654. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $26,848. $26,848. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $17,892. $17,892. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $630. $630. Anstead, Michael I 3048108073 Vertex Pharmaceuticals Inc A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetis and Pharmacodyhamics of VX-809 Alone and in Combination w/VX-770 in Subjects $0. $828. $828. Anstead, Michael I 3048108191 Mpex Pharmaceuticals Mpex 207 study Anstead, Michael I Mpex Pharmaceuticals Mpex 207 study
3048108191
$0.
$3,068.
$3,068.
$0. $-27,207. $-27,207. Anstead, Michael I 3048108230 Cystic Fibrosis Foundation Evaluation of Pseudomonas Aeruginosa Serology for a Three-Part Study Consisting of EPIC-001 Clinical (Part 1) AZ0004 (Part 2) and EPIC-002 Observation (Part 3)
Page 90 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$315.
$315.
Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$3,362.
$3,362.
Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$142.
$142.
Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$14,813.
$14,813.
Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$12,865.
$12,865.
Anstead, Michael I Mpex Pharmaceuticals Mpex 209 Study
3048108381
$0.
$8,321.
$8,321.
$0. $630. $630. Anstead, Michael I 3048109714 Vertex Pharmaceuticals Inc A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation $0. $11,167. $11,167. Anstead, Michael I 3048109714 Vertex Pharmaceuticals Inc A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation $2. $0. Anstead, Michael I 3048109714
$2.
Vertex Pharmaceuticals Inc A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation $0. $945. $945. Anstead, Michael I 3048109714 Vertex Pharmaceuticals Inc A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation $2. $0. Anstead, Michael I 3048109845
$2.
Vertex Pharmaceuticals Inc VX12-770-112 / A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long-Term Ivacaftor Treatment in Subjects 6 Years of Age and Older $2. $0. $2. Anstead, Michael I 3048109995 Seattle Childrens Research Institute A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy
Page 91 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics $0. $3,535. Anstead, Michael I 3048109995 Seattle Childrens Research Institute A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy $0. $998. Anstead, Michael I 3048110073
$3,535.
$998.
Chiltern International Incorporated KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy Anstead, Michael I 3048110073 Chiltern International Incorporated KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy
$2.
$0.
$2.
Anstead, Michael I 3048110073 Chiltern International Incorporated KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy
$0.
$3,378.
$3,378.
Anstead, Michael I 3048110073 Chiltern International Incorporated KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy
$0.
$2,500.
$2,500.
Bada, Henrietta S Yale University Gene Targets for IVH
3048108787
$0.
$5,900.
$5,900.
Bada, Henrietta S Yale University Gene Targets for IVH
3048109855
$1,000.
$0.
$1,000.
Bada, Henrietta S Yale University Gene Targets for IVH--Per Patient
3048109856
$2.
$0.
$2.
Bada, Henrietta S Yale University Gene Targets for IVH--Per Patient
3048109856
$0.
$3,498.
$3,498.
$0. $143. $143. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re $0. $1,144. $1,144. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re $0. $376. $376. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re Page 92 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics $0. $504. $504. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re $0. $-2. $-2. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re $2. $0. $2. Bayliff, Sherry L 3048109660 Purdue Pharma LP OTR3001 - An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Re $0. $5,380. $5,380. Bayliff, Sherry L 3048109661 Purdue Pharma LP OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study $2. $0. Bayliff, Sherry L 3048109661
$2.
Purdue Pharma LP OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study $0. $209. $209. Bayliff, Sherry L 3048109661 Purdue Pharma LP OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study $0. $630. $630. Bayliff, Sherry L 3048109661 Purdue Pharma LP OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study $0. $3,428. $3,428. Bayliff, Sherry L 3048109661 Purdue Pharma LP OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study $0. $250. $250. Bernard, Philip 3048109469 Astellas Pharma US Inc A Phase III, Double-Blind, Randomzied, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol) in Pediatric Subjects with Euvolemic or Hypervolemic Hyponatremia. Proto $0. $4,952. $4,952. Cottrill, Carol M 3048105440 Merck and Company Inc A Phase III, Randomized, Open-Label, Parallel-Group, Dose Ranging Clinical Trial to Study the Safety and Efficacy of MK-0954/Losartan Potassium in Pediatric Patients with Hypertension $0. $91,900. $91,900. Cunningham, Melvin D 3048109688 KY Cabinet for Health and Family Services Infant Intensive Care Page 93 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics Cunningham, Melvin D 3048109688 KY Cabinet for Health and Family Services Infant Intensive Care
$221,500.
$0.
$0. $9,227. Danov, Zoran 3048110085 KaloBios Pharmaceuticals Incorporated KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa $0. $4,723. Danov, Zoran 3048110085
$221,500.
$9,227.
$4,723.
KaloBios Pharmaceuticals Incorporated KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa $2. $0. Danov, Zoran 3048110085
$2.
KaloBios Pharmaceuticals Incorporated KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa $0. $5,158. Danov, Zoran 3048110354
$5,158.
Savara Incorporated A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02) $2. $0. Danov, Zoran 3048110354
$2.
Savara Incorporated A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02) $402,187. $0. $402,187. Fornwalt, Brandon 3048109960 Office of the Director Exploring the role of dyssynchrony in pediatric heart disease with MRI $0. $30. Geil, John D 3048108826 Helsinn Healthcare A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC o $0. $2,407. Geil, John D 3048108826
$2,407.
Helsinn Healthcare A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC o $2. $0. Greenwood, Martha F 3048110023
$2.
$30.
Childrens Hospital of Philadelphia BMS Work Order to the Master Subaward Agreement for the Industry Funding Sources Between CHOP and UKRF Greenwood, Martha F Childrens Hospital of Philadelphia CHOP Per Patient
3048110070
$0.
$26,513.
$26,513.
Greenwood, Martha F Childrens Hospital of Philadelphia CHOP Per Patient
3048110070
$0.
$25,000.
$25,000.
Page 94 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics Greenwood, Martha F Childrens Hospital of Philadelphia CHOP Per Patient
3048110070
$0.
$-2.
$-2.
Greenwood, Martha F Childrens Hospital of Philadelphia CHOP Per Patient
3048110070
$0.
$25,000.
$25,000.
Greenwood, Martha F Childrens Hospital of Philadelphia CHOP Per Patient
3048110070
$2.
$0.
$2.
Greenwood, Martha F 3048110093 Childrens Hospital of Philadelphia CHOP Greenwood Workload Intensity
$22,800.
$0.
$22,800.
$0. $22,498. $22,498. Greenwood, Martha F 3048110238 Childrens Hospital of Philadelphia AALL07P1 Millennium Pharmaceuticals A Phase II Pilot Trial of Bortezomib in Combo iwth Intensive Re-Induction Therapy $2. $0. $2. Greenwood, Martha F 3048110238 Childrens Hospital of Philadelphia AALL07P1 Millennium Pharmaceuticals A Phase II Pilot Trial of Bortezomib in Combo iwth Intensive Re-Induction Therapy $2. $0. $2. Greenwood, Martha F 3048110240 Childrens Hospital of Philadelphia CHOP Millennium Pharm AAML 1031 Greenwood, Martha F 3048110421 Childrens Hospital of Philadelphia CHOP CCOP Per Case Reimbursement Grigsby, Donna J 3048109676 KY Cabinet for Health and Family Services Pediatric Assessment, Case Management and Training
$2.
$0.
$2.
$106,000.
$0.
$106,000.
Hong-McAtee, Irene Pfizer Inc Pfizer International Growth Study
3048107604
$0.
$1,000.
$1,000.
Hong-McAtee, Irene Pfizer Inc Pfizer International Growth Study
3048107604
$0.
$2,300.
$2,300.
$0. $2,217. $2,217. Kanga, Jamshed F 3048105677 Seattle Childrens Research Institute The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis $0. $1,775. $1,775. Kanga, Jamshed F 3048105677 Seattle Childrens Research Institute The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis Page 95 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics $0. $300. $300. Kanga, Jamshed F 3048105677 Seattle Childrens Research Institute The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis $115,010. $0. $115,010. Kanga, Jamshed F 3048109844 Cystic Fibrosis Foundation Cystic Fibrosis Center Program $75,938.
$0.
$75,938.
$11,500. Kiessling, Stefan G 3048110237 University of Wisconsin Clinical Course of STEC-HUS in a Contemporary Group of American Children
$0.
$11,500.
Li, Xiangan 3048104962 National Institute of General Medical Sciences Role of SR-BI LPS detoxification
$0.
$121,464.
$121,464.
Maguire, Grace F 3048109684 KY Cabinet for Health and Family Services Thomas H Pinkstaff Medical Home
$0.
$-390,592.
$-390,592.
Maguire, Grace F 3048109684 KY Cabinet for Health and Family Services Thomas H Pinkstaff Medical Home
$390,592.
$0.
$390,592.
Maguire, Grace F 3048109794 KY Cabinet for Health and Family Services Thomas H Pinkstaff Medical Home
$390,592.
$0.
$390,592.
3048110110
$7,500.
$0.
$7,500.
Northrip, Kimberly 3048110404 Health Resources and Services Administration Healthy Tomorrows
$33,683.
$0.
$33,683.
Northrip, Kimberly 3048110456 Foundation for a Healthy KY Matching Grant Healthy Tomorrows
$30,000.
$0.
$30,000.
Omar, Hatim 3048109498 KY Cabinet for Health and Family Services Young Parents Program
$0.
$-36,727.
$-36,727.
Omar, Hatim 3048109498 KY Cabinet for Health and Family Services Young Parents Program
$247,450.
$0.
$247,450.
Kanga, Jamshed F Cystic Fibrosis Foundation Therapeutics Development Center
Moscow, Jeffrey Childrens Hospital of Philadelphia CHOP Moscow Workload Intensity
Page 96 of 223
3048110337
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics $0. $1,260. $1,260. Radulescu, Vlad 3048109544 Baxter Healthcare Co A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients with Hemophilia A. Early Prophylaxis Immunologic Challen $0. $5,353. $5,353. Radulescu, Vlad 3048109544 Baxter Healthcare Co A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients with Hemophilia A. Early Prophylaxis Immunologic Challen $2. $0. $2. Radulescu, Vlad 3048109544 Baxter Healthcare Co A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients with Hemophilia A. Early Prophylaxis Immunologic Challen $100,800. $0. $100,800. Radulescu, Vlad 3048109693 KY Cabinet for Health and Family Services Hemophilia Treatment Center $17,000. Radulescu, Vlad 3048110061 Hemophilia of Georgia Incorporated Comprehensive Hemophilia Diagnostic and Treatment Center-MCHB
$0.
$21,665. $0. Radulescu, Vlad 3048110309 University of North Carolina CDC - Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders Radulescu, Vlad 3048110520 KY Cabinet for Health and Family Services Hemophilia Treatment Center FY 2014
$100,800.
$0.
$17,000.
$21,665.
$100,800.
$0. $550. $550. Schneider, Douglas 3048106659 AGA Medical Co Closure of Muscular Ventricular Septal Defects with the Amplatzer Muscular VSD Occluder--Post Approval Study (Muscular VPA) $0. $1,000. $1,000. Schneider, Douglas 3048106659 AGA Medical Co Closure of Muscular Ventricular Septal Defects with the Amplatzer Muscular VSD Occluder--Post Approval Study (Muscular VPA) $0. $2,250. $2,250. Smith, Wilburn J 3046897200 Genentech Inc Genentech National Cooperative Growth Study Post Marketing Surveillance Program for Protropin/Somatrem and Nutropin/ Somatropin $0. $474,543. $474,543. Steltenkamp, Carol L 3048107176 Office of the National Coordinator for Health Information T ARRA: University of Kentucky Medical Center Information Technology Regional Extension Center $0. $-30,334. Steltenkamp, Carol L 3048107176 Office of the National Coordinator for Health Information T ARRA: University of Kentucky Medical Center Information Technology Regional Extension Center Page 97 of 223
$-30,334.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics $0. $2,219,329. Steltenkamp, Carol L 3048107176 Office of the National Coordinator for Health Information T ARRA: University of Kentucky Medical Center Information Technology Regional Extension Center
$2,219,329.
$0. $30,334. Steltenkamp, Carol L 3048107176 Office of the National Coordinator for Health Information T ARRA: University of Kentucky Medical Center Information Technology Regional Extension Center
$30,334.
$0. $648,979. Steltenkamp, Carol L 3048107176 Office of the National Coordinator for Health Information T ARRA: University of Kentucky Medical Center Information Technology Regional Extension Center
$648,979.
$0. $18,000. $18,000. Steltenkamp, Carol L 3048107185 HealthBridge ARRA: University of Kentucky Medical Center Information Technology Regional Extenion Center with HealthBridge $0. $423,172. $423,172. Steltenkamp, Carol L 3048107185 HealthBridge ARRA: University of Kentucky Medical Center Information Technology Regional Extenion Center with HealthBridge $0. $603,532. $603,532. Steltenkamp, Carol L 3048107185 HealthBridge ARRA: University of Kentucky Medical Center Information Technology Regional Extenion Center with HealthBridge $0. $370,000. $370,000. Steltenkamp, Carol L 3048109973 KY Cabinet for Health and Family Services ARRA: Promoting EHR adoption and patient quality measures to Medicaid participating providers with the Kentucky Regional Extension Center- Year 2 $100,000. $0. $100,000. Steltenkamp, Carol L 3048109973 KY Cabinet for Health and Family Services ARRA: Promoting EHR adoption and patient quality measures to Medicaid participating providers with the Kentucky Regional Extension Center- Year 2 $21,398. $0. Steltenkamp, Carol L 3048110356
$21,398.
Jessamine County Health Department Syndromic Surveillance $0. $4,723. $4,723. Turner, Marion Dawn 3048109469 Astellas Pharma US Inc A Phase III, Double-Blind, Randomzied, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol) in Pediatric Subjects with Euvolemic or Hypervolemic Hyponatremia. Proto $15,000. $0. $15,000. Wagner, Lars Martin 3048110159 Childrens Hospital of Philadelphia CHOP Wagner Workload Intensity $52,500. Wagner, Lars Martin 3048110256 Cincinnati Childrens Hospital Medical Center Purchase Research Services Agreement / .5FTE Research RN/CRA
Page 98 of 223
$0.
$52,500.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Pediatrics Wallace, Carmel 3048109636 KY Cabinet for Health and Family Services Metabolic Newborn Screening
$262,000.
$0.
$262,000.
Wallace, Carmel 3048109637 KY Cabinet for Health and Family Services Genetics Clinic
$112,400.
$0.
$112,400.
Wallace, Carmel 3048109905 BioMarin Pharma Inc PKUDOS - PKU Demographics, Outcomes and Safety Registry
$0.
$8,694.
$8,694.
Wallace, Carmel 3048109905 BioMarin Pharma Inc PKUDOS - PKU Demographics, Outcomes and Safety Registry
$0.
$3,024.
$3,024.
Wallace, Carmel 3048109905 BioMarin Pharma Inc PKUDOS - PKU Demographics, Outcomes and Safety Registry
$0.
$3,148.
$3,148.
Wallace, Carmel 3048109905 BioMarin Pharma Inc PKUDOS - PKU Demographics, Outcomes and Safety Registry
$2.
$0.
$2.
$2,859,347.
$4,832,443.
$7,691,790.
Blalock, Eric 3048108016 National Institute on Aging Psychosocial Stress Interactions with Electrophysiology and Brain Aging
$0.
$273,081.
$273,081.
Blalock, Eric 3048108016 National Institute on Aging Psychosocial Stress Interactions with Electrophysiology and Brain Aging
$0.
$13,654.
$13,654.
Pediatrics Molecular & Biomedical Pharmacology
Totals:
$2,079,402. Cassis, Lisa A 3048109649 National Institute of General Medical Sciences COBRE Administrative Core A: Center of Research in Obesity and Cardiovascular Disease
$0.
$2,079,402.
Cassis, Lisa A 3048109936 National Heart Lung and Blood Institute Angiotensin: A link between obesity and hypertension
$0.
$-367,538.
$-367,538.
Cassis, Lisa A 3048109936 National Heart Lung and Blood Institute Angiotensin: A link between obesity and hypertension
$367,538.
$0.
$367,538.
Cassis, Lisa A 3048110216 National Heart Lung and Blood Institute Sex Differences in Angiotensin-Induced Vascular Diseases
$381,300.
$0.
$381,300.
Chen, Gang 3048110261 American Cancer Society The Mechanism of Arsenic-Induced Cell Transformation
$390,403.
$0.
$390,403.
Page 99 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Biomedical Pharmacology Chen, Gang 3048110261 American Cancer Society The Mechanism of Arsenic-Induced Cell Transformation
$0.
$-390,403.
$-390,403.
Chen, Gang 3048110279 National Institute on Alcohol Abuse and Alcoholism Rax, PKR and ethanol neurotoxicity
$0.
$241,684.
$241,684.
Chen, Gang 3048110279 National Institute on Alcohol Abuse and Alcoholism Rax, PKR and ethanol neurotoxicity
$0.
$-212,760.
$-212,760.
Chen, Gang 3048110279 National Institute on Alcohol Abuse and Alcoholism Rax, PKR and ethanol neurotoxicity
$212,760.
$0.
$212,760.
$0. Landfield, Philip W 3048106412 National Institute on Aging Hippocampal Electrophysiology and Myelinogenesis in Healthy Cognitive Aging
$571,727.
$571,727.
Landfield, Philip W 3048108051 National Institute on Aging Hippocampal Synaptic Structure - Physiology During Aging
$0.
$17,670.
$17,670.
Landfield, Philip W 3048108051 National Institute on Aging Hippocampal Synaptic Structure - Physiology During Aging
$0.
$353,442.
$353,442.
Luo, Jia 3048110223 National Institute on Alcohol Abuse and Alcoholism GSK 3beta, a mediator of ethanol neurotoxicity
$322,088.
$0.
$322,088.
Luo, Jia 3048110223 National Institute on Alcohol Abuse and Alcoholism GSK 3beta, a mediator of ethanol neurotoxicity
$0.
$10,738.
$10,738.
Luo, Jia 3048110241 National Institute on Alcohol Abuse and Alcoholism Alcohol and Breast Cancer
$17,502.
$0.
$17,502.
Luo, Jia 3048110241 National Institute on Alcohol Abuse and Alcoholism Alcohol and Breast Cancer
$0.
$-17,502.
$-17,502.
$0.
$20,760.
$0.
$315,543.
$20,760. Luo, Jia 3048110244 University of Mississippi Medical Center Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell death Plattner, Rina 3048109925 National Cancer Institute A role for c-Abl/Arg in Melanoma Progression
Page 100 of 223
$315,543.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Molecular & Biomedical Pharmacology $0. $284,011. Thibault, Olivier 3048106024 National Institute on Aging Metabolic Syndrome and Hippocampal Ca2+ Dysregulation in Aging-related Memory Decline Molecular & Biomedical Pharmacology Physiology
Totals:
$284,011.
$4,107,296.
$777,804.
$4,885,100.
$45,000. Boychuk, Jeffery 3048110140 Epilepsy Foundation of America A Role For Cytokine Interleukin-6 In Post-Traumatic Epileptogenesis
$0.
$45,000.
$74,250.
$0.
$74,250.
Esser, Karyn A 3048102201 National Institute Arthritis Musculoskeletal & Skin Intracellular Signaling during Skeletal Muscle Hypertrophy
$0.
$30,483.
$30,483.
Esser, Karyn A 3048107849 Johns Hopkins University The Growth Hormone/IGF-1 Axis in Skeletal Muscle
$0.
$37,125.
$37,125.
$334,125.
$0.
$334,125.
$0.
$266,845.
$266,845.
Doolen, Suzanne 3048109755 National Institute of Neurological Disorders & Stroke Glutamate-evoked calcium signaling in spinal cord after nerve injury
Esser, Karyn A 3048109493 National Institute Arthritis Musculoskeletal & Skin BetaCatenin Regulation of Skeletal Muscle Hypertrophy Estus, George Steven 3048106839 University of Illinois Apolioprotein E Receptor Biology and Neurodegeneration
$117,000. $0. $117,000. Estus, George Steven 3048110495 Alzheimers Drug Discovery Foundation Translating Genetics into Biomarkers and Therapies: apoE/Ab and apoJ/Ab Complex Levels and Lipidation State as AD Biomarkers Modulated by VPA $411,092. $0. $411,092. Frazier, Donald T 3048109899 National Institute of General Medical Sciences Interactive Learning Modules for Writing Grant Proposals $0. Frolenkov, Gregory I 3048105618 National Institute on Deafness & Other Communications Regulation of outer hair cell electromotility and noise-induced hearing loss
$13,425.
$13,425.
$0. Frolenkov, Gregory I 3048105618 National Institute on Deafness & Other Communications Regulation of outer hair cell electromotility and noise-induced hearing loss
$241,653.
$241,653.
$0.
$60,554.
$60,554.
Frolenkov, Gregory I 3048106934 University of Michigan Myosin 15:Genetics, Pathology, and Therapeutic Potential
Page 101 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Physiology $0.
$108,972.
$428,344.
$428,344.
$0.
$16,911.
$55,670. $0. McClintock, Timothy S 3048109689 National Institute on Deafness & Other Communications Fellowship for Heron: The Role of cAMP signaling in OSN axon convergence in the olfactory bulb
$55,670.
Frolenkov, Gregory I 3048110150 Childrens Hospital Medical Center Usher Proteins in the Inner Ear Structure and Function
$108,972.
$0. Gong, Ming Cui 3048109337 National Heart Lung and Blood Institute Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1 $16,911. Lee, Lu Yuan 3048110581 Lovelace Respiratory Research Institute Prenatal nicotinic exposure and depressed hypoxic ventilatory response in SIDS model
$0. McMullen, Colleen A 3048108362 National Institute on Deafness & Other Communications Response of aging intrinsic laryngeal muscles to chronic electrical stimulation
$299,784.
$299,784.
Nikolova-Karakashian, Mariana 3048108640 National Institute on Aging Ceramide and acute phase protein elevation during aging
$0.
$304,425.
$304,425.
Reid, Michael B 3048105774 National Institute Arthritis Musculoskeletal & Skin Respiratory Muscle Weakness in Chronic Inflammation
$0.
$251,501.
$251,501.
3048109813
$86,268.
$0.
$86,268.
Reid, Michael B 3048110060 National Institute Arthritis Musculoskeletal & Skin Skeletal muscle biologyin rheumatoid arthritis
$404,159.
$0.
$404,159.
Reid, Michael B 3048110385 Solae LLC Testing and Analysis Agreement - Addendum
$32,873.
$0.
$32,873.
Satin, Jonathan 3048105775 National Heart Lung and Blood Institute Mechanisms of Long-term Cardiac Ion Channel Regulation
$0.
$345,183.
$345,183.
Smith, Bret N. 3048105496 National Institute Diabetes & Digestive & Kidney Glucocorticoids and endocannabinoids in vagal complex
$0.
$20,299.
$20,299.
Smith, Bret N. 3048105496 National Institute Diabetes & Digestive & Kidney Glucocorticoids and endocannabinoids in vagal complex
$0.
$281,068.
$281,068.
Reid, Michael B Solae LLC Testing and Analysis Agreement
Page 102 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Physiology Smith, Bret N. 3048106409 National Institute Diabetes & Digestive & Kidney Neural circuitry in the dorsal vagal complex
$0.
$303,424.
$303,424.
Smith, Bret N. 3048106409 National Institute Diabetes & Digestive & Kidney Neural circuitry in the dorsal vagal complex
$0.
$314,429.
$314,429.
Smith, Bret N. 3048109351 University of North Texas Health Science Center Responsiveness to nicotine of nucleus tractus solitarius neurons
$0.
$-1.
$-1.
$61,597.
$0.
$61,597.
$53,942. Smith, Bret N. 3048110029 National Institute Diabetes & Digestive & Kidney Fellowship for Camille Bond Blake: Insulin effects in the vagal complex
$0.
$53,942.
Smith, Bret N. 3048109725 University of North Texas Health Science Center Responsiveness to Nicotine of Nucleus Tractus Solitarius Neurons
$24,166. $0. $24,166. Smyth, Susan 3048110406 National Heart Lung and Blood Institute NRSA Fellowship for Zach Fulkerson: Regulation of Lysolipid Signaling by Autotaxin-Integrin Interactions on Platelets $0. $43,950. $43,950. Snyder, Carol T 3048107801 KY Council on Postsecondary Education UK Professional Education Preparation Program Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$0.
$4,645.
$4,645.
Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$0.
$1,600.
$1,600.
Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$0.
$5,515.
$5,515.
Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$0.
$29,985.
$29,985.
Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$102,350.
$0.
$102,350.
Snyder, Carol T 3048109929 KY Council on Postsecondary Education UK Professional Education Preparation Program
$0.
$10,280.
$10,280.
Page 103 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Physiology Taylor, Bradley Kenneth 3048105684 National Institute of Neurological Disorders & Stroke PPAR Inhibition of Spinal Pain Transmission
$0.
$20,692.
$20,692.
Taylor, Bradley Kenneth 3048105684 National Institute of Neurological Disorders & Stroke PPAR Inhibition of Spinal Pain Transmission
$0.
$286,513.
$286,513.
Taylor, Bradley Kenneth 3048107090 National Institute of Neurological Disorders & Stroke Neuropeptidergic Inhibition of Spinal Pain Transmission
$0.
$20,692.
$20,692.
Taylor, Bradley Kenneth 3048107090 National Institute of Neurological Disorders & Stroke Neuropeptidergic Inhibition of Spinal Pain Transmission
$0.
$286,513.
$286,513.
$36,680.
$0.
$36,680.
Taylor, Bradley Kenneth 3048109938 Adynxx Incorporated Exploratory Studies of AYX1 Efficacy
$0. $-286. Taylor, Bradley Kenneth 3048110016 University of Alberta Targeting Amino Acid and Biogenic Amine Neurotransmitters to Improve Functional Outcomes in EAE
$-286.
$10,000. $0. Taylor, Bradley Kenneth 3048110016 University of Alberta Targeting Amino Acid and Biogenic Amine Neurotransmitters to Improve Functional Outcomes in EAE
$10,000.
$29,940. $0. Taylor, Bradley Kenneth 3048110231 National Institute on Drug Abuse NRSA Fellowship for Corder: Prolonged activation of endogenous opioid analgesia after inflammation
$29,940.
$32,208. $0. Taylor, Bradley Kenneth 3048110514 National Institute of Neurological Disorders & Stroke NRSA Fellowship for Griggs: Central and peripheral sensitization in type 2 painful diabetic neuropathy
$32,208.
$0.
$158,000.
$158,000.
$2,037,203.
$4,066,640.
$6,103,843.
Wilson, Melinda E 3048108576 National Science Foundation Molecular regulation of estrogen receptor gene expression in the adult Physiology Psychiatry
Totals:
$0. $1,034. $1,034. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $1,337. $1,337. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia
Page 104 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry $0. $1,034. $1,034. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $1,337. $1,337. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $1,961. $1,961. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $63. $63. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $1,034. $1,034. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $1,034. $1,034. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia
Page 105 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry $0. $990. $990. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $971. $971. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $5,303. $5,303. Glaser, Paul E 3048105960 Eli Lilly and Company A Long Term OPen Label Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disporder (Manic or Mixed Episodes) or Schizophrenia $0. $746. $746. Glaser, Paul E 3048108106 Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,526. Glaser, Paul E 3048108106
$2,526.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $746. Glaser, Paul E 3048108106
$746.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $4,044. Glaser, Paul E 3048108106
$4,044.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $3,529. Glaser, Paul E 3048108106
$3,529.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $3,737. Glaser, Paul E 3048108106
$3,737.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $5,459. Glaser, Paul E 3048108106
$5,459.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,492. Glaser, Paul E 3048108106
$1,492.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI
Page 106 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry $0. $1,034. Glaser, Paul E 3048108106 Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,400. Glaser, Paul E 3048108106
$1,034.
$2,400.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $903. Glaser, Paul E 3048108106
$903.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,006. Glaser, Paul E 3048108106
$2,006.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $126. Glaser, Paul E 3048108106
$126.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,492. Glaser, Paul E 3048108106
$1,492.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,213. Glaser, Paul E 3048108106
$2,213.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,871. Glaser, Paul E 3048108106
$2,871.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,478. Glaser, Paul E 3048108106
$2,478.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $3,261. Glaser, Paul E 3048108106
$3,261.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,701. Glaser, Paul E 3048108106
$1,701.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI
Page 107 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry $0. $1,492. Glaser, Paul E 3048108106 Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,991. Glaser, Paul E 3048108106
$1,492.
$2,991.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,260. Glaser, Paul E 3048108106
$1,260.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $3,850. Glaser, Paul E 3048108106
$3,850.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,492. Glaser, Paul E 3048108106
$1,492.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $5,845. Glaser, Paul E 3048108106
$5,845.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,238. Glaser, Paul E 3048108106
$2,238.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $2,100. Glaser, Paul E 3048108106
$2,100.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $3,185. Glaser, Paul E 3048108106
$3,185.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $1,034. Glaser, Paul E 3048108106
$1,034.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $0. $966. Glaser, Paul E 3048108106
$966.
Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI
Page 108 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry $0. $2,256. Glaser, Paul E 3048108106 Eli Lilly and Company A Double Blind, Efficacy and Safety Study of Duloxetine versus Placebo in the Treatment of Children and Adolescents with Generalizd Anxiety Disorder. F1J-MC-HMGI $2. $0. Glaser, Paul E 3048110497
$2,256.
$2.
Shire Development Inc A Phase 4, Randomized, Double-Blind, Multicenter, Parallel Group, Active-Controlled, Dose-Optimization Safety and Efficacy Study of SPD489 (Vyvanse) Compared with OROS-MPH (Concerta) with a Placebo Reference Arm, in Adolescents Aged 13-17 Years with Atten $0. $-333. $-333. Lommel, Karen Marie 3048108512 Purdue Pharma LP An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Requiring Op $0. $-1,282. $-1,282. Lommel, Karen Marie 3048108512 Purdue Pharma LP An Open-Label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children from Ages 6 to 16 Years Old, Inclusive, with Moderate to Severe Malignant and/or Nonmalignant Pain Requiring Op $0. $-210. $-210. Lommel, Karen Marie 3048108931 Purdue Pharma LP An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study. Protocol No. OTR3002. $10,000. $0. $10,000. Lommel, Karen Marie 3048109478 East Foundation Blazing New Trails in Injury Prevention: An Interactive ATV Safety Education Program Martin, Catherine A 3048110142 American Academy of Child & Adolescent Psychiatry AACAP Physician Scientist Program in Substance Abuse
$0.
$7,188.
$7,188.
Martin, Catherine A 3048110142 American Academy of Child & Adolescent Psychiatry AACAP Physician Scientist Program in Substance Abuse
$10,733.
$0.
$10,733.
Sprang, Mary 3048110285 KY Cabinet for Health and Family Services Early Childhood Mental Health Program
$0.
$661.
$661.
Sprang, Mary 3048110285 KY Cabinet for Health and Family Services Early Childhood Mental Health Program
$0.
$-662.
$-662.
Sprang, Mary 3048110285 KY Cabinet for Health and Family Services Early Childhood Mental Health Program
$5,907.
$0.
$5,907.
Page 109 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Psychiatry Sprang, Mary 3048110285 KY Cabinet for Health and Family Services Early Childhood Mental Health Program
$0.
$10,000.
$10,000.
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048110286
$0.
$-78.
$-78.
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048110286
$37,495.
$0.
$37,495.
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048110286
$0.
$-22,994.
$-22,994.
Sprang, Mary 3048110290 KY Cabinet for Health and Family Services Comprehensive Assessment and Training Services: CATS
$282,736.
$0.
$282,736.
Sprang, Mary 3048110290 KY Cabinet for Health and Family Services Comprehensive Assessment and Training Services: CATS
$0.
$8,688.
$8,688.
Sprang, Mary 3048110294 Eastern KY University Breaking the Cycle of Child Maltreatment and Neglect
$0.
$-19,030.
$-19,030.
Sprang, Mary 3048110294 Eastern KY University Breaking the Cycle of Child Maltreatment and Neglect
$59,774.
$0.
$59,774.
Sprang, Mary 3048110306 Substance Abuse & Mental Health Services Administr Child andAdolescent Trauma Treatment and Training Institute
$0.
$4,006.
$4,006.
Sprang, Mary 3048110306 Substance Abuse & Mental Health Services Administr Child andAdolescent Trauma Treatment and Training Institute
$0.
$-35,398.
$-35,398.
Sprang, Mary 3048110306 Substance Abuse & Mental Health Services Administr Child andAdolescent Trauma Treatment and Training Institute
$264,241.
$0.
$264,241.
$670,888.
$42,982.
$713,870.
Psychiatry Surgery
Totals:
$0. $3,307. $3,307. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS)
Page 110 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $924. $924. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $298. $298. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $298. $298. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $595. $595. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $595. $595. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $4,035. $4,035. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $595. $595. Beck, Sandra 3048108724 Covidien Prospective Singel Blinded Randomized Controlled Trial Comparing the Covidien EEA Hemorrhoid and Prolapse Stapling Set with DST Series Technology vs. Ethicon PPH03 in a Hemorrhoidopexy Procedure (HEMOSTASIS) $0. $958. $958. Bernard, Andrew C 3048108572 Agennix Inc A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients with Severe Sepsis $0. $1,278. $1,278. Bernard, Andrew C 3048108572 Agennix Inc A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients with Severe Sepsis $0. $66. $66. Bernard, Andrew C 3048108572 Agennix Inc A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients with Severe Sepsis $2. $0. $2. Bernard, Andrew C 3048110346 Nestle HealthCare Nutrition Incorporated Enteral Formula Tolerance In the Obese Critical Care Population
Page 111 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $22,260. $22,260. Chang, Phillip K 3048106626 GlaxoSmithKline A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Anti-Inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS $0. $25,825. $25,825. Chang, Phillip K 3048106626 GlaxoSmithKline A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Anti-Inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS $0. $8,016. $8,016. Chang, Phillip K 3048106626 GlaxoSmithKline A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Anti-Inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS $0. $24,720. $24,720. Chang, Phillip K 3048106626 GlaxoSmithKline A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Anti-Inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS $0. $9,616. $9,616. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $24,910. $24,910. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $14,944. $14,944. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $2,157. $2,157. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $9,459. $9,459. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $37,749. $37,749. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $0. $17,246. $17,246. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis
Page 112 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $38,373. $38,373. Chang, Phillip K 3048108216 SAFE bt Incorporated Randomized, Multi-Center, Controlled Clinical Study on the Effect of S.A.F.E. Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects Due to Severe Sepsis $7,408. $0. $7,408. Chang, Phillip K 3048109764 GlaxoSmithKline A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients with Acute Lung Injury $993. $0. Endean, Eric D 3048109635
$993.
Blue Grass Community Fdtn Jane Keeble Resident Education Fund 2012-13 $0.
$990.
$0. Erickson, Deborah 3048109576 Lexington Biomedical Research Institute MIF: A Pro-inflammatory Cytokine as a Novel Target to Reduce Bladder Inflammation
$288.
$288.
$6,327. Erickson, Deborah 3048109576 Lexington Biomedical Research Institute MIF: A Pro-inflammatory Cytokine as a Novel Target to Reduce Bladder Inflammation
$0.
$6,327.
Endean, Eric D 3048110564 Blue Grass Community Fdtn Jane Keeble Resident Education Fund 2013-14
$990.
$0. $794. $794. Gedaly, Roberto 3048104407 Wyeth Pharmaceuticals Inc A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus $0. $1,546. $1,546. Gedaly, Roberto 3048104407 Wyeth Pharmaceuticals Inc A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus $0. $630. $630. Gedaly, Roberto 3048104532 Novartis A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation $0. $630. $630. Gedaly, Roberto 3048104532 Novartis A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation $0. $3,752. $3,752. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients
Page 113 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $630. $630. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $750. $750. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $12,433. $12,433. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $1,960. $1,960. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $911. $911. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $502. $502. Gedaly, Roberto 3048105361 Novartis A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients $0. $3,616. $3,616. Gedaly, Roberto 3048106625 Wyeth Pharmaceuticals Inc Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients $0. $5,814. Gedaly, Roberto 3048106625
$5,814.
Wyeth Pharmaceuticals Inc Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients $0. $2. Gedaly, Roberto 3048106625
$2.
Wyeth Pharmaceuticals Inc Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients $0. $2,858. Gedaly, Roberto 3048106625
$2,858.
Wyeth Pharmaceuticals Inc Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients
Page 114 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $628. $628. Gedaly, Roberto 3048106625 Wyeth Pharmaceuticals Inc Planned Transition to Sirolimus-Based Therapy vs. Continued Tacrolimus-Based Therapy in Renal Allograft Recipients $0. $33,368. $33,368. Gedaly, Roberto 3048109300 United Biosource Corp Switching Study of Kidney Transplant Patients with Tremor to LCP-Tacro (STRATO) $0. Gedaly, Roberto 3048109300 United Biosource Corp Switching Study of Kidney Transplant Patients with Tremor to LCP-Tacro (STRATO)
$19,583.
$19,583.
$0. Gedaly, Roberto 3048109300 United Biosource Corp Switching Study of Kidney Transplant Patients with Tremor to LCP-Tacro (STRATO)
$2,000.
$2,000.
$0. Gedaly, Roberto 3048109300 United Biosource Corp Switching Study of Kidney Transplant Patients with Tremor to LCP-Tacro (STRATO)
$6,908.
$6,908.
$0. $19,445. $19,445. Gedaly, Roberto 3048110092 ICON Clinical Research Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A $0. $9,234. $9,234. Gedaly, Roberto 3048110092 ICON Clinical Research Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A $0. $10,613. $10,613. Gedaly, Roberto 3048110092 ICON Clinical Research Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A $0. $5,073. Gedaly, Roberto 3048110092
$5,073.
ICON Clinical Research Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A $2. $0. Gedaly, Roberto 3048110092
$2.
ICON Clinical Research Veloxis PK - A Phase 2, Double-Blind, Double-Dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-Daily for the Prevention of Acute Allograft Rejection in De Novo A $0. $17,404. $17,404. Hoopes, Charles W. 3048109114 SynCardia Systems Incorporated SynCardia Freedom Driver System Study
Page 115 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery Hoopes, Charles W. 3048109114 SynCardia Systems Incorporated SynCardia Freedom Driver System Study
$0.
$13,460.
$13,460.
Hoopes, Charles W. 3048109114 SynCardia Systems Incorporated SynCardia Freedom Driver System Study
$0.
$1,000.
$1,000.
Hoopes, Charles W. 3048109114 SynCardia Systems Incorporated SynCardia Freedom Driver System Study
$0.
$4,156.
$4,156.
$0. $630. Hoopes, Charles W. 3048109224 Thoratec Laboratories Co Official Title: Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
$630.
$0. $630. Hoopes, Charles W. 3048109224 Thoratec Laboratories Co Official Title: Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
$630.
$0. Hoopes, Charles W. 3048109334 SynCardia Systems Incorporated SynCardia Temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study
$4,153.
$4,153.
$0. Hoopes, Charles W. 3048109334 SynCardia Systems Incorporated SynCardia Temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study
$-4,158.
$-4,158.
$0. Hoopes, Charles W. 3048109334 SynCardia Systems Incorporated SynCardia Temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study
$4,158.
$4,158.
Hoopes, Charles W. 3048110204 Thoratec Laboratories Co Thoratec Corporation CentriMag RVAS Post Approval Study
$2.
$0.
$2.
Hoopes, Charles W. 3048110204 Thoratec Laboratories Co Thoratec Corporation CentriMag RVAS Post Approval Study
$0.
$4,128.
$4,128.
$2,300.
$0.
$2,300.
$0. $300,593. Kyprianou, Natasha 3048107764 National Institute Diabetes & Digestive & Kidney Novel Effectors of TGF-Beta Signaling in Prostate Growth Regulation and Tumor Progression
$300,593.
$369,775. Kyprianou, Natasha 3048110268 Sanofi Aventis US Inc Effect of Microtubule-Targeting Chemotherapy on EMT in Prostate Cancer Model
$369,775.
Jones, Raleigh O Synthes Inc Synthes Educational Grant
Page 116 of 223
3048109933
$0.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $2. $0. McKenzie, Shaun Patrick 3048110178 Grifols Biologicals Inc A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgeries $0. $37. Ramaiah, Chandrashekhar 3048108260
$37.
Hoffmann La Roche Inc A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety and Tolerability of 20 mg/kg Dose of Ro4905417 Administered Every 4 Weeks for 32 Weeks in Patients Undergoing Coronary Artery Bypass Surgery (CABG) $2. $0. Reda, Hassan 3048110357
$2.
$2.
AbbVie Incorporated A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery $2. $0. $2. Reda, Hassan 3048110511 AbbVie Incorporated M13-958: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery $0. $630. $630. Rinker, Brian 3048106594 AxoGen Incorporated A Multicenter, Prospective, Randomized, Comparative Study of Hollow Nerve Conduit and AVANCE Nerve Graft Evaluating Recovery Outcomes of Nerve Repair in the Hand (CHANGE) $0. $391. $391. Rinker, Brian 3048106991 AxoGen Incorporated A Multi-Center Retrospective Study of AdvancTM Nerve Graft Utilization, Evaluations, and Outcomes in Peripheral Nerve Injury Repair (RANGER) $0. $2. $2. Roth, John Scott 3048105759 Covidien Feasibility Study of the Use of Permacol Surgical Implant in the Closure of Abdominal Wall Defects after Removal of Infected Prosthetic Mesh $0. $1,764. $1,764. Roth, John Scott 3048107635 Davol Inc Speciality Access Products A Single-Arm, Multi-Center, Retrospective Study with Prospective Follow-up of Complex Ventral Hernia Repair Utlizing the AlloMax Surgical Graft $0. $14,693. $14,693. Roth, John Scott 3048108003 Musculoskeletal Transplant Foundation Feasibility Study of the Use of Flex HD Surgical Implant in the Closure of Abdominal Wall Defects with Component Separation in Clean or Contimainated Cases $0. $8,542. $8,542. Roth, John Scott 3048108003 Musculoskeletal Transplant Foundation Feasibility Study of the Use of Flex HD Surgical Implant in the Closure of Abdominal Wall Defects with Component Separation in Clean or Contimainated Cases $0. $32,158. $32,158. Roth, John Scott 3048108003 Musculoskeletal Transplant Foundation Feasibility Study of the Use of Flex HD Surgical Implant in the Closure of Abdominal Wall Defects with Component Separation in Clean or Contimainated Cases
Page 117 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $4,941. $4,941. Roth, John Scott 3048108003 Musculoskeletal Transplant Foundation Feasibility Study of the Use of Flex HD Surgical Implant in the Closure of Abdominal Wall Defects with Component Separation in Clean or Contimainated Cases $0. $13,940. $13,940. Roth, John Scott 3048108003 Musculoskeletal Transplant Foundation Feasibility Study of the Use of Flex HD Surgical Implant in the Closure of Abdominal Wall Defects with Component Separation in Clean or Contimainated Cases $61,000. $0. $61,000. Roth, John Scott 3048109666 Foundation for Surgical Fellowships Foundation for Surgical Fellowship 2012-2013 Roth, John Scott 3048110072 Society of American Gastrointestinal and Endoscopic Sur SAGES 2013 Brandeis Award
$3,200.
$0.
$3,200.
$2. $0. Roth, John Scott 3048110246 Davol Inc Speciality Access Products A Prospective, Observational Study Utilizing Phasix Mesh During Ventral and Incisional Hernia Repair Surgery
$2.
$0. $13,640. $13,640. Roth, John Scott 3048110246 Davol Inc Speciality Access Products A Prospective, Observational Study Utilizing Phasix Mesh During Ventral and Incisional Hernia Repair Surgery $0. $662. $662. Roth, John Scott 3048110246 Davol Inc Speciality Access Products A Prospective, Observational Study Utilizing Phasix Mesh During Ventral and Incisional Hernia Repair Surgery $0. $-2,000. $-2,000. Roth, John Scott 3048110246 Davol Inc Speciality Access Products A Prospective, Observational Study Utilizing Phasix Mesh During Ventral and Incisional Hernia Repair Surgery Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$18,272.
$18,272.
Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$8,810.
$8,810.
Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$13,157.
$13,157.
Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$800.
$800.
Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$10,226.
$10,226.
Page 118 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery Saha, Sibu CVRx Inc Rheos Pivotal Trial
3048103829
$0.
$883.
$0. $5,536. Saha, Sibu 3048106850 CSL Behring GmbH An Open-Label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX P/N Compared with Plasma for Rapid Reversal of Coagulopathy $0. $1,260. Saha, Sibu 3048106850
$883.
$5,536.
$1,260.
CSL Behring GmbH An Open-Label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX P/N Compared with Plasma for Rapid Reversal of Coagulopathy $0. $628. Saha, Sibu 3048108405
$628.
Talecris Biotherapeutics A Phase Two, Randomized, Open-Label (with Blinded Plasminogen Activator and Placebo Control Group Study to Evaluate the Effects of Different Intra-Thrombus Infusion Regimens of Plasmin (Human) Compared to Plasminogen Activator and Placebo $0. $25. $25. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $630. $630. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $1,500. $1,500. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $10,793. $10,793. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $22,521. $22,521. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $50. $50. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
Page 119 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $0. $1,500. $1,500. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $4,977. $4,977. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $11,441. $11,441. Saha, Sibu 3048109246 Nycomed Amersham Inc TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery $0. $750. $750. Saha, Sibu 3048109415 Grifols Biologicals Inc A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery. $0. $7,125. $7,125. Saha, Sibu 3048109415 Grifols Biologicals Inc A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery. $0. $5,327. $5,327. Saha, Sibu 3048109415 Grifols Biologicals Inc A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery. $0. $6,699. $6,699. Saha, Sibu 3048110062 Pluristem Therapeutics Incorporated Pluristem - A Phase 2, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermitte $2. $0. $2. Saha, Sibu 3048110062 Pluristem Therapeutics Incorporated Pluristem - A Phase 2, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermitte $0. $304,425. $304,425. Saito, Hiroshi 3048108617 National Institute on Aging The Role of Adipose Tissue in Age-dependent Sensitivity to Critical Illiness $0. $7,256. $7,256. Shah, Malay B 3048110392 Astellas Pharma Global Development Incorporated A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de novo Kidney Transplant Recipients
Page 120 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery $2. $0. $2. Shah, Malay B 3048110392 Astellas Pharma Global Development Incorporated A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de novo Kidney Transplant Recipients $2. $0. $2. Shah, Malay B 3048110394 Astellas Pharma Global Development Incorporated A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients $1,891. $0. $1,891. Stewart, Daniel 3048110125 Stryker Instruments Stryker Education Grant for Textbooks Strup, Stephen 3048107725 Galil Medical Incorporated Tracking Renal Tumors After Cryoablation Evaluation (TRACE)
$0.
$378.
$378.
Strup, Stephen 3048107725 Galil Medical Incorporated Tracking Renal Tumors After Cryoablation Evaluation (TRACE)
$0.
$630.
$630.
Strup, Stephen 3048107725 Galil Medical Incorporated Tracking Renal Tumors After Cryoablation Evaluation (TRACE)
$0.
$1,386.
$1,386.
Tharappel, Job C 3048109406 Davol Inc Speciality Access Products Davol Fellowship
$0.
$73,557.
$73,557.
$0. $1,000. $1,000. Turner, Vicky L 3048107626 University of Rochester Randomized, Prospective Evaluation of 2% Chlorhexidine Gluconate Cloths to Reduce Surgical Site Infection in Elective Cardiothoracic Surgery Patients $2,500. $0. $2,500. Vasconez, Henry 3048110284 Synthes Inc Andrew M Moore Sr., MD Visiting Professor March 2013 Vasconez, Henry 3048110349 Stryker Instruments Andrew M Moore Sr. MD Visiting Professor
$2,500.
$0.
$2,500.
$0. $1,260. $1,260. Waid, Thomas 3048107992 Tolera Therapeutics Incorporated A Two Part, Phase 1/2, Safety, PK and PD STudy of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation $0. $630. $630. Waid, Thomas 3048107992 Tolera Therapeutics Incorporated A Two Part, Phase 1/2, Safety, PK and PD STudy of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Page 121 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Medicine Surgery $0. $12,147. $12,147. Waid, Thomas 3048107992 Tolera Therapeutics Incorporated A Two Part, Phase 1/2, Safety, PK and PD STudy of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation $49,396. $0. $49,396. Wang, Dongfang 3048110315 W-Z Biotech LLC SBIR: Development of Double Lumen Cannula for Percutaneous Right Heart Support $2. $0. $2. Ziada, Ali 3048109759 Pfizer Inc A 12-Week Randomized, Open-Label, Active Comparator Period Followed by a 12-Week Safety Extension Period to Evaluate the Safety and Efficacy of Fesoterodine in Subjects Aged 6 to 16 Years and > 25 KG with Symptoms of Detrusor Overactivity Associated with $0. $9,073. $9,073. Ziada, Ali 3048109759 Pfizer Inc A 12-Week Randomized, Open-Label, Active Comparator Period Followed by a 12-Week Safety Extension Period to Evaluate the Safety and Efficacy of Fesoterodine in Subjects Aged 6 to 16 Years and > 25 KG with Symptoms of Detrusor Overactivity Associated with $0. $3,694. $3,694. Zwischenberger, Joseph 3048108807 Exatherm LLC Development of a Perfusion-Induced Systemic Hyperthermia Delivery Apparatus $0. Zwischenberger, Joseph 3048108807 Exatherm LLC Development of a Perfusion-Induced Systemic Hyperthermia Delivery Apparatus Surgery Neurology
Totals:
$508,302.
$4,535.
$4,535.
$1,380,627.
$1,888,929.
$0. $9,120. $9,120. Bensalem Owen, Meriem Katrened3048105126 Pfizer Inc An Open Label Multicenter Extension Study to Determine Long Term Safety and Efficacy of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures $0. $1,645. $1,645. Bensalem Owen, Meriem Katrened3048105382 PPD Development Inc An Open-Label, Multinational, Multicenter, Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Brivaracetam, Used at a Flexible Dose up to a Maximum of 150 mg/day, in Subjects aged 16 years or older suffering from Epilepsy $0. $36. Bensalem Owen, Meriem Katrened3048105554
$36.
Quintiles Inc Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome $0. $1,670. Bensalem Owen, Meriem Katrened3048105554 Quintiles Inc Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome
$1,670.
$0. $5,155. Bensalem Owen, Meriem Katrened3048105554 Quintiles Inc Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome
$5,155.
Page 122 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $3,334. Bensalem Owen, Meriem Katrened3048105554 Quintiles Inc Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome
$3,334.
$0. $4,668. Bensalem Owen, Meriem Katrened3048107075 Schwarz BioSciences Inc A Historical-Controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400 mg/day Monotherapy in Subjects with Partial-Onset Seizure (SP902) $0. $4,408. Bensalem Owen, Meriem Katrened3048107105
$4,668.
$4,408.
Schwarz BioSciences Inc An Open-Label, Extension Study to Assess the Safety and Seizure Frequency Associated with Long-Term Oral Lacosamide for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects wit Idiopathic Generalized Epilepsy (SP0962) $0. $8,144. $8,144. Bensalem Owen, Meriem Katrened3048107938 Sunovion Pharmaceuticals Incorporated Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Not Well Controlled by Current Antiepiletic Drugs (P#093-046) $0. $200. Bensalem Owen, Meriem Katrened3048107938
$200.
Sunovion Pharmaceuticals Incorporated Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Not Well Controlled by Current Antiepiletic Drugs (P#093-046) $0. $1,110. $1,110. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304 $0. $1,364. $1,364. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304 $0. $576. $576. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304 $0. $318. $318. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304 $0. $1,558. $1,558. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304
Page 123 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $1,639. $1,639. Bensalem Owen, Meriem Katrened3048108110 Sunovion Pharmaceuticals Incorporated Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial - Protocol # BIA-2093-304 $0. $9,097. $9,097. Bensalem Owen, Meriem Katrened3048108701 Lundbeck Incorporated 13098A: A prospective, open-label study of the structure and function of the retina in adult patients with refractory complex partial seizures treated with vigabatrin (Sabril®) $0. $1,191. $1,191. Bensalem Owen, Meriem Katrened3048108701 Lundbeck Incorporated 13098A: A prospective, open-label study of the structure and function of the retina in adult patients with refractory complex partial seizures treated with vigabatrin (Sabril®) $0. $2,986. $2,986. Bensalem Owen, Meriem Katrened3048108701 Lundbeck Incorporated 13098A: A prospective, open-label study of the structure and function of the retina in adult patients with refractory complex partial seizures treated with vigabatrin (Sabril®) $0. $5,342. $5,342. Bensalem Owen, Meriem Katrened3048108701 Lundbeck Incorporated 13098A: A prospective, open-label study of the structure and function of the retina in adult patients with refractory complex partial seizures treated with vigabatrin (Sabril®) $0. $1,241. $1,241. Bensalem Owen, Meriem Katrened3048108813 Sunovion Pharmaceuticals Incorporated 093-050: Long-Term Eslicarbazepine Acetate Extension Study Bensalem Owen, Meriem Katrened3048108813 Sunovion Pharmaceuticals Incorporated 093-050: Long-Term Eslicarbazepine Acetate Extension Study
$0.
$-2.
$-2.
$2. $0. $2. Bensalem Owen, Meriem Katrened3048110556 UCB Pharma PROTOCOL N01394: A RANDOMIZED, OPEN-LABEL, MULTICENTER, PARALLEL-GROUP, EXPLORATORY STUDY TO EVALUATE THE EFFICACY OF INTRAVENOUS BRIVARACETAM AND INTRAVENOUS PHENYTOIN IN SUBJECTS EXPERIENCING NONCONVULSIVE ELECTROGRAPHIC SEIZURES $0. $325. $325. Berger, Joseph R 3048105911 Biogen Research Co TYGRIS: TYSABRI Global Observational Program in Safety Berger, Joseph R 3048105911 Biogen Research Co TYGRIS: TYSABRI Global Observational Program in Safety
$0.
$566.
$566.
Berger, Joseph R 3048105911 Biogen Research Co TYGRIS: TYSABRI Global Observational Program in Safety
$0.
$2,520.
$2,520.
Berger, Joseph R 3048105911 Biogen Research Co TYGRIS: TYSABRI Global Observational Program in Safety
$0.
$240.
$240.
Page 124 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology Berger, Joseph R 3048105911 Biogen Research Co TYGRIS: TYSABRI Global Observational Program in Safety
$0.
$85.
$85.
$0. $5,923. $5,923. Berger, Joseph R 3048107265 Biogen Research Co A Multi-Center, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon B-1a) to Natalizumab in Subjects with Relapsing Multiple Sclerosis $0. $3,416. $3,416. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $1,436. $1,436. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $185. $185. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $2,698. $2,698. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $1,447. $1,447. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $718. $718. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $3,231. $3,231. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $2,541. $2,541. Berger, Joseph R 3048107779 Biogen Research Co Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2 $0. $1,309. $1,309. Berger, Joseph R 3048108214 AB Science AB07002: A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, 2-Parallel Group, Phase 3 Study to Compare Efficacy and Safety of Masitinib 6 mg/kg/Day/ Versus Placebo
Page 125 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology Berger, Joseph R 3048108762 PML Consortium LLC Sites of JC Virus Latency and Genotypic Differences Underlying Tropism
$0.
$283,003.
$283,003.
$0. $2,426. $2,426. Berger, Joseph R 3048108802 Biogen Research Co 101MS326: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects with Secondary Progressive Multiple Sclerosis $0. $1,496. $1,496. Berger, Joseph R 3048109390 Quintiles Inc Protocol Number: 101MS407:A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patient $0. $2,998. $2,998. Berger, Joseph R 3048109390 Quintiles Inc Protocol Number: 101MS407:A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patient $0. $8,607. $8,607. Cambi, Franca 3048108185 Biotie Therapeutics Incorporated A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of YSN115 as Adjunctive Therapy in Levodopa-Treated Parkinson's Subjects with End of Dose Wearing Off (Protocol: SYN115-CL02) $0. $3,572. $3,572. Cambi, Franca 3048108185 Biotie Therapeutics Incorporated A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of YSN115 as Adjunctive Therapy in Levodopa-Treated Parkinson's Subjects with End of Dose Wearing Off (Protocol: SYN115-CL02) $0. $19,989. $19,989. Cambi, Franca 3048108185 Biotie Therapeutics Incorporated A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of YSN115 as Adjunctive Therapy in Levodopa-Treated Parkinson's Subjects with End of Dose Wearing Off (Protocol: SYN115-CL02) $50,000. $0. $50,000. Cambi, Franca 3048109538 KY Science and Technology Co Inc KSEF RDE: GSK3 and Regulation of Alternative Splicing in Oligodendrocytes:A Target to Enhance Remyelination in Human Disease $50,999. $0. $50,999. Cambi, Franca 3048110136 National Institute of Neurological Disorders & Stroke Neuroprotection Exploratory Trials in PD (NET-PD) $2. $0. Cambi, Franca 3048110141 UCB Pharma PD0004: A multicenter, multinational, double-blind, placebo controlled, 2 arm study to evaluate the efficacy of Rotigotine on Parkinson's Disease associated pain $0. $255. Dobbs, Michael R 3048108835
$255.
Medpace Inc MultiStem-B01-02: Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke $0. $306. Dobbs, Michael R 3048108835
$306.
$2.
Medpace Inc MultiStem-B01-02: Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke Page 126 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $1,052. Dobbs, Michael R 3048108835 Medpace Inc MultiStem-B01-02: Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke $0. $3,458. Dobbs, Michael R 3048108835
$1,052.
$3,458.
Medpace Inc MultiStem-B01-02: Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke $0. $4,489. Dobbs, Michael R 3048108835
$4,489.
Medpace Inc MultiStem-B01-02: Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke $0. $1,191. Kapoor, Siddharth 3048108575
$1,191.
Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $3,821. $3,821. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $1,395. $1,395. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $11,607. $11,607. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $8,189. $8,189. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $3,699. $3,699. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $5,034. $5,034. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures
Page 127 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $427. $427. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $7,532. $7,532. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $2,000. $2,000. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $10,878. $10,878. Kapoor, Siddharth 3048108575 Eisai Medical Research Inc E2007-G000-332: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures $0. $11,387. $11,387. Kapoor, Siddharth 3048108781 UCB Pharma No1258: A multicenter, open-label, four-arm, randomized trial, evaluating the safety and tolerability of BRIVARACETAM intravenous infusion and bolus, administered in b.i.d. regimen as an adjunctive antiepileptic treatment in subject from 16 to 70 years su $0. $14,238. $14,238. Kapoor, Siddharth 3048108781 UCB Pharma No1258: A multicenter, open-label, four-arm, randomized trial, evaluating the safety and tolerability of BRIVARACETAM intravenous infusion and bolus, administered in b.i.d. regimen as an adjunctive antiepileptic treatment in subject from 16 to 70 years su $0. $8,769. $8,769. Kapoor, Siddharth 3048108781 UCB Pharma No1258: A multicenter, open-label, four-arm, randomized trial, evaluating the safety and tolerability of BRIVARACETAM intravenous infusion and bolus, administered in b.i.d. regimen as an adjunctive antiepileptic treatment in subject from 16 to 70 years su $0. $6,688. $6,688. Kapoor, Siddharth 3048108781 UCB Pharma No1258: A multicenter, open-label, four-arm, randomized trial, evaluating the safety and tolerability of BRIVARACETAM intravenous infusion and bolus, administered in b.i.d. regimen as an adjunctive antiepileptic treatment in subject from 16 to 70 years su $0. $2,520. $2,520. Kapoor, Siddharth 3048108782 UCB Pharma NO1379: An Open-Label, Multicenter, Follow-Up Study TO Evaluate the Long-Term Safety and Efficacy Of Brivaracetam Usedas Adjunctive Treatment in Subjects Aged 16 Years or Older with Partial Onset Seizures $0. $509. Kapoor, Siddharth 3048108782
$509.
UCB Pharma NO1379: An Open-Label, Multicenter, Follow-Up Study TO Evaluate the Long-Term Safety and Efficacy Of Brivaracetam Usedas Adjunctive Treatment in Subjects Aged 16 Years or Older with Partial Onset Seizures Page 128 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $1,573. Kapoor, Siddharth 3048108782 UCB Pharma NO1379: An Open-Label, Multicenter, Follow-Up Study TO Evaluate the Long-Term Safety and Efficacy Of Brivaracetam Usedas Adjunctive Treatment in Subjects Aged 16 Years or Older with Partial Onset Seizures $0. $1,043. Kapoor, Siddharth 3048109416
$1,573.
$1,043.
UCB Pharma NO1358: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (16 to 80 years old) With Partial Onset Seizures $0. $4,899. $4,899. Kapoor, Siddharth 3048109416 UCB Pharma NO1358: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (16 to 80 years old) With Partial Onset Seizures $0. $1,916. $1,916. Kasarskis, Edward J 3048105777 Massachusetts General Hospital Ceftriaxone in ALS - Kentucky Subcontract Kasarskis, Edward J 3048105777 Massachusetts General Hospital Ceftriaxone in ALS - Kentucky Subcontract
$0.
$3,797.
$3,797.
Kasarskis, Edward J 3048105777 Massachusetts General Hospital Ceftriaxone in ALS - Kentucky Subcontract
$0.
$2,787.
$2,787.
Kasarskis, Edward J 3048105777 Massachusetts General Hospital Ceftriaxone in ALS - Kentucky Subcontract
$0.
$3,811.
$3,811.
$0. Kasarskis, Edward J 3048106861 Columbia University Multicenter ALS Cohort Study of Oxidative Stress and Disease Progression
$2,268.
$2,268.
$0. Kasarskis, Edward J 3048106861 Columbia University Multicenter ALS Cohort Study of Oxidative Stress and Disease Progression
$261.
$261.
$0.
$1,054.
$1,054.
Kasarskis, Edward J 3048107693 Columbia University WOWS ALS Research at the Eleanor & Lou Gehrig MDA/ALS Center
$0. $1,975. $1,975. Kasarskis, Edward J 3048108153 Neuraltus Pharmaceuticals Incorporated Protocol: NP001-10-002 "A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects with Amyotrophic Lateral Sclerosis (ALS): $0. $93,966. $93,966. Kasarskis, Edward J 3048108153 Neuraltus Pharmaceuticals Incorporated Protocol: NP001-10-002 "A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects with Amyotrophic Lateral Sclerosis (ALS):
Page 129 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $100,000. $0. $100,000. Kasarskis, Edward J 3048110160 ALS Association Developing a Virtual ALS Center at a Remote Site Incorporating Regional Resources and Telemedicine Links Kedar, Sachin 3048109161 St Lukes Roosevelt Institute for Health Sciences IIHTT: Idiopathic Intracranial Hypertension Treatment Trial
$0.
$240.
$240.
Kedar, Sachin 3048109161 St Lukes Roosevelt Institute for Health Sciences IIHTT: Idiopathic Intracranial Hypertension Treatment Trial
$0.
$480.
$480.
Kedar, Sachin 3048109161 St Lukes Roosevelt Institute for Health Sciences IIHTT: Idiopathic Intracranial Hypertension Treatment Trial
$0.
$2,647.
$2,647.
Kedar, Sachin 3048109161 St Lukes Roosevelt Institute for Health Sciences IIHTT: Idiopathic Intracranial Hypertension Treatment Trial
$0.
$1,878.
$1,878.
$0. $934. Kedar, Sachin 3048109652 Eli Lilly and Company NAION: A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) $0. $480. Kedar, Sachin 3048109652
$934.
$480.
Eli Lilly and Company NAION: A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) $2. $0. Kedar, Sachin 3048109652
$2.
Eli Lilly and Company NAION: A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) $0. $-480. $-480. Kedar, Sachin 3048109652 Eli Lilly and Company NAION: A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) $2. $0. Kedar, Sachin 3048110426
$2.
St Lukes Roosevelt Institute for Health Sciences IIHTT: Idiopathic Intracranial Hypertension Treatment Trial $0. $3,498. Khan, Gulam Qutubuddin 3048109931 Eisai Medical Research Inc An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Le $2. $0. Khan, Gulam Qutubuddin 3048109931
$3,498.
Eisai Medical Research Inc An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Le Page 130 of 223
generated on 7/1/2013 15:07:29
$2.
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $-2,611. $-2,611. Pettigrew, Luther C 3046749700 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial) $0. $9,950. $9,950. Pettigrew, Luther C 3046749700 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial) $0. $-1,147. $-1,147. Pettigrew, Luther C 3048107116 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial $0. $2,394. Pettigrew, Luther C 3048107594 W L Gore Association Inc GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study) $0. $4,500. Pettigrew, Luther C 3048107594
$2,394.
$4,500.
W L Gore Association Inc GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study) $0. $1,323. Pettigrew, Luther C 3048107594
$1,323.
W L Gore Association Inc GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study) $0. $8,724. Pettigrew, Luther C 3048107594
$8,724.
W L Gore Association Inc GORE HELEX Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients Foramen Ovale (PFO) (the REDUCE Study) $0. $6,094. Pettigrew, Luther C 3048108895
$6,094.
Yale University Insulin resistance Intervention after Stroke (IRIS) Trail Pettigrew, Luther C 3048108895 Yale University Insulin resistance Intervention after Stroke (IRIS) Trail
$0.
$1,049.
$1,049.
Pettigrew, Luther C 3048108895 Yale University Insulin resistance Intervention after Stroke (IRIS) Trail
$0.
$3,359.
$3,359.
Pettigrew, Luther C 3048108895 Yale University Insulin resistance Intervention after Stroke (IRIS) Trail
$0.
$4,716.
$4,716.
$0. $1,498. $1,498. Pettigrew, Luther C 3048110014 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial)
Page 131 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $2. $0. $2. Pettigrew, Luther C 3048110014 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial) $0. $2,611. $2,611. Pettigrew, Luther C 3048110014 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial) $0. $500. $500. Pettigrew, Luther C 3048110014 AGA Medical Co Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial) $0. $2,091. $2,091. Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial
$0.
$1,239.
$1,239.
Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial
$0.
$2,244.
$2,244.
Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial
$0.
$2,997.
$2,997.
Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial
$0.
$4,483.
$4,483.
Pettigrew, Luther C 3048110032 Yale University Insulin Resistance Intervention after Stroke (IRIS) Trial
$2.
$0.
$2.
$0.
$2.
$2. Pettigrew, Luther C 3048110348 GlaxoSmithKline A Proof of Concept Study for GSK249320 versus placebo in Stroke Patients. MAG104615
$0. $153,405. $153,405. Slevin, John T 3048105620 Quintiles Inc Open -label, 6-12 months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations, Protocol# S187.3.004 $0. $54,727. $54,727. Slevin, John T 3048105620 Quintiles Inc Open -label, 6-12 months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations, Protocol# S187.3.004 Page 132 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $5,603. $5,603. Slevin, John T 3048105620 Quintiles Inc Open -label, 6-12 months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations, Protocol# S187.3.004 $0. $33,750. $33,750. Slevin, John T 3048106766 Quintiles Inc A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, who Continue to $0. $105,000. $105,000. Slevin, John T 3048106766 Quintiles Inc A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, who Continue to $0. $2,205. $2,205. Slevin, John T 3048106766 Quintiles Inc A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, who Continue to $0. $2,722. $2,722. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $29,996. $29,996. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $56,303. $56,303. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $6,563. $6,563. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $2,816. $2,816. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $9,005. $9,005. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects $0. $16,473. $16,473. Slevin, John T 3048107048 Quintiles Inc Solvay S187.3.003: Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects Page 133 of 223 generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Neurology $0. $3,376. $3,376. Slevin, John T 3048107219 Quintiles Inc Solvay S187.3.005: Open-Label, Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease and Severe Motor Fluctuations who have Exhibited A Persistent and Positive Effect to Treatment $0. $1,879. $1,879. Slevin, John T 3048107219 Quintiles Inc Solvay S187.3.005: Open-Label, Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease and Severe Motor Fluctuations who have Exhibited A Persistent and Positive Effect to Treatment $0. $75,968. $75,968. Slevin, John T 3048107219 Quintiles Inc Solvay S187.3.005: Open-Label, Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease and Severe Motor Fluctuations who have Exhibited A Persistent and Positive Effect to Treatment $0. $62,167. $62,167. Slevin, John T 3048107219 Quintiles Inc Solvay S187.3.005: Open-Label, Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease and Severe Motor Fluctuations who have Exhibited A Persistent and Positive Effect to Treatment $0. $8,728. $8,728. Slevin, John T 3048108822 American Parkinsons Disease Association Parkinson Disease Information and Referral Center Slevin, John T 3048108822 American Parkinsons Disease Association Parkinson Disease Information and Referral Center
$0.
$8,730.
$8,730.
Slevin, John T 3048108822 American Parkinsons Disease Association Parkinson Disease Information and Referral Center
$0.
$8,728.
$8,728.
Slevin, John T 3048108822 American Parkinsons Disease Association Parkinson Disease Information and Referral Center
$0.
$8,727.
$8,727.
$2. $0. $2. Slevin, John T 3048110228 Inc Research Inc A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients with Parkinson#s Disease $2. $0. $2. Slevin, John T 3048110263 AbbVie Incorporated M12-920: An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Neurology Surgery - Neurosurgery
Totals:
Pittman, Thomas 3048110383 University of California San Francisco Radiosurgery or Open Surgery for Epilepsy (ROSE) Page 134 of 223
$201,019.
$1,364,887.
$1,565,906.
$3,194.
$0.
$3,194.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Surgery - Neurosurgery $0. $2,500. $2,500. Swartz, Karin R 3048109742 Asubio Pharmaceuticals Incorporated A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury $0. $3,150. $3,150. Swartz, Karin R 3048109742 Asubio Pharmaceuticals Incorporated A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury $2. $0. Swartz, Karin R 3048109742
$2.
Asubio Pharmaceuticals Incorporated A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury $0. $35,487. $35,487. Tibbs, Phillip A 3048082800 DePuy Spine SLIM-Loc Plating fusion vs. DISCOVER Arificial Disc Tibbs, Phillip A 3048082800 DePuy Spine SLIM-Loc Plating fusion vs. DISCOVER Arificial Disc
$0.
$79.
$0. $2,758. Tibbs, Phillip A 3048104419 Kyphon Inc Treatment of Lumbar Spinal Stenosis with X-Stop IPD in Moderately Symptomatic Patients to Assess the Long-Term Safety and Performance of X-Stop Interspinous Decompression System $0. $1,173. Tibbs, Phillip A 3048104419
$79.
$2,758.
$1,173.
Kyphon Inc Treatment of Lumbar Spinal Stenosis with X-Stop IPD in Moderately Symptomatic Patients to Assess the Long-Term Safety and Performance of X-Stop Interspinous Decompression System $0. $2,744. Tibbs, Phillip A 3048104419
$2,744.
Kyphon Inc Treatment of Lumbar Spinal Stenosis with X-Stop IPD in Moderately Symptomatic Patients to Assess the Long-Term Safety and Performance of X-Stop Interspinous Decompression System $0. $309,885. Yurek, David M 3048108397
$309,885.
National Institute of Neurological Disorders & Stroke DNA Nanoparticle Gene Therapy in Brain Surgery - Neurosurgery Ophthalmology
Totals:
$3,196.
$357,776.
$360,972.
Ambati, Jayakrishna 3048102202 Burroughs Wellcome Fund Target-Independent Suppression of Angiogenesis by siRNAs
$0.
$75,000.
$75,000.
Ambati, Jayakrishna 3048102202 Burroughs Wellcome Fund Target-Independent Suppression of Angiogenesis by siRNAs
$0.
$75,000.
$75,000.
$272,730.
$272,730.
$0. Ambati, Jayakrishna 3048105306 Doris Duke Charitable Foundation Short non-Interfering RNAs as Novel Therapies for Age Related Macular Degeneration Page 135 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Ophthalmology $0. Ambati, Jayakrishna 3048105306 Doris Duke Charitable Foundation Short non-Interfering RNAs as Novel Therapies for Age Related Macular Degeneration
$136,190.
$136,190.
$0. Ambati, Jayakrishna 3048105306 Doris Duke Charitable Foundation Short non-Interfering RNAs as Novel Therapies for Age Related Macular Degeneration
$-566.
$-566.
$0. Ambati, Jayakrishna 3048105306 Doris Duke Charitable Foundation Short non-Interfering RNAs as Novel Therapies for Age Related Macular Degeneration
$6,695.
$6,695.
Ambati, Jayakrishna 3048107068 National Eye Institute Endogenous Specific Inhibitor of Corneal Lymphangiogenesis
$0.
$17,820.
$17,820.
Ambati, Jayakrishna 3048107068 National Eye Institute Endogenous Specific Inhibitor of Corneal Lymphangiogenesis
$0.
$320,760.
$320,760.
Ambati, Jayakrishna 3048108911 National Eye Institute Functional Studies of DICER1 and Alu RNA in Geographic Atrophy
$0.
$497,237.
$497,237.
$222,750.
$0.
$222,750.
$0.
$25,000.
$-63,905.
$-63,905.
Ambati, Jayakrishna 3048109875 Ellison Medical Foundation Somatic Retrotransposition as a Driver of Aging
$25,000. Ambati, Jayakrishna 3048110287 Carl Marshall Reeves and Mildred Almen Reeves Founda Therapeutic MyD88 Inhibition in a Novel Model of Dry Age-Related Macular Degeneration Baffi, Judit Zsuzsanna 3048108623 National Eye Institute Soluble VEGFR-2 as an Endogenous Inhibitor of Retinal Lymphatics
$0.
$0. $13,598. $13,598. Blackburn, Peter 3048108536 Alimera Sciences Incorporated C-01-11-008: An Open Label, Multi-center Extension Study of the Safety and Utility of the New Inserter of ILUVIEN (Fluocinolone Acetonide Intravitreal Insert) 0.19 mg and the Safety of ILUVIEN in Subjects with Diabetic Macular Edema $0. $387. $387. Capoor, Seema 3048044500 Bausch and Lomb A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis $0. $-2. $-2. Deokule, Sunil 3048107053 Quark Pharmaceuticals Incorporated A Phase I Open Label, Dose Escalation Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Patients with Optic Nerve Athrophy (Stratum I) and Acute Non-Arteritic Anterior Ischemic Optic Neuopathy (NAION) (Stratum II)
Page 136 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Ophthalmology $0. $2,520. $2,520. Deokule, Sunil 3048107053 Quark Pharmaceuticals Incorporated A Phase I Open Label, Dose Escalation Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Patients with Optic Nerve Athrophy (Stratum I) and Acute Non-Arteritic Anterior Ischemic Optic Neuopathy (NAION) (Stratum II) $0. $2,469. $2,469. Deokule, Sunil 3048108849 pSivida Corp A Phase 1, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension $0. $251. $251. Deokule, Sunil 3048108849 pSivida Corp A Phase 1, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension $0. $630. $630. Deokule, Sunil 3048109310 Merck and Company Inc A Prospective Longitudinal Observational Study to Assess the Development of OSD (Sahara) $53,263. Deokule, Sunil 3048109740 pSivida Corp Safety of Modified Extended Release Latanoprost Implant in Rabbit Eyes
$0.
$53,263.
$0.
$321,335.
$321,335.
$75,000. Kleinman, Mark E 3048109735 Foundation Fighting Blindness Identification and Therapeutic Targeting of Pathogenic Nucleic Acids in AMD
$0.
$75,000.
$62,500. Kleinman, Mark E 3048110191 Research to Prevent Blindness Epigenetic Regulation of Chemokine Signaling in Age-Related Macular Degeneration
$0.
$62,500.
$110,000.
$110,000.
Kleinman, Mark E 3048108478 National Eye Institute Endothelial Cell Dysregulation in Neovascular AMD
Pearson, Paul A 3048105483 Research to Prevent Blindness Research To Prevent Blindness Unrestricted Grant
$0.
$2. $0. Pearson, Paul A 3048110411 Auritec Pharmaceuticals Incorporated Open-Label Pilot Safety Study of AP-104IVT (Sustained-Release Fluticasone, Intravitreal) after a Single Intravitreal Injection in Patients with Diabetic Macular Edema $0. $3,505. VanMeter, W S 3048109474
$3,505.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol $0. $5,940. VanMeter, W S 3048109474
$5,940.
$2.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol
Page 137 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Ophthalmology $0. $1,925. VanMeter, W S 3048109474 Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol $0. $1,357. VanMeter, W S 3048109474
$1,925.
$1,357.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol $0. $9,430. VanMeter, W S 3048109474
$9,430.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol $0. $1,650. VanMeter, W S 3048109475
$1,650.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol (EYE BANK) $0. $1,375. VanMeter, W S 3048109475
$1,375.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol (EYE BANK) $0. $6,680. VanMeter, W S 3048109475
$6,680.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol (EYE BANK) $2. $0. VanMeter, W S 3048109475
$2.
Jaeb Center for Health Research Inc Effect of Corneal Preservation Time on Long-Term Graft Success Cornea Preservation Time Study (CPTS) Protocol (EYE BANK) Ophthalmology Totals: $438,517. $1,820,011. $2,258,528. Orthopaedic Surgery $50,356. $0. $50,356. Johnson, Darren L 3048109739 Smith and Nephew Richards Inc Sports Medicine Sports Lab Video Conferencing and AV System Equipment $0. $25,061. Lattermann, Christian 3048105458 Advanced Technologies and Regenerative Medicine A multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation $0. $13,801. Lattermann, Christian 3048105458 Advanced Technologies and Regenerative Medicine A multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation $0. $-100,000. Lattermann, Christian 3048109112
$25,061.
$13,801.
$-100,000.
Arthritis Foundation IL-1RA Treatment in Patients with Acute ACL Tear and Painful Effusions
Page 138 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Orthopaedic Surgery $100,000.
$100,000.
$98,149.
$98,149.
$100,000. Lattermann, Christian 3048110243 Arthritis Foundation IL-1RA Treatment in Patients with Acute ACL Tear and Painful Effusions
$0.
$100,000.
$1,334.
$0.
$1,334.
Lattermann, Christian 3048109112 Arthritis Foundation IL-1RA Treatment in Patients with Acute ACL Tear and Painful Effusions
$0.
$0. Lattermann, Christian 3048109154 National Institute Arthritis Musculoskeletal & Skin Clinical and Biochemical Predictors of Outcome After Knee Injury in Young Patients
Milbrandt, Todd 3048109349 Orthopedic Research and Education Foundation Resident Enhancement Grant- Scholarship Grant
$10,319. $0. $10,319. Moghadamian, Eric Scott 3048109726 Synthes Inc Surgical Approaches to the Distal Femur and Proximal Tibial and Blade Plate Osteosynthesis of the Distal Femur Orthopaedic Surgery Radiation Medicine
Totals:
$162,009.
$137,011.
$299,020.
$0. $-771. $-771. Kudrimoti, Mahesh 3048108344 SciClone Pharmaceuticals Inc A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV-07 in Attenuating Oral Mucositis in Subjects with Head and Neck Cancer Receiving Concurrent Chemotherapy $0. $831. $831. Kudrimoti, Mahesh 3048108344 SciClone Pharmaceuticals Inc A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV-07 in Attenuating Oral Mucositis in Subjects with Head and Neck Cancer Receiving Concurrent Chemotherapy $0. $3,999. $3,999. Kudrimoti, Mahesh 3048108344 SciClone Pharmaceuticals Inc A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV-07 in Attenuating Oral Mucositis in Subjects with Head and Neck Cancer Receiving Concurrent Chemotherapy $0. $136,539. $136,539. Kudrimoti, Mahesh 3048108344 SciClone Pharmaceuticals Inc A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV-07 in Attenuating Oral Mucositis in Subjects with Head and Neck Cancer Receiving Concurrent Chemotherapy $0. $586. $586. Kudrimoti, Mahesh 3048109236 AMGen A Phase 3 Study to Evaluate the Efficacy and Safety of Weeky Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects with Advanced Head and Neck Cancer Receiving Radiotherapy
Page 139 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Radiation Medicine $0. $-2. $-2. Kudrimoti, Mahesh 3048109236 AMGen A Phase 3 Study to Evaluate the Efficacy and Safety of Weeky Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects with Advanced Head and Neck Cancer Receiving Radiotherapy $0. $5,770. $5,770. McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$320.
$320.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$25,980.
$25,980.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$2,500.
$2,500.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$6,420.
$6,420.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$7,450.
$7,450.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$3,250.
$3,250.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$50.
$50.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$3,250.
$3,250.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$800.
$800.
McGarry, Ronald 3048105548 American College of Radiology Radiation Therapy Oncology Group: Master Agreement
$0.
$20,200.
$20,200.
$72,339. $0. $72,339. Molloy, Janelle 3048109556 Varian Medical Systems Development of institutional consistency metrics for the prevention of injurious and reportable radiation delivery errors Page 140 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Medicine Radiation Medicine Randall, Marcus American Cancer Society Transportation Grant
3048108876
$0.
$1,340.
$1,340.
Randall, Marcus American Cancer Society Transportation Grant
3048108876
$0.
$1,400.
$1,400.
Randall, Marcus American Cancer Society Transportation Grant
3048108876
$0.
$1,460.
$1,460.
Randall, Marcus American Cancer Society Transportation Grant
3048108876
$0.
$1,140.
$1,140.
Randall, Marcus American Cancer Society Transportation Grant
3048108876
$0.
$1,600.
$1,600.
$0. Randall, Marcus 3048109276 Gynecologic Oncology Group Chair or Co-Chair of the Corpus Committee Gynecologic Oncology Group
$2,465.
$2,465.
$5,176. Randall, Marcus 3048110470 Gynecologic Oncology Group Chair or Co-Chair of the Corpus Committee Gynecologic Oncology Group
$0.
$5,176.
$226,577.
$304,092.
Radiation Medicine Physical Medicine and Rehabilitation
Totals:
$77,515.
$60,500. $0. $60,500. Chelette, Kenneth Charles 3048109489 American Heart Association Great Rivers Affiliate Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-Stroke Hemiparesis High, Walter 3048108604 Pfizer Inc Growth Hormone and Brain Functioning After Traumatic Brain Injury
$0.
$28,497.
$28,497.
$98,797. $0. $98,797. Sawaki Adams, Lumy 3048109942 Department of Education Combining brain stimulation and peripheral nerve stimulation to improve upper extremity function after severe stroke $35,000. $0. $35,000. Springer, Joe E 3048110311 Morton Cure Paralysis Fund Compensatory Cerebellar Reorganization Following Spinal Cord Injury Physical Medicine and Rehabilitation
Page 141 of 223
Totals: Medicine Totals:
$194,297. $54,539,318.
$28,497. $44,360,153.
$222,794. $98,899,471.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Pharmacy Pharmaceutical Tech $0. Anderson, Bradley D 3048109765 National Cancer Institute The University of KY Cancer Nanotechnology Training Center (UK CNTC)
$-6,436.
$-6,436.
$328,290. Anderson, Bradley D 3048109765 National Cancer Institute The University of KY Cancer Nanotechnology Training Center (UK CNTC)
$0.
$328,290.
Dwoskin, Linda P 3048106407 Boston University Cognitive Aspects of Addiction-Related Behavior
$0.
$130,018.
$130,018.
Dwoskin, Linda P 3048109462 National Institute on Drug Abuse Training Drug Abuse Related Research
$270,933.
$0.
$270,933.
Dwoskin, Linda P 3048109609 University of Arkansas Development of M5 Selective Muscarinic Antagonists
$113,029.
$0.
$113,029.
Dwoskin, Linda P 3048109618 National Institute on Drug Abuse Development of Novel Therapies for Methamphetamine Abuse
$541,568.
$0.
$541,568.
$0.
$83,153.
$83,153. Garneau-Tsodikova, Sylvie 3048110508 National Institute of Allergy and Infectious Diseases Chemoenzymatic studies of aminoglycoside-resistance enzymes toward new drugs Guo, Peixuan 3048108953 National Cancer Institute RNA Nanotechnolgy in Cancer Therapy
$0.
$30,394.
$30,394.
Guo, Peixuan 3048109257 National Institute of Biomedical Imaging & Bioengineer Phi29 Motor Nanopore for Single Molecule Sensing
$0.
$295,553.
$295,553.
Guo, Peixuan 3048109895 National Cancer Institute RNA Nanotechnology in Cancer Therapy
$0.
$79,887.
$79,887.
Guo, Peixuan 3048109895 National Cancer Institute RNA Nanotechnology in Cancer Therapy
$408,591.
$0.
$408,591.
$46,336.
$0.
$46,336.
$0.
$-1,077.
$-1,077.
Kim, Kyung Bo AllTranz Synthesis of codrugs
3048110100
Li, Tonglei 3048107246 National Science Foundation Toward Building a Crystal Structure Prediction Framework
Page 142 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Pharmacy Pharmaceutical Tech $0. $1,890,650. $1,890,650. Lodder, Robert A 3048108028 National Institute for Hometown Security Development of Food Model Systems and Application of QuEChERS Technologies for Detection of Chemical and Bilogical Threats to the Food Supply $0. $55,000. $55,000. Munson, Eric Jon 3048108277 National Science Foundation Center for Pharmaceutical Development $0. Munson, Eric Jon 3048108589 Multiple Industry Sponsors Center for Pharmaceutical Development - Industry Member Consortium Contribution
$40,000.
$40,000.
$0. Munson, Eric Jon 3048108589 Multiple Industry Sponsors Center for Pharmaceutical Development - Industry Member Consortium Contribution
$40,000.
$40,000.
$0. Munson, Eric Jon 3048108589 Multiple Industry Sponsors Center for Pharmaceutical Development - Industry Member Consortium Contribution
$40,000.
$40,000.
$0. Munson, Eric Jon 3048108589 Multiple Industry Sponsors Center for Pharmaceutical Development - Industry Member Consortium Contribution
$80,000.
$80,000.
$45,319. $0. Munson, Eric Jon 3048109531 KY Science and Technology Co Inc KSEF RDE: Systematic Investigation of Drug-Excipient Interactions in Lyophilized Formulations
$45,319.
$11,257. Munson, Eric Jon 3048110281 National Science Foundation GOALI New Techniques for Solid-State NMR Studies of Pharmaceuticals
$0.
$11,257.
$34,000. Munson, Eric Jon 3048110439 National Institute for Pharmaceutical Technology and Edu Characterization of Polymorphs in Tablets Using Advanced Analytical Techniques
$0.
$34,000.
$327,489.
$327,489.
Nixon, Kimberly 3048104311 National Institute on Alcohol Abuse and Alcoholism Ethanol Alteration of the Neurogenic Niche
$0.
$30,000. $0. $30,000. Shu, Dan 3048109777 University of Wisconsin pRNA Nanoparticles as Tools to Improve Human Pluripotent Stem Cell-based Transplantation Strategies for Retinal Degenerative Disease $0. $65,817. $65,817. Thorson, Jon 3048109362 National Cancer Institute Studies on Calicheamicin Biosynthesis and Self Resistance Thorson, Jon 3048109656 National Institute of Allergy and Infectious Diseases In vitro glycorandomization of Natural Products Page 143 of 223
$0.
$343,447.
$343,447.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Pharmacy Pharmaceutical Tech Thorson, Jon 3048109656 National Institute of Allergy and Infectious Diseases In vitro glycorandomization of Natural Products
$365,806.
$0.
$365,806.
Thorson, Jon 3048110269 Rice University Enzyme Discovery for NaturalProduct Biosynthesis
$66,910.
$0.
$66,910.
Tracy, Timothy S. 3048108270 University of Minnesota Pharmacogenetics and Drug Interactions
$0.
$154,820.
$154,820.
Tracy, Timothy S. 3048108440 University of Illinois Altered Drug Metabolism in Pregnancy
$0.
$19,087.
$19,087.
$20,030. Tsodikov, Oleg V. 3048110447 Cornell University Determine the Crystal Structure of Complexes of Rv3671c (MarP) with Inhibitors
$0.
$20,030.
$158,193. Upreti, Meenakshi 3048110378 National Cancer Institute Targeting solid-tumor vasculature with coencapsulated arsenic-and platinum-based
$0.
$158,193.
$336,888.
$336,888.
Van Lanen, Steven 3048108279 National Institute of Allergy and Infectious Diseases Biosynthesis of Nucleoside Antibiotics Targeting Bacterial Translocase I
$0.
$50,000. $0. $50,000. Van Lanen, Steven 3048109601 KY Science and Technology Co Inc KSEF RDE: Novel, Improved Aminoglycoside Antibiotics through Enzymatic Total Synthesis/Combinatorial Biosynthesis $0. $6,432. $6,432. Zhan, Chang-Guo 3048109330 National Institute on Drug Abuse Development of Cocaine-Metabolizing Enzyme for Drug Overdose Treatment $0. Zhan, Chang-Guo 3048109330 National Institute on Drug Abuse Development of Cocaine-Metabolizing Enzyme for Drug Overdose Treatment
$549,203.
$549,203.
$34,511.
$0.
$34,511.
$1,176,703. Zhan, Chang-Guo 3048110289 National Institute on Drug Abuse Long-lasting cocaine-metabolizing enzyme for cocaine addiction treatment
$0.
$1,176,703.
$4,477,172.
$8,261,801.
Zhan, Chang-Guo 3048109685 University of Arkansas Development_of_M5_Selective_Muscarinic_Antagonists
Pharmaceutical Tech
Page 144 of 223
Totals:
$3,784,629.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Pharmacy Pharmacy Practice & Science $0.
$4,000.
$4,000.
$4,156.
$0.
$4,156.
$363,645. Feola, David J 3048109329 National Institute of Allergy and Infectious Diseases Alternative Macrophage Activation in Acute Pseudomonas Pneumonia
$0.
$363,645.
$15,000.
$15,000.
Adams, Val R 3048109371 Alcomed Incorporated STTR: A Pilot Pharmacokinetic and Local Tolerability Study Cook, Aaron Michael 3048110428 Virginia Commonwealth University Sodium Management in Patients with Acute Neurological Injury
$0. Kuhn, Robert J 3048108494 Alkymos Inc Construction and assessment of prototype devices to remove aluminium from solutions Rippetoe Freeman, Patricia E 3048109943 National Institute of Justice Optimizing PDMPs to Support Law Enforcement Activities
$0.
$-20,000.
$-20,000.
Rippetoe Freeman, Patricia E 3048109943 National Institute of Justice Optimizing PDMPs to Support Law Enforcement Activities
$363,226.
$0.
$363,226.
$24,995. $0. $24,995. Rippetoe Freeman, Patricia E 3048110454 ASHP Foundation Improving Transitions of Care from Hospital to Home: Impact of Pharmacist-to-Pharmacist Handoff and Early Pharmacist Follow-up on Patient Outcomes $1,878,785. $0. $1,878,785. Talbert, Jeffery C 3048109511 KY Cabinet for Health and Family Services Money Follows the Person (MFP) - Implementation and Evaluation $927,639.
$0.
$927,639.
Talbert, Jeffery C 3048109827 Urban Institute Medicaid Managed Care in Kentucky
$0.
$47,121.
$47,121.
Talbert, Jeffery C 3048109827 Urban Institute Medicaid Managed Care in Kentucky
$55,512.
$0.
$55,512.
Talbert, Jeffery C 3048110024 Kentuckiana Health Collaborative Kentuckiana Health Collaborative Quality Indicator Aggregation
$27,197.
$0.
$27,197.
Talbert, Jeffery C 3048110304 Artemetrx ArtemetRx Data Analytics and Management
$28,816.
$0.
$28,816.
Talbert, Jeffery C 3048109699 KY Department for Behavioral Health, Developmental and Research and Info Systems Mgmt for KY Dept DBHDID
Page 145 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Pharmacy Pharmacy Practice & Science Wermeling, Daniel P 3048108189 Alcomed Incorporated STTR: Intranasal Nalaxone: An Opioid Overdose Antidote - Part 2
$0.
$-3,750.
$-3,750.
Wermeling, Daniel P 3048108189 Alcomed Incorporated STTR: Intranasal Nalaxone: An Opioid Overdose Antidote - Part 2
$0.
$45,000.
$45,000.
$182,172.
$0.
$182,172.
$3,856,143. $7,640,772.
$87,371. $4,564,543.
$3,943,514. $12,205,315.
$20,000.
$20,000.
Wermeling, Daniel P 3048110457 AntiOp Incorporated STTR: Naloxone Nasal Spray Development Phase 2 b Pharmacy Practice & Science
Totals: Pharmacy Totals:
Health Sciences Rehabilitation Sciences $0. Butterfield, Timothy 3048109384 Ohio State University Massage Therapy in Eccentric Exercise Induced Muscle Weakness and Inflammation
$985. $0. $985. Butterfield, Timothy 3048109780 NATA Research & Education Foundation Dissertation Award for Emily Brownell: Utilization of massage to limit disuse atrophy and enhance regrowth in skeletal muscle $46,049. $0. $46,049. Butterfield, Timothy 3048110083 NATA Research & Education Foundation Load dependent effects of massage on immunomodulation and afferent density Capilouto, Gilson J 3048109808 East Carolina University Discourse and Cognitive Database across the Lifespan
$27,472.
$0.
$27,472.
$224,813. $0. $224,813. Dupont-Versteegden, Esther 3048110482 National Institute on Aging Cyclic compressive loading as an intervention for skeletal muscle atrophy and impaired regrowth in the aged. $0.
$199,538.
$199,538.
$0. Effgen, Susan K 3048108226 Department of Education Relationship of Student Outcomes to School-Based Physical Therapy Services
$203,778.
$203,778.
Effgen, Susan K 3048105863 Department of Education PREPaRE: Preparing Related Services Personnel for Rural Employment
$1,880. $0. $1,880. Mattacola, Carl 3048110580 Southeast Athletic Trainers Association The Relationship between Patient Expectations, Functional Outcome, and Rehabilitation Adherence Following Cartilage Repair of the Knee: A Sequential Explanatory Analysis $125,411. $0. $125,411. NOEHREN, BRIAN 3048110203 National Institute Arthritis Musculoskeletal & Skin Prolonged alterations to muscle following knee surgery and physical therapy Page 146 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Health Sciences Rehabilitation Sciences $14,537. Olson, Anne 3048110408 Gallaudet University Efficacy of Aural Rehabilitation Intervention with Adult Cochlear Implant Users
$0.
$14,537.
$0.
$-71,477.
$-71,477.
$441,147.
$351,839.
$792,986.
$46,898. Lee, Jonah D 3048109507 American Federation for Aging Research The role of satellite cells in aged-skeletal muscle maintenance and hypertrophy
$0.
$46,898.
Peterson, Charlotte A. 3048107057 National Institute Diabetes & Digestive & Kidney Mechanisms Underlying Metabolic Syndrome in Obesity
$0.
$336,385.
$336,385.
Peterson, Charlotte A. 3048107057 National Institute Diabetes & Digestive & Kidney Mechanisms Underlying Metabolic Syndrome in Obesity
$0.
$24,293.
$24,293.
$0. Peterson, Charlotte A. 3048107682 National Institute Arthritis Musculoskeletal & Skin The role of satellite cells in adult skeletal muscle growth and maintenance
$310,284.
$310,284.
$670,962.
$717,860.
$0. Powdrill, Samuel G 3048110095 Help Me See Incorporated Development of Simulated Instruction for Manual Small Incision Cataract Surgery
$7,503.
$7,503.
$24,132. Powdrill, Samuel G 3048110095 Help Me See Incorporated Development of Simulated Instruction for Manual Small Incision Cataract Surgery
$0.
$24,132.
$24,132. $512,177.
$7,503. $1,030,304.
$31,635. $1,542,481.
$0.
$-12,800.
$-12,800.
$0.
$-12,800.
$-12,800.
Patel, Rita R. 3048107907 National Institute on Deafness & Other Communications Clinical Measurement of Vocal Fold Impact Stress in Children Rehabilitation Sciences Administrative Services
Totals:
Administrative Services Clinical Sciences
Clinical Sciences
Totals:
Totals: Health Sciences Totals:
$46,898.
Public Health Public Health Leadership Institute Scutchfield, F Douglas 3048108420 KY Cabinet for Health and Family Services FY12 CHFS/DPH UK KY Public Health Public Health Leadership Institute Preventive Med & Environmental Health
Totals:
$72,986. Dearinger, Angela Tackett 3048109900 KY Public Health Association Assessing and Improving Cultural and Linguistic Competency in Local Health Departments
Page 147 of 223
$0.
$72,986.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Public Health Preventive Med & Environmental Health $32,060. Johnson, Nancy E 3048110082 Ohio State University Evaluation Soil and Dust Exposure in Coal Mining Communities in Kentucky
$0.
$32,060.
$0. $630. $630. Mannino, David M 3048109108 Boehringer Ingelheim A 12-week, randomised, placebo-controlled, double-blind, parallel group, multi-center trial to assess the efficacy and safety of tiotropium bromide (18 #g) delivered via theHandiHaler# in patients with newly diagnosed and/or maintenance treatment na#ve C $0. $359. $359. Mannino, David M 3048109108 Boehringer Ingelheim A 12-week, randomised, placebo-controlled, double-blind, parallel group, multi-center trial to assess the efficacy and safety of tiotropium bromide (18 #g) delivered via theHandiHaler# in patients with newly diagnosed and/or maintenance treatment na#ve C $0. $5,998. $5,998. Mannino, David M 3048109323 Forest Laboratories Inc A 52-week, Double-Blind, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 #g on Exacerbation Rate in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Treated with a Fixed Dose Combination of Long-Acti $0. $100,000. $100,000. Mannino, David M 3048110033 University of Michigan Design and Testing of practical tools to Identify individuals at high risk for COPD $36,075. Mannino, David M 3048110033 University of Michigan Design and Testing of practical tools to Identify individuals at high risk for COPD
$0.
$36,075.
$122,805.
$0.
$122,805.
$263,926.
$106,987.
$370,913.
$0.
$38,340.
$0. $530,045. Crosby, Richard 3048108500 National Institute of Mental Health A Clinic-Based, Safer Sex Program for Young African American Men Who Have Sex With Men
$530,045.
Valvi, Deepa R. 3048110361 KY Department for Public Health FY 13-14 UK BRFSS and Asthma Program Preventive Med & Environmental Health Health Behavior
Totals:
$38,340. Alexander, Linda 3048109963 National Cancer Institute Intergovernmental Personnel Act--Basic & Biobehavioral and Tobacco Control Research
Stone, Ramona-Elena 3048109727 University of Louisville Evaluation of the Kentucky INBRE Student Outcomes
$93,730.
$0.
$93,730.
Stone, Ramona-Elena 3048110386 Louisville Metro Housing Authority Sheppard Square HOPE VI Evaluation
$60,000.
$0.
$60,000.
Page 148 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Public Health Health Behavior $0.
$17,120.
$17,120.
$0. Swanson, Mark 3048110200 National Institute on Minority Health and Health Disparitie Appalachians Together Restoring the Eating Environment (APPAL-TREE)
$84,874.
$84,874.
$272,252. Swanson, Mark 3048110200 National Institute on Minority Health and Health Disparitie Appalachians Together Restoring the Eating Environment (APPAL-TREE)
$0.
$272,252.
Swanson, Mark 3048110292 University of South Florida Community Based Prevention Marketing
$51,475.
$0.
$51,475.
White, Connie 3048109525 KY Department for Public Health UK Woman's Health Consultant FY13
$0.
$-16,890.
$-16,890.
White, Connie 3048109525 KY Department for Public Health UK Woman's Health Consultant FY13
$31,500.
$0.
$31,500.
$2.
$0.
$2.
$547,299.
$615,149.
$1,162,448.
$0. Borders, Tyrone Finley 3048110037 National Institute on Drug Abuse Rural and Urban African American Cocaine Users' Perceived Need for Care
$304,310.
$304,310.
$169,551. Borders, Tyrone Finley 3048110037 National Institute on Drug Abuse Rural and Urban African American Cocaine Users' Perceived Need for Care
$0.
$169,551.
$60,000.
$0.
$60,000.
$122,311. Mays, Glen P 3048110528 Robert Wood Johnson Foundation Quick Strike Research for Practice-Based ResearchNetworks 2013
$0.
$122,311.
$36,936.
$0.
$36,936.
$388,798.
$304,310.
$693,108.
Swanson, Mark 3048109164 University of South Florida Community Based Prevention Marketing
White, Connie 3048109738 Northern Kentucky Independent District Health Departme Medical Consultation for the Northern Kentucky Health Department Health Behavior Health Services Management
Totals:
Costich, Julia F 3048110103 KY Office of Highway Safety Expanded Kentucky Trauma Registry Data Collection and Analysis
Redmond, Jennifer 3048110575 KY Department for Public Health University of Kentucky Strategic Planning and Facilitation Health Services Management
Page 149 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Public Health Epidemiology Chesnut, Lorie 3048109543 KY Department for Public Health UK MCH Workforce and PH Policy Development
$162,525.
$0.
$162,525.
Chesnut, Lorie University of Arizona Certificate in MCH Public Health
3048109703
$18,707.
$0.
$18,707.
Chesnut, Lorie University of Arizona Certificate in MCH Public Health
3048110507
$18,707.
$0.
$18,707.
Fleming, Steven T 3048107705 Pennsylvania State University Pattern of Patient Care in Appalachia
$0.
$26,542.
$26,542.
Flinchum, Andrea H KY Department for Public Health HAI Prevention
$0.
$-672.
$-672.
$0. Hopenhayn, Claudia 3048109420 KY Lung Cancer Research Fund Building the Infrastructure for a Comprehensive Lung Cancer Data Source
$37,500.
$37,500.
$37,500. Hopenhayn, Claudia 3048109420 KY Lung Cancer Research Fund Building the Infrastructure for a Comprehensive Lung Cancer Data Source
$0.
$37,500.
$60,000. Hopenhayn, Claudia 3048110208 Foundation for a Healthy KY County-Level Analysis of Behavioral Risk Factor Surveillance System Data
$0.
$60,000.
$149,250.
$0.
$149,250.
Robl, Joyce M 3048109492 KY Department for Public Health UK Birth Surveillance Registry FY13 and FY14
$0.
$2,000.
$2,000.
Robl, Joyce M 3048109492 KY Department for Public Health UK Birth Surveillance Registry FY13 and FY14
$86,899.
$0.
$86,899.
Sanderson, Wayne 3048109702 National Institute of Occupational Safety and Health Central Appalachian Regional Education Research Center
$0.
$4,975.
$4,975.
Sanderson, Wayne 3048109702 National Institute of Occupational Safety and Health Central Appalachian Regional Education Research Center
$600,714.
$0.
$600,714.
3048109743
Nakayima, Peace Juliana 3048109532 KY Department for Public Health UK HIV/AIDS Epidemiologist and Research Analyst
Page 150 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Public Health Epidemiology Sands, L Fontaine KY Department for Public Health HAI Prevention
3048109743
Valvi, Nimish 3048109486 KY Department for Public Health FY13 UK Heart Disease and Stroke Prevention Program Epidemiology Biostatistics
Totals:
$254,742.
$0.
$254,742.
$69,390.
$0.
$69,390.
$1,458,434.
$70,345.
$1,528,779.
$50,000. $0. $50,000. Charnigo, Richard J 3048109959 Army Research Office Advances in Multivariate Nonparametric Regression with Application to Nanoscale-Gap Thermophotovoltaic Power Conversion $0. $37,500. $37,500. Yang, Lin 3048109421 KY Lung Cancer Research Fund Intelligent Imaging Informatics and Computer Aided Diagnosis and Control for Lung Cancer $37,500. Yang, Lin 3048109421 KY Lung Cancer Research Fund Intelligent Imaging Informatics and Computer Aided Diagnosis and Control for Lung Cancer Biostatistics Gerontology
Totals:
$0.
$37,500.
$37,500.
$125,000.
$145,019.
$145,019.
$0.
$145,019.
$145,019.
$75,000.
$0.
$75,000.
$87,500.
$0. Zanjani, Faika 3048109299 National Institute on Drug Abuse Community Intervention Research on Prescription Drug Safety in Older RuralAdults Gerontology KY Injury Prevention & Research Center
Totals:
Beaven, Shannon 3048109497 KY Cabinet for Health and Family Services Tramatic Brain Injury TBI Trust - KIPRC FY 2013-2014 Bunn, Terry L KY Department for Public Health State Injury Prevention Program
3048109560
$0.
$1,201.
$1,201.
Bunn, Terry L KY Department for Public Health State Injury Prevention Program
3048109560
$268,487.
$0.
$268,487.
Bunn, Terry L 3048109619 Center for Disease Control and Prevention Kentucky Occupational Safety and Health Surveillance
$268,581.
$0.
$268,581.
Bunn, Terry L 3048109716 Center for Disease Control and Prevention Core Violence and Injury Prevention Program
$247,813.
$0.
$247,813.
Page 151 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Public Health KY Injury Prevention & Research Center $199,992. McCool, Robert H 3048110452 Federal Emergency Management Agency Fire Prevention and Safety Grant - Smoke Alarm Installation and Fire Education (SAIFE)
$0.
$199,992.
$69,500.
$0.
$69,500.
$112,608.
$0.
$112,608.
$0. Singleton, Michael 3048105079 National Highway Traffic Safety Administration The Crash Outcome Data Evaluation System (CODES) Data Network Program
$20,000.
$20,000.
$0.
$50,735.
$212,974.
$0.
$212,974.
$1,505,690.
$21,201.
$1,526,891.
$70,090. McKnight, Robert H 3048109513 KY Department for Medicaid Services Kentucky Children's Health Program (KCHIP) Migrant Outreach FY13
$0.
$70,090.
$0. McKnight, Robert H 3048109898 National Institute of Occupational Safety and Health Southeast Center for Agricultural Health and Injury Prevention: Admin Core
$36,549.
$36,549.
$1,233,376. McKnight, Robert H 3048109898 National Institute of Occupational Safety and Health Southeast Center for Agricultural Health and Injury Prevention: Admin Core
$0.
$1,233,376.
$1,303,466.
$36,549.
$1,340,015.
$633,614.
$0.
$633,614.
$538,239. Mays, Glen P 3048109979 Robert Wood Johnson Foundation Public Health Practice-Based Research Network Program Year 2013
$0.
$538,239.
$1,221,130. Scutchfield, F Douglas 3048109820 Robert Wood Johnson Foundation National Coordinating Center for Public Health Services and Systems Research
$0.
$1,221,130.
McKee, Sarah E 3048109766 National Safety Council Safe Communities America Pilot Project Pollack, Susan H 3048109528 KY Department for Public Health CHFS/DPH KIPRC Child Fatality Review Injury Prevention
$50,735. Singleton, Michael 3048110107 KY Office of Highway Safety Integrate Kentucky's CRASH and Vehicle Registration Databases for 2008-2011 Walsh, Sabrina L 3048109921 Center for Disease Control and Prevention National Violent Death Reporting System KY Injury Prevention & Research Center Southeast Cntr for Ag Health & Injury Pr
Southeast Cntr for Ag Health & Injury Pr Center for Public Health Syst & Svcs Res Lamberth, Cynthia 3048109732 Health Resources and Services Administration Kentucky Appalachia Public Health Training Center
Page 152 of 223
Totals:
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Public Health Center for Public Health Syst & Svcs Res $198,635. Scutchfield, F Douglas 3048109926 Robert Wood Johnson Foundation National Coordinating Center for PHSSR - Junior Investigator Award Program
$0.
$198,635.
$2,591,618.
$0.
$2,591,618.
$1,103,042.
$0.
$1,103,042.
$1,103,042.
$0.
$1,103,042.
$191,443. Johnson, Helen A 3048109535 KY Department for Public Health KDPH-UK Emergency Preparedness For Aging & Long Term Care
$0.
$191,443.
$401,669.
$0.
$401,669.
$0. Johnson, Todd 3048108210 University of Texas Health Science Center at Houston ARRA: National Center for Cognitive Informatics and Decision making in Healthcare
$85,885.
$85,885.
$0. Johnson, Todd 3048110530 University of Texas Health Science Center at Houston ARRA: National Center for Cognitive Informatics and Decision making in Healthcare
$2,807.
$2,807.
$0. Johnson, Todd 3048110530 University of Texas Health Science Center at Houston ARRA: National Center for Cognitive Informatics and Decision making in Healthcare
$-2,807.
$-2,807.
$10,000.
$0.
$10,000.
$6,333.
$0.
$6,333.
$609,445. $9,859,218.
$85,885. $1,410,145.
$695,330. $11,269,363.
Center for Public Health Syst & Svcs Res Kentucky Rural Cancer Prevention Center
Totals:
Crosby, Richard 3048109930 National Center for Chronic Disease Prevention & Healt Rural Cancer Prevention Center Kentucky Rural Cancer Prevention Center Dean
Totals:
Johnson, Helen A 3048109594 Health Resources and Services Administration OVAR GEC Interprofessional Healthcare Workforce Training
Lamberth, Cynthia 3048110006 National Network of Public Health Institutes Kentucky Public Health Institute Pfeifle, William G 3048110087 Health Resources and Services Administration University of Kentucky Public Health Traineeship Grant Dean
Totals: Public Health Totals:
Assoc Provost Undergrad Educati Undergraduate Studies $109,422. $0. Guerrant, Bessie M 3048110152 Council on Undergraduate Research Integrating and Leveraging Existing Societies to Facilitate the Development of URM in IOS Career Paths $0. Hollingsworth, Randolph 3048107347 Suder Foundation First Scholars Program and National Model Center at the University of Kentucky Page 153 of 223
$69,543.
$109,422.
$69,543.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Assoc Provost Undergrad Educati Undergraduate Studies $1,000. Hollingsworth, Randolph 3048109753 Association of American Colleges and Universities Bringing Theory to Practice: Engaged Scholarship at the University of Kentucky
$0.
$1,000.
$110,422. $110,422.
$69,543. $69,543.
$179,965. $179,965.
Reed, Michael R 3048107281 Foreign Agricultural Service Extension Services in Serbia and Montenegro
$0.
$48,950.
$48,950.
Reed, Michael R 3048107281 Foreign Agricultural Service Extension Services in Serbia and Montenegro
$0.
$22,000.
$22,000.
Reed, Michael R 3048109621 Foreign Agricultural Service Borlaug Fellowship Program-Ghana
$29,878.
$0.
$29,878.
$29,878.
$70,950.
$100,828.
$0.
$163,569.
$163,569.
$350,412.
$0.
$350,412.
$0. Cox, Nancy Marguerite 3048109982 Agricultural Research Service 2012-13 Acquisition of Goods & Services for USDA Offices in Ag North--Field Work
$14,331.
$14,331.
$7,618. Cox, Nancy Marguerite 3048109982 Agricultural Research Service 2012-13 Acquisition of Goods & Services for USDA Offices in Ag North--Field Work
$0.
$7,618.
$0. Cox, Nancy Marguerite 3048109985 Agricultural Research Service 2012-13 Acquisition of Goods & Services for USDA Offices in Ag North--O&M Account
$566.
$566.
$9,433. Cox, Nancy Marguerite 3048109985 Agricultural Research Service 2012-13 Acquisition of Goods & Services for USDA Offices in Ag North--O&M Account
$0.
$9,433.
$735,720.
$0.
$735,720.
$1,103,183.
$178,466.
$1,281,649.
Undergraduate Studies Totals: Assoc Provost Undergrad Education Totals: Agriculture International Programs
International Programs Assoc Dean Research/Director AES
Totals:
Cox, Nancy Marguerite 3048104749 Agricultural Research Service Improving Sustainability of Forage-Based Production Cox, Nancy Marguerite KY Horse Racing Authority Equine Medical Director
Cox, Nancy Marguerite Agricultural Research Service FAPRU SCA Assoc Dean Research/Director AES
Page 154 of 223
3048109550
3048110512
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Center for the Environment $59,934. Hanley, Carol D 3048109457 Environmental Protection Agency Engaging Partners in a Comprehensive Watershed Project, Urban Waters Small Grant
$0.
$59,934.
$59,934.
$0.
$59,934.
Batte, Marvin Thomas 3048108914 Ohio State University Organic food marketing:Panacea or Problem?
$0.
$2,678.
$2,678.
Batte, Marvin Thomas 3048109858 Agricultural Marketing Service Blueberry Product Development for Local Markets
$69,230.
$0.
$69,230.
Center for the Environment Agr Economics
Totals:
$31,300. $0. Batte, Marvin Thomas 3048109984 Ohio State University Initial Feasibility Assessment of a Seed Tape Production System, Strip Intercropping System for Corn and Soybeans, and Small Supervised Autonomous Equipment $65,536. $0. Davis, Alison F 3048109849
$31,300.
$65,536.
National Institute of Food and Agriculture Ready Communities Pilot and Program Evaluation $25,000.
$0.
$25,000.
$164,182.
$0.
$164,182.
$26,000. Maynard, Leigh J 3048109536 Fayette County Farm Bureau Influence of the Agricultural Cluster on the Fayette County Economy
$0.
$26,000.
$22,000.
$0.
$22,000.
Meyer, Alphonse L 3048109665 University of Georgia Developing an Organic Corn Enterprise in Kentucky
$0.
$-10,000.
$-10,000.
Meyer, Alphonse L 3048109665 University of Georgia Developing an Organic Corn Enterprise in Kentucky
$10,000.
$0.
$10,000.
$0.
$561,564.
Davis, Alison F 3048109893 Appalachian Regional Commission Local Economic Development in Bath County Davis, Alison F 3048109927 Appalachian Regional Commission An Evaluation of ARC Health Projects in Appalachia
Meyer, Alphonse L 3048109595 University of Georgia So SARE PDP Ky Model State Plan - Program Assistant
$561,564. Meyer, Alphonse L 3048109667 National Institute of Food and Agriculture KyFarmStart II: A Whole Farm Management Education Program for Beginning Farmers
Page 155 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Agr Economics Meyer, Alphonse L 3048110382 University of Wyoming USDA SARE Fellows Spring 2013 Tour to Kentucky
$8,350.
$0.
$8,350.
$7,177. $0. $7,177. Skees, Jerry R 3048110019 Purdue University U.S. Borlaug Fellows in Global Food Security: A FTF 21st Century Borlaug Leadership Program (Launching Climate Risk Index Futures and Options Markets) $0. $100,000. $100,000. Stowe, Christina Jill 3048109795 Kentucky Horse Council Kentucky Equine Survey $200,000.
$0.
$200,000.
Stowe, Christina Jill 3048109868 Alltech Biotechnology Inc Kentucky Equine Survey -- Economic Impact Analysis
$27,000.
$0.
$27,000.
Woods, Timothy A Meat Hook LLC Meat Hook Butcher Shop Market
$39,679.
$0.
$39,679.
$49,840. Woods, Timothy A 3048109912 Agricultural Marketing Service National Survey of CSAs: Emerging Marketing and Business Strategies
$0.
$49,840.
Woods, Timothy A 3048110104 University of Arkansas Grape and Winery Contracting and supply Chain Management
$44,132.
$0.
$44,132.
Woods, Timothy A 3048110169 University of Arkansas Evaluating the Economic Impact of MarketReady
$10,042.
$0.
$10,042.
$1,361,032.
$92,678.
$1,453,710.
$0.
$4,949.
$0.
$28,454.
$113,000. $0. Fehr, Robert L 3048109558 KY Energy and Environment Cabinet A Cooperative Extension Program for Kentucky's Energy Efficiency Education Needs 2012-2013
$113,000.
Stowe, Christina Jill Kentucky Horse Council Kentucky Equine Survey
Agr Economics Biosystems & Ag Eng
3048109795
3048109504
Totals:
$4,949. Agouridis, Carmen 3048110063 KY Department of Fish and Wildlife Stream Restoration in Guy Cove II, Laurel Fork Fees in Lieu of Stream Restoration Project Crofcheck, Czarena 3048110364 Eastern KY University Low Cost Biomass Saccharification Process for Producing Biofuels
Page 156 of 223
$28,454.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Biosystems & Ag Eng $0.
$27,500.
$500,000. $0. Higgins, Stephen F 3048110259 KY Energy and Environment Cabinet Managing Mud, Manure, and Runoff: Kentucky Livestock BMP Demonstration and Training Project
$500,000.
Higgins, Stephen F 3048110115 Natural Resources Conservation Service Conservation Practice Code 590 Nutrient Management Training
$27,500.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$1,050.
$1,050.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$450.
$450.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$3,600.
$3,600.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$1,500.
$1,500.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$900.
$900.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$450.
$450.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$1,500.
$1,500.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$900.
$900.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$900.
$900.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$150.
$150.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$550.
$550.
Page 157 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Biosystems & Ag Eng McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$900.
$900.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$450.
$450.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$150.
$150.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$300.
$300.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$150.
$150.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$300.
$300.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$400.
$400.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$-400.
$-400.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$400.
$400.
McNeill, S G 3048107844 Rural Development Energy Audits for Grain and Poultry Producers in Kentucky
$0.
$300.
$300.
McNeill, S G 3048109754 University of Georgia Developing an Organic Corn Enterprise in Kentucky
$10,000.
$0.
$10,000.
Montross, Michael D 3048110098 Case New Holland America LLC Evaluation of pressure in crop processing systems
$41,000.
$0.
$41,000.
$0. $90,000. $90,000. Nokes, Sue E 3048109826 National Institute of Food and Agriculture On-Farm Biomass Processing: Towards an Integrated High Solids Transporting/Storing/Processing System
Page 158 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Biosystems & Ag Eng $0. $1,056,261. $1,056,261. Nokes, Sue E 3048109826 National Institute of Food and Agriculture On-Farm Biomass Processing: Towards an Integrated High Solids Transporting/Storing/Processing System $4,786,525. $0. $4,786,525. Nokes, Sue E 3048109826 National Institute of Food and Agriculture On-Farm Biomass Processing: Towards an Integrated High Solids Transporting/Storing/Processing System Warner, Richard C 3048108632 Virginia Polytechnic Institute and State University Appalachian Research Initiative for Environmental Science (ARIES)
$0.
$287,350.
$287,350.
$0. $-25. Wells, Larry G 3048109748 Association Nationale Interprofessionnelle Et Technique D Implementation and Assessment of Mechanical Burley Tobacco Harvesting Systems in France during 2012
$-25.
$15,117. $0. $15,117. Wells, Larry G 3048109748 Association Nationale Interprofessionnelle Et Technique D Implementation and Assessment of Mechanical Burley Tobacco Harvesting Systems in France during 2012 $15,000. Wells, Larry G 3048110407 Association Nationale Interprofessionnelle Et Technique D Support of the French tobacco sector in mechanization of Burley tobacco
$0.
$15,000.
$5,541,545.
$1,448,486.
$6,990,031.
Bailey, William A 3048110355 Altria Corporate Services Inc Project 1 - Effect of Excess Heat on TSNA
$91,000.
$0.
$91,000.
Bailey, William A 3048110540 Altria Corporate Services Inc Conservation tillage management systems for tobacco
$48,640.
$0.
$48,640.
$0.
$137,800.
$137,800.
Biosystems & Ag Eng Plant & Soil Sciences
Totals:
Bertsch, Paul M 3048105332 Duke University Center for the Environmental Implications of Nanotechnology (CEIN)
$47,730. $0. Bertsch, Paul M 3048109477 University of Chicago Synchrotron X-Ray Microprobe and Microspectroscopy Research at Low Temperature Geochemistry Bruening, William P 3048109873 Kentucky Small Grain Growers Association Performance of Small Grain Varieties in Kentucky
$47,730.
$8,500.
$0.
$8,500.
Carter, Sara K Syngenta Crop Protection Syngenta Soybean
3048110446
$14,000.
$0.
$14,000.
Carter, Sara K Bayer CropScience GmbH Bayer Soybean
3048110460
$10,000.
$0.
$10,000.
Page 159 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Plant & Soil Sciences Carter, Sara K Monsanto Co Monsanto 24-14
3048110481
$6,000.
$0.
$61,355. $0. D'Angelo, Elisa Marie 3048110449 KY Energy and Environment Cabinet Remediation of coal slurry impoundment liquids using a multi-stage constructed treatment wetland system Ditsch, David C 3048110079 KY Governor's Office of Agricultural Policy UK Robinson Center Farmer's Market Shelter
$40,000.
$0.
$6,000.
$61,355.
$40,000.
$35,000. $0. $35,000. Grove, J H 3048110343 Kentucky Soybean Promotion Board Raising Soybean Yield Potential in Dry Seasons: Increased Rooting Depth and Greater Soil Water Extraction with Deeper Depth to the Fragipan $10,000. $0. $10,000. Hildebrand, David F 3048109909 Kentucky Small Grain Growers Association Establishing Salvia hispanica as a Sustainable Grain Crop for KY Farmers $24,694. $0. $24,694. Hildebrand, David F 3048110300 Consortium for Plant Biotechnology Research Inc Development of Chia, Salvia hispanica L., as a Sustainable Oil Source for Renewable Chemical Applications $0. $5,000. $5,000. Hunt, Arthur G 3048105143 National Science Foundation Collaborative Proposal: CPSF30 at the Convergence of RNA Processing, Cellular Signaling and Development in Plants $0. $11,661. $11,661. Hunt, Arthur G 3048105143 National Science Foundation Collaborative Proposal: CPSF30 at the Convergence of RNA Processing, Cellular Signaling and Development in Plants $40,000. $0. $40,000. Karathanasis, Anastasios D 3048109828 KY Department for Public Health Soils Morphology Course Lee, Brad Davis 3048105666 Texas A&M University 2008 Southern Regional Water Resource Project
$0.
$7,000.
$7,000.
Lee, Brad Davis 3048105666 Texas A&M University 2008 Southern Regional Water Resource Project
$0.
$25,000.
$25,000.
Lee, Chad D 3048108961 University of Minnesota Agronomic Maximization of Soybean Yield and Quality
$0.
$70,000.
$70,000.
$6,800.
$0.
$6,800.
Lee, Chad D 3048109876 Kentucky Small Grain Growers Association Genotype x Environment x Management Interactions in Wheat Page 160 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Plant & Soil Sciences $51,932.
$0.
$51,932.
$6,950. Martin, James R 3048109651 Monsanto Co Residual Timing for Marestail Control in Soybean. (Service order no 16)
$0.
$6,950.
Martin, James R 3048109881 Kentucky Small Grain Growers Association Evaluating Marestail Control with Wheat Herbicides
$3,000.
$0.
$3,000.
Martin, James R 3048109882 Kentucky Small Grain Growers Association Using Wheat as a Tool for Managing Palmer Amaranth
$5,000.
$0.
$5,000.
Lee, Chad D 3048110324 Kentucky Soybean Promotion Board Stressing Soybeans to Increase Yield
$30,000. $0. Martin, James R 3048109968 Purdue University Development of Effective Educationmal Programs to Manage and Mitigate Herbicide Resistant Weeds
$30,000.
$15,770. Martin, James R 3048110334 Kentucky Soybean Promotion Board Developing Control Strategies for Glyphosate - Resistant Weeds in Kentucky
$0.
$15,770.
$9,600. Martin, James R 3048110552 Monsanto Co RR2X Soybean Systems Recommendations: Midwest (conventional tillage)
$0.
$9,600.
Miller, Robert D 3048106988 Philip Morris International Management SA Burley Tobacco Breeding and Genetics
$0.
$325,000.
$325,000.
Miller, Robert D 3048108164 Altria Corporate Services Inc Evaluation of Altria Burley Breedling Lines
$0.
$-22,240.
$-22,240.
$43,940. $0. $43,940. Moe, Luke A. 3048109480 KY Science and Technology Co Inc KSEF RDE: Bacteria and Bioethanol Fermentation: Characterizing the Impact of Bacterial Contaminants and Bacterial Community Structure on Bioethanol Fermentations Across the US $0. $25,000. $25,000. Mueller, Thomas G 3048107465 Forest Service Methodology for Designing Vegetative Buffers Using GIS and Terrain Analysis $75,000. $0. $75,000. Mueller, Thomas G 3048109590 Natural Resources Conservation Service GIS and Cloud Computing Tools for Soil and Water Conservation: Grassed Waterways and Nitrogen Fertilizer Recommendations. $13,888. $0. $13,888. Murdock, Lloyd W 3048109989 Kentucky Small Grain Growers Association Small Grain Fragipan Remediation Page 161 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Plant & Soil Sciences Murdock, Lloyd W 3048109996 Kentucky Soybean Promotion Board Soybean Fragipan Remediation
$35,000.
$0.
$35,000.
Murdock, Lloyd W 3048110001 Kentucky Corn Growers Association Corn Growers Fragipan Remediation
$35,000.
$0.
$35,000.
Murdock, Lloyd W 3048110331 Kentucky Soybean Promotion Board Fragipan Remediation
$35,000.
$0.
$35,000.
$35,000. $0. $35,000. Ritchey, Edwin L 3048109298 KY Corn Growers Association An Integrated Approach to Understand the Agronomic Responses to Poultry Litter Use and Soybean and Corn Production Systems $35,000. $0. $35,000. Ritchey, Edwin L 3048110325 Kentucky Soybean Promotion Board An Integrated Approach to Understanding the Dynamics of Poultry Litter Use in Corn-Soybean Production systems Slack, Charles H 3048109584 Monsanto Co Monsanto Test - Service Order No. 13
$8,400.
$0.
$8,400.
Slack, Charles H 3048109614 Monsanto Co Warrant Soybean tests 2012 - Service Order No. 15
$6,000.
$0.
$6,000.
Slack, Charles H Monsanto Co MON 09-08
$6,000.
$0.
$6,000.
3048110476
$49,482. $0. Smalle, Jan A H 3048109523 KY Science and Technology Co Inc KSEF RDE: Stability control of the microtubule-associated protein SPIRAL1 and its role in plant salt stress tolerance $0. $20,000. Smith, Samuel Ray 3048108696
$49,482.
$20,000.
KY Forage and Grasslands Council Farm Scale Biomass Production for Electricity Gerneration and Community Development $0.
$-26,250.
$-26,250.
$75,000. Smith, Samuel Ray 3048109586 Natural Resources Conservation Service Multiple Uses for Switchgrass Stands Following Biomass Production
$0.
$75,000.
Smith, Samuel Ray 3048109418 Ceres Inc Seeded Switchgrass Yield Trial--Annex 1
$0. $49,571. Unrine, Jason M 3048109477 University of Chicago Synchrotron X-Ray Microprobe and Microspectroscopy Research at Low Temperature Geochemistry Page 162 of 223
$49,571.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Plant & Soil Sciences $0. Van Sanford, D A 3048105647 Agricultural Research Service Accelerating the Development of FHB-Resistant Soft Red Winter Wheat Varieties
$58,632.
$58,632.
$65,676.
$65,676.
$0. Van Sanford, D A 3048108107 Agricultural Research Service U.S. Wheat and Barley Scab Initiative's Networking and Facilitation Office and Website
$93,329.
$93,329.
$0. Van Sanford, D A 3048108107 Agricultural Research Service U.S. Wheat and Barley Scab Initiative's Networking and Facilitation Office and Website
$41,388.
$41,388.
$35,700. Van Sanford, D A 3048109877 Kentucky Small Grain Growers Association Soft Red Winter Wheat Breeding and Variety Development For Kentucky
$0.
$35,700.
$6,500. Wendroth, Ole Otto 3048109874 Kentucky Small Grain Growers Association Managing Within-Field Variability of Winter Wheat # Upscaling from Transect to Field
$0.
$6,500.
Van Sanford, D A 3048107999 University of California Davis Imrproving Barley and Wheat Germplasm for Changing Environments
$0.
Williams, David W 3048104694 South Dakota State University Regional Biomass Feedstock Partnership
$0.
$12,500.
$12,500.
Williams, David W 3048108688 Ceres Inc Evaluation of Miscanthus Species as Feedstock Biofuels
$0.
$7,297.
$7,297.
Williams, David W 3048108688 Ceres Inc Evaluation of Miscanthus Species as Feedstock Biofuels
$0.
$7,297.
$7,297.
Williams, David W 3048108688 Ceres Inc Evaluation of Miscanthus Species as Feedstock Biofuels
$0.
$-29,190.
$-29,190.
Witt, William W 3046705900 KY Transportation Cabinet Management of Troublesome Weeds in Highway Rights of Way
$0.
$1.
$1.
$0.
$50,000.
$1,110,881.
$884,472.
$1,995,353.
$9,641.
$0.
$9,641.
$50,000. Zhu, Hongyan 3048109518 KY Science and Technology Co Inc KSEF RDE: Host genetic control of strain-specific nitrogen fixation in Medicago truncatula Plant & Soil Sciences Animal and Food Sciences
Totals:
Amaral-Phillips, Donna M 3048110161 Washington State University Improving Fertility of Dairy Cattle Using Translational Genomics Page 163 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Animal and Food Sciences $15,492. $0. Amaral-Phillips, Donna M 3048110433 Texas A&M University Genomic Selection for Improved Fertility of Dairy Cows with Emphasis on Cyclicity and Pregnancy
$15,492.
$4,909. $0. $4,909. Bewley, Jeffrey M 3048109491 Organic Valley Family of Farms A Preliminary Assessment of the Potential for Compost Bedded Pack Barns in Sustainable Organic Dairy Farming Systems $0. $-49,872. $-49,872. Bewley, Jeffrey M 3048109731 KY Science and Technology Co Inc KSEF RDE:Automation of Dairy Cattle Body Condition Scoring through Image Processing $49,872. Bewley, Jeffrey M 3048109731 KY Science and Technology Co Inc KSEF RDE:Automation of Dairy Cattle Body Condition Scoring through Image Processing
$0.
$49,872.
$49,872. Bewley, Jeffrey M 3048109756 KY Science and Technology Co Inc KSEF RDE: Automation of Dairy Cattle Body Condition Scoring through Image Processing
$0.
$49,872.
$43,027. Bewley, Jeffrey M 3048110069 Alltech Biotechnology Inc Effects of supplementing rations differing in forage level with live yeast culture
$0.
$43,027.
$53,875.
$0.
$53,875.
$3,000.
$0.
$3,000.
Bewley, Jeffrey M 3048110135 KY Governor's Office of Agricultural Policy Compost Bedded Pack Dairy Barn Management Bewley, Jeffrey M 3048110302 KY Academy of Science Foundation Assessment of Heat Stress in Kentucky Dairy Cows
$126,011. $0. $126,011. Bewley, Jeffrey M 3048110308 University of Tennessee Southeast Quality Milk Initiative: Implementing Science-Based Recommendations to Control Mastitis & Improve Milk Quality in the Southeast $13,750. $0. $13,750. Bewley, Jeffrey M 3048110318 University of Georgia Clinical Mastitis Incidence in Compost Bedded Pack Barns as Compared to Freestall Barns $40,120. Harmon, David L 3048110560 Zoetis LLC Use of In Vitro Fermentation as a Comparative Measure of Ionophore Function
$0.
$40,120.
Hennig, B 3048108838 Miami University Fighting with Food: Battling Chemical Toxicity with Good Nutrition
$0.
$29,431.
$29,431.
Hennig, B 3048108838 Miami University Fighting with Food: Battling Chemical Toxicity with Good Nutrition
$0.
$32,691.
$32,691.
Page 164 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Animal and Food Sciences Hennig, B 3048109205 Elsevier Science Inc Editor of the Journal of Nutritional Sciences
$0.
$38,365.
$38,365.
Hennig, B 3048109205 Elsevier Science Inc Editor of the Journal of Nutritional Sciences
$0.
$37,613.
$37,613.
$86,471. Lawrence, Laurie M KY Horse Racing Commission Dietary mitigation of antibiotic-induced changes in equine hindgut bacteria
$0.
$86,471.
$122,601. Lawrence, Laurie M 3048110319 Prairie Oat Growers Association Oats-preventing equine disease:role of starch source in large intestinal microbial disturbances
$0.
$122,601.
3048110198
$243,735.
$0.
$243,735.
Matthews, James Clyde 3048044200 Alltech Biotechnology Inc The Alltech-UK Animal Nutrigenomics Alliance
$0.
$44,000.
$44,000.
Matthews, James Clyde 3048044200 Alltech Biotechnology Inc The Alltech-UK Animal Nutrigenomics Alliance
$0.
$30,000.
$30,000.
$0. Pescatore, Anthony J 3048109252 Agricultural Research Service Use of Natural Remedies to Alleviate Enteric Pathogensin Organic Poultry
$83,381.
$83,381.
Lehmkuhler, Jeffrey W KY Beef Network Kentucky Beef Network
Pescatore, Anthony J Alltech Biotechnology Inc Student Sponorship Good
3048109645
$0.
$15,750.
$15,750.
Pescatore, Anthony J Alltech Biotechnology Inc Student Sponorship Good
3048109645
$12,960.
$0.
$12,960.
Pescatore, Anthony J 3048109646 Alltech Biotechnology Inc Student Sponsorship van Benschoten
$0.
$34,650.
$34,650.
Pescatore, Anthony J 3048109646 Alltech Biotechnology Inc Student Sponsorship van Benschoten
$37,800.
$0.
$37,800.
$0.
$15,750.
$15,750.
Pescatore, Anthony J Alltech Biotechnology Inc Student sponsorship Fisher
Page 165 of 223
3048109647
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Animal and Food Sciences Pescatore, Anthony J Alltech Biotechnology Inc Student sponsorship Fisher
3048109647
$37,800.
$0.
$460,000. $0. Urschel, Kristine L 3048109383 National Institute of Food and Agriculture Threonine nutrition in growing and mature horses: effect of diet composition on threonine requirements
$37,800.
$460,000.
$0. $37,008. $37,008. Xiong, Youling 3048107592 Alltech Biotechnology Inc Nutrigenomics Applied to Meat Science: Understanding the impact of Alltech Antioxidant Nutrients on the Quality and Storage Stability of Chicken Meat $0. $15,420. $15,420. Xiong, Youling 3048107592 Alltech Biotechnology Inc Nutrigenomics Applied to Meat Science: Understanding the impact of Alltech Antioxidant Nutrients on the Quality and Storage Stability of Chicken Meat Animal and Food Sciences Totals: $1,410,936. $364,187. $1,775,123. Entomology $0. $30,580. $30,580. Bessin, Ricardo T 3048107133 Pioneer Hi Bred International Inc 2010 University Protocol for Evaluating Field Efficacy of Herculex I, YieldGard Corn Borer, and Bt11xMIR162 Deployed Against Corn Earworm, Fall Armyworm, and Other Southern U.S. Ledidoptera Larvae $0. $93,645. $93,645. Bessin, Ricardo T 3048107580 National Institute of Food and Agriculture IPM in Kentucky: Integrated Development and Delivery $84,309. $0. Bessin, Ricardo T 3048110026 Rutgers University Whole Farm Organic Management of BMSB and other Pentatomids through Habitat Manipulation
$84,309.
Collins, Joseph T 3048109232 Animal and Plant Health Inspection Service Pine Shoot Beetle (Tomicus piniperda) Survey
$0.
$8,468.
$8,468.
Collins, Joseph T 3048109641 Animal and Plant Health Inspection Service Biological Control of the Hemlock Woolly Adelgid
$15,000.
$0.
$15,000.
Collins, Joseph T 3048109728 Animal and Plant Health Inspection Service Forest Pest Outreach
$37,500.
$0.
$37,500.
Collins, Joseph T 3048109815 KY Energy and Environment Cabinet Regional Firewood Outreach and Educational Campaign
$55,000.
$0.
$55,000.
$5,000.
$0.
$5,000.
Collins, Joseph T 3048109816 KY Energy and Environment Cabinet EAB Public Awareness
Page 166 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Entomology $0. $-36,638. Dobson, Stephen Leonard 3048104232 Bill and Melinda Gates Foundation Supplemental Vector Intervention Required to Eliminate Lymphatic Filariasis in the South Pacific
$-36,638.
$0. $20,460. Dobson, Stephen Leonard 3048104232 Bill and Melinda Gates Foundation Supplemental Vector Intervention Required to Eliminate Lymphatic Filariasis in the South Pacific
$20,460.
Dobson, Stephen Leonard 3048109799 Intellectual Ventures Management LLC Trial of IV Formulae using Aedes mosquito species
$2,797.
$7,073. Dobson, Stephen Leonard 3048110009 MosquitoMate Incorporated SBIR Phase I: Self-delivering, biological control of Aedes albopictus mosquitoes
$0.
$2,797.
$0.
$7,073.
Dobson, Stephen Leonard 3048110199 MosquitoMate Incorporated Mass production of Aedes albopictus males for Experimental Use
$11,458.
$0.
$11,458.
Harper, Carl W 3048110461 Animal and Plant Health Inspection Service Pine Shoot Beetle Survey
$11,290.
$0.
$11,290.
$0. $62,000. Harwood, James Douglas 3048107617 Binational Agricultural Research & Development Fun Biological Control of Cereal Aphids in Wheat: Implications of Alternative Foods and Intraguild Predation Harwood, James Douglas 3048109598 University of Georgia Importance of Natural Enemies for Stink Bug Control Harwood, James Douglas 3048109880 Kentucky Small Grain Growers Association Tracking the source of aphid-vectored virus in winter wheat Haynes, Kenneth F 3048109608 Valent BioSciences Corporation Valent Bioscience VBC3 for bed bug control
$62,000.
$12,000.
$0.
$12,000.
$8,262.
$0.
$8,262.
$10,467.
$0.
$10,467.
$424,542. $0. $424,542. Kajita, Yukie 3048109502 National Science Foundation A bio-economic study of an introduced biological control agent: ecological, evolutionary, and economic factors in sustainable agricultural systems $25,000. $0. $25,000. Lensing, Janet R 3048109639 Animal and Plant Health Inspection Service Phytophthora ramorum Survey Lensing, Janet R 3048109640 Animal and Plant Health Inspection Service Thousand Cankers Disease Survey
Page 167 of 223
$17,157.
$0.
$17,157.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Entomology Lensing, Janet R 3048110121 Animal and Plant Health Inspection Service Cooperative Agricultural Pest Surveys - Infrastructure
$0.
$66,246.
$66,246.
Lensing, Janet R 3048110121 Animal and Plant Health Inspection Service Cooperative Agricultural Pest Surveys - Infrastructure
$0.
$26,414.
$26,414.
Lensing, Janet R 3048110121 Animal and Plant Health Inspection Service Cooperative Agricultural Pest Surveys - Infrastructure
$8,800.
$0.
$8,800.
Lensing, Janet R 3048110278 Animal and Plant Health Inspection Service Emerald Ash Borer Survey in Kentucky
$0.
$59,870.
$59,870.
Lensing, Janet R 3048110278 Animal and Plant Health Inspection Service Emerald Ash Borer Survey in Kentucky
$34,450.
$0.
$34,450.
Lensing, Janet R 3048110409 Animal and Plant Health Inspection Service Orchard Survey
$15,035.
$0.
$15,035.
Lensing, Janet R 3048110440 Animal and Plant Health Inspection Service Gypsy Moth Survey
$0.
$57,559.
$57,559.
Lensing, Janet R 3048110440 Animal and Plant Health Inspection Service Gypsy Moth Survey
$19,186.
$0.
$19,186.
Lensing, Janet R 3048110459 Animal and Plant Health Inspection Service Grape Survey
$12,613.
$0.
$12,613.
Palli, Subba R 3048106860 National Institute of General Medical Sciences Molecular Analysis of Juvenile Hormone Action
$0.
$185,774.
$185,774.
Palli, Subba R 3048109717 National Science Foundation Planning Grant: I/UCRC for Arthropod Management Technologies
$11,499.
$0.
$11,499.
Palli, Subba R Agricultural Research Service P450 inhibition assays
$25,918.
$0.
$25,918.
$0.
$40,000.
3048110217
$40,000. Potter, Daniel A 3048110344 United States Golf Association Benefits of golf course naturalized areas for biological control and pollinator conservation
Page 168 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Entomology $0. $30,000. Rieske-Kinney, Lynne K 3048107055 Forest Service Post-Invasion Forests: Composition and Structure Following Invasive Species Establishment
$30,000.
$85,000. Rieske-Kinney, Lynne K 3048109720 Forest Service Integrating biological control and chemical suppression to save our ash resources
$0.
$85,000.
$0.
$2,500.
$0.
$5,555.
$2,500.
Rieske-Kinney, Lynne K 3048109746 Forest Service 3rd Kentucky Invasive Species Conference
$5,555. Rieske-Kinney, Lynne K 3048109981 Northern Nut Growers Association Recruitment of Natural Enemies MIitigates Impacts of the Asian Chestnut Gall Wasp
$0. $55,461. $55,461. Sharkey, Michael Joseph 3048108809 University of Delaware TCN: Collaborative Research: Plants, Heribivores, and Parasitoids: A Model System for the Study of Tri-Trophic Associations $0. $27,500. $27,500. Townsend, Lee H 3048109414 KY Department of Agriculture 2013-14 UK Private Pesticide Applicator Townsend, Lee H 3048109414 KY Department of Agriculture 2013-14 UK Private Pesticide Applicator
$27,500.
$0.
$27,500.
Townsend, Lee H 3048109883 National Institute of Food and Agriculture Pesticide Safety Education
$10,000.
$0.
$10,000.
$1,024,911.
$687,339.
$1,712,250.
Entomology Forestry
Totals:
$0. $33,490. $33,490. Barton, Christopher D 3048108882 Forest Service Evaluation of acidic atmospheric deposition and its influence on soil solution composition in the Daniel Boone National Forest $150,000. $0. $150,000. Barton, Christopher D 3048110229 American Rivers Mower Tract Ecological Restoration $0. $10,500. $10,500. Cox, John J 3048109593 KY Department of Fish and Wildlife Resource Selection, Movement Patterns, Survival, and Cause-Specific Mortality of Adult Bull Elk in Kentucky $50,000. $0. $50,000. Cox, John J 3048109593 KY Department of Fish and Wildlife Resource Selection, Movement Patterns, Survival, and Cause-Specific Mortality of Adult Bull Elk in Kentucky
Page 169 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Agriculture Forestry $90,000. Cox, John J 3048109643 KY Department of Fish and Wildlife Population Growth and Expansion of the Black Bear in Eastern Kentucky
$0.
$90,000.
$17,879.
$0.
$17,879.
$45,140. Fackler, Francis C 3048110078 KY Energy and Environment Cabinet Regional Secondary Wood Using Industry Online and Hardcopy Directory
$0.
$45,140.
$0. $20,000. Lacki, Michael J 3048107619 Forest Service Fire Management and Habitat Quality for Endangered Bats in Mammoth Cave National Park, JFSP
$20,000.
Cox, John J 3048110097 Rocky Mountain Elk Foundation Cow Elk Survival and Mortality Study
Stringer, Jeffrey W 3048109591 KY Energy and Environment Cabinet UK Forest Stewardship Public Awareness, Publicity & Training
$10,000.
$0.
$10,000.
Stringer, Jeffrey W 3048109592 KY Energy and Environment Cabinet Forest and Wood Product Certification Educational Outreach
$22,500.
$0.
$22,500.
$32,000. Stringer, Jeffrey W 3048109830 KY Energy and Environment Cabinet Kentucky Woodlands Magazine - Woodland Health Update & Educational Opportunity Issues
$0.
$32,000.
$2,000. Thomas, William R 3048109589 KY Energy and Environment Cabinet Restoring Bottomland Hardwood Forests to Improve Watershed Health Outreach
$0.
$2,000.
$419,519.
$63,990.
$483,509.
$164,519.
$0.
$164,519.
$0.
$59,380.
$59,380.
Forestry Horticulture
Totals:
Coolong, Timothy 3048110022 Iowa State University Shielding cucurbit crops for resilient agroecosystems
DeBolt, Seth 3048108610 Kansas State University The Impact of Sterol Biogenesis on Cellulose Synthesis in Higher Plants
$0. $160,522. DeBolt, Seth 3048108772 Cornell University Defining determinants and dynamics and cellulose microfibril biosynthesis, assembly and degradation
$160,522.
$185,799. $0. Geneve, Robert L 3048110196 Brigham Young University Impact and social acceptance of selected sustainable practices in ornamental crop production systems
$185,799.
Ingram, Dewayne L KY Horticulture Council KHC VI - Lexington Page 170 of 223
3048110139
$560,000.
$0.
$560,000.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Horticulture $15,000. $0. $15,000. Ingram, Dewayne L 3048110390 Horticultural Research Institute Greenhouse gas emissions (carbon footprint) and associated costs of field-grown, deciduous shrub production system components and the subsequent impact in the landscape $50,791. $0. $50,791. Jacobsen, Krista L. 3048110253 KY Department of Agriculture Building technical support capacity for Kentucky's high tunnel specialty crop producers $450,000. Wilson, Patsy E 3048109879 Kentucky Vineyard Society The Kentucky Viticulture and Enology Extension and Research Program
$0.
$450,000.
$11,000.
$0.
$11,000.
$1,437,109.
$219,902.
$1,657,011.
$99,084.
$0.
$99,084.
$2,840.
$2,840.
$0.
$12,000.
$18,500. $0. Hershman, Donald E 3048110333 Kentucky Soybean Promotion Board Evaluation of Soybean Vein Necrosis-Associated Virus Infected Soybean for Seed Transmission
$18,500.
$40,000. $0. Kachroo, Aardra P 3048109476 KY Science and Technology Co Inc KSEF RDE: Towards Understanding The Mechanisms of Plant Extreme Resistance to Viruses
$40,000.
Wright, Shawn KY Department of Agriculture UK Ginseng 2013 Monitoring Horticulture Plant Pathology
3048110402
Totals:
Farman, Mark L 3048110371 Kansas State University Novel Strategies for Managing Blast Diseases on Rice and Wheat
$0. Hershman, Donald E 3048109412 Agricultural Research Service Effects of Local Corn Debris Management on FHB and DON Levels (Year Two): KY $12,000. Hershman, Donald E 3048110332 Kentucky Soybean Promotion Board 2013 Kentucky Soybean Rust Monitoring Network and Early Warning System
Kachroo, Aardra P 3048110342 Kentucky Soybean Promotion Board Broadening host specificity in soybean-rhizobium symbiosis
$42,810.
$0.
$42,810.
$0. $6,000. $6,000. Kachroo, Pradeep 3048104688 National Science Foundation Glycerol Metabolism and Its Role in Biotrophy Versus Necrotrophy in an Arabidopsis/Fungal Hemibiotroph Model System $0. $200,897. $200,897. Nagy, Peter D 3048109279 National Science Foundation Key role of the multifunctional translation elongation factor in virus replication.
Page 171 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Plant Pathology $45,550. $0. $45,550. Nagy, Peter D 3048109484 KY Science and Technology Co Inc KSEF RDE: Screening of temperature sensitive and deletion libraries for host factors affecting virus replication $230,769. $0. Schardl, Christopher L 3048109578 West Virginia University Alteration of alkaloid profiles of forage and turf grasses by genetic manipulation of endophytic fungi $0. $10,742. Seebold, Kenneth W 3048108217 Regents of the University of California Riverside Reducing Losses to Potato and Tomato Late Blight by Enhanced Monitoring of Pathogen Populations and Improved Resistant Plants, Education and Extension. $22,000. $0. Vincelli, Paul 3048110081
$230,769.
$10,742.
$22,000.
University of Florida Southern Plant Diagnostic Network, Kentucky Component $15,000. $0. Ward, Nicole 3048110339 University of Georgia Elucidating the Spread and Transmissibility of Blueberry Mosaic Virus, a New Disease of Blueberry in the Southeastern U.S. Plant Pathology Totals: $525,713. $220,479. Community & Leadership Devel $1,179. $0. Dyk, Patricia H 3048109951
$15,000.
$746,192. $1,179.
University of Massachusetts Dissemination of Core Health Messages: Using Community-Based Participatory Research to Strengthen the Health of rural, Low-Income Families $7,213. $0. $7,213. Epps, Rebekah 3048110475 KY Department of Education Greenhouse Management for the Agricultural Educator Hains, Bryan 3048109633 KY Education and Workforce Development Cabinet UK Perkins Teacher Education Award 2012-2013
$4,500.
$0.
$4,500.
$0. $3,889. $3,889. Tanaka, Keiko 3048109597 University of Georgia Mapping Sustainable Farm Systems: An Integrated Focus on Upper South New Producers as Catalysts of "Good Stewardship." $270,000. $0. $270,000. Tanaka, Keiko 3048109597 University of Georgia Mapping Sustainable Farm Systems: An Integrated Focus on Upper South New Producers as Catalysts of "Good Stewardship." Community & Leadership Devel Totals: $282,892. $3,889. $286,781. Veterinary Science $51,370. $0. $51,370. Adams, Amanda A 3048110397 Boehringer Ingelheim Characterization of Cell-mediated and Humoral immune responses to a multi-valent #Combination# vaccine in na#ve ponies.
Page 172 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Veterinary Science $57,551. $0. $57,551. Adams, Amanda A 3048110398 Boehringer Ingelheim Do horses with Pituitary Pars Intermedia Dysfunction (PPID) respond as well to vaccination (Vetera# Gold) when compared to non-PPID, aged-matched horses? $15,218. $0. $15,218. Bailey, Ernest F 3048110270 KY Horse Racing Commission The Influence of Genetic Deficits in Aggrecan Structure (Cartilage) on Race Track Breakdown $0. Balasuriya, Udeni 3048108184 Kansas State University Rapid Detection of Foreign, Emerging and Zoonotic Pathogens of Equines
$45,000.
$362,112. $0. Balasuriya, Udeni 3048110111 Merial Ltd Development of recombinant vaccines against PRRS: EAV-vectored chimeric vaccines against PRRS.
$45,000.
$362,112.
$654,810. $0. $654,810. Balasuriya, Udeni 3048110154 National Institute of Food and Agriculture Identification of Genetic Factors Responsible for Establishment of Equine Arteritis Virus Carrier State in Stallions. $44,855. Chambers, Thomas M 3048109485 KY Science and Technology Co Inc KSEF RDE: Role of the horse in interspecies transmission of influenza viruses
$0.
$44,855.
$49,234.
$0.
$49,234.
Chambers, Thomas M 3048110272 KY Horse Racing Commission Influenza, Secondary Bacterial Infection, and Interleukin-23.
$54,378. $0. $54,378. Horohov, David W 3048110257 Morris Animal Foundation Use of Recombinant Proteins to Identify Antibody Responses Associated with Equine Proliferative Enteropathy. $147,781. Horohov, David W 3048110350 Zoetis LLC The use of Excede metaphylatically to prevent post-influenzal respiratory infections
$0.
$189,297. $0. Horohov, David W 3048110505 KY Horse Racing Commission The effect of exercise on pro-inflammatory cytokine expression in the young racehorse and its impact on training-related injuries. $0. $306,495. Issel, Charles J 3048105557
$147,781.
$189,297.
$306,495.
University of Pittsburgh EIAV Envelope Variation and Vaccine Efficacy $0. $-25,002. MacLeod, James N 3048107238 KY Horse Racing Commission Safety and Anti-inflammatory Efficacy of Glucocorticoids for Intra-articular Therapy in Racehorses
$-25,002.
$24,992. $0. MacLeod, James N 3048110113 KY Horse Racing Commission Safety and Anti-inflammatory Efficacy of Glucocorticoids for Intra-articular Therapy in Racehorses
$24,992.
Page 173 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Veterinary Science Nielsen, Martin K 3048110347 Grayson Jockey Club Research Foundation Inc The Interaction between Anthelmintic Treatment and Vaccination
$60,466.
$0.
$60,466.
Nielsen, Martin K Zoetis LLC Parasite Material Agreement
$21,364.
$0.
$21,364.
3048110359
$0. $-14,080. $-14,080. Nielsen, Martin K 3048110360 Zoetis LLC Objective evaluation of deworming regimens in horses - growth rates, disease incidence and financial aspects $126,941. $0. $126,941. Nielsen, Martin K 3048110360 Zoetis LLC Objective evaluation of deworming regimens in horses - growth rates, disease incidence and financial aspects Veterinary Science Landscape Architecture
Totals:
$1,860,369.
$312,413.
$2,172,782.
$8,369.
$0.
$8,369.
$8,369.
$0.
$8,369.
$0.
$1,850.
$1,850.
$131,792.
$0.
$131,792.
$131,792.
$1,850.
$133,642.
Carter, Craig N 3048109768 KY Department of Agriculture Bovine Spongiform Encephalopathy Testing and Related Services
$0.
$-1,080.
$-1,080.
Carter, Craig N 3048109768 KY Department of Agriculture Bovine Spongiform Encephalopathy Testing and Related Services
$0.
$3,000.
$3,000.
Carter, Craig N 3048109768 KY Department of Agriculture Bovine Spongiform Encephalopathy Testing and Related Services
$8,640.
$0.
$8,640.
$50,875.
$0.
$50,875.
Hargrove, Ryan Anthony 3048110400 Louisville Central Community Center West Muhammed Ali Boulevard Corridor Study Landscape Architecture Regulatory Services
Totals:
Green, Kristen M 3048108368 Food and Drug Administration Medicated Feed Mill & BSE Rule Inspections Webb, Sharon F. 3048109451 Food and Drug Administration Enhancing and Building the Capability of Feed Safety in Kentucky Regulatory Services Veterinary Diagnostic Laboratory
Carter, Craig N 3048110420 Animal and Plant Health Inspection Service Diagnostic Laboratory Support of NAHLN
Page 174 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Veterinary Diagnostic Laboratory Carter, Craig N 3048110486 KY Department of Agriculture Bovine Spongiform Encephalopathy 5/1/13-3/31/14
$4,000.
$0.
$4,000.
$16,500. $0. $16,500. Gaskill, Cynthia Lynn 3048109770 Food and Drug Administration FDA Vet-LRN Veterinary Diagnostic Laboratory Cooperative Agreement Program funding to increase sample analysis in the event of animal food or drug related illness Veterinary Diagnostic Laboratory Totals: $80,015. $1,920. $81,935. Family & Consumer Sciences $0. $42,500. $42,500. Ashurst, Kerri Lynn 3048108708 Kansas State University Operation Millitary Kids Kentucky 2012 Ashurst, Kerri Lynn 3048108708 Kansas State University Operation Millitary Kids Kentucky 2012 Ashurst, Kerri Lynn Kansas State University Kentucky 2013 OMK Camp grant
3048110266
Ashurst, Kerri Lynn 3048110291 Purdue University Kentucky Military-Extension Adventure Camp Initiative Ashurst, Kerri Lynn Army KY OMK 2013
3048110322
$0.
$40,000.
$40,000.
$40,000.
$0.
$40,000.
$203,890.
$0.
$203,890.
$42,500.
$0.
$42,500.
$0. $-42,538. Stephenson, Laura F 3048109149 KY Department of Agriculture Specialty Crop: Plate It Up Kentucky Proud Recipe Development for Consumers with Nutrition Research Component $0. $-51,353. Stephenson, Laura F 3048110189
$-42,538.
$-51,353.
KY Department of Agriculture Specialty Crop: Plate It Up Kentucky Proud Recipe Development for Consumers and Producers, with Family Meals Research Component $52,350. $0. $52,350. Stephenson, Laura F 3048110189 KY Department of Agriculture Specialty Crop: Plate It Up Kentucky Proud Recipe Development for Consumers and Producers, with Family Meals Research Component $48,709. $0. $48,709. Torres, Nayda Ivette 3048110551 National Institute of Food and Agriculture Children, Youth and Families at Risk Liaison $619,037. Vail, Ann 3048109494 KY Cabinet for Health and Family Services UK Supplemental Nutrition Assistance Program-Education (SNAP-Ed)
Page 175 of 223
$0.
$619,037.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Family & Consumer Sciences $0.
$22,932.
$22,932.
$2,622,170. Vail, Ann 3048110031 KY Cabinet for Health and Family Services UK Supplemental Nutrition Assistance Program Education (SNAP Ed)
$0.
$2,622,170.
$3,628,656.
$11,541.
$3,640,197.
Wood, Craig H 3046887200 University of Nebraska ECOP/CSREES E-eXtension-Supplement
$0.
$201,748.
$201,748.
Wood, Craig H 3048108837 University of Nebraska Building Cooperative Extension's 21st Century Network
$0.
$395,324.
$395,324.
$0.
$194,444.
$194,444.
$597,072.
$791,516.
$25,000.
$0.
$25,000.
$25,000.
$0.
$25,000.
$112,600.
$0.
$112,600.
$0.
$162,000.
$162,000.
$66,180. $0. Higdon, Andrea Lynn 3048109744 National Institute of Food and Agriculture Strengthening community agrosecurity preparedness: Building National Networks and Partnerships
$66,180.
Vail, Ann 3048110031 KY Cabinet for Health and Family Services UK Supplemental Nutrition Assistance Program Education (SNAP Ed)
Family & Consumer Sciences e-Extension
Totals:
$194,444. Wood, Craig H 3048110372 University of Nebraska ECOP/CSREES E-extension Supplement Amendment 18 to contract #26-6365-001-301 e-Extension 4-H Central Operations
Totals:
Mains, Mark Allen 3048109549 National Four H Council Engaging Youth, Serving Community 10 4-H Central Operations Agr Programs
Totals:
Gumbert, Amanda Claire Abnee 3048110080 KY Energy and Environment Cabinet University of Kentucky Cooperative Extension Service Liaison Hancock, John N 3048107082 National Institute of Food and Agriculture Kentucky AgrAbility
Agr Programs Nutrition and Food Science
Totals:
$178,780.
$162,000.
$340,780.
$100,000. $0. $100,000. Adams, Ingrid K 3048110282 Robert Wood Johnson Foundation Development of strategies and culturally appropriate models for addressing disparities in obesity prevention for Asian Americans $149,074. $0. $149,074. Gustafson, Alison 3048110435 National Institute of Food and Agriculture Adolescent and Parent Food Activity Patterns as Drivers of Food Choices and Behaviors Page 176 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Agriculture Nutrition and Food Science Kurzynske, Janet S 3048109867 National Institute of Food and Agriculture CYFAR Capacity Building Supplement
$0.
$98,738.
$98,738.
Kurzynske, Janet S 3048109867 National Institute of Food and Agriculture CYFAR Capacity Building Supplement
$31,262.
$0.
$31,262.
Kurzynske, Janet S 3048110469 National Institute of Food and Agriculture 2013 Children, Youth, and Families at Risk Sustainable Community
$80,000.
$0.
$80,000.
Perry, Robert R. 3048109519 American Livestock Breeds Conservancy Saving Endangered Hog Breeds
$0.
$-2,277.
$-2,277.
Perry, Robert R. 3048109519 American Livestock Breeds Conservancy Saving Endangered Hog Breeds
$38,170.
$0.
$38,170.
$398,506.
$96,461.
$494,967.
Easter, Elizabeth P 3048110151 Cotton Incorporated Cotton Incorporated Laundry Study 2013
$30,000.
$0.
$30,000.
Easter, Elizabeth P Association for Linen Management Quality Control Lab for NAILM
$28,149.
$0.
$28,149.
$58,149.
$0.
$58,149.
$0.
$153,437.
$153,437.
$0. $20,871,613.
$153,437. $5,571,532.
$153,437. $26,443,145.
$1,500.
$0.
$1,500.
$1,500. $1,500.
$0. $0.
$1,500. $1,500.
Nutrition and Food Science Merchandising, Apparel & Textiles
Totals:
3048110166
Merchandising, Apparel & Textiles Ky Tobacco Research & Dev Center
Totals:
Yuan, Ling 3048109135 University of California Berkeley Folium - Evaluation of Tobacco BioFuels Production Ky Tobacco Research & Dev Center
Totals: Agriculture Totals:
Student Affairs Student Involvement Pyatte, Jillian LeeAnn North Carolina Campus Compact MLK Collegiate Challenge Student Involvement
Page 177 of 223
3048110101
Totals: Student Affairs Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Academic Administration Academic Administration $65,741. $0. $65,741. Pfeifle, Andrea L 3048109463 Josiah Macy Jr Foundation Southeast Consortium for Interprofessional Education: Using Interprofessional e-Learning Communities to Teach Collaborative Practice, Principles Academic Administration Totals: $65,741. $0. $65,741. Academic Administration Totals: $0. $65,741. $65,741. Library Administration Library Administration $0.
$251,634.
$251,634.
$0. Molinaro, Mary H 3046894500 National Endowment for the Humanities National Digital Newspaper Program Phase One: The Kentucky Test Bed, or KNP Redux
$-342.
$-342.
$0. Molinaro, Mary H 3048109200 National Endowment for the Humanities National Digital Newspaper Program Phase One: The Kentucky Test Bed, or KNP Redux
$342.
$342.
$0. $35,913. Molinaro, Mary H 3048109200 National Endowment for the Humanities National Digital Newspaper Program Phase One: The Kentucky Test Bed, or KNP Redux
$35,913.
Greenwell, Stacey C 3048090900 Lexmark International Inc Lexmark International, Inc. Information Center
$0. Molinaro, Mary H 3048109200 National Endowment for the Humanities National Digital Newspaper Program Phase One: The Kentucky Test Bed, or KNP Redux
$3,950.
$3,950.
Molinaro, Mary H 3048110102 KY Council on Postsecondary Education Kentuckiana Digital 13/14
$252,000.
$0.
$252,000.
Molinaro, Mary H 3048110132 Open Knowledge Commons Digital Public Library of America Digital Hubs Pilot - NEH
$100,000.
$0.
$100,000.
$99,997.
$0.
$99,997.
$0.
$-22,722.
$-22,722.
$451,997.
$268,775.
$720,772.
$139,596. $0. Molinaro, Mary H 3048110368 National Endowment for the Humanities Coal, Camps, and Railroads: Digitizing primary sources on Appalachian economic development
$139,596.
Molinaro, Mary H 3048110133 Open Knowledge Commons Digital Public Library of America Digital Hubs Pilot - Knight Scaggs, Deirdre A Keeneland Association Library Director Agreement Library Administration Libraries
Libraries Page 178 of 223
3048107197
Totals:
Totals:
$139,596.
$0.
$139,596.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Library Administration Medical Center Library Davison, Laura University of Illinois Outreach Library
3048108899
$0.
$5,000.
$5,000.
Davison, Laura University of Illinois Outreach Library
3048108899
$0.
$5,000.
$5,000.
Medical Center Library
Totals: Library Administration Totals:
$0. $591,593.
$10,000. $278,775.
$10,000. $870,368.
Kern, Philip A. 3048109109 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science - KL2
$0.
$-500,392.
$-500,392.
Kern, Philip A. 3048109110 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science
$0.
$-72,917.
$-72,917.
Kern, Philip A. 3048109110 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science
$0.
$-3,280,269.
$-3,280,269.
Kern, Philip A. 3048109111 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science
$0.
$-150,086.
$-150,086.
Kern, Philip A. 3048109629 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science - KL2
$0.
$7,671.
$7,671.
Kern, Philip A. 3048109629 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science - KL2
$0.
$-7,671.
$-7,671.
Kern, Philip A. 3048109629 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science - KL2
$500,392.
$0.
$500,392.
Kern, Philip A. 3048109797 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science
$3,353,186.
$0.
$3,353,186.
Kern, Philip A. 3048109807 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science
$150,086.
$0.
$150,086.
Kern, Philip A. 3048110232 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science (TL1)
$150,065.
$0.
$150,065.
Office of the Provost Center for Clinical & Translational Scie
Page 179 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Office of the Provost Center for Clinical & Translational Scie Kern, Philip A. 3048110233 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science (KL2)
$482,961.
$0.
$482,961.
Kern, Philip A. 3048110248 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science (UL1)
$0.
$-337,063.
$-337,063.
Kern, Philip A. 3048110248 National Center for Advancing Translational Sciences Kentucky Center for Clinical and Translational Science (UL1)
$3,370,638.
$0.
$3,370,638.
$8,007,328.
$-4,340,727.
$3,666,601.
$0.
$997,437.
$997,437.
$0.
$997,437.
$0.
$-50,492.
$-50,492.
$0.
$-50,492.
$-50,492.
$150,000.
$0.
$150,000.
Zeidler-Watters, Kimberly Jean 3048109914 KY Department of Education Science Leadership Support Network - Eastern Region Year 3
$97,500.
$0.
$97,500.
Zeidler-Watters, Kimberly Jean 3048109915 KY Department of Education Science Leadership Support Network - Central Region Year 3
$97,500.
$0.
$97,500.
Zeidler-Watters, Kimberly Jean 3048110193 KY Council on Postsecondary Education IEQ: Continuous Assessment and Algebraic Thinking - Year 2
$150,000.
$0.
$150,000.
$130,000. Zeidler-Watters, Kimberly Jean 3048110194 KY Council on Postsecondary Education IEQ: Success in Algebra: Improving Special Education Teaching Practice
$0.
$130,000.
$140,000. Zeidler-Watters, Kimberly Jean 3048110288 KY Department of Education MSP: Modeling for Understanding in Science and Engineering (MUSE)
$0.
$140,000.
$0.
$765,000.
Center for Clinical & Translational Scie Office of the Provost
Totals:
$997,437. Kellen, Vincent J 3048110055 National Science Foundation CC-NIE Integration: Advancing Science through Next Generation SDN Networks Office of the Provost Art Museum
Totals:
Walsh-Piper, Kathleen A 3048109327 Institute of Museum and Library Services Art Museum Storage, Capacity and Conservation Improvements Art Museum Partnership Inst. for Math and Science
Totals:
Zeidler-Watters, Kimberly Jean 3048109787 KY Department of Education Partnering to Progress in Elementary Science (PPES)
Partnership Inst. for Math and Science
Page 180 of 223
Totals:
$765,000.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Office of the Provost International Center Carvalho Chumney, Susan E 3048107205 Academy for Educational Development Iraqi University Linkages Program ULP
$0.
$249.
$249.
Carvalho Chumney, Susan E 3048107205 Academy for Educational Development Iraqi University Linkages Program ULP
$0.
$-697,844.
$-697,844.
Carvalho Chumney, Susan E 3048108901 FHI Development 360 LLC Iraqi University Linkages Program ULP
$0.
$-249.
$-249.
Carvalho Chumney, Susan E 3048108901 FHI Development 360 LLC Iraqi University Linkages Program ULP
$0.
$15,150.
$15,150.
Carvalho Chumney, Susan E 3048108901 FHI Development 360 LLC Iraqi University Linkages Program ULP
$0.
$230,870.
$230,870.
Carvalho Chumney, Susan E 3048108901 FHI Development 360 LLC Iraqi University Linkages Program ULP
$0.
$20,112.
$20,112.
Carvalho Chumney, Susan E 3048109264 Chemonics International Incorporated Indonesia Higher Education Leadership and Management Project
$0.
$150,605.
$150,605.
Carvalho Chumney, Susan E 3048109521 German American Fulbright 2012 Discover USA (formally German Fulbright Diversity Institute)
$56,000.
$0.
$56,000.
Carvalho Chumney, Susan E 3048109522 Association of the Sponsors and Friends of the German A 2012 Discover USA (fromally German Fulbright Diversity Institute
$14,000.
$0.
$14,000.
Goldstein, Beth L 3048018900 Freeman Foundation National Consortium for teaching About Asia- Year IX
$0.
$600.
$600.
Goldstein, Beth L 3048109772 Freeman Foundation National Consortium for teaching About Asia- Year IX
$0.
$-9.
$-9.
Goldstein, Beth L 3048109772 Freeman Foundation National Consortium for teaching About Asia- Year IX
$600.
$0.
$600.
Goldstein, Beth L 3048109772 Freeman Foundation National Consortium for teaching About Asia- Year IX
$5,384.
$0.
$5,384.
Page 181 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Office of the Provost International Center $0.
Maske, Huajing X. 3048107933 Confucius Institute Headquarters of China Confucius Institute
$100,000.
$100,000.
$0. $-100,000. $-100,000. Tanaka, Keiko 3048108676 Department of State American Stories from the South - University of Kentucky American Cultural Center at Shanghai University $100,000. $0. $100,000. Tanaka, Keiko 3048110137 Department of State American Stories from the South - University of Kentucky American Cultural Center at Shanghai University International Center
Totals: Office of the Provost Totals:
$175,984. $9,945,749.
$-280,516. $-4,671,735.
$-104,532. $5,274,014.
Arts & Sciences Appalachian Center $0. $35,000. $35,000. Kingsolver, Ann Elizabeth 3048108580 Mary Reynolds Babcock Foundation Building Community Capacity for Regional Business and Marketplace alliances in Appalachian Eastern Kentucky $0. $35,000. $35,000. Kingsolver, Ann Elizabeth 3048108580 Mary Reynolds Babcock Foundation Building Community Capacity for Regional Business and Marketplace alliances in Appalachian Eastern Kentucky Kingsolver, Ann Elizabeth 3048109901 Kentucky Humanities Council Incorporated History of Mother Jones:Appalachian Leader Appalachian Center Anthropology
Totals:
$1,000.
$0.
$1,000.
$1,000.
$70,000.
$71,000.
$6,184. $0. Ahler, Steven R 3048109757 KY Department of Fish and Wildlife Archaeological Survey of a Proposed Stream Restoration on Hatchery Creek in Russell Co., Kentucky
$6,184.
$0. $5,380. $5,380. Ahler, Steven R 3048109758 KY Department of Fish and Wildlife Phase I Archaeological Survey of a Proposed Stream Restoration on Ross Creek in Lee and Estill Counties, Kentucky $14,384. $0. $14,384. Ahler, Steven R 3048109758 KY Department of Fish and Wildlife Phase I Archaeological Survey of a Proposed Stream Restoration on Ross Creek in Lee and Estill Counties, Kentucky $17,587. $0. $17,587. Ahler, Steven R 3048109833 National Park Service Archeological Site Evaluation for Green River Ferry Improvement Project $4,855. $0. Ahler, Steven R 3048110027 KY Division of Environmental Analysis Phase I Arch Survey of Big Creek Bridge, Clay County, Kentucky Item No. 11-1069.00 - FRT164
Page 182 of 223
$4,855.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Anthropology $4,598. $0. $4,598. Ahler, Steven R 3048110028 KY Division of Environmental Analysis Menifee County: U.S. 460 Realignment, Phase III Data Recovery Mitigation 15MF632 Item #: 10-117- Field Work $65,902. Ahler, Steven R 3048110039 KY Division of Environmental Analysis Menifee County: U.S. 460 Realignment, Phase III Data Recovery Mitigation, Item #: 10-117
$0.
$65,902.
$4,142. $0. Ahler, Steven R 3048110044 KY Division of Environmental Analysis Boone County: Intersection of KY 18 and KY 237, Phase I Archaeological Survey Item #: 6-8001.00
$4,142.
$7,175. $0. Ahler, Steven R 3048110053 KY Division of Environmental Analysis Christian County: KY 911 from US 41A to Oak Grove, Phase I Archaeological Survey Item #: 2-180.00
$7,175.
$2,849. $0. Ahler, Steven R 3048110090 National Park Service Archeological Site Evaluation for Green River Ferry Improvement Project - (CESU Minor Construction Supplement) $6,699. $0. Ahler, Steven R 3048110129
$2,849.
$6,699.
KY Division of Environmental Analysis Hopkins County: Upgrade Morton's Gap Interchange Phase 1 Archaeological Survey (State Item No. 2-8633.00) $7,570. $0. $7,570. Ahler, Steven R 3048110167 KY Division of Environmental Analysis Logan County: KY 79 Bridge Replacement over Motts Lick Creek; Phase I Archaeological Survey; Item #:3-1068 $11,867. $0. Ahler, Steven R 3048110267 KY Division of Environmental Analysis Jessamine County: Brannon Road Extension Phase I Archaeological Survey, Item #: 7-376 Mile Point: NA
$11,867.
$19,745. $0. Ahler, Steven R 3048110340 KY Division of Environmental Analysis Christian County: Route: KY 911 Staged Phase II Investigation Item #2-180 Mile Point: 0.0 - 1.835
$19,745.
$11,387. Ahler, Steven R 3048110341 KY Division of Environmental Analysis Jefferson County: Route: River Road Phase III Archaeological Data Recovery Item #5-91.01
$11,387.
$0.
$10,049. $0. $10,049. Ahler, Steven R 3048110405 KY Division of Environmental Analysis Trigg County: Route: KY 1585 Phase I Archaeological Survey (Bridge Replacement) Item # 1-1133.00 Mile Point 4.80-4.95 $14,841. $0. $14,841. Ahler, Steven R 3048110544 KY Division of Environmental Analysis Hopkins County: Route: I-69 Phase I Archaeological Survey(W KY Parkway Interchange) $6,628. Brother, Janie Rice 3048110040 KY Division of Environmental Analysis Clay County: Big Creek Bridge Replacement Cultural Historic Survey Item #:11-1069 Page 183 of 223
$0.
$6,628.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Anthropology $0. $78,993. Crothers, George M 3048107267 National Park Service Conservation Assessment of War of 1812 Saltpeter Works, Mammoth Cave National Park
$78,993.
$12,188. $0. Lyon, Sarah M 3048109722 National Science Foundation Doctoral Dissertation Research: Anderson: Political Ecologies of Value: Tourism & Social Conflict in Baja California Sur, Mexico $30,000. $0. Monroe, Kristin Vanessa 3048110489
$12,188.
$30,000.
Woodrow Wilson National Fellowship Foundation Career Enhancement Fellowship for Junior Faculty $20,000. Pollack, David 3048109724 KY Department of Fish and Wildlife FY13 Phase I Survey of a Stream Restoration Project--Rogers Gap--Scott County
$0.
$20,000.
$279,956.
$0.
$279,956.
$558,606.
$84,373.
$642,979.
$15,000.
$0.
$15,000.
$0. Brother, Janie Rice 3048109994 City of Frankfort Update to South Frankfort National Register District Nomination, Phase IV Survey
$7,000.
$7,000.
$15,000. Brother, Janie Rice 3048109994 City of Frankfort Update to South Frankfort National Register District Nomination, Phase IV Survey
$0.
$15,000.
$0.
$4,750.
$4,750.
Pollack, David 3048109872 KY Finance and Administration Cabinet Analysis of Human Skeletal Remains, Eastern St Hospital Anthropology Ky Archaeological Survey
Totals:
Brother, Janie Rice 3048109965 CITY Properties Group Highlands NRHP District Revision, Louisville, KY
McBride, Kim A 3048106974 Summers County Historic Landmark Commission Continue Frontier Forts Project Pollack, David KY Heritage Council Kentucky Archaeological Survey
3048109587
$65,100.
$0.
$65,100.
Pollack, David KY Heritage Council Historic Preservation Initiative
3048109596
$50,000.
$0.
$50,000.
$0.
$20,000.
$20,000. Pollack, David 3048110041 KY Division of Environmental Analysis Bourbon County: Hopewell Museum Develop and Prepare Preservation Briefs Item #: 7-310
Page 184 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Ky Archaeological Survey $26,092. $0. $26,092. Pollack, David 3048110042 KY Division of Environmental Analysis Fayette County: Davis Bottom Finish Edited Video, Finalize Shotgun Shelter Unit and Prepare Booklet Item #: 7-593 $104,812. $0. $104,812. Pollack, David 3048110043 KY Division of Environmental Analysis Clark County: Indian Old Fields Complete Fieldwork and Survey Item #: 7-593 $150,000. $0. $150,000. Pollack, David 3048110045 KY Division of Environmental Analysis Cumberland County: Site 15Cu110 and 15Cu111 Additional Archaeological Investigation, Item #: 8-158.04 $8,301. $0. $8,301. Pollack, David 3048110046 KY Division of Environmental Analysis Cumberland County: KY 61 Realignment Extra Field Work for Archaeological Mitigation Site - Item #:8-158.04 $1,988. Pollack, David 3048110047 KY Division of Environmental Analysis Harrison County: Cynthiana By-Pass Prepare Final Report Item #: 6-119
$0.
$25,071. $0. Pollack, David 3048110048 KY Division of Environmental Analysis Cumberland County: KY 61 Realignment Analyze materials and Prepare Final Report Item #: 8-158.01
$1,988.
$25,071.
$174,181. $0. $174,181. Pollack, David 3048110049 KY Division of Environmental Analysis Cumberland County: KY 61 Realignment Process, Analyze Materials and Prepare Final Report Item #: 8-158.10 (FRT164 Mitigation Project) $29,284. $0. $29,284. Pollack, David 3048110050 KY Division of Environmental Analysis Casey County: KY 70 Re-Alignment Analyze Materials and Prepare Final Report Item #: 8-142 $15,191. Pollack, David 3048110051 KY Division of Environmental Analysis Scott County: Archaeology Fort Ancient Shelter Unit/Workshop- Item #: 7-122
$0.
$15,191.
$20,235. Pollack, David 3048110052 KY Division of Environmental Analysis Jessamine County: Site 15JS150 Research and Prepare Booklet Item # 7-318
$0.
$20,235.
$15,476. Pollack, David 3048110054 KY Division of Environmental Analysis Montgomery County: Phase II's Final Report Submittal; Item #: 7-317
$0.
$15,476.
$45,000. Pollack, David 3048110242 KY Department of Parks Pine Mountain State Scenic Trail Assessments - Archaeological Assessment
$0.
$45,000.
$11,575.
$0.
$11,575.
Pollack, David 3048110352 City of Frankfort Leslie Morris Park Survey (Fort Hill) Page 185 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Ky Archaeological Survey $295,000. Pollack, David 3048110363 KY Division of Environmental Analysis Jefferson County: Route: LSIORB Archaeological Survey (Rockshelters of the Falls Region) Pollack, David 3048110471 KY Department of Military Affairs National Register Evaluations of Marion and Hopkinsville Armories Pollack, David 3048110473 KY Department of Military Affairs Artemus Track Assessment Project
$0.
$295,000.
$6,499.
$0.
$6,499.
$89,031.
$0.
$89,031.
$19,500. $0. $19,500. Pollack, David 3048110478 KY Energy and Environment Cabinet Heritage Land Conservation Fund Archaeological Assessment (Burnett, Davis Bend, and Wilson Tracts (Rush Island)) Ky Archaeological Survey Totals: $1,202,336. $11,750. $1,214,086. Chemistry $0. $299,790. $299,790. Anthony, John Edward 3048107558 National Science Foundation Collaborative Research: High-performance Crystalline Bulk Heterojunction Organic Solar Cells $0. $65,000. Anthony, John Edward 3048107996 Office of Naval Research Development of new solution-processable electron acceptors for organic photovoltaic applications
$65,000.
$0. $65,000. Anthony, John Edward 3048107996 Office of Naval Research Development of new solution-processable electron acceptors for organic photovoltaic applications
$65,000.
Anthony, John Edward Office of Naval Research Graphene Nanoribbons By Design
3048109700
$0.
$80,000.
$80,000.
Anthony, John Edward Office of Naval Research Graphene Nanoribbons By Design
3048109700
$0.
$70,000.
$70,000.
Anthony, John Edward Office of Naval Research Graphene Nanoribbons By Design
3048109700
$10,000.
$0.
$10,000.
$0.
$569,400.
$125,000.
$125,000.
$569,400. Anthony, John Edward 3048109723 National Science Foundation G8 Initiative: Inkjet printing high-performance organic small-molecule optoelectronic devices Clouthier, Dennis J 3048108501 National Science Foundation Laser spectroscopy of jet-cooled main group reactive intermediates
Page 186 of 223
$0.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Chemistry $715,000. Glazer, Edith C. 3048110058 American Cancer Society Ruthenium complex scaffolds for the creation of targeted chemotherapeutics
$0.
$715,000.
Guiton, Beth Sara 3048108195 Oak Ridge National Laboratory UK/ORNL Joint Faculty Appointment - Guiton
$0.
$10,303.
$10,303.
Guiton, Beth Sara 3048108252 Oak Ridge National Laboratory Electron-beam-induced-current imaging on energy materials
$0.
$35,001.
$35,001.
Guiton, Beth Sara 3048108252 Oak Ridge National Laboratory Electron-beam-induced-current imaging on energy materials
$0.
$15,000.
$15,000.
Guiton, Beth Sara 3048108252 Oak Ridge National Laboratory Electron-beam-induced-current imaging on energy materials
$0.
$30,000.
$30,000.
$109,808. Kim, Doo Young 3048110444 General Electric Appliances Modified Carbon Block Materials for Chloramine Extraction/Reduction
$0.
$109,808.
$29,891. Ladipo, Folami T 3048109559 KY Science and Technology Co Inc KSEF RDE: Catalytic Hydrogenation and Hydrogenolysis of Carbon-Oxygen Bonds
$0.
$29,891.
$0.
$48,900.
$48,900.
$390,000. Watson, Mark Deas 3048109806 National Science Foundation Sterically Hindered Polymers for Organic Photovoltaic Applications (OPV)
$0.
$390,000.
$880,523.
$0.
$880,523.
$2,704,622.
$843,994.
$3,548,616.
Odom, Susan A. 3048108836 American Chemical Society Robust Redox Shuttles for Overcharge Protection of Lithium Ion Batteries
Yates, S W 3048110034 Battelle Energy Alliance LLC Elastic/Inelastic Measurement Project Chemistry Geography
Totals:
$14,450. $0. $14,450. Ehrkamp, Patricia 3048110369 National Science Foundation Doctoral Dissertation Research: Lane: Citizenship and the Geopolitics of Healthcare Access in the American South $15,439. $0. $15,439. Roberts, Susan 3048110336 National Science Foundation Doctoral Dissertation Research: Bigger: Environmental Governance in the Carbon Economy: Regulating Greenhouse Gas Emissions in California#s Cap-and-Trade Market
Page 187 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Geography $11,513. $0. $11,513. Robertson, Morgan M. 3048109790 National Science Foundation Doctoral Dissertation Research: Grabbatin: Land Ownership, Cultural Identity, and the Legal Displacement of Family Commons in the Southeastern United States $0. $16,357. $16,357. Zook, Matthew A 3048108864 Duke University The Emerging Commodity of Restored Streams: Science, Policy and Economics in New Economics in New Markes for Ecosystem Service Commodities Geography Totals: $41,402. $16,357. $57,759. Geology $0. $39,711. $39,711. Bemis, Sean Patrick 3048109366 University of Southern California SCEC4 - Development of a new paleoseismic site at Elizabeth Lake, central Mojave section of the San Andreas fault $0. $10,719. $10,719. Bemis, Sean Patrick 3048109366 University of Southern California SCEC4 - Development of a new paleoseismic site at Elizabeth Lake, central Mojave section of the San Andreas fault $19,574. $0. $19,574. Bemis, Sean Patrick 3048110071 State of Alaska Department of Transportation and Public Parks Highway MP 237 Riley Creek Bridge Replacement $239,890. $0. $239,890. Bemis, Sean Patrick 3048110328 National Science Foundation Collaborative Research: A late Cenozoic record of restraining bend initiation and evolution along the Denali Fault at Mount McKinley, Alaska $17,476. $0. $17,476. Bemis, Sean Patrick 3048110432 US Geological Survey Quaternary geologic map of the northern Healy B4 quadrangle, Alaska: Denali fault tectonic geomorphology and Nenana River incision history $197,299. $0. $197,299. Fryar, Alan E 3048109836 Department of State BOOST H2O (Helping Hydrologic Outreach) in Indonesia and Turkey Moecher, David P 3048110094 KY Department of Fish and Wildlife Stable isotope analysis of Indiana Bat hair
$11,000.
$0.
$14,355. $0. Moecher, David P 3048110462 US Geological Survey Bedrock Geologic Map of the West Half of the Petersham 7.5 Minute Quadrangle, Central Massachusetts $154,304. $0. Ravat, Dhananjay 3048110295 National Science Foundation Collaborative Research: Deciphering the Structure and Evolution of North America's Cratonic Core $29,962. Romanek, Christopher Scott 3048109773 National Aeronautics and Space Administration NESSF Fellowship for Levitt: Clumped Isotopes in Carbonates as a Potential Biosignature Page 188 of 223
$0.
$11,000.
$14,355.
$154,304.
$29,962.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Geology $22,314. Yeager, Kevin Michael 3048109686 University of Southern Mississippi Sediment-Associated Pollutants and Water Quality in St. Louis Bay, Mississippi
$0.
$22,314.
$706,174.
$50,430.
$756,604.
$59,000.
$0.
$59,000.
$2,000.
$0.
$2,000.
$20,000. Braun, Benjamin J. 3048110415 National Security Agency Rational Generating Functions, Enumeration, and Polyhedral Geometry
$0.
$20,000.
Brown, Russell M 3048108317 Simons Foundation Analysis and partial differential equations
$0.
$6,000.
$6,000.
Brown, Russell M 3048108674 Simons Foundation Enhancement: Analysis and partial differential equations
$0.
$1,000.
$1,000.
$55,264.
$0.
$55,264.
$0.
$32,500.
$32,500.
$47,500. Eakin, Paul M 3048110143 KY Council on Postsecondary Education Kentucky Online Testing Exams (KYOTE) Technology & Implementation
$0.
$47,500.
$39,076. Ehrenborg, Richard 3048110430 National Security Agency The Combinatorics of Flag Enumeration, Permutations and Material Science
$0.
$39,076.
$168,033.
$0.
$168,033.
$0.
$163,137.
$163,137.
$31,480.
$0.
$31,480.
Geology Mathematics
Totals:
Aossey, Cynthia A 3048109763 Northern Kentucky University KY Center for Mathematics (KCM) Regional Coordinator Braun, Benjamin J. 3048110190 Mathematical Sciences Research Institute Central Kentucky Mathematics Circles
Demlow, Alan R. 3048109162 Simons Foundation Finite element and discrete exterior calculus
Eakin, Paul M 3048110143 KY Council on Postsecondary Education Kentucky Online Testing Exams (KYOTE) Technology & Implementation
Gluesing-Lueerssen, Heide 3048109552 National Science Foundation Tail-BitingTrellis Realizations for Block Codes Lee, C W 3048105223 University of Louisville Geometry Assessments for Secondary Teachers (GAST) Nagel, Uwe R 3048110138 National Security Agency Liaison Theory and Related Problems in Commutative Algebra Page 189 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Mathematics $56,735. $0. Ovall, Jeffrey S. 3048109804 National Science Foundation Investigation of Auxiliary Subspace Techniques as a General Tool for A Posteriori Error Estimation
$56,735.
$191,769.
$0.
$191,769.
$0.
$6,000.
$6,000.
$0. Readdy, Margaret 3048108672 Simons Foundation Enhancement: Applications of Flag Enumeration in Algebra and Geometry
$1,000.
$1,000.
$193,438. Shen, Zhongwei 3048109271 National Science Foundation Harmonic Analysis and Homogenization of Partial Differential Equations
$0.
$193,438.
$67,272.
$0.
$67,272.
$931,567.
$209,637.
$1,141,204.
Perry, Peter 3048109512 National Science Foundation Inverse scattering and partial differential equations Readdy, Margaret 3048108308 Simons Foundation Applications of Flag Enumeration in Algebra and Geometry
Wang, Changyou 3048109153 Simons Foundation Analysis of some geometric variational problems and their evolution Mathematics Physics and Astronomy
Totals:
$50,000. $0. $50,000. Cao, Gang 3048109707 KY Science and Technology Co Inc KSEF RDE: Colossal Negative Volume Thermal Expansion Coupled to Magnetic and Orbital Orders in Mott Insulators $160,000. $0. $160,000. Cao, Gang 3048110424 National Science Foundation Novel Physical Phenomena in Single-Crystal Oxides Crawford, Christopher B. 3048109516 Department of Energy Precision Measurementswith Low Energy Neutrons
$0.
$150,000.
$150,000.
Crawford, Christopher B. 3048109516 Department of Energy Precision Measurementswith Low Energy Neutrons
$150,000.
$0.
$150,000.
Crawford, Christopher B. 3048110239 Oak Ridge National Laboratory Data Acquisition System for the Nab Experiment
$420,482.
$0.
$420,482.
$0.
$150,000.
$150,000.
Das, Sumit Ranjan 3048109602 National Science Foundation Research on Gauge Theories, Gravity, and Strings
Page 190 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Physics and Astronomy Das, Sumit Ranjan 3048109602 National Science Foundation Research on Gauge Theories, Gravity, and Strings
$150,000.
$0. Delong, L E 3048108328 Department of Energy Competing Interactions in Complex Transitions in Complex Transition Metal Oxides $800. Delong, L E 3048110059 Oak Ridge Associated Universities SEMPA Study of the Nucleation, Stability and Dynamics of Ferromagnetic Vortices....."
$0.
$150,000.
$120,000.
$120,000.
$0.
$800.
$0. $82,000. $82,000. Eides, Michael 3048108555 National Science Foundation Theory of Light Hydrogenlike Bound States: High Order Corrections Ions: High Order Corrections in Muonic and Electronic Atoms and Ions $0. $281,997. $281,997. Fatemi, Renee H. 3048109377 National Science Foundation Fundamental Studies of the Proton Spin in QCD Ferland, Gary 3048107809 Space Telescope Science Institute Plasma Simulations That Meet the Challenges of COS and STIS
$0.
$36,454.
$36,454.
Ferland, Gary 3048107915 National Aeronautics and Space Administration Cold gas and dust in cool-core galaxy clusters
$0.
$142,639.
$142,639.
$0. $90,000. Ferland, Gary 3048108156 National Aeronautics and Space Administration Understanding the Messages in the light- the general-purpose AMDfA atomic/molecular database
$90,000.
$0. $9,763. Ferland, Gary 3048108156 National Aeronautics and Space Administration Understanding the Messages in the light- the general-purpose AMDfA atomic/molecular database
$9,763.
$0. $32,052. Ferland, Gary 3048108156 National Aeronautics and Space Administration Understanding the Messages in the light- the general-purpose AMDfA atomic/molecular database
$32,052.
$0. Ferland, Gary 3048109287 Space Telescope Science Institute COS spectra of a Filament in NGC1275 - Testing the Particle Heating Mechanism
$14,842.
$14,842.
Ferland, Gary 3048109409 National Aeronautics and Space Administration The Nature of the Crab Nebula Filaments
$0.
$32,965.
$32,965.
Ferland, Gary 3048109409 National Aeronautics and Space Administration The Nature of the Crab Nebula Filaments
$0.
$22,592.
$22,592.
Page 191 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Physics and Astronomy $0. Gardner, Susan V 3048108556 Department of Energy Fundamental Physics with Hadrons and Nuclei, from Quarks to the Cosmos
$107,000.
$107,000.
$0.
$170,000.
$170,000.
$28,500.
$0.
$28,500.
$0.
$181,000.
$181,000.
$150,000. Kovash, Michael A 3048110381 Department of Energy Measurements of Low Energy Neutrons from Neutron-Induced Fission
$0.
$150,000.
$0. Liu, Kehfei 3048107974 Department of Energy Lattice QCD Study of Hadron Spectrum, Nucleon Structure, and Finite Density
$193,000.
$193,000.
Gorringe, Tim P 3048109359 National Science Foundation Low Energy, High Precision Muon Experiments Kocevski, Dalibor 3048110124 Space Telescope Science Institute Cosmic Assembly Near-IR Deep Extragalactic Legacy Survey (CANDELS) - I Korsch, Wolfgang 3048108199 Department of Energy Fundamental Study of Hadronic Structure
$0. $155,000. $155,000. Plaster, Bradley R. 3048105057 Department of Energy Neutrons and Fundamental Symmetries: Fundamental Electroweak and Hadronic Physics Studies of the Neutron $50,000. $0. Seo, Sung Seok 3048109673 KY Science and Technology Co Inc KSEF RDE: Two-Dimensional Confinement of Strongly Correlated and Spin-Orbit Coupled Electrons in 5d Transition-Metal Oxide Quantum-Wells $0. $39,672. Shlosman, Isaac 3048108925
$50,000.
$39,672.
Space Telescope Science Institute The Corollaries of the Ultra-Compact Nuclear Rings in Disk Galaxies Physics and Astronomy Psychology
Totals:
$1,159,782.
$2,010,976.
$3,170,758.
Akins, Chana National Institute on Drug Abuse Enhancement of Sexual Motivation
3048106852
$0.
$10,490.
$10,490.
Akins, Chana National Institute on Drug Abuse Enhancement of Sexual Motivation
3048106852
$0.
$157,351.
$157,351.
$0.
$311,267.
$311,267.
Bardo, Michael T 3048105936 National Institute on Drug Abuse Novelty, Dopamine and Response to Amphetamine
Page 192 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Psychology $0.
$324,656.
$324,656.
$1,449,556.
$0.
$1,449,556.
$0.
$6,060.
$0. $131,226. Beckmann, Joshua 3048109265 National Institute on Drug Abuse Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine Reinforcement
$131,226.
Bardo, Michael T 3048105936 National Institute on Drug Abuse Novelty, Dopamine and Response to Amphetamine Bardo, Michael T 3048109600 National Institute on Drug Abuse CDART - Center for Drug Abuse Research Translation
$6,060. Barron, Susan 3048110235 Synchroneuron Incorporated Can acamprosate have long-term neuroprotective effects on a glutamatergic challenge?
$0.
$37,923.
$37,923.
$0.
$20,360.
$0.
$299,619.
$299,619.
$0. Fillmore, Mark 3048108603 National Institute on Alcohol Abuse and Alcoholism NRSA Fellowship for Weafer: Alcohol Sensitivity and Abuse Potential in ADHD
$-3,739.
$-3,739.
DeWall, Nathan J. 3048107745 Ohio State University Effect of Self-Control on Antisocial and Prosocial Behavior
$20,360. DeWall, Nathan J. 3048109634 Childrens Hospital Medical Center Using SNA to Determine the Long-Term Outcomes of Socially Excluded Adolescents Fillmore, Mark 3048106627 National Institute on Alcohol Abuse and Alcoholism Alcohol Tolerance and Behavioral Disinhibitation in Humans
$33,146. $0. $33,146. Fillmore, Mark 3048109517 National Institute on Alcohol Abuse and Alcoholism NRSA Fellowship for Melissa Miller: Redundant Signal Effect and Alcohol Impairment of Behavioral Inhibition in ADHD and non-ADHD Drinkers $0. $291,132. $291,132. Giancola, Peter 3048108734 National Institute on Alcohol Abuse and Alcoholism Alcohol Myopia and Aggression $0.
$96,704.
$96,704.
$34,494.
$0.
$34,494.
$0.
$40,862.
Gottlob, Lawrence R 3048107505 National Science Foundation NSF Intergovernmental Personnel Act assignment for Lawrence Gottlob Gunjan, Samir K 3048110074 Naprogenix Phase 1 SBIR: Novel Pharmacotherapies for Alcoholism
$40,862. Kelly, Thomas H 3048110365 National Institute on Drug Abuse NRSA Fellowship Dustin Lee: Individual Differences in Escalation of Tobacco Use
Page 193 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Psychology Littleton, John M 3048109269 National Institute on Alcohol Abuse and Alcoholism Alcohol, the vagus nerve and multi-organ inflammation
$0.
$199,813.
$199,813.
Littleton, John M 3048109336 Naprogenix STTR Phase II: Novel estrogen receptor ligands from plant genomics
$0.
$79,786.
$79,786.
$30,215.
$0.
$30,215.
Littleton, John M 3048109907 Naprogenix STTR: Potential Anti-Relapse Drugs: A Plant Genomics Approach
$0. $502,464. $502,464. Lorch, E P 3048109005 Department of Education A Narrative Comprehension Intervention for Elementary School Children At-Risk for Attention-Deficit Hyperactivity Disorder $56,000. $0. $56,000. Lorch, Robert F 3048109948 Eastern State Hospital Eastern State Hospital Clinical Program Lorch, Robert F 3048110472 Cardinal Hill Hospital Cardinal Hill Rehabilitation Hospital Psychological Services
$216,439.
$0.
$216,439.
Milich, R 3048109419 University of South Carolina Mediators of social impairment among children with ADHD
$0.
$76,243.
$76,243.
$54,103. $0. $54,103. Miller, Saul L. 3048109869 National Science Foundation Collaborative Research: Grounding the Behavioral Immune System in Mental and Physiological Processes Prendergast, Mark A 3048106540 National Institute on Alcohol Abuse and Alcoholism Hippocamppal neurotoxicity induced by ethanol withdrawal
$0.
$335,613.
$335,613.
Segerstrom, Suzanne 3048109255 National Institute on Aging Self-Regulation and Aging: Substrates and Health Consequences
$0.
$14,071.
$14,071.
Segerstrom, Suzanne 3048109255 National Institute on Aging Self-Regulation and Aging: Substrates and Health Consequences
$0.
$126,642.
$126,642.
$0.
$42,232.
$0.
$438,854.
$42,232. Segerstrom, Suzanne 3048109767 National Institute on Aging NRSA Fellowship Dan Evans: Emotion regulation and self-regulation in older adults Segerstrom, Suzanne 3048109783 National Institute on Aging Self-Regulation, Immunological Aging, and Health in Older Adults
Page 194 of 223
$438,854.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Psychology $33,016. $0. $33,016. Smith, Gregory T 3048109805 National Institute on Alcohol Abuse and Alcoholism NRSA Fellowship for Jessica Combs: Sexual Assault, Personality and Problem Drinking in College Women $0. Widiger, Thomas A 3048108045 University of Notre Dame Validity & Clinical Utility of 2-Part System for Personality Disorder Diagnosis.
$27,166.
$27,166.
$2,455,337.
$3,018,427.
$5,473,764.
Stromberg, Arnold J 3048109499 University of Louisville KY IDeA Networks of Biomedical Research Excellence
$0.
$-38,238.
$-38,238.
Stromberg, Arnold J 3048109499 University of Louisville KY IDeA Networks of Biomedical Research Excellence
$371,250.
$0.
$371,250.
Stromberg, Arnold J 3048110479 University of Louisville KY IDeA Networks of Biomedical Research Excellence
$333,012.
$0.
$333,012.
$704,262.
$-38,238.
$666,024.
$1,000. Bell, Shannon Elizabeth 3048110177 Rural Sociological Society Farming Masculinities and Gendered Ideology Construction in Industrial Agriculture
$0.
$1,000.
$39,955. Perry, Brea L. 3048110358 Spencer Foundation Racing to Punish: Examining Intersections of Race, Class, and Gender in School Discipline
$0.
$39,955.
Psychology Statistics
Statistics Sociology
Totals:
Totals:
$2,000. $0. Stamatel, Janet P. 3048109784 American Sociological Association Comparing the Effectiveness of Lecturing vs. Team-Based Learning for Teaching Introductory Criminology Sociology Biological Sciences
Totals:
$42,955.
$2,000.
$0.
$42,955.
$0. $22,484. Jones, Grace M 3048108076 National Science Foundation Does the Nuclear Receptor USP Integrate Methyl Farnesoate Signaling During Metamorphosis?
$22,484.
$50,000. $0. $50,000. Krupa, James J 3048109941 KY Science and Technology Co Inc KSEF RDE: Conservation and Ecology of an Insect Feeding Guild Containing a Kentucky State-endangered Carnivorous Plant. $203,932. $0. $203,932. Linnen, Catherine R. 3048110245 National Science Foundation Comparative analysis of host-shift speciation in the redheaded pine sawfly, Neodiprion lecontei (Hymenoptera: Diprionidae)
Page 195 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Biological Sciences $0.
$60,000.
$60,000.
Morris, Ann C. 3048109291 Knights Templar Eye Foundation Inc The role of Sox11in vertebrate ocular development
$60,000.
$0.
$60,000.
Morris, Ann C. 3048109606 National Eye Institute The role of Insm1a in photoreceptor differentiation
$252,270.
$0.
$252,270.
$25,000.
$25,000.
$0.
$39,900.
$384,485.
$384,485.
$276,477.
$276,477.
$0. $75,000. Voss, Stephen Randal 3048107569 Army Application of Comparative Functional Genomics to Identify Regeneration-Specific Genes
$75,000.
Morris, Ann C. 3048108444 Pew Charitable Trusts Photoreceptor Development and Regeneration in the Vertebrate Retina
$0. O'Hara, Bruce 3048109152 University of Tennessee Gender and Genetic Effects on Sleep:Wake Parameters Following Ethanol Exposure $39,900. Rucker, Edmund B. 3048109537 KY Science and Technology Co Inc KSEF RDE: Autophagy in female reproductive tract development and fertility $0. Voss, Stephen Randal 3048106778 Tulane University Signaling Network Interactions Controlling Mouse and Salamander Limb Regeneration Voss, Stephen Randal 3048107178 National Science Foundation LSCBR: Operational Support for the Ambystoma Genetic Stock Center
$0.
Voss, Stephen Randal 3048109701 Office of the Director Research Resources for Model Amphibians
$317,970.
$0.
$317,970.
Voss, Stephen Randal 3048109999 University of Dayton Research Institute Sequencing of Newt Genome
$100,000.
$0.
$100,000.
Westneat, David F 3048110451 Sigma XI Scientific Research Society Inc Describing relatedness patterns in bess beetles
$520.
$0.
$520.
$1,024,592.
$843,446.
$1,868,038.
Clayton, Thomas M 3048110109 Kansas State University Go Teacher Noncredit Certificate Program
$0.
$978,500.
$978,500.
Clayton, Thomas M 3048110109 Kansas State University Go Teacher Noncredit Certificate Program
$0.
$-77,250.
$-77,250.
Biological Sciences Center for English as Second Language
Page 196 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Arts & Sciences Center for English as Second Language Clayton, Thomas M 3048110109 Kansas State University Go Teacher Noncredit Certificate Program
$0.
$676,608.
$676,608.
Clayton, Thomas M 3048110109 Kansas State University Go Teacher Noncredit Certificate Program
$482,142.
$0.
$482,142.
$482,142.
$1,577,858.
$2,060,000.
$76,864. Firey, Abigail 3048110173 St Johns University MANUWEB: Discovering, Learning, and Exploring Manuscript Cultures
$0.
$76,864.
$27,209. Firey, Abigail 3048110174 St Johns University MANUWEB: Discovering, Learning, and Exploring Manuscript Cultures
$0.
$27,209.
Hamilton, D E 3048109683 KY Historical Society Fellowship for Robert Murray: Graduate Editorial Assistantship
$20,000.
$0.
$20,000.
Popkin, J D 3048109615 National Humanities Center Freedom and Unfreedom in the Age of Revolution
$50,000.
$0.
$50,000.
$0.
$17,500.
$45,000.
$0.
$45,000.
$236,573.
$0.
$236,573.
$50,400.
$0.
$50,400.
$50,400. $12,301,750.
$0. $8,699,010.
$50,400. $21,000,760.
$10,000.
$0.
$10,000.
$10,000.
$0.
$10,000.
Center for English as Second Language History
Totals:
$17,500. Roberts, Sophie Beth 3048110088 United States Holocaust Memorial Museum Vichy in North Africa: The Experience of Jews in French North Africa in World War II Taylor, Scott K. 3048109859 American Council of Learned Societies A Genealogy of Addiction: Stimulants in Early Modern Europe History Philosophy
Totals:
Look, Brandon C 3048109294 National Endowment for the Humanities Leibniz, Kant and the Possibility of Metaphysics Philosophy
Totals: Arts & Sciences Totals:
Business & Economics Accountancy Ramsay, Robert J 3048109800 PricewaterhouseCoopers Endowment Diversity Initiative 2012-13 Accountancy
Page 197 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Business & Economics Finance & Quantitative Methods $0. Borgatti, Stephen 3048107845 Charles River Analytics Incorporated Detection, Explanation and Prediction of Emerging Network Developments (DEPEND)
$-2,777.
$-2,777.
$0.
$-21,196.
$-21,196.
$0.
$-23,973.
$-23,973.
$113,000. Borgatti, Stephen 3048110416 Charles River Analytics Incorporated Rapid Ethnographic Assessment and Data Management Integration Toolkit (READ-IT)
$0.
$113,000.
$1,670,740. Johnson, Nancy B 3048109922 Department of State University Partnership with Pakistani Universities in KPK, Pakistan
$0.
$1,670,740.
$1,783,740.
$0.
$1,783,740.
$5,000.
$0.
$5,000.
$109,100. Yelowitz, Aaron S 3048109954 Manhattan Institute for Policy Research The Impact of Intensive Job Search Assistance Outcomes of Former Inmates
$0.
$109,100.
$114,100.
$0.
$114,100.
Ziliak, James P 3048108673 US Department of Agriculture Research Program on Childhood Hunger, Task Order #2
$0.
$84,750.
$84,750.
Ziliak, James P 3048108673 US Department of Agriculture Research Program on Childhood Hunger, Task Order #2
$0.
$1,661,338.
$1,661,338.
Ziliak, James P 3048109631 US Department of Agriculture Research Program on Childhood Hunger, Task Order 3
$0.
$1,364,828.
$1,364,828.
Ziliak, James P 3048109631 US Department of Agriculture Research Program on Childhood Hunger, Task Order 3
$0.
$22,939.
$22,939.
Ziliak, James P 3048109631 US Department of Agriculture Research Program on Childhood Hunger, Task Order 3
$2.
$0.
$2.
$2.
$3,133,855.
$3,133,857.
Borgatti, Stephen 3048108833 Charles River Analytics Incorporated High Risk Rapid Ethnographic Assessment Tool (HRREAT) Finance & Quantitative Methods Management
Management Center for Business & Econ Res
Totals:
Totals:
Bollinger, Christopher R 3048110466 Eastern KY University Updated County Attorneys' Offices Funding Predictions
Center for Business & Econ Res B&E Poverty Center
B&E Poverty Center
Page 198 of 223
Totals:
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Business & Economics Center for Entrepreneurship $0.
$10,000.
$10,000.
$0. $1,907,842.
$10,000. $3,119,882.
$10,000. $5,027,724.
France, Linda P 3048109781 James Graham Brown Foundation Next Generation Leadership Academy
$0.
$-28,360.
$-28,360.
France, Linda P 3048109781 James Graham Brown Foundation Next Generation Leadership Academy
$0.
$91,867.
$91,867.
France, Linda P 3048109781 James Graham Brown Foundation Next Generation Leadership Academy
$111,817.
$0.
$111,817.
$57,323.
$0.
$57,323.
Guskey, Thomas R 3048109998 Morehead State University SB-1 Morehead State University Collaboration Initiative Grant
$20,000.
$0.
$20,000.
Guskey, Thomas R 3048110419 KY Community & Technical College System/University of Kentucky Latino Education Alliance (K'LEA )
$35,000.
$0.
$35,000.
Proffitt, Mary E 3048110179 KY Council on Postsecondary Education UK - STEMx Batelle / College Readiness
$30,000.
$0.
$30,000.
$0.
$10,550.
$5,400.
$0.
$5,400.
$270,090.
$63,507.
$333,597.
$0.
$-289,019.
$-289,019.
Naugle, Lottie Becky 3046356600 Small Business Administration OnGoing SBDC PROGRAM INCOME ACCOUNT Center for Entrepreneurship Totals: Business & Economics Totals: Education Education
France, Linda P KY Department of Education Next Generation Learning Grant
3048109822
$10,550. Proffitt, Mary E 3048110214 Georgetown College Teacher Recruitment and Retention for Educational Excellence (Project TRREE) Fy2013 Proffitt, Mary E KY Department of Education Kentucky STEMx Initiative
3048110399
Education Curriculum & Instruction Hruby, George G. 3048109620 KY Council on Postsecondary Education KY Adult Education (KYAE) 2012-2013
Page 199 of 223
Totals:
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Education Curriculum & Instruction $289,019.
$0.
$289,019.
$40,761.
$0.
$40,761.
$3,000.
$0.
$3,000.
3048110010
$250,000.
$0.
$250,000.
Swan, Kathleen O 3048107610 Council of Chief State School Officers Common State Standards for Social Studies
$0.
$22,828.
$22,828.
Swan, Kathleen O 3048107610 Council of Chief State School Officers Common State Standards for Social Studies
$0.
$13,311.
$13,311.
Hruby, George G. 3048109620 KY Council on Postsecondary Education KY Adult Education (KYAE) 2012-2013 Rintamaa, Margaret KY Department of Education University Writing Project - 2013
3048109823
Smith, Douglas C 3048109630 KY Education and Workforce Development Cabinet UK Perkins Teacher Education Award 2012-2013 Swan, Gerry M KY Department of Education Standards Based Reporting
$20,000. $0. $20,000. Swan, Kathleen O 3048109534 Spencer Foundation Common Core English Language Arts Standards Implementation: An Opportunity for Literacy through Social Studies $0. $3,000. $3,000. Swan, Kathleen O 3048109750 Illinois State University The Library of Congress Teaching with Primary Sources - Regional Center Pilot: Common Core English Language Arts Standards Implementation: An Opportunity for Social Studies $65,000. $0. $65,000. Swan, Kathleen O 3048109750 Illinois State University The Library of Congress Teaching with Primary Sources - Regional Center Pilot: Common Core English Language Arts Standards Implementation: An Opportunity for Social Studies Curriculum & Instruction Totals: $667,780. $-249,880. $417,900. Educational & Counseling Psych $29,984. $0. $29,984. Campbell, Jonathan M 3048110126 Organization for Autism Research Kit for Kids Evaluation Project: An Initial Evaluation of Evidence Based Peer Educational Materials $13,503. Campbell, Jonathan M 3048110144 Organization for Autism Research A Collaborative Autism Screening Project Utilizing Web-based Technology
$0.
$13,503.
$50,000.
$0.
$50,000.
Ma, Xin KY Department of Education Program Review Study
Page 200 of 223
3048109495
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Education Educational & Counseling Psych $81,118. Ma, Xin 3048110068 Northern Kentucky University Assessment for Quality and Effectiveness of the Kentucky Center for Mathematics(KCM)
$0.
$1,000. $0. Reese, Robert J 3048110379 American Psychological Association Doctoral Dissertation Research: Miserocchi: Therapist White Privilege Attitudes and their Effect on Client Outcomes and the Therapist-Client Therapeutic Relationship $8,671. $0. Rostosky, Sharon S 3048110280
$81,118.
$1,000.
$8,671.
Palo Alto University Longitudinal Study of Legal Status, Stigma, and Well-being among Diverse Couples $75,000. $0. Usher, Ellen Leigh 3048109760 National Science Foundation Collaborative Research: Research Initiation Grant: Influence of Motivation on Learning Outcomes in an Introductory Materials Engineering Course Educational & Counseling Psych Totals: $259,276. $0. Kinesiology and Health Promoti $101,300. $0. Shapiro, Robert 3048109408
$75,000.
$259,276. $101,300.
KY Department of Education UK - Delivery Unit - Data Analyst Kinesiology and Health Promoti STEM Education
Totals:
$101,300.
$0.
$101,300.
$316,494. $0. $316,494. Gearhart, Jana L. 3048109545 National Science Foundation REU Site: Supporting Undergraduate Research Fellows In Timely STEM Education Research Via the University of Kentucky's STEM Education Research Laboratory $800,000. $0. $800,000. Schroeder, Margaret Joan 3048109821 National Science Foundation UK NOYCE: New Opportunities Yeilding Classroom Excellence, Phase II $0. Schroeder, Margaret Joan 3048109896 Northern Kentucky University P20 STEM Education Innovation Lab - See Blue Mathematics Clinic & Camp
$59.
$59.
$50,000. Schroeder, Margaret Joan 3048109896 Northern Kentucky University P20 STEM Education Innovation Lab - See Blue Mathematics Clinic & Camp
$0.
$50,000.
$7,000.
$0.
$7,000.
$1,173,494.
$59.
$1,173,553.
$0.
$8,000.
Wilhelm, Jennifer 3048109991 Mentors & Meals Informal STEM Learning the REAL Way STEM Education Educational Policy Studies & Evaluation
Totals:
$8,000. Bradley, Kelly 3048110494 Eastern KY University External Evaluation of Environmental AIMS (Applied Investigation of Mathematics & Statistics)
Page 201 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Education Educational Policy Studies & Evaluation $50,000. Jensen, Jane 3048109935 KY Community & Technical College System/University of Evaluation of KCTCS Learn on Demand Complete College America Program
$0.
$50,000.
$58,000.
$0.
$58,000.
$242,468. Bausch, Margaret 3048109934 Special Education Programs Preparing Alternate Certificate Instructors for Rural Special Services (PAIRSS)
$0.
$242,468.
$240,973.
$0.
$240,973.
Educational Policy Studies & Evaluation Special Ed & Rehab Counseling
Collins, Belva J KY Department of Education Teachers of Visually Impaired
3048109505
Totals:
$0. $147,376. $147,376. Crystal, Ralph M 3048107846 Department of Education Partnership for Preparing Rehabilitation Counselors for Public Rehabilitation Employment: A Long Term Training Program $235,000. $0. $235,000. Grisham-Brown, Jennifer L 3048109503 KY Department of Education Kentucky Deaf Blind Supplement Grisham-Brown, Jennifer L 3048109680 KY Early Childhood Advisory Council KIDS NOW
$0.
$317,510.
$317,510.
Grisham-Brown, Jennifer L 3048109680 KY Early Childhood Advisory Council KIDS NOW
$311,652.
$0.
$311,652.
Grisham-Brown, Jennifer L KY Department of Education Deaf-Blind Main
$165,145.
$0.
$165,145.
3048109902
$0. $199,984. $199,984. Jung, Lee Ann 3048105918 Department of Education Combined Priority for Personnel Developent - Increasing the Number, Competence, and Resources of Early Interventions in Areas of Shortage through Distance Learning: INCREAS-DL $0. $14,576. $14,576. Jung, Lee Ann 3048109500 KY Cabinet for Health and Family Services UK First Step Consultative / Part C Coordinator Jung, Lee Ann 3048109500 KY Cabinet for Health and Family Services UK First Step Consultative / Part C Coordinator
$215,200.
$0.
$215,200.
$196,505. $0. $196,505. Rogers, Jackie 3048109831 Department of Education National Master's Rehabilitation Initiative with an Emphasis on Job Placement for Persons with Severe Disabilities in Rural Areas ( UK NMTRI) Special Ed & Rehab Counseling Totals: $1,606,943. $679,446. $2,286,389. Page 202 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Education Center for Professional Dev O'Hair, Mary John Hewlett Foundation Center for Innovative Education
3048110147
$400,000.
$0.
$400,000.
O'Hair, Mary John Bill and Melinda Gates Foundation Center for Innovation in Education
3048110205
$0.
$36,638.
$36,638.
O'Hair, Mary John Bill and Melinda Gates Foundation Center for Innovation in Education
3048110205
$1,000,000.
$0.
$1,000,000.
$1,400,000.
$36,638.
$1,436,638.
Cantrell, Susan Chambers 3048109547 Georgetown College Evaluation of Center for Culturally Responsive Pedagogy
$57,770.
$0.
$57,770.
Cantrell, Susan Chambers 3048110527 Georgetown College Evaluation of Center for Culturally Responsive Pedagogy
$54,411.
$0.
$54,411.
$0.
$375,656.
$375,656.
$289,019.
$0.
$289,019.
$401,200. $5,938,083.
$375,656. $905,426.
$776,856. $6,843,509.
$206,542. Bazrgari, Babak 3048109681 National Institute of Occupational Safety and Health Aging, Neuromuscular Behavior, and Risk of Occupational Low Back Pain
$0.
$206,542.
$0.
$9,700.
$9,700.
$313,435. Puleo, David A 3048109582 National Institute Arthritis Musculoskeletal & Skin Modulating Inflammation and Fibrosis to Control Scarring in Muscle Wounds
$0.
$313,435.
$0. Shin, Hainsworth Y 3048108755 American Heart Association Great Rivers Affiliate Modulation of Leukocyte Mechanotransduction of Fluid Shear Stress by the Cell Membrane
$1.
$1.
Center for Professional Dev Collaborative Center for Literacy Develo
Totals:
Embry, Julia 3048108000 Ohio State University ARRA: Reading Recovery: Scaling Up What Works Hruby, George G. 3048109932 KY Council on Postsecondary Education 12-13 KYAE (KY Adult Education) PD Collaborative Center for Literacy Develo
Totals: Education Totals:
Engineering Center for Biomedical Engineering
Puleo, David A 3048108874 Shriners Hospital for Crippled Children Biocompatibility of Biodegradable Poly(ß-Amino Ester) Hydrogels
Page 203 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Center for Biomedical Engineering Shin, Hainsworth Y 3048109577 American Heart Association Great Rivers Affiliate Influence of Pressure on Endothelial Tubulogenic Activity
$77,000.
$114,252. Sunderam, Sridhar 3048110335 Signal Solutions LLC SBIR: System for Automated Noninvasive Monitoring of Mouse Sleep and Behavior
$0.
$77,000.
$0.
$114,252.
Yu, Guoqiang 3048107397 National Cancer Institute Diffuse Optical Monitoring of Head and Neck Tumor Therapy
$0.
$68,020.
$68,020.
Yu, Guoqiang 3048109119 National Institute Arthritis Musculoskeletal & Skin Non-contact Diffuse Optical Assessment of Pressure Ulcer and Therapy
$0.
$148,156.
$148,156.
$0. $45,000. $45,000. Yu, Guoqiang 3048109455 American Heart Association Great Rivers Affiliate Fellowship for Yu Shang: Development of Diffuse Optical Spectroscopies for Monitoring Cerebral Blood Flow and Oxygenation in Mouse Stroke Model Center for Biomedical Engineering Totals: $711,229. $270,877. $982,106. Visualization Center $798,912. $0. $798,912. Cheung, Sen-Ching 3048109990 National Science Foundation SHB:Type II (INT): Synthesizing Self-Model and Mirror Feedback Imageries with Applications to Behavior Modeling for Children with Autism $0. $46,218. Donohue, Kevin D 3048109949
$46,218.
Indiana University Clinical measurement of vocal fold impact stress in children Donohue, Kevin D 3048109949 Indiana University Clinical measurement of vocal fold impact stress in children
$0.
$3,178.
$3,178.
Donohue, Kevin D 3048109949 Indiana University Clinical measurement of vocal fold impact stress in children
$13,068.
$0.
$13,068.
Jacobs, Nathan 3048108875 Department of the Interior Contextual Eyes: A Context-Aware Surveaillance System
$0.
$241,821.
$241,821.
Jacobs, Nathan 3048108875 Department of the Interior Contextual Eyes: A Context-Aware Surveaillance System
$0.
$240,000.
$240,000.
Jacobs, Nathan 3048109272 ObjectVideo Incorporated WALDO: Wide Area Localization of Depicted Objects
$0.
$-43,785.
$-43,785.
Page 204 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Visualization Center Jacobs, Nathan 3048109272 ObjectVideo Incorporated WALDO: Wide Area Localization of Depicted Objects
$0.
$43,785.
$43,785.
Jacobs, Nathan 3048109272 ObjectVideo Incorporated WALDO: Wide Area Localization of Depicted Objects
$0.
$60,707.
$60,707.
Jacobs, Nathan 3048110464 ObjectVideo Incorporated WALDO: Wide Area Localization of Depicted Objects
$43,785.
$0.
$43,785.
$0. $-20,048. Seales, William B 3048108757 Army Space and Missile Defense Command Image-Net: Discriminatory Imaging and Network Advancement for Missles, Aviation, and Space
$-20,048.
$0. $7,775. $7,775. Yang, Ruigang 3048106612 National Science Foundation MRI: Development of Versatile Mobile Range Scanning System-Enabling Large-scale High-density 3D Data Acquisition for Cross-Disciplinary Research $566,303. $0. $566,303. Yang, Ruigang 3048109793 National Science Foundation SHB:Type 1(EXP): High Accuracy Motion Analysis using Commodity Depth Camera for Clinical Lower Extremity Assessment $800,000. $0. $800,000. Yang, Ruigang 3048109838 National Science Foundation NRI-Small: Virtualized Welding: A New Paradigm for Intelligent Welding Robots in Unstructured Environment Visualization Center Computer Science
Totals:
$2,222,068.
$579,651.
$2,801,719.
Goldsmith, Judith A 3048109729 National Science Foundation ICES: Small: Collaborative Research: Robust Preference Aggregation
$0.
$6,000.
$6,000.
Goldsmith, Judith A 3048109729 National Science Foundation ICES: Small: Collaborative Research: Robust Preference Aggregation
$0.
$5,000.
$5,000.
$72,328. Goldsmith, Judith A 3048109729 National Science Foundation ICES: Small: Collaborative Research: Robust Preference Aggregation
$0.
$72,328.
Griffioen, James N 3048105220 BBN Technologies Instrumentation Tools for a GENI Prototype
$0.
$20,840.
$20,840.
Griffioen, James N 3048105220 BBN Technologies Instrumentation Tools for a GENI Prototype
$0.
$102,531.
$102,531.
Page 205 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Computer Science Griffioen, James N 3048109563 Indiana University GEMINI: A GENI Measurement and Instrumentation Infrastructure
$0.
$110,224.
$110,224.
Griffioen, James N 3048109563 Indiana University GEMINI: A GENI Measurement and Instrumentation Infrastructure
$99,983.
$0.
$99,983.
$0. $6,900. $6,900. Hayes, Jane E 3048104958 National Science Foundation CPA-SEL-T:Collaborative Research:Traceability+:a Service Oriented Framework to Support Value-added software Traceability $0. $41,125. $41,125. Liu, Jinze 3048109435 University of North Carolina Unlocking transcript diversity via differential analyses of splice graphs $0. $-800,000. $-800,000. Yang, Ruigang 3048109788 National Science Foundation NRI-Small: Virtualized Welding: A New Paradigm for Intelligent Welding Robots in Unstructured Environment $800,000. $0. $800,000. Yang, Ruigang 3048109788 National Science Foundation NRI-Small: Virtualized Welding: A New Paradigm for Intelligent Welding Robots in Unstructured Environment Computer Science Kentucky Transportation Center
Totals:
$972,311.
$-507,380.
$464,931.
3048110012
$65,000.
$0.
$65,000.
Agent, Kenneth R 3048110013 KY Office of Highway Safety Attitudes &Awareness Survey PT-13-66
$20,000.
$0.
$20,000.
Agent, Kenneth R 3048110106 KY Office of Highway Safety Safety Seat Usage Survey OP-13-32
$80,450.
$0.
$80,450.
$5,000.
$0.
$5,000.
$0.
$-33,417.
$-33,417.
$3,506,700.
$0.
$3,506,700.
Agent, Kenneth R KY Office of Highway Safety Crash Analysis RS-13-01
Ashurst, Kean 3048109952 KY Transportation Cabinet KHIT 84 : Madison County I-75 & KY 627 Pipe Inspection Crabtree, Joseph D 3048106591 Department of Transportation FMCSA Wireless Roadside Inspection Testing and Evaluation Crabtree, Joseph D KY Transportation Cabinet SPR 2013 Prime KTC
Page 206 of 223
3048109385
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Kentucky Transportation Center $0. $1,189,160. Crabtree, Joseph D 3048109404 Marshall University Research Co Multimodal Transportation and Infrastructure Consortium: Innovations inmultimodal freight & passenger transportationsystems and infrastructure to foster sustained economic development $230,000. $0. Crabtree, Joseph D 3048109741
$1,189,160.
$230,000.
KY Transportation Cabinet SPR Part III - State Funded Research Development $29,962. Graves, Ronnie C 3048109997 Louisiana Department of Transportation and Developmen Synthesis of Research Results: Regional Implementation of Warm Mix Asphalt
$0.
$29,962.
$65,000.
$0.
$65,000.
Graves, Ronnie C 3048110116 KY Transportation Cabinet FRT 2013 Urgent Federal-Aid Research Tasks
$0.
$200,000.
$200,000.
Graves, Ronnie C 3048110117 KY Transportation Cabinet KHIT 2013, Urgent Kentucky Highway Investigative Tasks
$0.
$200,000.
$200,000.
Graves, Ronnie C 3048110567 KY Transportation Cabinet KHIT 83, Field Trials of Non-Nuclear Methods for Compaction
$70,000.
$0.
$70,000.
Green, Eric R KY Office of Highway Safety Crash Corridor Project TR-13-02
3048110011
$75,000.
$0.
$75,000.
Green, Eric R 3048110221 KY Office of Highway Safety Police Training Follow-up, 408 Grant
$40,000.
$0.
$40,000.
$31,185.
$31,185.
$239,171.
$0.
$239,171.
$153,720. Grossardt, Theodore H 3048110277 National Waterways Foundation National Waterways Foundation Inland Waterways Economic Impact Study
$0.
$153,720.
$11,000.
$0.
$11,000.
Graves, Ronnie C 3048110114 KY Transportation Cabinet FRT 197, Forensic Pavement Evaluation (LSIORB)
$0. Grossardt, Theodore H 3048104480 University of Tennessee Southeastern Transportation Center Transportation Systems Management Program Grossardt, Theodore H 3048109374 KY Transportation Cabinet PS 2: GIS Information Technoology Technical Assistance
Harik, Issam E 3048109697 KY Transportation Cabinet KHIT 72, Bridge Repair Using High Performance Materials
Page 207 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Kentucky Transportation Center $130,000. Harik, Issam E 3048109835 KY Transportation Cabinet KHIT 80, CFRP Application on KY 100 over CSX Railroad in Simpson County
$0.
$130,000.
Hartman, Donald G 3048105033 KY Transportation Cabinet Construction Co-op Tech Program - Federal Aid Research Task no. 171
$0.
$30,000.
$30,000.
Hartman, Donald G 3048110116 KY Transportation Cabinet FRT 2013 Urgent Federal-Aid Research Tasks
$0.
$50,000.
$50,000.
Hartman, Donald G 3048110116 KY Transportation Cabinet FRT 2013 Urgent Federal-Aid Research Tasks
$50,000.
$0.
$50,000.
Hartman, Donald G 3048110117 KY Transportation Cabinet KHIT 2013, Urgent Kentucky Highway Investigative Tasks
$0.
$50,000.
$50,000.
Hartman, Donald G 3048110117 KY Transportation Cabinet KHIT 2013, Urgent Kentucky Highway Investigative Tasks
$50,000.
$0.
$50,000.
$0.
$220,000.
$220,000.
Hopwood, Theodore 3048109309 KY Transportation Cabinet KHIT 77 Natcher Bridge Cable Inspection Phase I
$0. $21,700. $21,700. Hopwood, Theodore 3048109627 KY Transportation Cabinet Taping and Minute Preparation for Pre-Bid and Pre-Construction Meetings to Support Maintenance Painting Operations for FY 2004--Kentucky Highway Investigative Task No. 46 $22,450. $0. $22,450. Hopwood, Theodore 3048109908 KY Transportation Cabinet FRT 196, Remove and Evaluate a Weld Crack on U29' on the I-65 JFK Bridge over the Ohio River at Louisville Hopwood, Theodore 3048110480 KY Transportation Cabinet KHIT 77, Natcher Bridge Cable Inspection (1B) Horseman, Martha H 3048109303 KY Transportation Cabinet FHWA/LTAP Technology Transfer to Local Agencies
$663,000.
$0.
$663,000.
$0.
$70,000.
$70,000.
Horseman, Martha H KY Transportation Cabinet Safety Circuit Rider Program
3048110453
$354,000.
$0.
$354,000.
Horseman, Martha H KY Transportation Cabinet LTAP 2013, Technology Transfer
3048110487
$73,150.
$0.
$73,150.
Page 208 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Kentucky Transportation Center $0.
$16,500.
$16,500.
$750,000. Kissick, Jerry 3048110165 KY Transportation Cabinet RSF 35, Implementation of Three PRISM-Based Ramp Screening Systems
$0.
$750,000.
$360,000.
$0.
$360,000.
$0.
$600,000.
$600,000.
$0.
$67,648.
Hunsucker, David Q 3048108861 KY Transportation Cabinet Maintenance of Prism-Based Ramp Screening System
Kissick, Jerry 3048110488 KY Transportation Cabinet RSF 36, Implementation and Evaluation of a Virtual Weigh Station Kreis, Steven D 3048105522 National Institute for Hometown Security North American Transportation Security Center
$67,648. Kreis, Steven D 3048109695 KY Transportation Cabinet Planning Study 16: FHWA Form 536 Study, County Road and City Street Finance
$0. $375,000. $375,000. Pigman, Jerry G 3048107313 KY Transportation Cabinet Technical Support for Kentucky's Highway Safety Improvement Program, Research Study-Federal No. 30 $25,000. Pigman, Jerry G 3048109664 KY Transportation Cabinet Update of the Kentucky Strategic Highway Safety Plan, RQS12 1071
$0.
$25,000.
$65,000. Pigman, Jerry G 3048109983 KY Transportation Cabinet Planning Study 21, Update of Data and Forecasting Program for Estimating ESALs
$0.
$65,000.
$75,000.
$0.
$75,000.
$15,000. Souleyrette, Reginald Roy 3048110465 KY Transportation Cabinet Planning Study 23: KYTC Long Range Plan and Vision Support PL23
$0.
$15,000.
$25,574. Taylor, Timothy 3048109967 Texas A&M University Effective Project Scoping to Improve On#Time and On#Budget Delivery of Highway Projects
$0.
$25,574.
$65,000.
$65,000.
$-3,385.
$-3,385.
Souleyrette, Reginald Roy 3048110222 KY Office of Highway Safety Assessment Program for Kentucky Traffic Records, 408 Grant
Walton, Jennifer R 3048043200 KY Transportation Cabinet Support of Kentucky s PRISM and CVISN Programs, Research Study-Federal no. 20
$0.
$0. Walton, Jennifer R 3048108763 Battelle Memorial Inst FMCSA International Border Crossing E-Screening System for Trucks and Buses
Page 209 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Kentucky Transportation Center $0. Walton, Jennifer R 3048108763 Battelle Memorial Inst FMCSA International Border Crossing E-Screening System for Trucks and Buses
$-38,657.
$-38,657.
Walton, Jennifer R 3048109737 Marshall University Research Co West Virginia DMW Motor Carrier Services Consolidation Study
$0.
$742.
$742.
Walton, Jennifer R 3048109737 Marshall University Research Co West Virginia DMW Motor Carrier Services Consolidation Study
$84,945.
$0.
$84,945.
$101,194. Walton, Jennifer R 3048110264 KY Transportation Cabinet Automated Prism Screening System, Research Study-Federal No. 27
$0.
$101,194.
$3,043,828.
$10,546,792.
Kentucky Transportation Center Chemical and Materials Engin.
Totals:
$7,502,964.
$0. $80,000. $80,000. Balk, Thomas John 3048105263 National Science Foundation CAREER: Understanding Nanoscale Deformation by Characterizing the Mechanical Behavior of Nanoporus Noble Metals $50,904. $0. $50,904. Berron, Bradley 3048109974 American Chemical Society Gas-Phase UV Grafting on Surface-Initiated ROMP Coatings for Improved Stability $89,896. $0. Bhattacharyya, Dibakar 3048110525 Southern Company Services Incorporated Lower Energy Consumption Membranes for Power Plant Scrubber Water Treatment and Reuse
$89,896.
$57,572. $0. Cheng, Yang-Tse 3048110571 General Motors Research A combined experimental and modeling approach for the design of high current efficiency Si electrodes
$57,572.
$0. Grulke, Eric A 3048103802 Department of Energy DOE EPSCoR: Nanoscale Materials and Architecture for Energy Conversion
$640,000.
$640,000.
$49,894. Grulke, Eric A 3048109708 National Science Foundation EAGER: Low-level detection of complex nanomaterials in biological media
$0.
$49,894.
$8,636. Grulke, Eric A 3048110380 National Institute of Standards & Technology NIST Summer Undergraduate Research Fellowship Program for Benjamin Hackett
$0.
$8,636.
$280,499.
$280,499.
Hinds, Bruce J 3048057100 National Institute on Drug Abuse Gated Carbon Nanotube Membrane Transdermal Drug Delivery
Page 210 of 223
$0.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Chemical and Materials Engin. $0.
Hinds, Bruce J 3048109117 Defense Advanced Research Projects Agency Ordered Molecular Transporters
$202,250.
$202,250.
$14,994. $0. $14,994. Seay, Jeffrey 3048109730 Environmental Protection Agency Developing a Novel Low Cost Biodiesel and Biochar Processor for Rural Cameroon Using Locally Sourced Materials and Feedstocks $0. $90,526. $90,526. Zhai, Tongguang 3048109785 National Science Foundation Quantification of 3-D effects of microstructure on fatigue crack initiation and early growth in planar slip alloys $87,682. $0. $87,682. Zhai, Tongguang 3048109785 National Science Foundation Quantification of 3-D effects of microstructure on fatigue crack initiation and early growth in planar slip alloys $45,000.
$0.
$45,000.
$404,578.
$1,293,275.
$1,697,853.
$22,500.
$0.
$22,500.
$51,074. Davis, Douglas 3048110526 Metal Building Manufacturers Association Shear Buckling Strength of Unstiffened Prismatic I-Shaped Steel Members
$0.
$51,074.
$49,951. Fox, James F 3048109607 KY Science and Technology Co Inc KSEF RDE: DIN Waste Management Tool For Estimating Nitrogen Removal By Sediments
$0.
$49,951.
$0.
$300,000.
Zhai, Tongguang 3048110555 Alcoa Foundation Investigation of Fatigue Crack Bifurcation in AA7050 AL Alloys Chemical and Materials Engin. Civil Engineering
Totals:
Davis, Douglas 3048110067 Structural Engineers Incorporated Floor Vibration Evaluation of Checkerboard Floor Framing
Harik, Issam E 3048110554 KY Transportation Cabinet FRT 198, Load Rating of Bridge Size Culverts
$300,000.
$49,707. $0. $49,707. Kalinski, Michael 3048110327 Society of Exploration Geophysicists Foundation Shear Wave Velocity Measurement and Estimation of Seismic Site Response at Critical Sites in Port au Prince, Haiti $0. $5,106. $5,106. Souleyrette, Reginald Roy 3048108862 MRIGlobal U.S. Road Assessment Program Souleyrette, Reginald Roy MRIGlobal U.S. Road Assessment Program
Page 211 of 223
3048108862
$0.
$67,001.
$67,001.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Civil Engineering Souleyrette, Reginald Roy MRIGlobal U.S. Road Assessment Program
3048108862
$0.
$5,907.
$5,907.
Souleyrette, Reginald Roy University of Illinois NURail
3048109357
$0.
$145,611.
$145,611.
$62,300. $0. Souleyrette, Reginald Roy 3048109515 Federal Highway Administration Fellowship for Michael McHenry: Dwight David Eisenhower Transporation Fellowship Program
$62,300.
Taylor, Timothy 3048109100 National Academy of Sciences Forecasting Construction Staffing Requirements for Future Projects
$0.
$8,000.
$8,000.
Taylor, Timothy 3048109100 National Academy of Sciences Forecasting Construction Staffing Requirements for Future Projects
$0.
$8,000.
$8,000.
Taylor, Timothy 3048109100 National Academy of Sciences Forecasting Construction Staffing Requirements for Future Projects
$0.
$16,000.
$16,000.
$0.
$78,500.
$255,625.
$869,657.
$0. $134,680. Honaker, Rick 3048108622 Virginia Polytechnic Institute and State University Appalachian Research Initiative for Environmental Sciences: UK Mining Engineering Tasks
$134,680.
$78,500. Yost, Scott 3048110375 CH2MHill Inc Physical modeling study of the Southwestern pump station upgrade for Louisville MSD Civil Engineering Mining Engineering
Totals:
$614,032.
$0. Honaker, Rick 3048109382 Korea Institute of Geosciences and Mineral Resources Dry Cleaning of fine coal using a Fluidized bed shaking table: Dr. B.K. Parekh
$21,721.
$21,721.
Honaker, Rick 3048110377 Korea Institute of Geosciences and Mineral Resources Dry Coal Cleaning Using Optical Sorting and Triboelectric Separation
$0.
$22,344.
$22,344.
Honaker, Rick 3048110377 Korea Institute of Geosciences and Mineral Resources Dry Coal Cleaning Using Optical Sorting and Triboelectric Separation
$2.
$0.
$2.
Lusk, Braden Trex 3048109562 KY Energy and Environment Cabinet University of Kentucky Experimental Mine Feasibility Study
$350,000.
$0.
$350,000.
Lusk, Braden Trex 3048109769 Department of the Interior Blasting Effects on Coal Refuse Impoundment Structures
$200,000.
$0.
$200,000.
Page 212 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Mining Engineering $151,377. Lusk, Braden Trex 3048110008 Marshall Miller and Associates Inc Assessment of Technology for Non-destructive Testing of In situ Underground Mine Seals
$0.
$151,377.
$103,451. $0. Novak, Thomas 3048109789 Center for Disease Control and Prevention Underground Coalmine Communications and Tracking Systems Performance and Maintenance
$103,451.
$0. $246,033. $246,033. Perry, Kyle A. 3048108655 Center for Disease Control and Prevention Identification of Potential Roof Problems Using LED Lighting & Numerical Modeling of Highwall Stability Using FLAC $364,011. $0. $364,011. Perry, Kyle A. 3048110438 KY Energy and Environment Cabinet Modern Rock Dust Development and Evaluation $0. Tao, Dongping 3048108820 Florida Institute of Phosphate Research Innovative RTS Technology for Efficient Separation of Dolomite from Phosphate $40,000. Tao, Dongping 3048110353 Spectrum Magnetics LLC SBIR: Advanced Separation Technologies for Extraction of Rare Earth Elements (REE)
$10,000.
$10,000.
$0.
$40,000.
$0. $205,537. $205,537. Wala, Andrzej M 3048106118 Center for Disease Control and Prevention Advancing Critical Health & Safety Aspects of Mine Ventilation Through Technical Developmment and Training Mining Engineering Electrical and Computer Engineering
Totals:
$1,208,841.
$640,315.
$1,849,156.
Adams, Robert J 3048108474 Office of Naval Research Large Scale Topside Electromagnetic Modeling
$0.
$20,000.
$20,000.
Adams, Robert J 3048108474 Office of Naval Research Large Scale Topside Electromagnetic Modeling
$0.
$106,050.
$106,050.
Cramer, Aaron M 3048109208 Office of Naval Research NGIPS Early Design Space Assessment
$0.
$36,060.
$36,060.
Cramer, Aaron M 3048109208 Office of Naval Research NGIPS Early Design Space Assessment
$0.
$18,000.
$18,000.
Gedney, Stephen D Office of Naval Research Magneto-Stress Analysis
$0.
$126,967.
$126,967.
Page 213 of 223
3048108263
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Electrical and Computer Engineering Gedney, Stephen D Office of Naval Research Magneto-Stress Analysis
3048108263
$0.
$100,000.
$100,000.
Gedney, Stephen D ERC Inc DGFETD Enhancements
3048110131
$118,568.
$0.
$118,568.
Gedney, Stephen D Office of Naval Research Magstrom Enhancements
3048110149
$63,287.
$0.
$63,287.
Gedney, Stephen D 3048110298 Office of Naval Research Closed Loop Degaussing of Surface Vessels
$50,000.
$0.
$50,000.
$0. $5,233. $5,233. Holloway, Lawrence E 3048106079 Adaptive Intelligent Systems LLC SBIR Phase 2: A Modified GMAW System for Distortion Reduction and Travel Speed Increase through Separate Heat Input and Deposition Rate Control $0. $62,000. $62,000. Holloway, Lawrence E 3048108680 Department of Energy Kentucky Industrial Assessment Center (KIAC): Developing the Next Generation Energy Assessment Engineering Workforce $0. $34,000. $34,000. Holloway, Lawrence E 3048108680 Department of Energy Kentucky Industrial Assessment Center (KIAC): Developing the Next Generation Energy Assessment Engineering Workforce $0. $33,202. $33,202. Holloway, Lawrence E 3048108680 Department of Energy Kentucky Industrial Assessment Center (KIAC): Developing the Next Generation Energy Assessment Engineering Workforce $0. $60,000. $60,000. Holloway, Lawrence E 3048108680 Department of Energy Kentucky Industrial Assessment Center (KIAC): Developing the Next Generation Energy Assessment Engineering Workforce $0. $120,000. $120,000. Holloway, Lawrence E 3048108680 Department of Energy Kentucky Industrial Assessment Center (KIAC): Developing the Next Generation Energy Assessment Engineering Workforce $10,000. $0. $10,000. Holloway, Lawrence E 3048109910 KY Finance and Administration Cabinet Energy Education Displays for the State Capital Education Center Lau, Daniel L Mutoh America Incorporated Web Enabled Embedded RIP
Page 214 of 223
3048110518
$47,209.
$0.
$47,209.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Engineering Electrical and Computer Engineering $7,000.
$0.
$7,000.
Liao, Yuan 3048109624 Owensboro Municipal Utilities Advanced power system planning for utility systems: Final Report
$15,000.
$0.
$15,000.
Liao, Yuan 3048109817 LG&E and KU Services Company Advanced transmission system planning studies
$24,500.
$0.
$24,500.
Liao, Yuan 3048109623 Owensboro Municipal Utilities Advanced power system planning for utility systems: Training
$45,500. $0. Liao, Yuan 3048109818 LG&E and KU Services Company Power system model identification and verification, and development of tools for simulation model update
$45,500.
$100,000. Qiu, Meikang 3048109704 National Science Foundation EAGER: Towards Low-Power Low-Latency Heterogeneous Memory Access
$0.
$100,000.
$64,121. Singh, Vijay 3048109711 Minerva Systems and Technologies LLC Development of Bulk and Thin Film Magneto-Dielectric Materials for Antenna Applications
$0.
$64,121.
$0.
$-45,000.
$-45,000.
$3,000.
$0.
$3,000.
$0.
$49,284.
$597,469.
$676,512.
$1,273,981.
$0.
$50,000.
$50,000.
$0. $120,000. Jawahir, Ibrahim S 3048109473 General Electric Company Cryogenic Machining and Burnishing of Titanium Alloys for Improved Product Surface Integrity
$120,000.
$60,000. $0. Jawahir, Ibrahim S 3048109473 General Electric Company Cryogenic Machining and Burnishing of Titanium Alloys for Improved Product Surface Integrity
$60,000.
Walcott, Bruce L 3048109391 Lockheed Visualization for Training and Simulation in Night Environments Walcott, Bruce L 3048109814 KY Department of Education 2012 Student Technology Leadership Program (STLP) Showcase
$49,284. Young, John Calvin 3048109696 KY Science and Technology Co Inc KSEF RDE: Photoconductive Antennas for Terahertz Spectroscopy and Imaging Electrical and Computer Engineering Institute for Sustainable Manufacturing
Totals:
Badurdeen, F Fazleena 3048108241 General Electric Company Next Generation Event Loss Minimazation System
Institute for Sustainable Manufacturing
Page 215 of 223
Totals:
$60,000.
$170,000.
$230,000.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Engineering Mechanical Engineering $50,000. $0. Bailey, Sean C. 3048109509 KY Science and Technology Co Inc KSEF RDE: Multi-component nano-scale thermal anemometyr probe for turbulence measurement
$50,000.
$66,000. $0. $66,000. Bailey, Sean C. 3048109678 National Aeronautics and Space Administration Fellowship for Mark Miller: Experiments on the Combined Effects of Roughness and Momentum Injection on Turbulence over an Ablative Thermal Protection System $0. $40,000. $40,000. Martin, Alexandre 3048108427 CFD Research Co Pyrolysis gas modeling for ablation in hypersonic regime Parker, Johne M 3048110000 Lexmark International Inc RFID for Healthcare Solutions, Phase I
$0.
$15,000.
$15,000.
Parker, Johne M 3048110000 Lexmark International Inc RFID for Healthcare Solutions, Phase I
$5,000.
$0.
$5,000.
$0. Parker, Johne M 3048110326 Lexmark International Inc Lexmark UHF RFID Solution Optimization by Component Characterization
$12,500.
$12,500.
$12,500. Parker, Johne M 3048110326 Lexmark International Inc Lexmark UHF RFID Solution Optimization by Component Characterization
$0.
$12,500.
$49,999. Seigler, Thomas M. 3048109581 KY Science and Technology Co Inc KSEF RDE: A Dynamic Systems Approach to Understanding Human Learning
$0.
$49,999.
$183,401. Sekulic, Dusan P 3048109771 National Science Foundation Colaborative Research: Wetting of Liquid Metals on Rough Surfaces
$0.
$183,401.
$575,000.
$575,000.
$0. Smith, Suzanne W 3048107336 National Aeronautics and Space Administration National Space Grant College and Fellowship Program (Space Grant) 2010-2014 Smith, Suzanne W 3048107645 KY Council on Postsecondary Education EPSCoR: Match for NASA Kentucky Space Grant
$0.
$-75,000.
$-75,000.
Smith, Suzanne W 3048107645 KY Council on Postsecondary Education EPSCoR: Match for NASA Kentucky Space Grant
$0.
$75,000.
$75,000.
Smith, Suzanne W 3048107646 KY Council on Postsecondary Education EPSCoR: KY NASA Research Awards - CubeLab
$0.
$100,000.
$100,000.
Page 216 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 Adjustments to Existing Accounts
New Accounts
Total
Engineering Mechanical Engineering $100,000.
$100,000.
$125,000. Smith, Suzanne W 3048109993 National Aeronautics and Space Administration NASA Kentucky EPSCoR Research Infrastructure Development (RID) 2013-2015
$0.
$125,000.
$75,000. Smith, Suzanne W 3048110213 KY Council on Postsecondary Education State Match for NASA Kentucky EPSCoR Research Infrastructure Dev 2013-2015
$0.
$75,000.
$750,000. Smith, Suzanne W 3048110296 National Aeronautics and Space Administration NASA EPSCoR: A Paradigm-Shifting Therapy for Humans Exposed to Radiation
$0.
$750,000.
$100,000. Smith, Suzanne W 3048110401 KY Council on Postsecondary Education KY EPSCoR: A Paradigm-Shifting Therapy for Humans Exposed to Radiation
$0.
$100,000.
Smith, Suzanne W 3048108856 KY Council on Postsecondary Education EPSCoR: KY NASA Research Awards - Shape Memory
$0.
$450. $0. $450. Smith, Suzanne W 3048110584 Army Space and Missile Defense Command Image-Net: Discriminatory Imaging and Network Advancement for Missles, Aviation, and Space: Shipping Equipment Mechanical Engineering Totals: $1,417,350. $842,500. $2,259,850. IR4TD $0. $90,000. $90,000. Saito, Kozo 3048110017 US Department of Agriculture Fire Research and Collaboration $12,500.
$0.
$12,500.
$12,500. $15,723,342.
$90,000. $7,355,203.
$102,500. $23,078,545.
$18,000.
$0.
$18,000.
$18,000. $18,000.
$0. $0.
$18,000. $18,000.
$0. Barnes, Beth 3048105222 American International Health Alliance Partnering with ZAMCOM to train Zambian Journalists in coverage of HIV/AIDS.
$14,200.
$14,200.
Saito, Kozo US Department of Agriculture Fire Research and Collaboration IR4TD
3048110017
Totals: Engineering Totals:
Law Law Murphy, Daniel P Bureau of Prisons Legal Assistance to Inmates Law
3048110314
Totals: Law Totals:
Communication & Information School of Journalism
Page 217 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Communication & Information School of Journalism $20,000.
$0.
$20,000.
$20,000.
$14,200.
$34,200.
$11,371. Cohen, Elisia 3048110089 Washington University Communication-based Strategies to Eliminate Cancer Disparities-Ozioma
$0.
$11,371.
$0. Cohen, Elisia 3048110329 Merck and Company Inc Project INSPIRE: Improving Adolescent Vaccination in Appalachian Kentucky
$52,092.
$52,092.
$2. Cohen, Elisia 3048110329 Merck and Company Inc Project INSPIRE: Improving Adolescent Vaccination in Appalachian Kentucky
$0.
$2.
Cross, Alvin 3048110252 Foundation for a Healthy KY Limited Time Trial, Kentucky Newpapers' Health Story Count School of Journalism Communication
Totals:
$0. $184,233. $184,233. Cupp, Pamela 3048108636 Environmental Protection Agency Community Engagement and Case Analysis: Methods for Developing Post-Incident Risk Communication Guidelines for an Intentional Biological Environmental Contamination $0. $25,000. $25,000. Harrington, Nancy G 3048109341 National Cancer Institute Advancing Health Communication Research Through the KCHC-DCHC Conference Series $25,000. Sellnow, Timothy L 3048109988 University of Southern California Instructional Strategies for Tailoring Risk Communication Messaging
$0.
$25,000.
$147,162. $0. Sellnow, Timothy L 3048110025 University of Minnesota National Center for Food Protection and Defence Project: Advancing the Robust Cast Study II
$147,162.
$0.
$18,532.
$18,532.
$0. Wittenberg-Lyles, Elaine M 3048109752 University of Missouri The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
$1,485.
$1,485.
$30,000. Wittenberg-Lyles, Elaine M 3048109752 University of Missouri The ACTIVE Intervention to Improve Hospice Caregiver Pain Management
$0.
$30,000.
$281,342.
$494,877.
Wittenberg-Lyles, Elaine M 3048109275 University of Washington A Problem Based Intervention for Hospice Caregivers
Communication
Page 218 of 223
Totals:
$213,535.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Communication & Information School of Library & Information Science $64,271.
$0.
$64,271.
$64,271. $297,806.
$0. $295,542.
$64,271. $593,348.
$336,671.
$0.
$336,671.
$0.
$15,340.
$15,340.
$50,000.
$0.
$50,000.
$386,671. $386,671.
$15,340. $15,340.
$402,011. $402,011.
$0.
$369,563.
$369,563.
Cerel, Julie A 3048109644 KY Department for Behavioral Health, Developmental and Campus Suicide Prevention Coordinator
$24,000.
$0.
$24,000.
Godlaski, Theodore M 3048109834 Catholic Social Services of the Diocese of Scranton Services in Supportive Housing
$43,453.
$0.
$43,453.
Godlaski, Theodore M 3048109843 KY River Community Care Inc Recovery Oriented System of Care PARK2 Program
$59,982.
$0.
$59,982.
Godlaski, Theodore M 3048110250 KY River Community Care Inc Families in Safe Homes Network - Initiative (FISHN-I)
$75,000.
$0.
$75,000.
Hoffman, Doris Kay 3048110313 KY Administrative Office of the Courts VAWA Domestic Violence Evaluation
$50,000.
$0.
$50,000.
Rompf, Elizabeth L 3048109574 Eastern KY University Public Child Welfare Certification Program
$8,428.
$0.
$8,428.
Bishop, Bradley Wade 3048109632 Drexel University L21 - Programs to Builde Institutional Capacity School of Library & Information Science Totals: Communication & Information Totals: Design Design Luhan, Gregory A 3048110396 Southern Tier Housing Corporation Southern Tier Housing Corporation TVA Mitigation Project Speaks, Michael Angelo 3046816600 KY Transportation Cabinet Interns for Cultural Historic Assessment of Highway Projects Speaks, Michael Angelo American Architectural Foundation Mayor's Institute on City Design Design
3048109694
Totals: Design Totals:
Social Work Social Work Cerel, Julie A 3048108924 Denver Research Institute Suicide Bereavement in Military and their Families
Page 219 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Social Work Social Work Segress, Melissa Jh 3048109567 Eastern KY University Training Resource Center: Medically Fragile Program
$117,346.
$0.
$117,346.
Segress, Melissa Jh 3048109569 Eastern KY University Training Resource Center: Resource Parent Training Program
$219,124.
$0.
$219,124.
$339,598. Segress, Melissa Jh 3048109570 Eastern KY University Training Resource Center: Resource Parent Mentor Program/Retention
$0.
$339,598.
$38,207.
$0.
$38,207.
$371,830. Segress, Melissa Jh 3048109573 Eastern KY University Training Resource Center: Adoption Support for Kentucky Program
$0.
$371,830.
Segress, Melissa Jh 3048109572 Eastern KY University Training Resource Center: Evidence Based Child Welfare Network
$338,125. $0. $338,125. Segress, Melissa Jh 3048109747 Eastern KY University Child Welfare Trng Consortium/IV-E Administrative/Targeted Case Management: Office of Technology & Outcome Support $96,236. $0. $96,236. Segress, Melissa Jh 3048109885 KY Cabinet for Health and Family Services Citizen's Review Panel (ZFA1) $0. Sprang, Mary 3048109514 KY Cabinet for Health and Family Services FY13 & FY14 Center for Trauma & Children: Early Childhood Mental Health Program
$-661.
$-661.
$0. Sprang, Mary 3048109514 KY Cabinet for Health and Family Services FY13 & FY14 Center for Trauma & Children: Early Childhood Mental Health Program
$-5,245.
$-5,245.
$10,000. Sprang, Mary 3048109514 KY Cabinet for Health and Family Services FY13 & FY14 Center for Trauma & Children: Early Childhood Mental Health Program
$0.
$10,000.
Tindall, Michele Staton 3048109575 Chrysalis Inc Chrysalis House PPW-4 Evaluation
$0.
$100,000.
$100,000.
Tindall, Michele Staton 3048109575 Chrysalis Inc Chrysalis House PPW-4 Evaluation
$100,000.
$0.
$100,000.
$0.
$538,592.
$538,592.
Tindall, Michele Staton 3048109612 National Institute on Drug Abuse Brief Intervention for Drug-Using Rural Women at High-Risk for HIV/HCV
Page 220 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Social Work Social Work $524,714. Tindall, Michele Staton 3048109612 National Institute on Drug Abuse Brief Intervention for Drug-Using Rural Women at High-Risk for HIV/HCV
$0.
$524,714.
Tindall, Michele Staton 3048109940 Chrysalis Inc Chrysalis House Bureau of Justice Mentoring Project
$0.
$5,000.
$5,000.
Tindall, Michele Staton 3048109940 Chrysalis Inc Chrysalis House Bureau of Justice Mentoring Project
$5,000.
$0.
$5,000.
Tindall, Michele Staton 3048110172 KY Department of Corrections Women's Offender Reentry Evaluation
$80,000.
$0.
$80,000.
Weeks, Pamela L 3048109736 Eastern KY University Credit for Learning/IV-E Administrative Support
$384,390.
$0.
$384,390.
Totals:
$2,885,433.
$1,007,249.
$3,892,682.
Sprang, Mary 3048109520 KY Cabinet for Health and Family Services Comprehensive Assessment and Training Services: CATS
$0.
$-291,424.
$-291,424.
Sprang, Mary 3048109520 KY Cabinet for Health and Family Services Comprehensive Assessment and Training Services: CATS
$858,000.
$0.
$858,000.
Social Work Center on Trauma and Children (CTAC)
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048109565
$0.
$78.
$78.
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048109565
$0.
$-14,501.
$-14,501.
Sprang, Mary Eastern KY University CTAC - Adoption Support Program
3048109565
$40,500.
$0.
$40,500.
$0. $-40,744. $-40,744. Sprang, Mary 3048109779 Eastern KY University Title IV-E Training/IV-E Administrative/Basic Child Abuse & Neglect: Breaking the Cycle of Child Maltreatment and Neglect (cfda 93.658) $162,216. $0. $162,216. Sprang, Mary 3048109779 Eastern KY University Title IV-E Training/IV-E Administrative/Basic Child Abuse & Neglect: Breaking the Cycle of Child Maltreatment and Neglect (cfda 93.658)
Page 221 of 223
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Social Work Center on Trauma and Children (CTAC) Sprang, Mary 3048109923 Substance Abuse & Mental Health Services Administr Child and Adolescent Trauma Treatment andTraining Institute
$0.
$-232,849.
$-232,849.
Sprang, Mary 3048109923 Substance Abuse & Mental Health Services Administr Child and Adolescent Trauma Treatment andTraining Institute
$400,000.
$0.
$400,000.
$1,460,716. $4,346,149.
$-579,440. $427,809.
$881,276. $4,773,958.
$0. Jennings, Edward T 3048109709 KY Council on Developmental Disabilities Policy Analysis for the Commonwealth Council on Developmental Disabilities
$171,747.
$171,747.
$164,123. Jennings, Edward T 3048109709 KY Council on Developmental Disabilities Policy Analysis for the Commonwealth Council on Developmental Disabilities
$0.
$164,123.
Jennings, Edward T 3048109791 KY Department of Military Affairs Hazard Mitigation Grants Program Office 2013 - 2014
$0.
$25,000.
$25,000.
Jennings, Edward T 3048109791 KY Department of Military Affairs Hazard Mitigation Grants Program Office 2013 - 2014
$172,235.
$0.
$172,235.
$335,779. Jennings, Edward T 3048110260 KY Department of Military Affairs Hazard Mitigation Grants Program Office Pre-disaster 2013 - 2014
$0.
$335,779.
$28,793.
$0.
$28,793.
$700,930.
$196,747.
$897,677.
Blackwell, J L 3048109801 National Science Foundation National Science Foundation Graduate Research Fellowship Program
$0.
$189,000.
$189,000.
Blackwell, J L 3048109801 National Science Foundation National Science Foundation Graduate Research Fellowship Program
$0.
$9,000.
$9,000.
$105,000. Blackwell, J L 3048109801 National Science Foundation National Science Foundation Graduate Research Fellowship Program
$0.
$105,000.
$198,000. $394,747.
$303,000. $1,200,677.
Center on Trauma and Children (CTAC) Totals: Social Work Totals: Graduate School Martin School of Public Policy
Toma, E F 3048109470 KY Education Professional Standards Board Data and the P-20 Initiative Martin School of Public Policy Graduate School Dean
Graduate School Dean
Page 222 of 223
Totals:
Totals: Graduate School Totals:
$105,000. $805,930.
generated on 7/1/2013 15:07:29
Sponsored Project Awards Received Through UKRF Fiscal Year 2013 as of 6/30/2013 New Accounts
Adjustments to Existing Accounts
Total
Fine Arts Music Gooding, Lori 3048110202 American Association of Retired Persons mUsiKcare Music Art Museum College of Fine Arts
Totals:
Walsh-Piper, Kathleen A 3048109710 Institute of Museum and Library Services Art Museum Storage, Capacity and Conservation Improvements
$35,000.
$0.
$35,000.
$35,000.
$0.
$35,000.
$50,492.
$0.
$50,492.
$2,564. $0. $2,564. Walsh-Piper, Kathleen A 3048109950 Lexington Fayette Urban County Government gARTening: an After-School Program for StudentsEnrolled in the Extended School Program throughout Fayette County Art Museum College of Fine Arts Totals: $53,056. $0. $53,056. Fine Arts Totals: $0. $88,056. $88,056. VP Student Sucess Administration VP Student Sucess Administration Carvalho Chumney, Susan E German American Fulbright Discover USA
3048110504
Carvalho Chumney, Susan E 3048110506 Association of the Sponsors and Friends of the German A Discover USA VP Student Sucess Administration Totals: VP Student Sucess Administration Totals: University Totals:
Page 223 of 223
$51,000.
$0.
$51,000.
$12,750.
$0.
$12,750.
$63,750. $63,750. $176,935,309.
$0. $0. $88,998,111.
$63,750. $63,750. $265,933,420.
generated on 7/1/2013 15:07:29
